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Abstract  
 
Background: Coeliac disease is an autoimmune disease triggered by an 
inappropriate immune response to dietary gluten. This condition affects 
around 1% of the population and can lead to serious health complications, 
including nutrient deficiencies, infertility, osteoporosis and cancer. 
Symptoms, such as diarrhoea, pain, fatigue and bloating, can be debilitating. 
The only treatment is a life-long gluten-free diet. Up to 58% of adult 
patients have sub-optimal adherence to a gluten-free diet, yet the reasons for 
this are poorly understood. The aim of this study was to gain a better 
understanding of the factors affecting adherence to a gluten-free diet in adult 
coeliac patients. 
 
Methods: Concept mapping is a participatory mixed method that involves 
generation of ideas through brainstorming. Ideas are prioritised and grouped 
for similarity by participants, producing visual concept maps that represent 
participants’ perceptions about what affects adherence to a gluten-free diet.   
 
Results: Seventy-three participants were recruited (34 adult coeliac patients; 
21 adults who live with them (household members); and 18 healthcare 
professionals). Analysis revealed a concept map containing 13 thematic 
clusters: The high cost of gluten-free food was perceived to be the most 
important factor. Healthcare professionals perceived the availability of 
gluten-free sandwiches to be significantly less important than people with 
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coeliac disease and household members. Other factors included: knowledge 
and information about coeliac disease and the gluten-free diet; access to 
gluten-free food; motivation and support; and difficulties eating away from 
home. There was a high degree of consistency between the perceptions of 
the three stakeholder groups. 
 
Conclusions: This study identified a complex interplay of factors associated 
with adherence to a gluten-free diet and their relative importance. This study 
provides a better understanding of how to support adherence to a gluten free 
diet in adults with coeliac disease. This knowledge could be used to inform 
interventions to improve dietary adherence. 
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Chapter 1: Introduction and 
background 
 
1.1 Introduction 
 
Coeliac disease (CD) is a chronic disease characterised by an immune 
response to dietary gluten (Hall et al., 2013). The wide-range of symptoms, 
nutrient deficiencies and serious health conditions associated with CD can 
only be avoided if patients adhere to a strict, life-long gluten-free diet 
(GFD) (Silvester & Rashid, 2007; Jacobsson et al., 2012). A diet that is free 
of gluten (principally from wheat, rye and barley) is the only successful 
treatment for CD (Green & Cellier, 2007; Herman et al., 2012). Gluten is 
ubiquitous in the modern Western diet and following a strict GFD for life 
places a great demand on people’s capacity to adapt. Commonly consumed 
gluten-containing products, such as bread, pasta, pizza, cakes, beer and 
breakfast cereals should be avoided by people with CD.  
 
Effective management of CD can be difficult to achieve and following a 
GFD can affect individuals both personally and socially (Lerner, 2010). As 
many as 58% of patients do not adhere to treatment, however, the reasons 
for suboptimal adherence are not well understood (Hall et al., 2009).   
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The aim of this study was to gain a better understanding of the factors 
affecting adherence to a GFD in adults with CD. A further aim was to 
identify similarities and differences in the perceptions of three stakeholder 
groups (patients, people who live with them (household members) and 
healthcare professionals) in relation to adherence to a GFD. A better 
understanding of the factors affecting dietary adherence and the perceptions 
of different stakeholder groups could be helpful in the design of an 
intervention to improve adherence to a GFD in adults with CD. 
 
I begin this chapter with an introduction to CD, incorporating an overview 
of the history of our understanding of the condition and leading up to a 
modern definition. The prevalence, clinical features and symptoms of CD 
are explored along with the associated conditions that can develop when CD 
is not treated with a strict GFD. Contradictory evidence exists on the impact 
of CD and the GFD on patient quality of life (QoL) and I discuss some of 
the research in this area. Recent advances in diagnostic testing for CD are 
presented and I explore the search for alternative treatments for CD. The 
complex issue of adherence to a GFD is presented and I provide a definition 
of the term 'adherence' in relation to the GFD. I describe some of the 
psychological models of behaviour that are most relevant to adherence to 
treatment. In this chapter I review current healthcare and other sources of 
support available to adults with CD in the UK. I conclude this chapter with 
the aims and objectives for this piece of research along with an outline of 
the structure of this thesis. 
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1.2 Coeliac disease 
 
1.2.1 What is coeliac disease? 
 
CD is a life-long autoimmune disease characterised by an inappropriate 
immune response to dietary gluten, principally from wheat (gliadin), rye 
(horedin) and barley (secalin) (Zarkadas et al., 2006). The term 'coeliac 
disease' (also known as gluten-sensitive enteropathy and coeliac sprue) 
originates from the word koeliakos, meaning 'suffering in the bowels' 
(Cataldo & Montalto, 2007). This condition occurs in genetically 
predisposed individuals who carry the human lymphocyte antigen (HLA)-
DQ2 or –DQ8 (Trynka et al., 2010). Genetic studies have found the 
prevalence of CD for first-degree relatives to be around 10% (Berrill et al., 
2012). 
 
Erosion of the intestinal villi (villous atrophy (VA)) in response to dietary 
gluten leads to a reduced capacity to absorb most nutrients (Ciclitira et al., 
2005; Kaukinen et al., 2010). CD presents with a wide-range of symptoms 
and untreated patients are at a higher risk of developing a number of serious 
health complications, including malignant diseases (Green et al., 2003), 
infertility (Raymond et al., 2006) and osteoporosis (Garcia-Manzanares & 
Lucendo, 2011). Rubio-Tapia et al. (2009) report that mortality rates in CD 
are double that of the wider population. A strict GFD is the only effective 
treatment for CD (Lerner, 2010). Symptoms resolve when dietary intakes of 
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gluten are removed and a strict GFD leads to the normalisation of mortality 
rates (Leffler et al., 2008).  
 
1.2.2 The prevalence of coeliac disease 
 
The prevalence of CD has been underestimated in the past because many 
people with CD are asymptomatic or they experience mild symptoms which 
are not investigated (National Institute for Health and Care Excellence 
(NICE), 2009a). In the past, CD was believed to be mostly confined to 
Northern Europe and Australasia (Kang et al., 2013). Evidence from large 
CD screening studies shows a prevalence of between 1% and 3% in most 
parts of the world (World Gastroenterology Organisation, 2007). A 
systematic review in 2013 reported that CD is rare in sub-Saharan Africa 
and the Orient (Kang et al., 2013). Of the 266 studies included in the 
systematic review by Kang et al. (2013) only six biopsy-proven cases in 
ethnic Japanese and eighteen cases among ethnic Chinese were reported. In 
the UK, the prevalence of CD is estimated to be around 1% (Cataldo & 
Montalto, 2007; Rubio-Tapia et al., 2009; Aggarwal et al., 2012). Fifteen 
studies using serological tests on adult populations showed a prevalence of 
0.07% to 1.9% (National Institute for Health and Care Excellence (NICE), 
2009a). Three of the 15 studies were conducted in the UK and these showed 
a prevalence of 0.8 – 1.9%.  
 
The rates of CD diagnosis are increasing in many countries, including the 
UK (Green & Jabri 2003; Mustalhati et al. 2010; Violato et al. 2012). The 
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increase in diagnosis has been attributed to improvements in the accuracy of 
diagnostic testing and better awareness of the wide-ranging symptoms 
(Loftus & Murray, 2003). Despite the rise in diagnosis, CD remains 
undiagnosed or misdiagnosed in the majority of cases (Lohi et al., 2007; 
National Institute for Health and Care Excellence (NICE), 2009a). This may 
be due to the protean nature of CD symptoms and the fact that 
approximately 50% of people with CD are asymptomatic (Casellas et al., 
2006; Tursi et al., 2009). 
 
Some researchers argue that environmental factors have led to a true rise in 
CD, regardless of whether or not cases are diagnosed (Lohi et al., 2007; 
Ivarsson et al., 2013). Gluten is being used more commonly by food 
manufacturers as an ingredient where it didn’t used to be present (e.g. as a 
thickener and food coatings) (McCary, 2010; Zarkadas, 2006). It is possible 
that this increased exposure to gluten is linked with the increased prevalence 
of CD. Bardella et al. (2000) and Shale et al. (1982) found discordance for 
CD in monozygotic twins and this is suggestive of an environmental 
influence on the development of the disease as well as the genetic 
association. It has been suggested that the age of weaning a child onto 
gluten foods may influence the development of CD (Ivarsson et al., 2013; 
Guandalini, 2007). It is recommended that children should be weaned no 
sooner than three months and no later than seven months of age 
(Guandalini, 2007). The evidence on the environmental influences on the 
development of CD is limited and more research is needed. 
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CD was previously thought to have the highest prevalence in people of 
European origin (Devlin et al., 2004; Cataldo & Montalto, 2007), however, 
new evidence shows that CD is common across many ethnic groups (Barada 
et al., 2010; Araya et al., 2000; Cataldo & Montalto, 2007). Populations 
with high exposure to dietary gluten, such as the Italian population, tend to 
have a higher prevalence of CD (Volta et al., 2001). The highest prevalence 
of CD (5.6%) was identified in a North African tribal population who 
consume a wheat-based diet (Barada et al., 2010). Over-exposure to gluten 
could account for the high prevalence of CD identified in this tribe.  
 
Two studies that compared frozen serum samples taken several years ago 
with current samples reported that CD had increased (Rubio-Tapia et al., 
2009; Lohi et al., 2007). Rubio-Tapia et al. (2009) compared CD test results 
on 9,133 frozen serum samples collected from men in the US Air Force 
between 1948 and 1954 with current serological tests from 7,210 healthy 
young men and 5,558 older men. This study identified a 4 and 4.5-fold 
increase in the prevalence of CD. The difference could be explained by the 
fact that people with CD may have been less likely to join the Air Force due 
to poorer health. Lohi et al. (2007) compared the results of CD tests in a 
cohort of 8,000 adults taken between the years 1978 and 1980 with the test 
results for a sample of 8,028 adults taken between the years 2000 and 2001. 
After adjusting for age and sex, this study reported that CD prevalence had 
doubled over two decades. The evidence from these two studies suggests a 
true increase in the prevalence of CD, regardless of improvements in 
detection methods. 
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Richard Logan developed the concept of the 'coeliac disease iceberg' in 
1991 to highlight the fact that for every diagnosed case of CD, many cases 
remain undetected (World Gastroenterology Organisation, 2007; West et al., 
2007). Despite the recent increase in diagnosed cases, evidence suggests 
that 75-90% of the coeliac population remains undetected in Western 
countries and mass-screening has been advocated by some researchers 
(Kaukinen et al., 2010). Poor detection of CD may be due to misdiagnosis 
(CD symptoms are often indistinguishable from irritable bowel syndrome 
(IBS) symptoms) or because CD is often asymptomatic (Fasano & Catassi, 
2001). Although mass-screening could reduce or eliminate the 'clinical 
iceberg', it could result in reduced QoL as a result of the drastic changes 
patients are required to make following diagnosis (Collin, 2005; Paavola et 
al., 2012).  
 
CD can be diagnosed at any age after an infant has been weaned onto a 
gluten-inclusive diet (National Institute of Health and Care Excellence 
(NICE), 2009a). In the past, CD was most commonly diagnosed in 
childhood, however, the pattern of diagnosis has changed and the average 
age of diagnosis in the UK is currently between 40-60 years (Rashtak and 
Murray, 2009).  
 
More females than males are diagnosed with CD, however, Ageep (2012) 
tested 172 patients suspected to have CD and found that men and women 
were equally affected. One possible explanation is that women are more 
likely to visit their GP and CD is more likely to be detected during 
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pregnancy when immune function is altered and nutrient deficiencies may 
be identified (Gazzola, 2011). Conflicting evidence on the association 
between gender and adherence to a GFD exists and further research is 
needed (Hall et al., 2009). 
 
Regardless of whether environmental factors or improved diagnosis are 
responsible for the rising prevalence of CD, improving adherence to the 
GFD in this growing population is a significant challenge. A better 
understanding of the factors affecting adherence is needed. In the next 
section I report how our understanding of CD has developed over the years. 
 
1.2.3 The history of coeliac disease 
 
Because wheat, rye and barley have not always been present in the human 
diet, CD has not always been around. As agricultural settlements developed 
and crop cultivation spread across the world, dietary intolerance to gluten 
emerged (Gazzola, 2011). CD was unlikely to have been recognised as a 
new illness because the symptoms of diarrhoea, lethargy and nutrient 
deficiency would have been common at that time due to bacterial infections.  
 
Recognition of CD originates from around 50AD (Cataldo & Montalto, 
2007). However, it was not until the late nineteenth century when Samuel 
Gee recognised that patients could only be treated by diet (Richman, 2012). 
Paediatrician Sydney Haas claimed that all eight children in his study were 
cured on a banana diet, whereas, two additional children, who did not follow 
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the banana diet, died (van Berge-Henegouwen & Mulder, 1993). At the end 
of the second world war, the Dutch paediatrician, Willem-Karel Dicke 
observed that the health of children with CD improved when wheat and rye 
flour supplies were cut off by the Nazis and relapsed when the crops became 
available again (Van Berge-Henegouwen & Mulder, 1993; Gazzola, 2011). 
Dicke had suspected the role of wheat in CD and by the 1950s he identified 
the role of gluten as the causative antigen of CD (Gazzola, 2011). 
 
In 1954 the British physician, John Paulley, reported that the damage to the 
small intestinal mucosa found in CD is caused by dietary gluten (Gazzola, 
2011). Paulley also found that a GFD could restore the gut architecture and 
the inflammation of the intestinal lining in coeliac patients (Gazzola 2011). 
Intestinal biopsy was subsequently developed as a technique to identify CD 
and today this method of diagnosis is considered to be the 'gold standard' 
(Ludvigsson & Green, 2011). In the 1970s, the genetic underpinnings of CD 
were discovered and the discovery of tissue transglutaminase (tTG) was 
made in 1997 (Schuppan et al., 2005). This discovery led to the 
development of tTG blood tests for use in the diagnosis and monitoring of 
CD. Much of our knowledge about CD and the GFD is relatively new and 
there remain many unanswered questions (Hall et al., 2009; Leffler et al., 
2008). 
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1.2.4 Modern definition of coeliac disease 
 
The first consensus definition of CD in 1970 did not take account of the 
genetic or immunological aspects of CD. This reflects the lack of 
understanding about these factors at that time (Meeuwisse, 1970). The 1970 
consensus definition identified CD as:  
 
'a permanent condition of gluten intolerance with mucosal 
flattening that reversed on a gluten-free diet (GFD) and then 
relapsed on re-introduction of gluten'.   
                                             (Meeuwisse, 1970) 
 
Until recently, there has been a lack of consensus on a revised definition of 
CD. In 2011, a multidisciplinary task force consisting of 16 physicians from 
seven countries redefined CD following a search of the literature for terms 
relating to CD (Ludvigsson et al., 2013). Our previous understanding of CD 
as a gastrointestinal disorder which mainly affects children has progressed 
to the modern definition of CD (known as the 'Oslo definitions'), which is: 
 
'a chronic small intestinal immune-mediated enteropathy 
precipitated by exposure to dietary gluten in genetically 
predisposed individuals'. 
      (Ludvigsson et al., 2013) 
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It has been argued that this definition is not very lucid (Marsh, 2013) and 
the terminology used may not be easily understood by the lay person. 
However, it does clear up some confusion around the terminology used to 
describe gluten-related disorders.  
 
In developing their definition of CD, Ludvigsson et al. (2013) identified a 
number of terms used to describe the spectrum of disorders related to the 
ingestion of gluten and they developed a set of definitions. Table 1.1 lists 
the definitions for terms that are relevant to this study. The umbrella term 
'gluten sensitivity' includes the terms listed in Table 1.1 as well as 'gluten 
intolerance', which is a response to gluten without significant immune 
reaction and with a negative blood test for CD. Refractory CD is a rare type 
of CD occurring in approximately 5% of patients and presents with 
persistent malabsorptive symptoms and VA, despite strict adherence to a 
GFD for 12 months or longer (Rubio-Tapia & Murray, 2010; Ludvigsson et 
al., 2013). This thesis addresses the types of CD listed in Table 1.1 with the 
exception of latent, potential and subclinical CD, which would not fit the 
criteria for a CD diagnosis. Refractory CD cannot be treated with a GFD 
and, therefore, is not relevant to this study. Dermatitis herpetiformis (DH) is 
a skin condition that is related to CD and is also treated with a GFD. I chose 
not to include DH in this study because the factors affecting adherence to a 
GFD in DH may differ to those in CD. 
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Table 1.1 - Definition of terminology for disorders relating to gluten 
ingestion 
 
Name of disorder Definition 
Asymptomatic coeliac 
disease
1 
No symptoms are exhibited. Patients with asymptomatic coeliac 
disease are usually detected through screening. 
Atypical coeliac 
disease
2
 
Historically, this term has been used to describe patients who do 
not experience weight-loss but they do exhibit one or more of 
the following symptoms: gastrointestinal symptoms; extra 
intestinal manifestations; neurological problems; reproductive 
problems; oral/cutaneous disease; and skeletal disorders.  
Classical coeliac disease Presenting with signs and symptoms of malabsorption, which 
includes diarrhoea, steatorrhoea (fatty stools), weight-loss or 
growth failure. 
Latent coeliac disease
3
 Positive serological test for coeliac disease but absence of 
villous atrophy. 
Non-classical coeliac 
disease 
Presenting without signs of malabsorption.  
Overt coeliac disease
4 
See symptomatic coeliac disease. 
Potential coeliac 
disease
3 
People with normal intestinal mucosa but with positive serology 
(see also latent coeliac disease). 
Silent coeliac disease
1 
See asymptomatic coeliac disease. 
Subclinical coeliac 
disease  
Below the threshold of clinical detection and symptoms are not 
sufficient to trigger coeliac disease testing in normal practice. 
Symptomatic coeliac 
disease
4 
Clinically evident symptoms (gastrointestinal or extra intestinal) 
that can be attributed to gluten intake. 
Typical coeliac disease
2
 Presenting with signs or symptoms of malabsorption (e.g. 
diarrhoea or malnutrition).  
Notes: 
1. Ludvigsson et al. (2013) discourage the use of the term 'silent coeliac disease' and 
suggest the term 'asymptomatic' should be used instead. 
2. Ludvigsson et al. (2013) discourage the use of the terms 'atypical coeliac disease' and 
'typical coeliac disease' as these terms do not reflect the modern understanding of 
coeliac disease as a condition that presents with a wide spectrum of symptoms. 
3. Ludvigsson et al.(2013) discourage the use of the term 'latent coeliac disease' as it is 
often used interchangeably with the term 'potential coeliac disease' and causes 
confusion. 
4. Ludvigsson et al. (2013) discourage the use of the term 'overt coeliac disease' and 
suggest the term 'symptomatic coeliac disease' should be used instead. 
 
 
1.2.5 Clinical features and symptoms 
 
Patients with CD vary in the type and severity of symptoms experienced. 
Until the late 1970's CD was perceived to be a disease affecting the 
gastrointestinal system (Lohi et al., 2007). CD is no longer seen as just an 
intestinal disease and it is now recognised as a systemic disease that affects 
the entire body, has impact on a patient’s social life and can cause 
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psychological issues (Leffler et al., 2003; Fera et al., 2003; Ukkola et al., 
2012). Evidence from several countries, including the UK, shows that as 
many as 50% of newly diagnosed coeliac patients present without 
symptoms (Fasano & Catassi, 2001). Symptoms of CD can be broken down 
into gastrointestinal and extra intestinal symptoms (Lohi et al., 2007): 
 
Gastrointestinal symptoms 
In CD, lymphocytes detect and respond to gluten in the diet and this 
inflammatory response causes damage to the small intestinal mucosa, 
resulting in VA. VA leads to nutrient malabsorption which causes weight-
loss and nutrient-deficiency in coeliac patients. The classically recognised 
gastrointestinal symptoms of CD include diarrhoea, abdominal distension, 
steatorrhoea and abdominal pain (National Institute for Health and Care 
Excellence (NICE) 2009b; Ludvigsson et al., 2013; Nachman et al., 2009). 
A validated gastrointestinal symptom rating scale (GSRS) has been used to 
assess gastrointestinal symptoms in CD (Ilus et al., 2012; Roos et al.,  
2009). The GSRS is a questionnaire divided into five categories: diarrhoea, 
indigestion syndrome, constipation, abdominal pain and gastro-oesophageal 
reflux (Ilus et al., 2012). Casellas et al. (2006) and Tursi et al. (2009) found 
as few as 55% and 45% of patients present with classical CD symptoms 
respectively and, therefore, the GSRS is no use in monitoring symptoms in 
around half of all patients. 
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Extra intestinal manifestations 
Signs and symptoms of CD that occur outside the intestinal system include: 
fatigue; neurological conditions (including depression); reproductive 
diseases; oral problems; and skeletal problems (Ludvigsson, et al., 2013). 
Untreated coeliac patients are at an increased risk of developing serious 
complications, including malignancies, other autoimmune conditions (e.g. 
insulin-dependent diabetes), iron-deficiency anaemia (IDA) and 
osteoporosis (Brousse & Meijer, 2005; Colleran et al., 2009; Freeman, 
2012). CD is associated with significant morbidity and a doubling of 
mortality rates compared to the wider population (Rubio-Tapia et al., 2009). 
This increase in mortality is mainly due to a heightened risk of lymphomas 
(Brousse & Meijer, 2005; Silano et al., 2008). Five conditions that are 
commonly associated with CD are presented in more detail below. 
 
 Iron deficiency anaemia (IDA)  
The most common condition associated with CD, which is found in 
two-thirds of all adult CD patients, is IDA (Griffiths, 2008). The 
main symptom of IDA is fatigue, which is seen in approximately 
82% of CD patients (García-Manzanares & Lucendo, 2011). VA in 
CD leads to the malabsorption of nutrients, such as iron and the 
British Society of Gastroenterology (BSG) (2009) recommend that 
patients who have IDA should be screened for CD. IDA leads to 
lethargy and patients with CD should be advised to eat a GFD 
containing high-iron foods (World Gastroenterology Organisation, 
2007). 
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 Reduced Bone Mineral Density and Osteoporosis  
As many as 40% of patients with CD have calcium and vitamin D 
malabsorption, resulting in diminished bone density or osteoporosis 
(Leeds et al., 2008). People with undiagnosed or untreated CD are 
likely to experience calcium and vitamin D malabsorption and low 
bone mineral density (BMD) is common in patients diagnosed with 
CD over the age of 40 (Griffiths, 2008). A study by Casella et al. 
(2012) reported a prevalence of osteoporosis of 67% in male and 
70% in female patients with CD aged >65 years compared to 14% 
for male and 9% for female patients with CD aged 18-64 years. 
Studies have shown that adherence to a GFD reverses calcium 
malabsorption and leads to a rapid increase in BMD (Bai et al., 
1997; Larussa, 2012). 
 
 Malignancy  
Malignancies that occur at a higher prevalence in people with CD 
include intestinal lymphoma, adenocarcinoma of the small intestine, 
the pharynx and the oesophagus (Catassi et al., 2005). The risk of 
malignancy in unmanaged CD is thought to be two-fold that of the 
wider population; for small intestinal lymphoma the risk may be as 
high as 50-fold (Leeds et al., 2008). Holmes et al. (1989) found that 
the risk of malignancy was similar to the wider population after five 
years on a GFD, whereas the risk was elevated in patients who did 
not adhere to the GFD. 
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 Reproductive problems - Women with CD are prone to reproductive 
problems. A study involving 11,000 women with CD of fertile age 
(15-45 years) reported that fertility was lower in this cohort for the 
two years prior to diagnosis compared to an age-matched control 
group (Zugna et al., 2010). Women with CD are likely to have a 
reduced period of fertility due to late menarche and earlier 
menopause (Zugna et al., 2010). Children born to women with CD 
have an increased risk of being born prematurely and of having a 
low birth weight (Martinelli et al., 2000). Following diagnosis and 
the uptake of a GFD, fertility in women with CD has been found to 
return to levels equal to that of the wider population (Sher & 
Mayberry, 1996). 
 
 Psychological conditions - Coeliac disease is associated with an 
increase in the incidence of psychological symptoms (Addolorato et 
al., 2004; Sainsbury et al., 2013a; Addolorato et al., 2008), including 
depression (Arigo et al., 2012; Ciacci, 1998; Siniscalchi et al., 
2005), anxiety (Addolorato et al., 2004; Fera et al., 2003) and eating 
disorders (Leffler et al., 2007a).  
 
1.2.6 Quality of life and coeliac disease 
 
Lee et al. (2012) acknowledge that eating encompasses more than just 
meeting the physiological need for nutrients. The act of eating is interwoven 
into the fabric of our lives and culture, as well as our social and emotional 
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needs. Several studies have reported a reduced quality of life (QoL) in 
people with CD (Barratt et al., 2011; Lee & Newman, 2003; Hauser et al., 
2006; Fera et al., 2003).  
Over the past 20 years there has been an increased focus on the development 
of instruments to measure health-related QoL in patients with digestive 
conditions (Yacavone, 2001). The Coeliac Disease Questionnaire (CDQ) is 
reported to be a reliable and valid tool for measuring health-related quality 
of life (HRQoL) in adult CD (Hauser et al., 2007). The CDQ contains four 
subscales: gastrointestinal symptoms; emotional well-being; social 
restrictions; and disease-related worries.  
 
Females commonly report a lower QoL compared to males with CD 
(Jacobsson et al., 2012). Feelings of deprivation in relation to following a 
GFD and a higher desire to control the preparation of food are reported 
more by females than males (Hallert et al., 2003). Having an intense focus 
on the avoidance of gluten can help in avoiding CD symptoms, but it may 
take the enjoyment out of eating. This focus on food may give rise to 
psychological issues, including eating disorders, as well as reducing QoL 
(Arigo et al., 2012; Leffler, 2007b).  
 
1.2.7 Diagnosing coeliac disease 
 
In the past, CD was most commonly diagnosed in childhood, however, the 
pattern of diagnosis has changed and the average age of diagnosis in the UK 
is now over 40 years (Ciclitira et al., 2010). Patients have expressed 
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dissatisfaction with the length of time taken by General Practitioners (GPs) 
to diagnose CD (British Society of Gastroenterology 2009). Delayed 
diagnosis could be due to the variability of symptoms as well as the 
common perception that CD is not a common disease. The National Institute 
for Health and Care Excellence (NICE) (2009) recommend that patients 
should be tested for CD if they show the following symptoms: 
 
 chronic or intermittent diarrhoea 
 failure to thrive or faltering growth (in children) 
 persistent or unexplained gastrointestinal symptoms including 
nausea and vomiting 
 prolonged fatigue ('tired all the time') 
 recurrent abdominal pain, cramping or distension 
 sudden or unexpected weight loss 
 unexplained iron-deficiency anaemia, or other unspecified anaemia 
 
In the UK, a patient suspected of having CD will be offered a serological 
test. No single test can diagnose or exclude CD, however, CD blood tests 
have become more reliable in recent years. The most highly sensitive and 
specific blood tests for CD are the IgA anti-tissue transglutaminase (tTG) 
antibody and the immunoglobulin A (IgA) endomysial antibody (EMA) 
indirect immunofluorescence assays (Ciclitira et al., 2010). Both tests 
provide sensitivities of around 95% and specificity of 100% (Hourigan 
2006).  
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If the result of the serological test is positive, the patient will be offered an 
intestinal biopsy to confirm the diagnosis. The diagnostic hallmark of CD is 
VA in the small intestine (Lee & Green, 2005), which is confirmed by 
intestinal biopsy. Intestinal biopsy is considered to be the gold standard in 
diagnosing CD (Leeds et al. 2008), however, problems can occur if the 
sample is not taken from the correct location or if insufficient sample is 
taken.  
 
In order to assure correct diagnosis, patients need to be eating a gluten-
containing diet at the time of diagnosis. If a person with CD is following a 
strict GFD when they are tested, they are likely to have no antibodies and 
the intestine may have healed. This would result in a false-negative result 
(McCary, 2010). People with severe symptoms in response to gluten may be 
reluctant to go back on a GFD to get a medical diagnosis. The advantage of 
receiving an accurate diagnosis in the UK is that patients will be offered 
healthcare advice and gluten-free food (GFF) on prescription. Much of this 
advice, however, is freely available from coeliac support groups and other 
sources. 
 
Only around 10% of people affected with CD receive an accurate diagnosis 
and this has led to the argument in favour of mass screening for CD (Collin, 
2005; Hershcovici et al., 2010). Undiagnosed CD is a concern because of 
the symptoms and associated conditions, such as osteoporosis, infertility and 
malignancy. However, the risk of serious health sequelae from CD are 
relatively low and the health economic argument for the value of mass 
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screening is dubious. If mass screening for CD was introduced in the UK, 
the cost to the NHS may be substantial. Not only would the NHS need to 
pay for the cost of the test, but money would also need to be found to 
provide a higher number of patients with prescribed GFF and appropriate 
healthcare. However, the costs and negative consequences associated with 
CD-related illness may be reduced through mass screening, provided that 
patients adhere to the GFD. 
 
1.2.8 Treating coeliac disease 
 
In the past, it has been incorrectly suggested that CD is a curable condition 
(Hopman et al., 2008). CD is now recognised as a life-long condition that 
needs to be treated with a permanent gluten-free diet. Since gluten was 
identified as the causative antigen in CD in the 1950s, a gluten-free diet has 
been the only accepted treatment (Rubio-Tapia et al., 2010). The clinical 
end points that justify the efficacy of a GFD as a treatment for CD are the 
elimination of symptoms and the correction (or prevention) of nutrient 
deficiencies. A reduction in the long-term complications of CD is also a 
justification for this treatment. 
 
With advances in our understanding of the molecular basis of CD, research 
into alternative treatments has been carried out in recent years. This work 
has been driven by the fact that the GFD is difficult to adhere to and many 
patients feel dissatisfied with having to stick to such a restrictive diet (Aziz 
et al., 2011; Bakshi et al., 2012). Investigations into novel treatments for 
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CD have included genetic modification of grains, alterations to gut 
permeability and vaccinations (Bakshi et al., 2012). To date, no successful 
alternative to the GFD has been established and the GFD is likely to remain 
the only accepted treatment for CD for the foreseeable future (Bakshi et al., 
2012). As no alternative treatment is currently available, it is important that 
patients are supported to adhere to a GFD. 
 
1.3 The gluten-free diet 
 
1.3.1  The role of gluten in food production 
 
Gluten is an alcohol-soluble protein found in wheat, rye and barley (Fasano 
& Catassi, 2001). The elastic and cohesive quality of gluten binds 
ingredients together and provides structure to baked goods. For example,  
gluten forms a three-dimensional mesh-like structure that traps bubbles of 
carbon dioxide, helping bread to rise (Shewry et al., 2002). 
 
Baking without gluten is challenging and the main problems are achieving a 
good flavour, structure and texture  (Moore et al., 2006).   GF dough is 
much less cohesive and more like a batter, which makes it difficult to handle 
compared to wheat dough (Houben et al., 2012). GF baking involves the 
replacement of gluten-inclusive flours with GF flours, such as rice flour and 
corn flour, which differ in flavour and appearance to gluten-inclusive flours 
(Gambus et al. 2009).The end product of GF baking is very different in taste 
and texture to gluten-inclusive baked products.  The GF versions tend to be 
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more crumbly, giving a dry feeling in the mouth and a less satisfying taste 
(Houben et al., 2012; Gambus et al., 2009). In addition to having poorer 
sensory qualities, GF baked goods tend to have a shorter shelf-life due to the 
quick drying effect of the crumb and a more rapid staling time (Gambus et 
al., 2009).  
 
GF biscuits are less difficult to produce than GF bread and cakes because 
the high sugar and fat content helps with achieving the desired crispy 
texture (Marti & Pagani, 2013). Producing good quality GF pasta that is 
firm and strong enough to withstand the cooking process is challenging 
(Marti & Pagani, 2013). GF pasta is often produced using either rice flour or 
corn flour and the sensory characteristics of GF pasta are generally 
perceived to be poorer than gluten-inclusive pasta (Marti & Pagani, 2013). 
 
People who follow a GFD often report dissatisfaction with the sensory 
characteristics of GFF compared similar gluten-inclusive products (Diaz-
Amigo & Popping, 2012). Araujo and Araujo (2011) found that only 34% of 
participants with CD were very satisfied with the texture of GFF. A study 
by Sverker et al. (2005) reported that tasty and varied GFF was not easy to 
find and that following a GFD was monotonous. Studies by Biagi et al. 
(2004), Lee et al. (2012) and Hopman et al. (2008) reported participants’ 
perceptions of GFF as ‘unpleasant’, ‘tasteless’ and ‘unpalatable’. 
 
With the aim of improving the quality of GF products, bakers have 
introduced natural, synthetic and biotechnological ingredients which behave 
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in a similar way to gluten (Houben et al., 2012). Hydrocolloids, such as 
xanthan gum and guar gum are often used in place of gluten to improve the 
viscosity, crumb structure and to slow down the staling process (Huttner & 
Arendt, 2010). Another method of improving the sensory qualities of GFF 
was the introduction of Codex wheat starch in GFF production (Coeliac UK, 
2014a). Starches are derived from cereal grains and they enhance the taste 
and texture of food. Codex wheat starch is a specially processed wheat 
starch that has been washed to reduce the gluten content in accordance with 
Codex standards (Coeliac UK, 2014a). Despite these efforts to improve the 
sensory characteristics of GFF, there are still no GF crusty French loaves, 
filo or puff pastry of comparable quality to those containing gluten (Houben 
et al., 2012).  
 
1.3.2 What is a gluten-free diet? 
 
A GFD is a diet that is free from wheat, rye and barley and their derivatives 
(Raymond et al., 2006). The GFD usually consists of both naturally GF 
products (e.g. fruit and vegetables, meat and dairy products) and GF 
substitutes (e.g. GF bread, biscuits and pasta). The term ‘gluten-free’ 
implies no gluten is present, however, this is not necessarily the case 
(Thompson, 2001). It has been argued that an absolute GFD is unrealistic 
and that occasional ingestion of gluten may not cause significant risk to 
many people with CD. Most CD patients can tolerate small amounts of 
gluten, but the amount of gluten tolerated, without experiencing any 
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deleterious effects, varies between individuals  (Bold & Rostami, 2011; 
Kaukinen et al., 1999).  
 
Products that are labelled as ‘gluten-free’ are allowed to contain up to 
20ppm of gluten (Food Standards Agency, 2012). Codex wheat starch, 
which is processed to contain less than 20ppm of gluten, is often used as an 
ingredient in the production of GFF (Coeliac UK, 2014a). Products 
containing <20ppm gluten are considered to be safe for people with CD and 
most people with CD can tolerate these products. However,  some patients 
require a naturally gluten-free diet in order to remain symptom free (Collin 
et al., 2004; Biagi et al., 2009). People with CD may also choose to 
consume products that are labelled as ‘low in gluten’. In the UK, these 
products are allowed to contain up to 200ppm of gluten and are considered 
to be safe for most people with CD (Food Standards Agency, 2012). 
 
Gluten-containing crops are widely consumed in the West and adapting to a 
GFD can involve drastic changes to normal dietary habits (Zarkadas, 2006). 
Patients are required to follow a strict life-long diet that is free from many 
of the foods they may have enjoyed before diagnosis. For the rest of their 
lives they cannot eat most of the food available on restaurant menus, they 
cannot order an ordinary pizza, they can never taste a warm crusty French 
baguette, or enjoy an ordinary glass of beer in the pub with friends, or a 
slice of birthday cake at a birthday party. Coeliac patients often complain 
that the quality of GF substitute foods are not equal to that of their gluten-
containing counterparts (Leffler et al., 2008). 
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1.3.3 Oats and the gluten-free diet 
 
The safe inclusion of oats in a GFD has been contested over the years. Oats 
contain a type of gluten, known as avenins, which was previously believed 
to be harmful to people with CD (Diaz-Amigo & Popping, 2012). In recent 
years, studies have found that pure, uncontaminated oats can be safely 
consumed by people with CD. The evidence regarding the safe inclusion of 
oats in a GFD was synthesised in a systematic review by Haboubi et al. in 
2012. It is now widely accepted that pure, uncontaminated oats are not 
harmful to coeliac patients. However, oats are often milled in the same 
factory as wheat, rye or barley and it is common for cross-contamination to 
occur. Therefore, patients with CD are advised only to consume oats that are 
labelled as 'Gluten-free.' Some people with CD have other dietary 
sensitivities which could include avenins and these patients should be 
advised to avoid oats. 
 
1.3.4 The cost of gluten-free products 
 
GFF is a niche market and GF products tend to be expensive (Mendoza 
2005; Singh & Whelan, 2011). When comparing the cost of a basket of GF 
products with a similar basket of gluten-inclusive products in the USA, Lee 
et al. (2007) found that every GF product was more expensive than its 
gluten-inclusive counterpart. GF bread and pasta were found to be around 
twice the price of similar gluten-containing products. Similar findings have 
been made in studies in the UK where all categories of GF products were 
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found to be more expensive than equivalent gluten-containing products 
(Coeliac UK, 2009; Singh and Whelan, 2011). To bring down the cost of a 
GFD in line with that of a gluten-inclusive diet, GFF is available on 
prescription for people with a confirmed CD diagnosis in the UK.  
 
1.3.5 The availability of gluten-free products 
 
Zarkadas et al. (2006) reported that 83% of CD patients had difficulties with 
finding GFF in shops. However, this study was conducted in Canada where 
GFF availability may differ to that in the UK. Heller (2009) argues that GFF 
has become more widely available in the UK for three main reasons: 1. CD 
diagnosis has increased; 2. The food industry is responding to a niche 
market; 3. Advances in modern technology. A recent increase in anxiety 
over gluten-consumption in people who do not have CD has also driven the 
demand for GFF (Anderson 2008). This has led to an increase in the size of 
the market and enhanced the availability of GFF.  
 
GF products are now widely available for purchase on the internet, although 
they are often expensive. Coeliac UK's Food and Drink Directory (Coeliac 
UK, 2013a) lists over 11,000 manufactured GF products which are available 
to buy in the UK. However the availability of GFF in specific contexts e.g. 
when travelling and eating away from home can be problematic for people 
with CD (Cureton, 2006). The availability of GFF on prescription in the UK 
enhances access for those with a diagnosis of CD (Coeliac UK, 2013b). 
There has been some debate over the recent cut-backs in the variety and 
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quantity of GFF available on prescription, and the cost of these foods to the 
NHS (Coeliac UK, 2013b).  
 
1.3.6 'Hidden' gluten and gluten contamination  
 
Avoiding gluten is a major challenge for people with CD. If gluten is 
consumed, either accidentally or intentionally, it can cause severe 
symptoms. Gluten is often present in many products where it may not be 
expected, such as soups, sauces, ice cream, cornflakes, chocolate bars, 
medicines and lip balm (McCabe et al., 2012). This is sometimes referred to 
as 'hidden gluten'. Gluten is a very useful and cheap product to use in food 
production and wheat flour is often used as a thickener or coating in many 
products that would otherwise be free from gluten (McCary, 2010; 
Zarkadas, 2006). People with CD need to be careful to avoid such products 
by carefully reading food labels (McCabe et al., 2012). 
 
GFF can become contaminated with gluten if prepared in the same 
environment as gluten-containing foods. This may occur when eating out or 
during food preparation at home (Schuppan et al., 2005). Occasionally, 
products that are labelled as GF are recalled by the manufacturer because 
they are found to have been contaminated with gluten (Food Standards 
Agency, 2013). Even patients who have the best of intentions to stick to a 
GFD only need to have out of date information, or miss a gluten containing 
ingredient on manufactured foods, or eat out and have their GFF fried in oil 
that had previously been used to fry gluten-containing foods, in order for 
49 
 
them to accidentally consume gluten (Biagi et al., 2009; McCabe et al., 
2012; Schuppan et al., 2005). Hence it is recommended that gluten 
contamination should be the first thing to be addressed when a patient does 
not respond to a GFD (Dewar et al., 2012). 
 
1.3.7 Gluten-free food labelling 
 
Most regulations of GFF labelling are based on the Codex Alimentarius 
Standard 118-1979 which are recommendations, rather than regulative 
(Diaz-Amigo & Popping, 2012). New GFF labelling legislation that was 
introduced in January 2012 has reduced the permitted amount of gluten 
present in foods labelled as ‘gluten-free’ from 200 parts per million (ppm) 
to 20 ppm (Food Standards Agency 2012). Foods containing up to 100 ppm 
can be labelled as ‘low in gluten’ under this new legislation. Some people 
may exceed their tolerable threshold if several products labelled as 'low in 
gluten' are consumed (Akobeng & Thomas 2008). Some foods that were 
previously labelled as GF are no longer permitted under the new legislation 
(Food Standards Agency 2012). Although this new legislation makes GF 
products safer for patients with very low tolerance to gluten, it is likely to 
have led to a reduction in the number of products labelled as 'gluten-free'. 
However, I am not aware of any research that has been carried out to 
investigate whether or not the new labelling legislation has affected the 
availability of GF products. 
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1.4 Adherence to treatment 
 
The World Health Organization (WHO) (2003) has adopted the following 
definition of adherence to long-term therapy: 
 
‘the extent to which a person’s behaviour – taking medication, 
following a diet, and/or executing lifestyle changes, 
corresponds with agreed recommendations from a health care 
provider’  
           (World Health Organization, 2003) 
 
Adherence to a GFD results in symptomatic, serologic and histologic 
remission and the normalisation of mortality rates as well as improving 
psychological wellbeing (Pietzak, 2005; Leffler et al., 2008; Griffiths, 
2008). Non-adherence to a GFD renders this treatment ineffective. 
Adherence to medication for chronic conditions in developed countries, 
including the UK, is around 50% (World Health Organization, 2003). Self-
management of dietary treatment tends to be more complicated than 
adherence to medication and dietary adherence tends to be worse than 
medication adherence (DiMatteo, 2004). Managing the effects of non-
adherence can place a great strain on healthcare resources. As well as the 
reduction in symptoms and a reduced risk of CD-associated conditions, 
adherence to treatment can have a broader impact on society in the lowering 
of healthcare costs associated with complications and increasing workplace 
productivity (Behner et al., 2012). 
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In theory, dietary treatments are straightforward (i.e. do not eat gluten), but 
in practice they are rather complicated and require a high degree of self-
management. A study investigating dietary regimen adherence in diabetic 
patients found a wide-range of factors affecting adherence, including socio-
demographic factors, psychosocial obstacles; and healthcare providers 
obstacles (Uchenna et al., 2010). The wide-range of factors found to be 
associated with following a restricted diet highlight the complexity of 
dietary adherence compared to medication adherence, which may involve 
simply remembering to take a pill each day. By developing a better 
understanding of the factors affecting adherence to a GFD in adult CD, it 
should be possible to develop an intervention that will improve adherence. 
 
1.4.1  Defining adherence to the gluten-free diet 
 
Hall et al. (2009) highlight the variability in the way adherence to a GFD is 
defined and measured. In some studies, Likert scales have been used to 
define adherence as strict, partial or fairly strict, whereas other studies 
defined adherence based on the results of histopathology or serological tests 
(Hall et al., 2009). Some studies have interpreted self-reported ‘partial-
adherence’ or ‘fairly adherent’ to be adherent whereas other studies 
considered these to be non-adherent (Hall et al., 2009). In addition, some 
studies regard accidental gluten consumption to be non-adherent, whereas 
other studies do not (Hall et al., 2009). There is a lack of consistency in the 
ways in which adherence has been defined and measured in previous CD 
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studies and Leffler et al. (2009) highlight the need for a more standardised 
approach.    
 
1.4.2 Measuring adherence to a gluten-free diet 
 
Table 1.2 summarises different methods of measuring adherence to a GFD 
as used in previous research. VA is used as the diagnostic hallmark of CD 
and recovery of the villi is an indication of dietary adherence (Lee & Green, 
2005). However, recovery of the intestinal mucosa may not be a good 
indicator of adherence to a GFD because the rate and extent of recovery is 
variable and, in some cases, the villi never fully recover (Rubio-Tapia et al., 
2010). However, the majority of patients do show signs of mucosal recovery 
over time (Hutchinson et al., 2010). 
 
The presence or absence of symptoms has been used in some studies as an 
indicator of adherence to a GFD (Jacobsson et al. 2012). However, it is 
argued that the elimination of symptoms is not a good indicator of 
adherence to a GFD. This is because CD symptoms are a poor guide to 
mucosal healing and they are irrelevant for around 50% of people with CD 
who are asymptomatic (Casellas et al., 2006; Tursi et al., 2009).  
 
There is no one measure of adherence that is cost effective, patient 
acceptable and accurate. Research in this area is inherently biased as non-
adherent patients may be less likely to participate in research into measures 
for adherence, and may also be less likely to attend clinics. Also patients 
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may tend to over-estimate their level of adherence (Leffler et al., 2009; Hall 
et al., 2009).  
 
In their systematic review, Hall et al. (2009) found that adherence to a GFD 
in adults with CD ranged from 42% to 91%.  The reason for the wide range 
of adherence estimates reported by Hall et al. (2009) could be due to the 
different ways in which adherence to a GFD was measured.  
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Table 1.2 Methods for evaluating adherence to a gluten-free diet in patients with coeliac disease 
Method Benefits Limitations 
Intestinal biopsy Gold standard for demonstration of impact 
on gut mucosa. 
Expensive, uncomfortable, can be painful, rare risk of gut perforation. 
Healing of the gut mucosa is often slow or incomplete, despite adherence to 
a gluten-free diet, it can take one to two years, so biopsy should not be 
repeated until after two years (Zanini et al., 2010). 
Serological testing  Simple blood test that can be repeated 
easily. Relatively cheap. Antibody titres 
drop when a patient adopts a gluten-free 
diet. Titre is associated with gut mucosa 
pathology (Ciacci et al., 2002a).  
Antibodies are not always present when someone with coeliac disease is 
occasionally non-adherent. The presence of antibodies provides little 
information about adherence and mucosal healing. There are substantial 
differences between the performance of each serological assay and between 
commercial kits for each assay, reducing their reproducibility (Korponay-
Szabo et al., 2005; Ciacci  et  al., 2002a).  
Dietitian-led Evaluation Non-invasive. High correlation with 
biopsy and serology results. Relatively low 
cost (Da Silva Kotze et al., 2009).  
Limitation to number of dietitians skilled in evaluating adherence. Not all 
people with coeliac disease see a dietitian. Assumes patient honesty in 
reporting diet (Vahedi et al., 2003; Leffler et al., 2008). 
Food Diary 
24 hour, 3 or 7 day 
Can be completed by the patient. 
Relatively low cost. 
Relies on accurate recall of food eaten. Also requires record of manufacturer 
of pre-prepared foods so that their recipes can be checked for gluten. Can 
also require estimation of food amounts. Relies on patient honesty (Corrao 
et al. 2001; Leffler et al., 2007b). 
Adherence Questionnaire 
e.g. The Coeliac Dietary 
Adherence Test (Leffler et 
al., 2009) 
Simple short questionnaires completed by 
patients. Low cost. Correlates highly with 
dietitian assessment of adherence (Leffler 
et al., 2007b; Leffler et al., 2009). 
Relies on patient honesty. Over-estimation of adherence may be common. 
  
55 
 
1.4.3 The financial cost of non-adherence to the 
National Health Service (NHS) 
 
Non-adherence to a GFD in coeliac patients is associated with poorer health 
outcomes and this is likely to increase the financial burden on the NHS. A 
study in Israel reported significantly higher healthcare use for a group of 
1,754 coeliac patients compared to 15,040 controls. The increase was based 
on hospital admission, medications, laboratory and imaging, some of which 
may have resulted from poor adherence (Heymann et al., 2013). As far as I 
am aware, and according to Violato et al. (2012), there are currently no 
published figures on the financial cost of non-adherence to the National 
Health Service (NHS) in relation to CD.  
 
With the increase in serious health complications associated with untreated 
CD, such as osteoporosis, cancer, psychological disorders and infertility, it 
is likely that improved adherence would result in reduced healthcare 
spending. In order to improve adherence, however, better healthcare 
provision may be needed and this could be expensive. A cost-effective 
strategy for improving adherence to a GFD is needed in order to reduce 
NHS spending on CD and improve patient wellbeing and productivity. In 
developing interventions to improve adherence to treatment, it is important 
to have a good understanding of the factors affecting adherence and to 
understand how such factors can be addressed.  
 
  
56 
 
1.5 Theoretical models of behaviour change 
 
Upon receiving a CD diagnosis, patients are required to undergo substantial 
changes in behaviour if they are to adhere to a GFD. The relationship 
between health behaviour and adherence to treatment has received a great 
deal of research attention in recent years (DiMatteo, 2004). Many 
interventions have been designed from behaviour change theory with the 
aim of improving adherence to medication in chronic conditions, however, 
less attention has been given to developing interventions to improve dietary 
adherence. In this section, I describe the six most common psychological 
theories on the determinants of behaviour change that are applicable for 
adherence to treatment (Leventhal & Cameron, 1987). It is possible that 
these models could be used in the development of an intervention to 
improve long-term adherence to a GFD. The development of an intervention 
to change behaviour requires knowledge of the concepts (or mediators of 
change) that need to be targeted (Sirur et al., 2009).  
 
Health belief model (HBM) 
The health belief model (HBM), which was developed by Rosenstock, 
Strecher and Becker, explains behaviour change as the result of a set of 
beliefs about a situation (Rosenstock et al., 1988). In this model, behaviour 
change is based on a balance between the barriers to and the benefits of a 
particular behaviour (e.g. adherence) (Blackwell, 1992). According to this 
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model, there are four key beliefs that are weighed up in a cost-benefits 
analysis and this determines behaviour: 1. Perceived susceptibility (e.g. 
what is the likelihood that poor health outcomes will result from non-
adherence?); 2. Perceived severity (e.g. how severe will the consequences of 
non-adherence be?); 3. Perceived benefit (e.g. adherence will be good for 
my health); and 4. Perceived barrier (e.g. GFF is expensive, difficult to find 
and does not taste good). Albert Bandura introduced the concept of self-
efficacy, which relates to how competent an individual feels to engage in a 
particular behaviour (Strecher & Rosenstock, 1997). The concept of self-
efficacy was recently added to the HBM. A person with a high sense of self-
efficacy is likely to be more motivated to take action than a person with low 
self-efficacy who would be likely to feel helpless and not in control of a 
given situation. 
 
According to the HBM, a person with CD must believe that they are 
susceptible to negative consequences of non-adherence before they will 
change their behaviour and start adhering to a GFD. However, an 
individual’s beliefs may not be the only reason for non-adherence and 
factors, such as the presence or absence of symptoms and the availability of 
GFF may also play a role. The HBM fails to take account of the fact that 
some behaviour is based on habit, rather conscious decisions. 
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Theory of reasoned action and planned behaviour 
Azjen and Fishbein recognised that attitudes and beliefs do not account for 
all behaviour (Sutton, 1997). According to this theory, the intention to act is 
the best predictor of behaviour and the intention to change behaviour is 
influenced by an individual’s attitudes towards the action (Sutton, 1997). 
The theory of planned behaviour suggests that behaviour is influenced by 
three factors: 1. Attitudes (beliefs about the likely outcome of behaviour); 2. 
Subjective norms (perceptions of other people’s expectations of them to 
perform the health behaviour); and 3. Perceived behavioural control (i.e. 
you have the resources / opportunity to engage in the behaviour). This 
model suggests that individuals need to believe that they are able to 
successfully engage in a particular behaviour (self-efficacy) before they will 
change their behaviour. This builds upon the idea of ‘locus of control’ 
theory which suggests that a person either views events as being controlled 
by their own actions (internal locus of control) or by other people (external 
locus of control).  
 
Sainsbury & Mullan (2011) used the theory of planned behaviour to predict 
adherence to a GFD in CD and found this to be a good predictor of 
adherence. According to the theory of planned behaviour, most behaviour is 
rational and an individual’s intention to behave in a particular way has a 
greater predictive ability than health beliefs. The theory of planned 
behaviour, however, does not account for unconscious or irrational 
behaviour that may result from emotional states or psychological problems. 
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Despite having an internal locus of control and strong self-efficacy a patient 
who does not value their health may not adhere to a GFD. 
 
Behavioural learning theory 
Behavioural learning theory relates to how people learn from their 
experiences and the conditioning that can take place during the early years 
(Lovell, 2011). This model focuses on the environment and teaching the 
skills and strategies required in managing adherence (World Health 
Organization (WHO), 2003). Behavioural learning theory explains actions 
in relation to internal and external antecedents (thoughts and environmental 
cues) and the consequences of adherence behaviour (punishment or reward). 
Patients with CD may have unique reasons for non-adherence to a GFD 
which may require a patient centred approach to care. The lack of an 
individual approach and the emphasis on immediate reward means that 
behavioural learning theory may not be appropriate for understanding 
behaviour or designing interventions in CD.  
 
Social-cognitive theory (SCT) 
Social cognitive theory (SCT) was developed by Bandura in 1986 and it is 
argued that this is the most comprehensive theory of behaviour change 
(Bandura, 1998; Redding et al., 2000). SCT relates to the choices 
individuals make and components of this theory include self-efficacy, 
beliefs and incentives or reinforcement (Chapman-Novakofski & Karduck, 
2005). In a study focusing on exercise behaviour, Wallace et al. (2000) 
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applied the SCT to examine the stage of exercise behaviour change in young 
adults. The study reported that self-efficacy played an essential role in 
determining exercise behaviour. It is possible, however, that the role of self-
efficacy in dietary behaviour may differ to that in exercise behaviour.  
 
Information motivation behaviour (IMB) skills theory 
The information, motivation and behavioural (IMB) skills model suggests 
that there are three components of behaviour change (information, 
motivation and behaviour skills) (World Health Organization (WHO), 
2003). Information and motivation are believed to activate behaviour. 
Information relates to the knowledge a person has about an illness and its 
treatment. The IMB model suggests that, although information is a 
prerequisite for adherence, it is not enough to change behaviour (World 
Health Organization (WHO) 2003). According to this model behaviour 
change requires motivation and a focus on developing behavioural skills. 
Motivation includes the attitudes towards the behaviour, perceived social 
support for such behaviour and the patient’s perception of how other people 
with the condition might behave (subjective norm). This model 
acknowledges the importance of having the necessary tools and strategies 
required for adherence. Self-efficacy is also an important aspect of this 
model. 
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Transtheoretical (stages of change) model 
The Transtheoretical (Stages of Change (SOC)) Model (TTM) describes an 
individual’s motivational readiness to change (World Health Organization, 
2003). This model incorporates some of Bandura's self-efficacy theory. 
According to this model, behaviour change is thought to progress through a 
series of five stages: 
 
1. Precontemplation (not considering behaviour change in the next six 
months) (e.g. I am not seriously thinking about following a GFD). 
2. Contemplation (considering changing behaviour in the next six months) 
(e.g. I think I should follow a GFD). 
3. Preparation (planning to change behaviour in the next 30 days) (e.g. I 
am planning in my diary to make the changes). 
4. Action (currently changing behaviour) (e.g. I am buying GFF). 
5. Maintenance (successful behaviour change for at least six months) (e.g. 
I have been sticking to my GFD every day). 
 
 The TTM is useful in understanding and predicting intentional behaviour 
change, however, Bandura argues that behaviour change is multifaceted and 
cannot be divided into discrete stages.  
 
All the theoretical models of behaviour described above make a number of 
assumptions. For example, these models assume that people will take an 
active role and are able to use foresight, plan and make decisions (cognitive 
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processes). In addition, these models also assume that people will self-
regulate their behaviour and behave in goal-orientated ways. Models of 
health behaviour have been used to develop interventions for a number of 
health conditions, however, few have been used for dietary interventions. As 
far as I am aware the TPB is the only model of behaviour change that has 
been applied in relation to adherence to a GFD in adult CD (Sainsbury & 
Mullan 2011). It is unclear whether any of the other models could be 
successfully used to explain adherence to a GFD or in the development of 
an intervention to improve adherence to a GFD in adult CD. 
 
1.6 Financial incentives to improve 
adherence 
 
A recent development has been the exploration of how financial incentives, 
or reward schemes, can be implemented for eliciting behaviour change and 
adherence to medication (Bremner et al., 2013). This idea has been used 
successfully in relation to adherence to a number of medical treatments, 
including medication in patients with mental illness, treatment attendance in 
substance abusers and in abstinence from smoking (Burton et al., 2010; 
Carey & Carey 1990; Tidey et al. 2002).  
 
As far as I am aware, financial incentives aimed at improving adherence to a 
GFD in patients with CD have not been investigated. Within the NHS, GFF 
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is available on prescription, with the intention of reducing the cost of the 
diet so that it is comparable to a non-GF diet. So, whilst this is not a 
financial incentive per se, it mitigates the additional cost of this diet. 
Furthermore, Coeliac UK has suggested that the provision of prescribed 
GFF does help people with CD to maintain a GFD (Coeliac UK, 2013c). 
 
1.7 Healthcare and support for adults with 
coeliac disease 
 
The NHS (2013) website states that: 'Coeliac disease is usually treated by 
simply excluding foods that contain gluten from your diet'. Although simple 
in theory, in practice following a GFD is more complicated than this 
statement suggest. Patients with CD need to be supported in sticking to a 
life-long GFD (Holmes, 2010; Del-Colle, 2010; Addolorato et al., 2004; 
Leggio et al., 2005). In this section, I focus on the support available to 
adults with CD in the UK, including support from the NHS, social support 
and support from Coeliac UK, the largest charitable organisation for people 
with CD in the UK. From the time of diagnosis, patients with CD in the UK 
are expected to self-manage their treatment with little support from 
healthcare professionals (Berrill et al., 2012). The sudden change to 
previous dietary habits can be overwhelming and eliminating favourite 
gluten-containing foods can be challenging (Hogberg et al., 2003).  
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Following a GFD is complicated and patients are required to acquire a vast 
amount of knowledge about CD and the GFD as well as coping with the 
psychosocial impact of living with CD (Ford et al., 2012; Hall et al., 2009; 
Ciacci et al., 2002b). Patients are required to learn which foods can and 
cannot be eaten, where GFF can be purchased, which restaurants serve GF 
meals and how to communicate their dietary needs to people who prepare 
food for them (Leffler et al., 2008; Hall et al., 2013). Support for people 
with CD can come from healthcare professionals, family, friends and 
coeliac support groups. The type and amount of support available to patients 
with CD is variable.  
 
1.7.1 Current healthcare provision for patients 
with coeliac disease in the United Kingdom 
 
According to Da Silva Kotze et al., (2009) patients with CD should receive 
regular evaluation by a healthcare team, including a physician and a 
dietitian. It is recommended that patients are seen by a dietitian at the time 
of diagnosis and at least annually for review (British Society of 
Gastroenterology, 2009; Nelson et al., 2007). However, there is a paucity of 
dietetic services in the UK and some patients have reported waiting six 
months before seeing a dietitian (James & Foley, 2011; British Society of 
Gastroenterology, 2009). The role of the dietitian is to provide expert 
dietary advice to patients on how to follow a strict GFD (British Society of 
Gastroenterology, 2009; Coeliac UK, 2013c). 
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Practitioners should regularly evaluate patients to identify nutrient 
deficiency and to check that patients are adhering to a strict GFD (Hart et 
al., 2011). Healthcare for patients with CD in the UK is variable and one 
study found just 62% of patients with CD were receiving active follow-up 
(Bebb et al., 2006). Similar findings were made in the USA where only 65% 
of participants received follow-up that was consistent with the American 
Gastroenterological Association (AGA) guidelines (Herman et al., 2012). 
However, both these studies included fairly small sample sizes which limits 
the reliability of the findings.  
 
Currently there are no clear guidelines on how best to follow-up patients 
and monitor their adherence to a GFD (Da Silva Kotze et al., 2009). The 
National Institute for Health and Care Excellence (NICE) provide guidelines 
for UK healthcare professionals on how best to manage a number of health 
conditions but they currently only offer guidance on the diagnosis of CD 
and not long-term management. NICE are in the process of developing a set 
of guidelines for managing CD which are due to be published in June 2015 
(National Institute for Health and Care Excellence (NICE), 2014). The 
British Society of Gastroenterology (BSG) produced the document 'The 
Management of Adults with Coeliac Disease' (Ciclitira et al., 2010). In this 
document, the BSG recommend that patients receive annual follow-up, 
however, they acknowledge that many patients do not receive this level of 
care.  
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Many patients with CD have expressed dissatisfaction with healthcare in 
relation to the lack of expertise and continuity of care (British Society of 
Gastroenterology, 2009). Ukkola et al. (2012) reported patient 
dissatisfaction in relation to doctor-patient communication. Establishing a 
good doctor-patient relationship is believed to reduce the burden of CD for 
patients (Ukkola et al., 2012). There is debate about what constitutes the 
most appropriate method of follow-up for patients with CD (Berrill et al., 
2012). Bebb et al. (2006) found that patients' preferred follow-up option was 
to see a dietitian and to have a doctor available and Stuckey et al. (2009) 
reported a preference for dietetic support over support from clinicians. 
However, patients have different needs and healthcare should be tailored to 
the individual (Bebb et al., 2006). Patients who are already established on a 
GFD may prefer to self-manage their condition and only consult with 
healthcare professionals if they experience problems (Berrill et al., 2012) 
whereas newly diagnosed patients are likely to need more support.  
 
1.7.2 Prescribed gluten-free food 
 
In the UK, patients with CD are supported by the provision of staple GF 
products (such as bread, flour, pasta, breakfast cereals and crackers) on 
prescription from the NHS (Coeliac UK; 2013d; British Specialist Nutrition 
Association Limited, 2013). GF products that have been approved by the 
Advisory Committee on Borderline Substances (ACBS) are prescribed to 
patients by their GP (Coeliac UK, 2013d). GPs have the responsibility of 
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deciding how much GFF is prescribed to patients based on national 
guidelines. Table 1.3 shows the monthly recommended amount of 
prescribed GFF for adults. Different amounts are recommended for different 
age and gender groups. In England patients are currently required to pay a 
prescription charge of £7.85 per item or they can purchase a pre-payment 
certificate for three or 12 months for £29.10 or £104 respectively (Coeliac 
UK, 2013d). Some patients in England are exempt from this charge and 
patients living in Scotland, Northern Ireland and Wales do not have to pay a 
prescription charge for their GFF (Coeliac UK, 2013d). 
 
Table 1.3 Recommended amount of prescribed gluten-free food for adults 
with coeliac disease in the UK 
 
 Number of units
1
 
recommended per 
month 
Males 
    18-59 years 
    60-74 years 
    75+ years  
 
Females 
   18-74 years 
   75+ years 
 
18 
16 
14 
 
 
14 
12 
Note: 
1. 1 Unit = 400g bread/rolls/baguette; 200g biscuits/crackers; 250g pasta; 2 
pizza bases.  1.5 Units = 500g oats; 300g breakfast cereal. 2 Units = 500g 
mix (Agarwal, 2012). 
 
 
The provision of GFF on prescription began in the 1960s at a time when the 
availability of substitute GFF was limited (Drug and Therapeutics Bulletin, 
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2013). The cost to the NHS of providing GFF on prescription was around 
£27 million in 2011 (Drug and Therapeutics Bulletin, 2013). It is possible 
that wider availability of GFF in recent years has made the provision of GFF 
through the NHS unnecessary. However, Coeliac UK (2013d) believe the 
provision of GFF on prescription is essential. Prescribed GFF is especially 
important for people who have difficulty obtaining GFF, such as those on a 
limited income who may find the price of GFF prohibitive, those who live 
in rural areas where GFF is not easy to find and the elderly who may 
experience difficulties with accessing GFF (Coeliac UK, 2013b). The 
provision of GFF on prescription is believed to make it easier for people 
with CD to follow a GFD (Coeliac UK, 2013d). Any savings made by the 
NHS through cancelling GF prescriptions may result in higher NHS 
spending on treating the consequences of non-adherence to a GFD. 
 
1.7.3 Social support 
 
The traditional medical model of treating disease, which is often criticised 
for being too paternalistic and reductionist (focusing only on the biological 
aspects of the disease and not the whole person), may not be appropriate for 
treating chronic conditions such as CD (Del-Colle, 2010). Following a GFD 
requires permanent and drastic behaviour change that affects an individual's 
entire social support system. Healthcare provision may be insufficient in 
helping patients adapt to a new life-long diet and the support provided by 
family and friends is believed to be integral in managing CD (Herman et al., 
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2012; Del-Colle, 2010). Leffler et al. (2008) found that friends with and 
without CD were better sources of information about CD for patients 
compared to healthcare professionals. Socialising in environments where 
food is provided is greatly affected by CD and support from family and 
friends can help people to cope better with following a GFD during social 
situations (Hallert et al., 2002; Zarkadas, 2006).  
 
1.7.4 Coeliac support groups 
 
Coeliac UK is the largest support group for people with CD in the UK and 
currently has over 60,000 members (Coeliac UK, 2013e). This charitable 
organisation was established in 1968, at a time when there was less 
awareness about CD and the GFD (Coeliac UK, 2013e). Coeliac UK is not 
funded by the government and relies on donations and membership fees, 
which are currently £20 per year for an individual or carer/parent, £25 for 
household membership or £10 for people on a low income, such as those 
receiving benefits or state pensions and students (Coeliac UK, 2013f). 
 
Coeliac UK has a remit of providing members with advice and support, with 
a strong focus on GFD knowledge and skills. Members are supported with 
information about the GFD, including being provided with a copy of 
Coeliac UK's annual Food and Drink Directory (Coeliac UK, 2013a). The 
Food and Drink Directory, which is updated online monthly, lists thousands 
of products that are suitable for people with CD along with advice about 
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choosing the right food and information about the recent changes to GF 
labelling laws. Access to a helpline, recipe database, local support group 
and a quarterly publication (Crossed Grain magazine) is also provided to 
members. There are over 90 local Coeliac UK support groups throughout 
the UK which fulfil a number of roles, including GF cookery 
demonstrations, fundraising, hosting food fairs and providing members with 
the opportunity to meet other people with CD (Coeliac UK, 2013f). 
 
1.8 Aims and objectives 
 
The aim of this study was to gain a better understanding of the factors 
affecting adherence to a GFD in adults with CD. A further aim was to 
identify similarities and differences in the opinions of three stakeholder 
groups (adults with CD, adults who live with them and healthcare 
professionals). To achieve these aims, I set three main objectives: 
 
1. To conduct a systematic review to identify the factors associated 
with adherence to a gluten-free diet from previous research and to 
synthesise the results with the results of a systematic review by Hall 
et al. (2009). 
2. To conduct a concept mapping study to explore the factors affecting 
adherence to a gluten-free diet from the perspectives of three 
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stakeholder groups (adults with CD; adults who live with them; and 
healthcare professionals). 
3. To develop a model of adherence to a GFD that represents the 
findings of this study and that can be used in the design of an 
intervention aimed at improving adherence to a GFD. 
 
1.9 The structure of this thesis 
 
The remainder of this thesis is divided into four chapters. I present the 
existing evidence on the factors affecting adherence to a GFD in a 
systematic review in Chapter 2. The method of investigation, concept 
mapping, is presented in Chapter 3 and I provide a justification for my 
decision to use this method. The results of this study are presented in 
Chapter 4 and, in this chapter, I pull together the results of this concept 
mapping study with the results of the systematic review to provide an up-to-
date overview of the factors affecting adherence to a GFD. In chapter 5, I 
discuss the implications of the findings of this study and I present a model 
of adherence to a GFD that I have developed from this piece of research.  
 
1.10   Summary 
 
In order to achieve optimal health outcomes for the 1% of the population 
who have CD, strict adherence to a GFD is required. Despite research into 
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alternative treatments, the GFD remains the only treatment for CD. This 
treatment eliminates symptoms and normalises mortality rates for people 
with CD. The GFD is simple in theory, however, in practice following a 
GFD is restrictive, costly and it may affect quality of life. Research has 
shown that as many as 58% of people with CD do not adhere to a strict 
GFD, however, the reasons for this are unclear (Hall et al., 2009). The aim 
of this thesis is to gain a better understanding of the factors affecting 
adherence to a GFD. In Chapter 2, I provide an update to a systematic 
review into the factors affecting adherence to a GFD in adults with CD by 
Hall et al. (2009). 
 
 
 
 
 
  
73 
 
Chapter 2: A systematic review 
of factors affecting adherence to 
a gluten-free diet in adults with 
coeliac disease 
 
2.1 Introduction 
 
In Chapter 1, I highlighted the importance of adherence to a gluten-free diet 
(GFD) in eliminating symptoms, improving quality of life (QoL) and 
normalising mortality rates in people with coeliac disease (CD). A GFD is 
complicated and as many as 58% of patients with CD do not adhere to this 
treatment (Hall et al., 2009; Leffler et al., 2008). Studies into the factors 
affecting adherence to a GFD have produced inconsistent results and a 
systematic review by Hall et al. (2009) (with the search being conducted in 
2007) concluded that more rigorous research is needed. Since the systematic 
review was carried out by Hall et al. (2009), a number of new studies 
relating to adherence to a GFD in adults with CD have been published. In 
this chapter, I present an update to the systematic review by Hall et al 
(2009).  
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The aim of this chapter is to systematically review the evidence of factors 
that affect adherence to a GFD in adults with CD published between 2007 
and August 2013. To develop a broader overall picture of the evidence, I 
will present the results of my update along with the results of the original 
systematic review by Hall et al. (2009).  
 
2.2 Background and rationale for this 
systematic review 
 
2.2.1 Background  
 
Adherence to a strict, life-long GFD can be challenging for patients with CD 
and research into the factors affecting adherence to a GFD is inconclusive 
(Hall et al., 2009). Poor adherence to a GFD results in an increased risk of 
morbidity and mortality and sub-optimal adherence can affect a patient's 
QoL. Knowledge about the factors affecting adherence to a GFD could help 
to better understand how to provide appropriate care for patients with CD 
and improve adherence to the GFD. 
 
2.2.2 Rationale for this systematic review 
 
Adherence to a GFD in adults with CD is notoriously poor. It is likely that 
any attempt to develop a targeted intervention to improve adherence would 
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prove futile without a good and up-to-date understanding of the factors 
affecting adherence to a GFD. The evidence presented in the 38 studies 
included in the systematic review by Hall et al. (2009) was often 
inconsistent and the authors suggested that further research was needed. 
Since that time, several new studies have been carried out, however, I am 
not aware of any up-to-date systematic review that has pulled together the 
results of this new research. Conflicting evidence reported in the Hall et al. 
(2009) systematic review may be resolved through synthesis with the new 
research in this area. 
  
Since the systematic review was conducted by Hall et al. (2009) several 
factors relating to living with CD and a GFD may have changed. For 
example, Hall et al. (2009) reported the availability of GFF was a problem 
for people with CD, however, Coeliac UK claims that the retail market for 
GFF has grown substantially in the last five years (Coeliac UK, 2013g)  
 
The aim of this systematic review was to identify peer reviewed journal 
articles that provide evidence on the factors affecting adherence to a GFD in 
adults with CD. In this chapter, I report the results of my systematic review 
and I synthesise the evidence with the findings from the study by Hall et al. 
(2009). 
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2.3 Methods 
 
This systematic review is an update to the review by Hall et al. (2009) and 
the method employed here is based on that used by Hall et al. (2009) with 
some adaptions as detailed in the sections below. 
 
2.3.1 The systematic search 
 
Relevant experimental and non-experimental studies were identified using a 
method based on that employed by Hall et al. (2009). In order to capture as 
many relevant citations as possible, I conducted an extensive search of 
seven medical and scientific databases: AMED (Ovid, 1985); CINAHL 
(EbscoH, 1982); Cochrane Library; Embase (Ovid, 1974); Medline (Ovid, 
1946), Psychinfo (1806); and PubMed. The previous review by Hall et al. 
(2009) collected information up to and including 2007, therefore, I searched 
the databases for relevant studies published after 2007 up to and August 
2013.  
 
After searching the up-to-date literature for relevant key words, I slightly 
adapted the search string used by Hall et al. (2009) to create a 
comprehensive set of search terms. To ensure I identified as many relevant 
papers as possible, the following search string was used: (celiac or coeliac 
or gluten sensitiv$ or gluten-sensitiv$ enteropathy) and (adher$ or comply 
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or complian$ or concordan$ or manag$ or non-adher$ or non-complian$) 
and (gluten or gluten-free or diet$ or treat$ or therap$). The search string 
was adapted slightly to allow for differences between the required searching 
criteria for each database. Where the databases provided the facility to use 
MeSH terms, the search strategy included the MeSH terms ‘celiac disease’ 
and 'Diet, gluten-free' and all their derivations. The full search string used 
for each of the seven databases is shown in Appendix 1.  
 
To avoid duplication, all 2007 articles that were already included in Hall et 
al.'s (2009) systematic review were excluded. The reference lists from 
included papers were examined and any eligible articles found in this way 
were included in the review. The search was limited to human studies, 
English language studies and full papers where the databases allowed. I did 
not have the facilities to translate papers from non-English languages.  
 
2.3.2 The identification and selection of 
relevant papers 
 
Records were imported to Mendeley referencing manager (Mendeley, 2013) 
and all duplicated papers were removed. A review of the title and abstract 
was carried out and any studies that were not relevant were removed. I 
obtained and read the full text articles for the remaining studies and 
excluded those that did not fit my inclusion criteria (Table 2.1). Only peer 
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reviewed published articles were included. All types of study design were 
eligible for inclusion in this review. 
 
Table 2.1 – Systematic review inclusion and exclusion criteria 
Inclusion Criteria Exclusion criteria 
English language Childhood studies or studies involving 
adults and children where data is combined 
Human studies If coeliac disease is not the primary disease 
being studied 
Adult studies or studies including children 
where adult results are presented separately 
Non-English language 
Primary research Animal studies 
Studies published between 2007-August 
2013 
Poster abstracts and dissertations 
Full paper articles only Already included in 2007 systematic review 
by Hall et al. (2009). 
Qualitative, quantitative and mixed method 
studies with be included 
 
Evidence of at least one factor affecting 
adherence to a gluten-free diet in coeliac 
disease 
 
 
 
2.3.3 Data extraction and quality assessment 
 
Having identified the studies for inclusion in this review, the next step was 
to extract the relevant data and assess the quality of each of the included 
studies. To do this, it was necessary to establish the most appropriate data 
extraction and quality appraisal tools. The Cochrane Handbook for 
systematic reviews (Higgins & Green, 2011) advises that quality assessment 
should check for validity and sources of bias. I judged the tools used in a 
systematic review in adherence to medication in Parkinson’s disease by 
Daley et al., 2012) to be the most suitable for assessing the quality of 
studies in this systematic review. Hall et al. (2009) used appraisal tools 
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developed by Crombie (1996) and Poppay et al. (1998). I chose to use the 
recently developed tools by Daley et al. (2012) because they focused more 
on the quality of methodological rigor and the risk of bias. 
 
Data extraction  
The full text of the included articles was reviewed and data were extracted 
using a slightly adapted version of the pre-determined form taken from 
Daley et al. (2012). The use of a pre-determined form can reduce the 
likelihood of bias and it helps to ensure the data extraction process is 
systematic. I adapted the data extraction sheet slightly by including the 
percentage of participants who were adherent/non-adherent and by 
including both the factors that affect adherence in both a negative and a 
positive way (rather than the factors affecting non-adherence only). I also 
decided to include the country where the study was conducted as this could 
be used to explain any conflicts in the evidence (for example, the 
availability of GFF may differ between countries).  
 
The extracted data were tabulated and the emerging adherence factors were 
grouped together according to the six themes identified in the systematic 
review by Hall et al. (2009): 
1. Sociodemographic factors 
2. Knowledge, attitudes and beliefs 
3. Illness and symptom factors 
4. Treatment factors 
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5. Socio-cultural/Environmental factors 
6. Quality of life and psychological well-being 
 
Quality assessment for risk of bias/internal validity 
The purpose of the quality assessment is to check for bias and internal 
validity. Systematic error and bias are terms that are interchangeable with 
the term ‘internal validity’. Internal validity is the extent to which the design 
and conduct of a research study are likely to affect the reliability of the 
results (Higgins & Green, 2011).  
 
Daley et al. (2012) developed a quality appraisal tool to assess the risk of 
bias in the observational studies included in their systematic review. The 
assessment tool included an overall summation of the risk of bias for each 
study (Daley et al., 2012). Although summary scores are not recommended 
by some reviewers (Higgins & Green, 2011) because the influence 
(weighting) of each quality item is not equal, I used this because it helped 
with descriptive clarity in appraising which study’s results were trustworthy 
or not. The quality checking form used by Daley et al. (2012) was adapted 
slightly for this study. For example, Daley et al. (2012) specified their 
diagnostic criterion for Parkinson’s disease, and I specified that CD should 
be biopsy confirmed. 
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The studies included in my review were assessed against five potential 
sources of bias using this adapted version of the quality checking criteria 
developed by Daley et al. (2012):  
 
1) Selection bias 
 
Diagnostic inaccuracy 
Diagnosis of CD using an intestinal biopsy is considered to be the 
gold standard (Leeds et al., 2008). I believe the accuracy of CD 
diagnosis is an important factor in this review because patients who 
have been incorrectly diagnosed with CD may behave differently in 
relation to following a GFD.  Papers that included CD patients who 
were diagnosed by internal biopsy were judged to have a low risk of 
selection bias in relation to diagnostic accuracy. Where any other 
method of diagnosis was used the risk of bias in relation to 
diagnostic inaccuracy was deemed to be high. 
 
Participant representativeness 
Studies that included a population that is representative of the wider 
population of people with CD was regarded as low risk in relation to 
participant representativeness. Where participants were recruited 
from coeliac support groups (which are known to have members that 
are not representative of the wider population (Butterworth et al.,  
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2004)), or other non-representative groups, the risk of selection bias 
was judged to be high.  
 
Sampling methods 
Studies were judged on whether or not they employed an appropriate 
sampling method to discount selection bias, such as random 
sampling. Both the source and the method of sampling were 
considered in this assessment. Samples that were not likely to be 
representative of the wider population were given a lower rating than 
samples that provided the opportunity for a more representative 
sample to be selected. 
 
2) Random variation/chance 
 
Sample size calculation 
Studies that reported a sample size calculation and the target 
population was reached were judged to be low risk with regards to 
random variation/chance.  
 
3)   Detection bias 
 
Validity of adherence measures 
In assessing the validity of adherence measures I considered the 
methods of measuring adherence to a GFD. Serological testing and 
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intestinal biopsy were considered to be valid measures, whereas self-
reporting, interview or assessment by a healthcare professional 
(based on the patient’s self-reporting) were considered not to be 
valid measures of adherence. 
Follow-up 
Was follow-up the same for cases and controls (where applicable)? 
Were appropriate measures taken at follow-up? 
 
4)   Attrition bias 
 
Loss to follow up 
Participants who are lost to follow-up (where applicable) can lead to 
bias in the results and this can compromise the validity of the results. 
Participants who drop out of a study may differ in some way to those 
who continue to participate. Studies that showed a high loss to 
follow-up were rated as having a high risk of attrition bias. 
 
5)   Reporting bias 
 
Appropriateness of analysis 
Reporting bias was judged based upon whether the authors used an 
appropriate method of analysing the data. I also considered whether 
significance was likely to be a result of chance and whether missing 
data was dealt with appropriately. 
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2.3.4 Data analysis 
 
Once data extraction was completed, I grouped the data in order of the six 
themes identified in the systematic review by Hall et al. (2009). I also 
included the results from the Hall et al. (2009) systematic review in my 
results. Merging the results of my updated systematic review with the 
results of the original systematic review by Hall et al. (2009), allowed me to 
generate an overall summary of the evidence. This summary is presented in 
the following section. 
 
2.4 Results 
 
2.4.1 Search results 
 
The literature search, using seven databases, resulted in the identification of 
1812 records. Seven hundred and twenty-two duplicated papers were 
removed. A hand search of relevant reference lists yielded a further 17 
papers, giving a total of 1107. 
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Table 2.2 Results of the systematic review search of seven databases 
DATABASE NUMBER OF 
RECORDS 
AMED 1 
CINAHL 221 
Cochrane Library 45 
Embase 1011 
Medline OVID 488 
PsychInfo 7 
PubMed 39 
Hand search 17 
 
 
2.4.2 The selection of papers for inclusion 
 
The potential relevance of all 1107 citations was reviewed. Figure 2.1 is a 
PRISMA flow diagram showing the steps taken in the selection of papers 
for inclusion in this review. One thousand and sixteen papers were excluded 
as irrelevant from the title and abstract. The full papers of the remaining 91 
citations were assessed to select relevant primary studies that matched the 
inclusion criteria. These criteria excluded 70 studies and left 21 in the 
review. Appendix 2 shows a list of the 70 excluded papers with the reasons 
for exclusion. 
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IDENTIFICATION 
 
 
 
SCREENING 
 
 
ELIGIBILITY 
 
INCLUDED 
 
Figure 2.1 PRISMA flow diagram of the selection process of studies for inclusion in the systematic review 
Records identified through 
database searching (n=1812) 
722 duplicates removed (n=1090) 
Records identified through 
reference lists from full-text 
articles (n=17) 
Records after duplicates removed (n=1107) 
 
Records screened 
(n=1107) 
1012 Records excluded from title 
(n=836) and abstract (n = 180) 
Full text articles assessed 
for eligibility (n=91) 
Full text articles 
excluded, with reasons 
(n=70) 
Studies included in review (n=21) 
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2.4.3 Summary of the studies included in this 
systematic review 
 
I identified 21 studies for inclusion in this systematic review. The 
characteristics of the included papers are detailed in Appendix 3. Studies 
that provide figures on gender all show fewer male participants than female. 
Adherence ranged from to 44.2% to 100%. The included studies came from 
nine countries (Table 2.3) and included a total of 12,222 participants. 
 
Table 2.3 Country where the research was carried out for the 21 studies 
included in the systematic review 
 
Country of study Number of 
included 
articles 
UK studies 6 
USA 5 
Australia 2 
Finland 2 
Italy 2 
Argentina 1 
Canada 1 
Netherlands 1 
Sweden 1 
 
 
Table 2.4 shows the risk of bias for each of the 21 studies included in this 
systematic review. A low risk of bias is represented with a ‘✓’ and a high 
risk of bias is represented with an ‘X’. Where ‘n/a’ is shown, this measure 
was not relevant to that particular study’s methodology. Where ‘?’ is shown, 
this measure of bias could not be assessed because the author did not 
provide sufficient information for a judgement to be made.  
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I calculated the overall risk of bias and this was used to represent the quality 
of each study. The overall risk of bias was calculated by dividing the 
number of ✓ by the total number of risk of bias items (X and ?) and 
multiplying by 100 to produce a percentile for each study (✓ / (X + ?) x 100 
= %). Where a source of bias was not applicable (N/A) this was not included 
in the calculation. Studies scoring >70% were judged to be of high quality; 
40-69% were moderate quality; and <40% was low quality. 
 
Table 2.4 shows that seven of the 21 studies were of high quality (low risk 
of bias); ten had a moderate risk of bias (moderate quality); and four studies 
were deemed to be of low quality because they had a high risk of bias. Five 
of the 21 studies used a measure of adherence that was deemed to be valid. 
Five studies employed a sample size calculation and 12 of the 21 studies 
recruited participants from a population that was judged to be representative 
of the wider population of adults with CD. The majority of studies (n=19) 
included coeliac patients who had been diagnosed with CD by intestinal 
biopsy. All papers included in this review were judged to have used 
appropriate methods of analysing the results. 
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Table 2.4 Quality assessment of the 21 included studies 
Study Risk of Bias/threat to validity 
Diagnostic 
inaccuracy 
Participant 
representativeness 
Sampling 
methods 
Sample size 
calculation 
Validity of 
Adherence 
measures  
Follow-
up 
Loss to 
follow-
up 
Appropriateness 
of analysis 
Overall risk of bias Overall 
quality 
Barratt et al., 2011 ? ✓ ✓ ? X n/a n/a ✓ (3÷6) x 100 = 50 Moderate 
Black & Orfila, 2011 ✓ X ✓ ? X n/a n/a ✓ (3÷6) x 100 = 50 Moderate 
Casella et al., 2012 ✓ ✓ ✓ ? ✓ ✓ X ✓ (6÷8) x 100 = 75 High 
Edwards-George et al. 2009 ✓ ✓ ✓ ? ✓ ✓ ✓ ✓ (7÷8 x 100 = 87.5 High 
Errichello et al. 2010 ✓ ✓ ✓ ? X n/a n/a ✓ (4÷6) x 100 = 67 Moderate 
Ford et al. 2012 ✓ X ✓ ✓ X n/a n/a ✓ (4÷6) x 100 = 67 Moderate 
Hall et al., 2013 ✓ ✓ ✓ ? X n/a n/a ✓ (4÷6) x 100 = 67 Moderate 
Hopman et al., 2009 ✓ ✓ ✓ ? X n/a n/a ✓ (4÷6) x 100 = 67 Moderate 
Hutchinson et al., 2010 ✓ ✓ ✓ ✓ X ✓ ✓ ✓ (7÷8) x 100 = 87.5 High 
Kabbani et al., 2012 ✓ ✓ ✓ ? X ✓ ✓ ✓ (6÷8) x 100 = 75 High 
Kurppa et al., 2012 ✓ ✓ ✓ ✓ ✓ n/a n/a ✓ (6÷6) x 100 = 100 High 
Lee et al., 2012 ✓ X X ? X n/a n/a ✓ (2÷6) x 100 = 33 Low 
Mahadev et al., 2013 ✓ X X ? X n/a n/a ✓ (2÷6) x 100 = 33 Low 
Nachman et al., 2010 ✓ ✓ ✓ ? ✓ ✓ X ✓ (6÷8 x 100 = 75 High 
Paavola et al., 2012 ✓ ✓ ✓ ? ✓ ✓ ✓ ✓ (7÷8) x 100 = 87.5 High 
Sainsbury & Mullan 2011 ✓ X X ? X n/a n/a ✓ (2÷6) x 100 = 33 Low 
Sainsbury et al., 2013a ✓ X X ✓ X n/a n/a ✓ (3÷6) x 100 = 50 Moderate 
Sey et al., 2011 ✓ X X ? X ✓ ✓ ✓ (4÷8) x 100 = 50 Moderate 
Smith and Goodfellow 2011 ✓ X X ✓ ? n/a X ✓ (3÷7) x 100 = 43 Moderate 
Sverker et al., 2009 ✓ ✓ ✓ ? ? n/a n/a ✓ (4÷6) x 100 = 67 Moderate 
Van Hees et al., 2013 X X X ? X n/a n/a ✓ (1÷6) x 100 = 17 Low 
Note:  
X = high risk of bias; ✓= low risk of bias; ?=the author did not provide enough information for a judgement of the risk of bias to be made and, therefore, this was considered to represent a high risk of 
bias.
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2.4.4 Factors affecting adherence to a gluten-
free diet 
 
This update to the systematic review by Hall et al. (2009) has identified a 
number of new factors associated with adherence to a GFD. The studies 
included in this update varied in the number of adherence factors they 
identified. Appendix 3 shows a list of the factors with details of the studies 
that identified each adherence factor. Hall et al. (2009) grouped the factors 
associated with adherence to a GFD identified in their study into six themes. 
In the following six sections, I present the results of my update of Hall et al. 
(2009) systematic review using the same six themes. I have also included 
the results of the systematic review by Hall et al. (2009) to provide an 
overall summary of the evidence.  
 
Tables 2.5 to 2.10 show the results of my analysis along with the results of 
the quality assessment for each study included in this review. I have 
reported the quality of the papers used in Hall et al.’s (2009) systematic 
review as moderate/high which reflects the decision by the authors to 
exclude papers that were judged to be of poor quality from their review. I 
have included papers from my update to Hall et al.’s (2009) systematic 
review that I judged to be of low quality, however, I have taken into account 
the limitations of these studies when interpreting the results. 
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Sociodemographic factors 
Table 2.5 shows the results of the analysis for studies that report on 
sociodemographic factors in relation to adherence to a GFD. All of the 
studies that assessed sociodemographic factors were judged to be of 
moderate or high quality except for one low quality study (Lee et al 2012). 
The results of this study were in line with all of the other new studies results 
which report that gender is not associated with adherence to a GFD, so it 
was judged that the result was probably trustworthy. 
 
Hall et al. (2009) identified two studies that reported education as a factor 
that was associated with adherence to a GFD, but five where it was not. I 
identified a further two studies, one reported better adherence in people with 
a university education (Barratt et al. (2011) but the other study (Hall et al., 
2013) found no association. Therefore, education does not have a consistent 
relationship with adherence to a GFD. 
 
Age was identified by Hall et al. (2009) as a factor that was associated with 
adherence in three studies, and not associated in a further seven studies. I 
identified three more studies which found an association with age (n=1124), 
and four that did not (n=3437). The three studies that found an association 
between age and adherence to a GFD, all reported that older age was 
associated with better adherence. Overall, age does not appear to have a 
consistent relationship with adherence.  
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Hall et al. (2009) identified just one study that associated gender with 
adherence and seven studies that did not. I identified a further five studies 
(n= 4745) that showed no association of gender with adherence. Overall, the 
evidence suggests that gender is not associated with adherence to a GFD. 
 
No association was found between social class and adherence to a GFD in 
two studies included in the systematic review by Hall et al. (2009).  I 
identified one more study that showed an association with having an 
affluent background. Social class does not appear to have a consistent 
relationship with adherence. 
 
Hall et al. (2009) identified one study (n=234) that showed an association 
with urban living with adherence. I identified no further studies that 
examined this factor. Overall, there is weak evidence for an association of 
urban living with adherence. 
 
Hall et al. (2009) identified two studies that showed no association of 
employment status with adherence, and I did not identify any additional 
studies. Therefore overall there is evidence that employment status is not 
associated with adherence. 
 
One study (n=154) identified in the systematic review by Hall et al. (2009) 
showed marital status was associated with adherence. I identified one more 
study (n=255) that showed no association between marital status and 
 93 
 
adherence. Therefore, marital status does not have a consistent relationship 
with adherence to a GFD. 
 
Hall et al. (2009) identified one study (n=87) that showed ethnicity was 
associated with adherence, but I identified one larger study (n=679) that 
showed no such association. Therefore overall it is unlikely that ethnicity is 
associated with adherence to a GFD. 
 
Finally I identified one study (n=204) that showed smoking status was 
associated with adherence. This single study provides weak evidence that 
non-smokers have better adherence to a GFD. Overall there is little evidence 
that any of the sociodemographic factors associate with adherence 
behaviours. 
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Table 2.5 Sociodemographic factors (including results from Hall et al.’s 
(2009) systematic review) 
 
Authors Adherence factor Number of 
participants in 
studies that show 
an association 
with adherence  
Number of 
participants in 
studies that did 
not show an 
association 
with adherence 
Assessment of 
quality 
Hall et al., 2009 Education 2/71 (n=971) 5/71 (n=566) Moderate/High 
Barratt et al., 2011 Education (university 
education is 
associated with better 
adherence) 
n = 573  Moderate 
Hall et al., 2013 Education  n=287 Moderate 
Hall et al., 2009 Age 3/101 (n=673) 7/101 (n =1132) Moderate/High 
Barratt et al., 2011 Age  n=573 Moderate 
Casellas et al. 2012 Age  n=1898 High 
Ford, 2012 Age (older age is 
associated with better 
adherence) 
n=228  Moderate 
Hall et al., 2013 Age  n=287 Moderate 
Hopman, 2009 Age (older age is 
associated with better 
adherence) 
n=53  Moderate 
Kabbani et al., 2012 Age  n=679 High 
Kurppa, 2012 Age (older age is 
associated with better 
adherence) 
n=843  High 
Hall et al., 2009  Gender 1/71 (n=128)  6/71 (n=1806) Moderate/High 
Barratt, 2011 Gender  n=573 Moderate 
Hall, 2013 Gender  n=287 Moderate 
Hutchinson, 2010 Gender  n=284 High 
Kabbani et al., 2012 Gender  n=679 High 
Lee et al., 2012 Gender  n=2922) Low 
Hall et al., 2009  Social 
Class/socioeconomic 
status 
 2/21 (n=282) Moderate/High 
Barratt et al., 2011 An affluent 
background/wealthy 
achievers show better 
adherence 
n=573  Moderate 
Hall et al., 2009  Urban residence  1/11 (n=234)  Moderate/High 
Hall et al., 2009 Employment status / 
Occupation 
 2/21 (n=544) Moderate/High 
Hall et al., 2009  Marital status 1/11 n=154  Moderate/High 
Barratt et al., 2011 Marital status  n=225 Moderate 
Hall et al., 2009 Ethnicity 1/11 (n=87)  Moderate/High 
Kabbani, 2012 Ethnicity  n=679 High 
Errichello, 2010 Non-smokers had 
better adherence 
n=204   Moderate 
Note: 
1. The figures shown here indicate the number of studies included in the systematic review by Hall et 
al. (2009) in relation to a particular adherence factor. For example, for ‘Education’ two out of seven 
(2/7) studies from the Hall et al. (2009) systematic review showed an association between education 
and adherence to a GFD and five out of seven (5/7) studies showed no association between adherence 
and education.
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Knowledge, attitudes and beliefs 
Table 2.6 shows the results of the analysis for studies that report on 
knowledge, attitudes and beliefs in relation to adherence to a GFD. All of 
the factors relating to knowledge, attitudes and belief were identified in just 
five out of the 21 studies included in this systematic review update. There 
may be issues of the same or similar factors being labelled differently by 
different authors. I have grouped factors together in a way that seemed 
logical to me. 
 
Hall et al. (2009) and I both identified one study each that identified 
knowledge and understanding of a GFD as being associated with better 
adherence. One new study showed that improved awareness and 
understanding were believed to make adherence to a GFD easier. Therefore, 
it appears that knowledge and understanding is associated with better 
adherence to a GFD. 
 
Hall et al. (2009) identified two studies that investigated the association 
between reading food labels and adherence to a GFD. One of these studies 
was associated with adherence to a GFD and the other was not. In my 
update, I found one further study (N=278, low quality) that found reading 
food labels to be associated with better adherence to a GFD. 
 
Hall et al. (2009) found a study showing an association between adherence 
to a GFD and beliefs about the harm of exposure to gluten. Two new studies 
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showed evidence of association between worry about the long term impact 
of the disease with adherence and another new study showed no association. 
One new study showed an association between having a low belief in the 
cyclical nature of CD and better adherence to a GFD. Overall, it appears that 
beliefs about the seriousness of the consequences of non-adherence are 
associated with adherence to a GFD. 
 
A high quality study by Edwards-George (2009) (N=154) examined 
personality traits and found that higher conscientiousness, values, order, 
self-discipline and deliberation traits were all associated with better 
adherence. Another study by Sainsbury (2013a), which was larger (n=390) 
but of moderate quality, identified that intention to adhere, task orientated 
coping and emotion orientated coping were all associated with improved 
adherence to a GFD. Overall, it appears that personality trait, intention and 
coping style are associated with adherence to a GFD.  
 
Two new studies showed that self-efficacy was associated with better 
adherence. This may also be related to one study that showed that being 
prepared and organised was associated with better adherence. Additionally, 
a low quality study (N=278) (Sainsbury et al., 2011) showed that having the 
confidence to ask about contamination is associated with improved 
adherence. Trusting other people to prepare their food was associated with 
poorer adherence. 
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Overall knowledge, attitudes and beliefs are usually associated with 
adherence. However, reading food labels is unlikely to be associated with 
adherence. 
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Table 2.6 Knowledge, attitudes and beliefs (including results from Hall et 
al.’s (2009) systematic review) 
Authors Adherence factor Number of 
participants in 
studies that 
show an 
association 
with adherence  
Number of 
participants 
in studies 
that did not 
show an 
association 
with 
adherence 
Assessment of 
quality 
Hall et al., 2009 Understanding of gluten-free 
food 
1/11 (n=154)  Moderate/High 
Sainsbury et al., 
2011 
Knowledge of gluten-free 
ingredients was associated 
with better adherence 
n=278  Low 
Hall et al., 2013 Improved awareness and 
understanding was linked 
with better adherence 
n=287  Moderate 
Hall et al., 2009  Understanding and use of 
food labelling 
1/21 (n=87) 1/21 (n=234) Moderate/High 
Sainsbury et al., 
2011 
Reading food labels was 
associated with better 
adherence 
n=278  Low 
Hall et al., 2009 Beliefs about harm from 
exposure to gluten 
1/11 (n=154)  Moderate/High 
Ford, 2012 Belief in the serious 
consequences of non-
adherence was associated 
with better adherence 
n=288  Moderate 
Hall et al., 2013 Worry about the long-term 
impact of gluten consumption 
was associated with better 
adherence 
n=287  Moderate 
Sainsbury et al., 
2011 
Worry about the long-term 
impact of gluten consumption 
 n=278 Low 
Ford et al., 2012 Weaker belief in the cyclical 
nature of coeliac disease was 
associated with better 
adherence 
n=288  Moderate 
Edwards-
George, 2009 
Higher conscientiousness was 
associated with better 
adherence 
n=154  High 
Edwards-
George, 2009 
Higher values trait was 
associated with better 
adherence 
n=154  High 
Edwards-
George, 2009 
Higher order trait was 
associated with better 
adherence 
n=154  High 
Edwards-
George, 2009 
Higher self-discipline trait 
was associated with better 
adherence 
n=154  High 
Edwards-
George, 2009 
Higher deliberation trait was 
associated with better 
adherence 
n=154  High 
Sainsbury et al., 
2013a 
Intention to adhere was 
associated with better 
adherence 
n=390  Moderate 
Sainsbury et al., 
2013a 
Task oriented coping 
(problem solving) was 
associated with better 
adherence 
 
n=390  Moderate 
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Sainsbury et al., 
2013a 
Emotion oriented coping 
(feeling anxious or blaming 
oneself) was associated with 
better adherence 
n=390  Moderate 
Ford, 2012 Higher self-efficacy was 
associated with better 
adherence 
n=288  Moderate 
Hall et al., 2013 Higher self-efficacy was 
associated with better 
adherence 
n=287  Moderate 
Sainsbury et al., 
2011 
Being prepared and organised 
was associated with better 
adherence 
n=278  Low 
Sainsbury et al., 
2011 
Confidence to ask questions 
about contamination was 
associated with better 
adherence 
n=278  Low 
Sainsbury et al., 
2011 
Having trust in others to 
prepare GFF was associated 
with poorer adherence 
n=278  Low 
Note: 
1. Figures shown here indicate the number of studies included in the systematic review by Hall et al. 
(2009) in relation to a particular adherence factor. For example, for ‘Understanding of gluten-free 
food’ one study out of one (1/1) from the Hall et al. (2009) systematic review showed an association 
between understanding of gluten-free food and adherence to a gluten-free diet 
 
 
Illness and symptom factors 
Table 2.7 shows the results of the analysis for studies that report on illness 
and symptom factors in relation to adherence to a GFD.  
 
I identified two new studies examining time since CD diagnosis in relation 
to adherence, however, neither of these studies found an association with 
adherence to a GFD. Hall et al. (2009) found one small study (N=76) (out of 
three) that reported an association between adherence to a GFD and time 
since CD diagnosis. Overall, it is likely that time since CD diagnosis is not 
associated with adherence. 
 
Hall et al. (2009) reported that most studies in their systematic review found 
no association between age at diagnosis and adherence to a GFD. I 
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identified three new studies with more disparate results. Two of these 
studies reported that diagnosis at an older age was associated with better 
adherence to a GFD. There are now three studies that found an association, 
and six that found no association between age at diagnosis and adherence. 
So overall there is no strong evidence that age at diagnosis is associated 
with adherence to a GFD. 
 
Two studies in the review by Hall et al. (2009) found the presence of 
symptoms at diagnosis to be associated with adherence to a GFD and one 
study that did not find an association. I found three new studies relating to 
symptoms at diagnosis which showed no association with adherence to a 
GFD. Overall, symptoms at diagnosis is now a factor with inconsistent 
evidence to support it. 
 
Diagnostic delay was reported to be associated with adherence in one study 
(n=300) that was included in the review by Hall et al. (2009). I did not 
identify any further studies for this factor. 
 
Hall et al. (2009) identified inconsistent evidence regarding whether having 
CD symptoms was associated with adherence. I identified three further 
studies that were also inconsistent in their results. One of these three studies 
showed no association with the presence of symptoms at diagnosis (n=278). 
One study reported poorer adherence in individuals who had experienced 
symptoms in the past four weeks (n=154) and one study showed better 
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adherence in individuals who experience severe symptoms if gluten is 
consumed (n=390). In total four studies identified an association between 
CD symptoms and adherence to a GFD and five studies did not find an 
association, therefore, the evidence is inconclusive. 
 
The presence of additional food intolerances was found to be associated 
with better adherence in one study in Hall et al.’s (2009) systematic review.  
I identified one further study that also found this association (Edwards-
George et al., 2009). 
 
I identified one large (n=1018) high quality study that reported an 
association between body weight and adherence to a GFD. This study 
showed that having a normal body weight was associated with better 
adherence, whilst being overweight was associated with non-adherence. 
 
Overall, the level of symptoms, whether they led to a diagnosis, the time the 
person has had a diagnosis for CD, and at what age they received the 
diagnosis were not associated with adherence. The association between 
diagnostic delay and adherence to a GFD was evident in one study in the 
systematic review by Hall et al. (2009).  There are two small studies that 
suggest that having additional food intolerances may be associated with 
adherence. One study that suggests that a patient’s body weight is associated 
with adherence. 
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Table 2.7 Illness and symptom factors (including results from Hall et al.’s 
(2009) systematic review) 
Authors Adherence factor Number of 
participants in 
studies that 
show an 
association 
with adherence  
Number of 
participants in 
studies that did 
not show an 
association 
with adherence 
Assessment of 
quality 
Hall et al., 
2009 
Time since diagnosis 1/31 (n=76)2 2/31 (n=230)2 Moderate/High 
Barratt et al., 
2011 
Time since diagnosis  n573 Moderate 
Hall et al., 
2013 
Time since diagnosis  n=287 Moderate 
Hall et al., 
2009 
Age at diagnosis 1/61 (n=29)2 5/61 (n=1284)2 Moderate/High 
Hall et al., 
2013 
Age at diagnosis (those 
diagnosed as adults had better 
adherence) 
n=287  Moderate 
Hopman, 
2009 
Age at diagnosis (those 
diagnosed at an older age had 
better adherence) 
n=53  Moderate 
Hutchinson, 
2010 
Age at diagnosis  n=284 High 
Hall et al., 
2009 
Presence of symptoms at 
diagnosis 
2/31 (n=454)2 1/3 (n=154)2 Moderate/High 
Barratt et al., 
2011 
Presence of symptoms at 
diagnosis 
 n=573 Moderate 
Paavola, 2012 Screen detected/ symptom 
detected 
 n=576 High 
Kabbani, 2012 Type of symptoms present at 
diagnosis (gastrointestinal or 
extra-gastrointestinal) 
 n=679 High 
Hall et al., 
2009 
Diagnostic delay 1/11 (n=300)2  Moderate/High 
Hall et al. 
(2009) 
Coeliac disease symptoms 
experienced 
2/61 (n=590)2 4/61 (n=642)2 Moderate/High 
Edwards-
George (2009) 
Symptoms experienced in the 4 
weeks prior to the study was 
associated with poorer 
adherence 
n=154  High 
Sainsbury et 
al., 2011 
Coeliac disease symptoms 
experienced 
 n=278 Low 
Sainsbury et 
al., 2013a 
Higher severity of symptoms 
was associated with better 
adherence 
n=390  Moderate 
Hall et al., 
2009 
Presence of additional food 
intolerances was associated 
with better adherence 
1/11 (n=154)2  Moderate/High 
Edwards 
George et al.., 
2009 
Presence of additional food 
intolerances was associated 
with better adherence 
n=154  High 
Kabbani, 2012 Body weight (obesity higher in 
non-adherent group; normal 
BMI is higher in adherent 
group) 
n=1018  High 
Note: 
1. The figures shown here indicate the number of studies included in the systematic review by Hall et 
al. (2009) in relation to a particular adherence factor. For example, for ‘Time since diagnosis’ one out 
of three (1/3) studies from the Hall et al. (2009) systematic review showed an association between 
time since diagnosis and adherence to a gluten-free diet and two out of three (2/3) showed no 
association between adherence and time since diagnosis. 
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Healthcare treatment factors 
Table 2.8 shows the results of the analysis for studies that report on 
healthcare treatment factors in relation to adherence to a GFD. Hall et al. 
(2009) identified five studies that showed disparate results regarding the 
duration of following a GFD with adherence. Although there were four 
studies showing no association, the total number of participants in these 
studies (n=385) was not substantially larger than the one study that showed 
an association (n=200). I identified no further studies for this factor. 
 
I identified two new studies that showed that people who believe that 
following a GFD is difficult was associated with adherence, however, the 
results of these two studies were conflicting. One study (n=2922) found 
poorer adherence in those who believed the GFD was difficult to follow, 
whereas the other study (n=278) found poorer adherence in individuals who 
believe it is not difficult to eat a nutritionally balanced GFD. Hall et al. 
(2009) found one small (n=73) study that showed no association between 
adherence and perception of difficulty in following the GFD. Although my 
two new studies were large (total N= 3200) their quality was low and the 
conflicting findings lead me to conclude that there appears to be no 
association between perceived difficulty in following a GFD being 
associated with adherence. 
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Receiving GFF on prescription was a new factor that one moderate quality 
study by Hall et al. (2013) identified as being associated with better 
adherence to a GFD (N=287). 
 
In their systematic review, Hall et al. (2009) found inconsistent support for 
satisfaction with information from a healthcare provider being associated 
with adherence. I found no new studies in relation to this factor. 
 
I identified one new study that showed no association between attendance at 
a coeliac clinic and adherence to a GFD (n=413). This finding is in contrast 
to Hall et al. (2009) who found one study that showed an association 
between attendance at a coeliac clinic and adherence to a GFD (n=99). 
Overall there is inconsistent support to show that this factor is associated 
with adherence to a GFD. 
 
The regularity of follow-up was shown by Hall et al. (2009) to have 
inconsistent support for its association with adherence. I identified one more 
study that showed an association with adherence, and overall the balance of 
evidence does appear to be tending towards there being an association. In 
total, three studies (total N=764) reported an association between adherence 
and the regularity of follow-up and one study (N=207) did not find an 
association. 
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I identified one more study that showed that membership of a coeliac 
support group is associated with better adherence, which is in concordance 
with the two studies reported in the systematic review by Hall et al. (2009).  
 
Overall I have identified inconsistent support for duration of GFD, difficulty 
of GFD, satisfaction with information from healthcare providers, attendance 
at coeliac clinics and regularity of follow-up. There is limited evidence that 
provision of GFF on prescription may enhance adherence. There is 
increasingly strong evidence that membership of a coeliac support group is 
associated with better adherence to a GFD. 
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Table 2.8 Healthcare Treatment factors (including results from Hall et al.’s 
(2009) systematic review) 
Authors Adherence factor Number of 
participants in 
studies that 
show an 
association 
with adherence  
Number of 
participants in 
studies that did 
not show an 
association 
with adherence 
Assessment of 
quality 
Hall et al., 
2009 
Duration of gluten-free 
diet 
1/51 (n=200) 4/51 (n=385) Moderate/High 
Hall et al., 
2009 
Difficulty of gluten-free 
diet 
 1/11 (n=73) Moderate/High 
Lee, 2012 Finding the gluten-free 
diet difficult to follow 
was associated with 
poorer adherence 
n=2922  Low 
Sainsbury et 
al., 2011 
Belief that eating a 
nutritionally balanced 
gluten-free diet is not 
difficult was associated 
with poorer adherence 
n=278  Low 
Hall, 2013 Receiving gluten-free 
food on prescription 
was associated with 
better adherence 
n=287  Moderate 
Hall et al., 
2009  
Satisfaction with 
information from health 
care provider 
2/31 (n=321) 1/31 (n=154) Moderate/High 
Hall et al., 
2009 
Attendance at coeliac 
clinic 
1/11 (n=99)  Moderate/High 
Mahadev, 
2013 
Attendance at coeliac 
clinic (use of dietician) 
 n=413 Low 
Hall et al., 
2009 
Regularity of follow-up 2/31 (n=477) 1/31 (n=207) Moderate/High 
Hall, 2013 Receiving regular 
follow-up was 
associated with better 
adherence 
n=287  Moderate 
Hall et al., 
2009 
Coeliac support group 
membership 
2/21 (n=241)  Moderate/High 
Hall, 2013 Coeliac support group 
membership was 
associated with better 
adherence 
n=287  Moderate 
Note: 
1. The figures shown here indicate the number of studies included in the systematic review by Hall et 
al. (2009) in relation to a particular adherence factor. For example, for ‘Duration of gluten-free diet’ 
one study out of five (1/5) from the Hall et al. (2009) systematic review showed an association 
between duration of gluten-free diet and adherence to a gluten-free diet and four out of five (4/5) 
studies showed no association between adherence and duration of gluten-free diet. 
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Socio-cultural and environmental factors 
Table 2.9 shows the results of the analysis for studies that report on socio-
cultural and environmental factors in relation to adherence to a GFD. One 
small study (n=146) identified a new factor, eating convenience foods, as 
being associated with poorer adherence. 
 
Hall et al. (2009) identified inconsistent evidence that eating away from 
home was associated with adherence with one study showing an association 
with adherence and another showing no association. I identified five further 
studies (total n=3526) that all associated eating away from home with 
poorer adherence to a GFD. Overall the evidence suggests this factor is 
associated with adherence to a GFD. 
 
Having supportive family and friends was not associated with adherence to 
a GFD in the systematic review by Hall et al. (2009). I identified no further 
research on this factor. 
 
I identified four new studies examining the association of the availability of 
GFF with adherence, which added to the singular study identified by Hall et 
al. (2009). Overall, the evidence was inconsistent with three studies (n=499) 
showing an association with adherence and two studies (n=395) showing no 
association for this factor. 
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A new factor regarding the level of choice or restriction represented by a 
GFD was identified in two studies both of which found this to be associated 
with adherence. Hall et al. (2013) reported that having a better choice of 
GFF would improve adherence and participants in a larger study by Lee et 
al. (2013) reported a reason for non-adherence was because the GFD was 
too restrictive. These two studies provide evidence that having a larger 
choice of GFF is associated with improved adherence to a GFD. 
 
Hall et al. (2009) identified inconsistent evidence that the quality (e.g. taste 
and texture) of GFF was associated with adherence (one study was 
associated with adherence, one study was not). I identified three further 
studies (total n=3365) that all associated the quality of GFF with adherence. 
Overall the evidence suggests that the poor quality of GFF is associated 
with non-adherence to a GFD. 
 
The higher cost of GFF compared to non-GFF has inconsistent support in 
the evidence identified. Overall two studies (N=308) found no association, 
but four other studies (n=3599) did find an association. Overall the evidence 
suggests that the cost of GFF is associated with adherence to a GFD. 
 
Overall the availability of GFF is inconsistently associated with adherence. 
Having supportive family and friends has not been associated with 
adherence to the GFD. However eating convenience foods, eating away 
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from home, the choice of GFF, the quality of GFF and the cost of GFF are 
all associated with adherence. 
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Table 2.9 Socio-cultural/environmental factors (including results from Hall 
et al.’s (2009) systematic review) 
Authors Adherence factor Number of 
participants 
in studies 
that show an 
association 
with 
adherence  
Number of 
participants 
in studies 
that did not 
show an 
association 
with 
adherence 
Assessment of 
quality 
Black et al., 
2011 
Eating convenience foods was 
associated with poorer adherence 
N=146  Moderate 
Hall et al., 
2009  
Eating away from home 1/21 (n=154) 1/21 (n=234) Moderate/High 
Black et al., 
2011  
Eating away from home in 
restaurants/take-away was 
associated with poorer adherence 
N=146  Moderate 
Hall et al., 
2013 
Difficulty when eating out (unclear 
information) was associated with 
difficulty adhering 
N=287  Moderate 
Lee et al., 
2012 
Eating in restaurants was associated 
with non-adherence 
N=2922  low 
Sey, 2011 Eating away from home when 
travelling 
N=15  Moderate 
Smith, 2011 Eating away from home in 
restaurants and when travelling was 
reported to make adherence difficult 
N=156  Moderate 
Sainsbury et 
al., 2011 
Having supportive family and 
friends 
 N278 Low 
Hall et al., 
2009 
Availability of gluten-free food  1/11 n=241 Moderate/High 
Black and 
Orfila, 2011 
Poor  availability of gluten-free 
breakfast cereals was reported to 
make adherence difficult 
N=146  Moderate 
Edwards-
George et 
al., 2009 
Poor availability of gluten-free food 
was associated with poorer 
adherence 
 N=154 High 
Sverker et 
al., 2009 
Poor  availability of gluten-free 
food was associated with poorer 
adherence (hunger leads to gluten 
consumption) 
N=66  Moderate 
Hall et al., 
2013 
Improved availability of gluten-free 
food was believed to make 
adherence easier 
N=287  Moderate 
Hall et al., 
2013 
Improved choice of gluten-free food 
was believed to make adherence 
easier 
N=287  Moderate 
Lee et al., 
2013 
Belief that the gluten-free diet is too 
restrictive was associated with non-
adherence 
N=2922  Low 
Hall et al., 
2009 
Quality of gluten-free food 1/21 (N=154) 1/2 1(N=234) Moderate/High 
Hall et al., 
2013 
Participants believed that better 
quality of gluten-free food would 
make adherence easier 
N=287  Moderate 
Lee, 2012 Poor quality (taste) of gluten-free 
food was associated with non-
adherence 
N=2922  Low 
Smith, 2011 Poor quality (taste) of gluten-free 
food was associated with poorer 
adherence 
N=156  Moderate 
Hall et al., 
2009 
Cost of GFF (satisfaction with the 
price of GFF) 
1/21 (n=234) 1/21 (n=154) Moderate/High 
Edwards- Cost of gluten-free food  N=154 High 
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George et 
al., 2009 
Hall et al., 
2013 
The higher cost of gluten-free food 
was reported to make adherence 
difficult 
N=287  Moderate 
Lee et al. 
(2012) 
The higher cost of gluten-free food 
was associated with non-adherence 
N=2922  Low 
Smith, 2011 The higher cost of gluten-free food 
was associated with non-adherence 
N=156  Moderate 
Note: 
1. The figures shown here indicate the number of studies included in the systematic review by Hall et 
al. (2009) in relation to a particular adherence factor. For example, for ‘Eating away from home’ one 
of two studies (1/2) from the Hall et al. (2009) systematic review showed an association between 
eating away from home and adherence to a gluten-free diet and one study (1/2) showed no association 
between adherence and eating away from home. 
 
  
Quality of life and psychological well-being factors 
Table 2.10 shows the results of the analysis for studies that report on 
Quality of life and psychological well-being factors in relation to adherence 
to a GFD.  
 
Hall et al. (2009) identified inconsistent evidence for depression being 
associated with adherence. I also found inconsistent results, identifying 
three studies that showed an association between depression and non-
adherence (total n=822) and one large low quality study (n=2265) that 
showed no association between depression and adherence. Overall there is 
inconsistent evidence for any association between depression and adherence 
to a GFD. 
 
Having an eating disorder was a new factor that was associated with poorer 
adherence in one study (n=390) (Sainsbury et al. (2013a). 
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Five studies included in the systematic review by Hall et al. (2009) found no 
association between anxiety and adherence (total n=1696). I identified a 
further three studies (total n=3354) that all showed an association between 
anxiety and poor adherence to a GFD. Therefore, there is inconsistent 
evidence to support any association between anxiety and adherence to a 
GFD 
 
Hall et al. (2009) identified two studies that showed no association between 
mood or stress, anger, or psychological disturbance and adherence. I 
identified no new studies for these three factors. 
 
In the systematic review by Hall et al. (2009), five studies were reported to 
show an association between QoL and adherence to a GFD and two studies 
showed no association. In my update to this systematic review, I found QoL 
to be inconsistently associated with adherence. In a study by Lee et al. 
(2012) (n=2922) participants who are adherent to a GFD were reported to 
have a lower QoL, whereas Nachman (2010) and Sainsbury et al. (2011) 
reported reduced QoL in participants who are non-adherent. In total eight 
studies showed an association between QoL and adherence (n= 4882) and 
five studies did not (n=1656). The evidence suggests that there is not a 
strong relationship between QoL and adherence to a GFD. 
 
One new study by Ford et al. (2012) reported that wellbeing was not 
associated with adherence (n=288). No other studies reported on wellbeing 
in association to adherence to a GFD. 
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Overall the evidence for an association between adherence to a GFD and the 
factors in the area of quality of life and psychological well-being is not 
strong. One study found an association between eating disorders and 
adherence to a GFD. 
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Table 2.10 Quality of life and psychological well-being (including results 
from Hall et al.’s (2009) systematic review) 
Authors Adherence factor Number of 
participants in 
studies that 
show an 
association 
with adherence  
Number of 
participants in 
studies that did 
not show an 
association with 
adherence 
Assessment of 
quality 
Hall et al., 2009 Depression 1/31 (n=66) 2/31 (n=540) Moderate/High 
Edwards George 
et al., 2009 
Depression was associated 
with poorer adherence 
n=154  High 
Sainsbury, 2011 Depression was associated 
with poorer adherence 
n=278  Low 
Sainsbury, 2013a Depression was associated 
with poorer adherence 
n=390  Moderate 
Van Hees, 2013 Depression  n=2265 Low 
Hall et al., 2009 Presence of psychological 
disturbance 
 1/11 (n=154) Moderate/High 
Sainsbury, 2013a Eating disorders were 
associated with poorer 
adherence 
n=390  Moderate 
Hall et al., 2009 Anxiety  5/51 (n=1696) Moderate/High 
Edwards George, 
2009 
Anxiety was associated with 
poorer adherence 
n=154  High 
Lee, 2012 Anxiety (uncomfortable in 
social settings) was associated 
with poorer adherence 
n=2922  Low 
Sainsbury, 2011 Anxiety (worry about 
inconveniencing or offending 
other people associated with 
poorer adherence) 
n=278  Moderate 
Hall et al., 2009 Anger  1/1 (n=139) Moderate/High 
Hall et al., 2009 Mood or stress  1/1 (n=154) Moderate/High 
Hall et al., 2009 Quality of life 5/71 (n=1559) 2/71 (n=507) Moderate/High 
Ford et al., 2012 Quality of life  n=288 Moderate 
Lee et al., 2012 Quality of life was lower in 
adherent participants 
n=2922  Low 
Nachman, 2010 Quality of life was lower in 
non-adherent participants  
n=123  High 
Barratt et al., 
2009 
Quality of life  n=573 Moderate 
Sainsbury, 2011 Quality of life was lower in 
non-adherent participants 
n=278  Low 
Ford et al., 2012 Wellbeing  n=288 Moderate 
Note: 
1. The figures shown here indicate the number of studies included in the systematic review by Hall et 
al. (2009) in relation to a particular adherence factor. For example, of the three studies from the Hall 
et al. (2009) systematic review that showed results for depression, one of the three studies (1/3) 
showed an association between depression and adherence to a gluten-free diet and the other two (2/3) 
showed no association between adherence and depression. 
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2.5 Discussion 
 
Since the previous systematic review search was carried out in 2007 by Hall 
et al. (2009) several new studies reporting on factors affecting adherence to 
a GFD have been published This update to Hall et al.’s (2009) systematic 
review identified 21 new studies. In this section, I present a brief discussion 
of the results of this systematic review. A fuller discussion of the results will 
be presented in the discussion chapter of this thesis along with the results of 
my concept mapping study.  
 
In the systematic review by Hall et al. (2009) levels of strict adherence to a 
GFD was found to vary considerably (range = 42% to 91% adherence). In 
my update to Hall et al.’s (2009) review, I also found that adherence to a 
GFD was variable (range = 44.2% to 100% adherence). However, the one 
study that reported 100% adherence had an inclusion criterion that only 
allowed adherent participants to be recruited (Sey et al., 2011). Two other 
studies reported high levels of adherence to a GFD at 98% (Lee et al. 2012) 
and 96% (Black & Orfila, 2011). However, Lee et al. (2012) highlighted the 
fact that participants had over-estimated their level of adherence with a 
‘surprising number’ later admitting to dietary transgressions. Similarly, a 
study by Leffler et al. (2008), which was included in the systematic review 
by Hall et al. (2009) found that participants tended to over-report their level 
of adherence to a GFD. It is likely that this over-estimation of adherence 
also occurred in other studies included in this systematic review. Further, it 
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is known that members of CD advocacy groups tend to be better at adhering 
to a GFD (Leffler et al., 2008). As several of the studies included in this and 
the previous systematic review recruited participants from coeliac advocacy 
groups, it is possible that the levels of adherence presented here are lower 
than those seen in the wider population of adults with CD. In addition, 
individuals who volunteer to take part in research may be more likely to be 
adherent to a GFD. Therefore, the true rates of non-adherence may be far 
higher than is reported in this systematic review. 
 
This systematic review found no consistent relationship between adherence 
and demographic factors, which supports the findings from the previous 
systematic review by Hall et al. (2009). Education, age, gender, social class, 
employment status, marital status and ethnicity do not appear to be 
associated with adherence to a GFD. Further evidence is needed in relation 
to the association between smoking and adherence to a GFD. 
 
Studies have examined a number of factors relating to knowledge and 
understanding in relation to adherence to a GFD. Being knowledgeable 
about the GFD and understanding the consequences of no-adherence appear 
to be associated with better adherence. However, no association was found 
between adherence to a GFD and understanding or reading food labels. 
There may be a need for better education in relation to CD and the GFD.  
 
Personality traits and self-efficacy were associated with adherence to a 
GFD. Developing patients’ organisational skills, teaching them the skills 
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needed to confidently ask for GFF when eating away from the home may 
help to improve adherence to a GFD.  
 
Interestingly, having trust in others to prepare GFF was associated with 
poorer adherence. The authors suggest this is related to being less vigilant in 
relation to avoiding gluten (Sainsbury et al., 2011). 
 
Factors relating to illness and symptoms vary in their association with 
adherence to a GFD. No association was found between adherence and time 
since diagnosis, age at diagnosis, the presence of symptoms at diagnosis or 
the presence of symptoms when gluten is consumed. One study from the 
previous systematic review by Hall et al. (2009) reported that diagnostic 
delay was associated with adherence to a GFD. However, this is based on 
just one study and more evidence is needed. 
 
Having an additional food intolerance may be associated with better 
adherence to a GFD. However, the reason for the association with adherence 
is not reported and further research is needed. Investigations into the 
association between body weight and adherence to a GFD suggest that 
obesity is linked with poorer adherence. This evidence is based on just one 
study, however, the study was judged to be of high quality and it included a 
large population (n=1018).  
 
The provision of GFF on prescription in the UK is thought to make it easier 
for people with CD to follow a GFD (Coeliac UK 2013d). One UK study 
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reported that receiving GFF on prescription was associated with better 
adherence to a GFD. Although this evidence is based on just one study 
(n=287), it does support Coeliac UK’s argument against the recent cutbacks 
in prescribed GFF (Coeliac UK 2013b). 
 
No association was found between adherence to a GFD and the duration of 
the GFD or perceiving the GFD to be difficult.  
 
Healthcare professionals are responsible for providing the patients with 
information and advice at the time of CD diagnosis and it is recommended 
that patients are regularly reviewed after this time. The regularity of follow-
up with healthcare professionals was associated with better adherence in this 
review and it is possible that healthcare for people with CD may need to 
improve in order to increase adherence to a GFD.  This review did not find 
strong evidence of an association between adherence and satisfaction with 
the information received from healthcare professionals or attendance at a 
coeliac clinic. 
 
Coeliac support groups are available in several countries and this systematic 
review provides strong evidence that membership to a support group is 
associated with better adherence to a GFD. However, the direction of 
causality is not known and it is possible that those people who are better at 
sticking to a GFD are more likely to join a coeliac support group than those 
who are non-adherent. 
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Travelling and eating away from the home can be problematic for people 
with CD and the evidence from my review shows that eating away from 
home is linked with poorer adherence. Poor awareness of CD by staff in 
restaurants (Karajeh et al., 2005) and poor availability of GFF when eating 
away from the home can make adherence to a GFD difficult. People with 
CD were reported to have difficulties with adhering to a GFD because it is 
restrictive with limited choice. These findings suggest that better provision 
of GFF is needed for people with CD when eating outside of the home. 
However, the availability of GFF was a factor that was not associated to 
adherence to a GFD. 
 
Although it is claimed that the quality of GFF has improved in recent years, 
evidence from this systematic review highlights the ongoing dissatisfaction 
with the taste and texture of GFF and this is linked with poorer adherence. 
Olsson et al. (2008) found that the poor sensory qualities of GFF was linked 
with non-adherence in Australian adolescents. Patients are often unwilling 
to give up their favourite gluten-inclusive foods because they taste better 
than comparable GF products (Stuckey, 2008). 
 
One of the barriers to adherence to a GFD may be the high cost of substitute 
gluten-free foods (Cureton 2007). The cost of speciality GFF is usually 
more expensive than gluten-inclusive equivalent foods (Lee et al., 2007) 
and the high price of GFF has been found to be associated with non-
adherence to a GFD. In the UK, prescribed GFF is provided to patients with 
a CD diagnosis and this is believed to bring the cost of a GFD in line with a 
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gluten-inclusive diet. In this systematic review, one study that reported the 
high cost of GFF as a barrier to adherence was conducted in the UK. The 
other new studies that associated cost with adherence were conducted in the 
USA where GFF is not provided through the healthcare system. 
 
Adhering to a GFD in the face of psychological problems, may be 
particularly challenging, however, the link between psychological 
symptoms and GFD adherence is tenuous. Contradictory evidence exists in 
relation to the association between depression and anxiety and adherence to 
a GFD. Although some studies found depression and anxiety to be related to 
poorer GFD adherence, the direction of causality is unknown. 
 
Although several studies have reported on the relationship between QoL and 
adherence to a GFD, the evidence is contradictory and more research is 
needed.  
 
This systematic review has some limitations. Nine different countries were 
represented in the studies included in this review. It is likely that people 
with CD will experience different problems associated with following a 
GFD depending on the country in which they the live. For example, some 
countries may provide better healthcare and resources for CD patients and 
this may affect the types of problems faced by people trying to follow a 
GFD. In the UK, GFF is provided on prescription, and this mitigates some 
of the costs associated with following a GFD. Furthermore, the availability 
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of GFF is likely to vary between countries. These differences could explain 
some of the conflicting findings reported in this systematic review.  
 
Another limitation is the differences between how adherence to a GFD is 
assessed and defined. This makes it difficult to make comparisons between 
studies. The reliability of the methods of measuring adherence to a GFD 
was generally poor. Self-reported adherence is not regarded as a reliable 
measure, however, this method was used in several of the studies included 
in this and the previous systematic review. There is a requirement for further 
research to identify the true levels of adherence to a GFD using more 
reliable means of assessment. In addition agreement on what constitutes 
adherence to a GFD is needed.  
 
Much of the research into the factors affecting adherence to a GFD in 
coeliac patients has produced conflicting results. In summary, this 
systematic review found that the factors affecting adherence to a GFD 
include knowledge and understanding of CD and the GFD, self-efficacy, 
organisational skills, the presence of additional food intolerances, body 
weight, the provision of GFF on prescription, membership of a coeliac 
advocacy group, eating away from the home and the cost and quality of 
GFF. I have been unable to find conclusive evidence about many of the 
factors reported in relation to adherence to a GFD and further studies are 
required. Additionally the relative importance of these factors to dietary 
adherence is not clear, thus making targeting of an adherence intervention 
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difficult, as it is impossible to currently know which factors have the 
greatest impact on adherence behaviours. 
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Chapter 3: Methods 
 
3.1 Introduction 
 
“The best way to have a good idea is to have a lot of ideas” 
Linus Pauling. 
 
Concept mapping is a mixed methods participatory approach that allows the 
views of participants from multiple stakeholder groups to be explored. In 
this study, participants were recruited from three stakeholder groups who 
were experienced in coeliac disease (CD): adults with CD; adults who live 
with them (household members); and healthcare professionals who work 
with adult coeliac patients. 
 
In the first part of this chapter I provide a rationale for selecting concept 
mapping as an effective method for investigating the factors affecting 
adherence to a gluten-free diet (GFD). Comparisons are made between 
concept mapping and alternative methods that were considered for this 
study. In the remainder of this chapter I explain how the six-step concept 
mapping process was used to plan the study, gather and analyse the data and 
in interpreting the results. 
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3.2 Steering group 
 
A steering committee was set up to guide decisions about how this project 
was conducted from start to end. Along with myself, the steering group 
consisted of: two PhD supervisors (KD and RG); two representatives from 
Coeliac UK (NM and LM (LM was later replaced by HU); a 
Gastroenterologist (IF) working at Norfolk and Norwich University 
Hospital (NNUH); two experts in the concept mapping method (SS and AI) 
and a lay advisor with CD (GN).  
 
This expert panel included representatives from each of the three 
stakeholder groups that participated in this study: Two members have CD; 
one has a wheat intolerance; one member lives with an adult who has CD; 
and one is a health care professional working with adult coeliac patients. I 
invited our lay advisor to all steering group meetings but, unfortunately, he 
could only attend one.  
 
Having a steering group helped to ensure that service-user views and expert 
opinion were taken into account in the design and conduct of this study. As 
Chief Investigator, I was responsible for chairing the meetings and ensuring 
steering group members were clear about the aims of the project. 
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3.3 Choice of method 
 
To achieve the aims of this study it was important to select the most 
appropriate research method. The primary aim of this study was to gain a 
better understanding of the factors affecting adherence to a gluten-free diet 
(GFD). A further aim was to uncover differences and similarities in the 
views of three stakeholder groups (adults with CD; household members; and 
healthcare professionals).  
 
3.3.1 Potential methods of investigation 
 
To understand health behaviour, it is necessary to listen to the people whose 
behaviour we want to change. Currently, little is known about the impact of 
CD on daily living from patients' perspectives (Ukkola et al., 2012). In order 
to get a better understanding of the problems encountered by patients in 
relation to sticking to a GFD, I endeavoured to select a method that would 
allow me to collect patients’ views. In addition, I also wanted to gather the 
perspectives of other stakeholders who have close contact with people with 
CD.  
 
The views of people who live with coeliac patients was deemed to be 
important for this study because these individuals are likely to have 
experience of what life is like for the person with CD, how they cope with 
avoiding gluten and what causes them to be non-adherent. Household 
 126 
 
members may also be more willing to disclose information relating to non-
adherence than patients.  
 
I also wanted to collect the views of healthcare professionals who work with 
adult coeliac patients because they are likely to have a good insight into the 
patients’ views about what helps them to stick to their GFD. Healthcare 
professionals are likely to work with a diverse range of coeliac patients and 
I felt this would be a useful way of collecting information about the factors 
affecting adherence from a broader perspective. 
 
The steering group met to discuss ideas about the most appropriate research 
method for this study. From the five methods that were considered as 
potential approaches, concept mapping was selected as the most appropriate 
for achieving the study’s aims. In addition, concept mapping was deemed to 
be a suitable method for working within the resources available for this 
study. 
 
Mixed methods research has gained support in recent years and it can draw 
on the strengths from both qualitative and quantitative methods. Mixed 
methods research is useful for obtaining rich, subjective data and 
transferring it into a useful quantitative format. A mixed methods approach 
was suggested during the steering group meeting as a useful method for 
understanding the complexities of dietary behaviour and developing the 
results in a quantifiable way that can be used to develop a model of 
adherence for use in an intervention.  
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Table 3.1 shows the criteria used in selecting the most appropriate research 
method. Unlike some studies into adherence to a GFD, I wanted to avoid 
using pre-determined questionnaires as this would not allow participants to 
generate new ideas in relation to what helps them stick to a GFD. 
 
Table 3.1 – Criteria for confirming the most appropriate research method 
for this study 
 Comparisons can 
be easily made 
between 
stakeholder groups 
Data is easily 
quantifiable 
Identifies new 
adherence factors, 
rather than pre-
determined factors 
Concept Mapping 
 
Yes Yes Yes 
Focus Groups 
 
No No Yes 
Interviews 
 
No No Yes 
Questionnaires 
 
Yes Yes No 
Delphi technique 
 
No No No 
 
 
Concept mapping uses sophisticated multivariate analysis to produce 
quantitative results which are presented in the form of easily interpreted 
visual maps. These maps can be used to guide the development of an 
adherence intervention. Focus groups are a less sophisticated 
conceptualisation approach which, unlike concept mapping, does not 
generate a well-defined set of quantitative results (Kane & Trochim, 2007). 
 
Interviews can be a useful method for gaining a deeper insight into complex 
human behaviour. However, interviews are time consuming, open to bias 
and the results are not usually quantifiable. Questionnaires can be a useful 
way of collecting quantifiable data. However, questionnaires relating to 
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adherence to a GFD mostly rely on using pre-determined adherence factors 
identified in previous studies, rather than allowing participants to freely 
determine the influences on adherence to a GFD. The questionnaires 
designed by (Leffler et al., (2008) and Butterworth et al. (2007) are 
examples of this.  
 
Both the Delphi technique and concept mapping involve participants who 
are considered to be expert in the subject being explored. The Delphi 
technique is useful for gaining consensus on things such as healthcare 
policies and guidelines. The Delphi technique was deemed to be 
inappropriate for this study because it does not represent a range of ideas in 
a framework that can be used for planning an intervention. In addition, the 
Delphi technique would not produce data that would allow comparisons to 
be made between different stakeholder groups. 
 
Concept mapping was successfully used in a previous adherence study 
which investigated adherence to medication in people with schizophrenia 
(Kikkert et al., 2006). This study used three stakeholder groups with 
approximately 25 participants in each group. The success of this study 
confirms that concept mapping is a suitable method for investigating 
adherence to treatment and it provides a useful framework for the design of 
this study. 
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3.4 Background to concept mapping 
 
Concept mapping is a participatory mixed methods approach that was 
developed by Trochim in the 1980s (Kane & Trochim, 2007). This 
participatory mixed methods approach is designed to increase understanding 
of complex topics, such as health behaviour. The method involves 
participants at each stage of a six step process and seeks to yield an 
interpretable visual map of their ideas. Statements generated during 
brainstorming are sorted in order of priority and clustered into themes by 
participants. Data are analysed to produce interpretable concept maps. The 
topology of thoughts and ideas generated from this study can be used to 
guide the development of a novel adherence intervention for people with 
CD. This will be the first study to explore the factors affecting adherence to 
a GFD in adults with CD using concept mapping. 
 
3.5 The six steps in concept mapping 
 
3.5.1 Step 1: Preparing for concept mapping 
 
Planning the project 
Concept mapping commences with the development of a focus for the study 
and the identification of suitable stakeholder groups from which samples of 
participants can be recruited (Kane & Trochim 2007). This step also 
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involves making preparations for the remaining steps in the concept 
mapping process.  
 
Deciding on the focus 
Concept maps are constructed in reference to a particular focus question on 
a topic that is familiar to the participants (Novak & Canas, 2008). To 
achieve the aim of this study, the task for the steering group was to decide 
on a focus question, or prompt, that would generate responses from 
participants during brainstorming in answer to the research question. The 
focus statement was also used during the statement sorting exercises 
(prioritising and clustering) and was intended to act as an instruction or 
prompt for responses from participants. Ideas for the focus question were 
discussed during a meeting with members of the steering group and the 
group arrived at a decision to use the following focus prompt: 'It would be 
easier for adults with coeliac disease to stick to a gluten-free diet if…'. The 
prompt was designed to encourage only relevant statements to be generated. 
 
Ethical approval 
An ethics application was drawn up which included a study protocol and 
several participant documents (Appendices 4 to 22). A positive opinion was 
gained from the North East – Newcastle and North Tyneside 2 Research 
Ethics Committee (Appendix 23). A research and development application 
was also approved by the NNUH and Norfolk PCT (Appendix 24). 
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Recruitment 
Concept mapping projects are most successful when they involve a wide 
variety of relevant people (Kane & Trochim, 2007). The steering group 
identified three key stakeholder groups with expert knowledge about the 
topic of interest. These were: adult coeliac patients, adults who live with 
them (household members) and healthcare professionals who work with 
adult coeliac patients. Kane & Trochim (2007) suggest that there is no strict 
limit concerning the number of participants included in a concept mapping 
study. Successful concept generation has been conducted with one lone 
participant, and also groups of 75-80 people.  
 
I based my recruitment strategy on that employed by Kikkert et al. (2006) 
who conducted a concept mapping study to investigate adherence to 
medication in schizophrenia. This study included 27 patients; 29 carers and 
28 healthcare professionals. I aimed to recruit 25 adult patients with CD, 25 
adults who live with an adult who has CD (household members) and 25 
healthcare professionals who work with adult coeliac patients. Although it 
was not possible to do a power calculation for this study, I felt confident that 
I would reach data saturation with a population of 75 participants. Sainsbury 
& Mullan (2011) interviewed 13 participants on factors affecting adherence 
to a GFD and 30 out of the 36 items raised were endorsed by five or more 
people and the remaining six were endorsed by  either three or four people, 
suggesting data saturation. 
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To help me collect a diverse range of opinions relating to the factors 
affecting adherence to a gluten-free diet, I sought to recruit patients with 
varying levels of adherence to a GFD. In the context of this study, the term 
‘adherence’ refers to the life-long exclusion of gluten from the diet. 
Although foods labelled as ‘gluten-free’ or ‘low in gluten’ often contain 
small amounts of gluten, consumption of these products is not regarded as 
non-adherent. The reason for this is that the gluten content is thought to be 
too low to trigger a response and the use of these products is recommended 
by healthcare professionals (Food Standards Agency, 2012).  
 
In this study I only regarded those people who knowingly consume gluten 
as being non-adherent. A problem with this definition is that some people 
who regard themselves to be adherent may be unaware that they are 
inadvertently consuming gluten (Hall et al., 2013). Reasons for this could be 
that they are consuming ‘hidden gluten’, as described in Section 1.3.6, their 
food may be contaminated with gluten or they may be misinformed about 
which products do or do not contain gluten. Unfortunately, this limitation in 
my definition of adherence to a GFD cannot easily be avoided, particularly 
when using self-reporting to measure adherence, as I am doing in this study.  
 
Due to financial constraints, the steering group agreed that adherence should 
be self-reported by participants, rather than being confirmed through clinical 
testing, which is costly. To establish the level of adherence to a GFD in 
potential participants with coeliac disease were asked to report their level of 
adherence on a 3-point Likert scale. This measure has been used in several 
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previous studies into adherence to a GFD (Hall et al., 2009). Participants 
were asked to select from the following statements the one that was most 
relevant to them: 
 
1). I always stick to a strict gluten-free diet  
2). I occasionally consume food/drinks containing gluten 
3). I do not follow a gluten-free diet 
 
The inclusion criteria for each stakeholder group is shown in Table 3.1. 
 
Table 3.1 - Inclusion criteria for the recruitment of participants from three 
stakeholder groups 
 
Adults with coeliac 
disease 
Household members Healthcare professionals 
 
  All participants must be aged >18 years 
All participants must be capable of giving informed consent 
Because the method involves agreeing the wording of statements, only English speaking 
participants will be enrolled 
 
Has been medically 
diagnosed with coeliac 
disease 
Must have lived with an 
adult with coeliac disease 
for at least 1 year 
Currently working with at 
least 1 adult patient with 
coeliac disease 
  Has at least one year's 
experience of working with 
coeliac patients 
 
 
Early in the study, the steering group agreed that recruitment should be 
within a 10 mile radius of Norwich. This would make it more convenient for 
participants attending group data collection sessions at the University of 
East Anglia. As we were offering to refund travel expenses, this strategy 
would help to keep expenses to a minimum. However, I later decided to 
extend the recruitment area to the whole of England and Wales when I 
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found recruitment of healthcare professionals and partially- or non-
adherence participants with CD to be slow. All participants who lived 
outside 10 miles of Norwich were invited to complete the data collection 
exercises remotely by email or post. Participants who lived further than 10 
miles away from Norwich were advised that they were welcome to join the 
group sessions, but that we would not be able to refund their travel 
expenses. I gained approval for this change to the study design from the 
North East – Newcastle and North Tyneside 2 Research Ethics Committee 
(Appendix 25). 
 
Seven methods of recruitment were used in this study: 
 
1. Invitation letters posted by Coeliac UK 
Coeliac UK has approximately 1000 Members living within 10 miles of 
Norwich (Postcodes: NR1-NR10; NR12-NR16 and NR18). This includes 
both rural and urban areas. It would not have been appropriate for me to 
send invitation letters to all 1000 Coeliac UK Members as I only aimed to 
recruit 25 participants with CD. I agreed with the steering group and Coeliac 
UK that a random sample of 100 members was a sufficient number to invite. 
Computer randomisation was used by Coeliac UK to select 100 of their 
adult Members with CD in the Norwich area. Invitation letters (Appendix 6) 
were distributed by post to this random selection of Coeliac UK Members. 
To avoid the need for me to gain access to personal information, invitation 
letters were sent out by Coeliac UK on my behalf. A reply slip and a 
postage paid return envelope were enclosed. 
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Coeliac UK Members who responded to the invitation letter were sent a full 
information pack by post (Appendices 7, 12, 15, 18 and 21) along with an 
information pack addressed to ‘Household Member’ (Appendices 9, 13, 16, 
19 and 22). The patient information pack consisted of an invitation letter, an 
information sheet, a consent form, a self-assessment of adherence and a 
postage paid return envelope. People with CD were asked to identify an 
adult in their household who might be interested in participating in the study 
and to pass on the household member's pack to that person. 
 
2. Invitation packs distributed by Norfolk and Norwich University 
Hospital (NNUH). 
Invitation packs were handed to patients with CD during outpatient 
consultations at NNUH. Community dietitians were given invitation packs 
to distribute to non-adherent patients who they came in contact with during 
their working activities. These invitation packs also contained a household 
member's pack. 
 
3. Press release in two local newspapers. 
Not all coeliac patients join Coeliac UK, and patients referred to NNUH are 
normally discharged after diagnosis and proof of adherence to a GFD. 
Therefore to pick up a more representative population of people with CD, I 
put an advertisement in two local newspapers (The Eastern Daily Press and 
the Norwich Evening News) to invite partially-adherent and non-adherent 
people with CD and household members to participate in this study 
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(Appendix 26). This was done after I had recruited a sufficient number of 
adherent participants.   
 
4. Advertisement on Coeliac UK website. 
An advertisement for the project was placed on the Coeliac UK website 
(Appendix 27). This targeted healthcare professionals, partially-adherent or 
non-adherent people with CD and household members. This was done after 
I had recruited sufficient adherent participants.   
 
5. Advertisements on the University of East Anglia website. 
An advert for the project was placed on the University of East Anglia’s 
website (Appendix 28). This targeted healthcare professionals, partially-
adherent or non-adherent people with CD and household members. This was 
done after I had recruited sufficient adherent participants.   
 
6. E-mail to the British Dietetic Association (BDA) Gastroenterology 
Specialist Group. 
An e-mail to the BDA Gastroenterology Specialist Group was sent by 
Coeliac UK to invite healthcare professional members who work with 
coeliac patients to participate in the study (Appendix 29). Interested 
professionals were invited to contact me to request an information pack. 
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7. Invitation packs posted to GP practices in Norfolk. 
One hundred and twelve invitation packs were posted to GPs, GP assistants, 
Nurse Practitioners and Practice Nurses working in GP surgeries listed on 
the PCT (now CCG) website as being within 10 miles of Norwich.  
 
Effort was made to ensure diversity within the group of participants. The 
information packs contained a short questionnaire which captured 
demographic data from participants. For the patient group, I also captured 
some clinical data, including self-reported level of adherence to a GFD 
(Appendices 15 to 17). Table 3.2 shows a list of participant characteristics 
captured by the questionnaires. I also asked participants to inform me about 
their availability for attending the group brainstorming and statement sorting 
sessions. 
 
Table 3.2 Recorded Participant Characteristics 
 
Adults with coeliac disease Household members Healthcare professionals 
Age 
Gender 
Ethnicity 
Level of education 
Level of adherence to a GFD 
Age 
Gender 
Ethnicity 
Level of education 
Gender 
Profession 
 
Informed consent was obtained from all participants. This was done face-to-
face for patients and household members living in the Norwich area and by 
telephone and post for those living outside of the Norwich area. All 
healthcare professionals were assumed to have a high level of competency 
and, therefore, consent was completed by post. 
 
 
 138 
 
Confidentiality 
To maintain participant anonymity, random 3-digit participant reference 
numbers were generated using a random-three-digit code selector. Any 3-
digit numbers generated that were too memorable (e.g. 999) were not used.  
Reply slips and consent forms were stored securely in a locked filing 
cabinet inside a locked room at the University of East Anglia. Electronic 
documents were password protected and stored on a University of East 
Anglia computer with password security. Participants were allocated a 3-
digit reference number and this was used in place of the participant's name 
whenever relevant. 
 
Preparation for the next steps 
During Step 1, action was taken to prepare for the following steps in the 
concept mapping process. The steering group members agreed that the 
University of East Anglia would be a suitable venue to host the group 
meetings with participants. The venue provided free car parking, 
refreshment facilities, disabled access, toilet facilities and good public 
transport links. 
 
I contacted participants who had indicated that they wished to attend the 
group sessions to advise them of the dates when the meetings would be 
held. The dates were scheduled to accommodate the availability of as many 
participants as possible as they had indicated on their reply slips 
(Appendices 21 and 22). Participants were also given the option to complete 
brainstorming remotely by e-mail or post if they preferred to do so. To 
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reduce the likelihood of drop-out or disruption at the start of the group 
sessions, reminder letters were sent out to participants in advance (Appendix 
31). This letter contained information about travel to the venue with a map, 
venue details and a travel expenses claim form. 
 
To ensure that participant attending the group brainstorming sessions were 
given the opportunity to contribute their ideas, I included a maximum of 
eight participants in each group brainstorming session. This also helped me 
to ensure that perspectives on adherence to a GFD were explored in depth. 
All adults with coeliac disease and household members were invited to 
either attend group brainstorming sessions with other participants at UEA or 
to complete brainstorming remotely by post or e-mail. To encourage 
recruitment and prevent drop out from a group that proved difficult to 
recruit, all health professionals were invited to complete brainstorming 
remotely and no group sessions were held for this group. 
 
To ensure consistency in the information that was provided during group 
sessions, a script was designed which included instructions to participants 
(Appendix 31). For those completing the tasks remotely, instructions were 
posted or e-mailed according to participants’ preferences. The steering 
group agreed on a list of prompts that could be used during group 
brainstorming if the flow of ideas dried up (Appendix 31). These prompts 
were based on evidence taken from the literature. 
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In preparing for the group brainstorming and statement sorting sessions, I 
sent e-mails or letters to 28 gluten-free food (GFF) manufacturers to request 
donations of gluten-free (GF) products so that I could provide participants 
with snacks during the group sessions (Appendix 32). Nine companies 
donated products which enabled me to provide participants with snacks 
during the group sessions. 
 
3.5.2  Step 2: Brainstorming 
 
Concept mapping begins with a structured brainstorming session where 
participants are asked to generate statements in response to a focus prompt. 
The focus prompt used in this study was:  ‘It would be easier for adults with 
coeliac disease to stick to a gluten-free diet if…’. Participants were asked to 
brainstorm their ideas in response to this focus prompt until all ideas were 
exhausted.  
 
Participants who completed brainstorming remotely by post or e-mail were 
asked to record as many statements as they could think of in response to the 
focus prompt. Responses were returned to me by post or e-mail. 
 
Group brainstorming sessions were held for adults with CD and household 
members. Where sessions were held at the same time for these two groups 
of stakeholders, separate rooms were used. The sessions were facilitated by 
one of four members of the research team (HF, KD, SS or AI) with another 
of the four members acting as an assistant. All facilitators were given the 
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same set of instructions. Written and verbal instructions were provided to all 
participants at the start of the session. The time allowed for all group 
brainstorming sessions was 2 hours. The facilitator read out instructions at 
the start of the session and used prompts from a list (taken from the existing 
literature) if the session dried up (Appendix 31). The assistant wrote the 
statements up on a flip-chart and pinned the statements on the wall where 
they could be viewed throughout the session. The duration of the 
brainstorming sessions was two hours with 15 minute refreshment break 
half way through. 
 
In a concept mapping study by Bayer et al. (2010), it was recognised that 
participants did not participate in the first brainstorming session during 
research into adolescent sexuality. It was suggested that this may be due to 
the fact that some adolescents may have felt too embarrassed to raise certain 
issues in relation to their sexuality. However, in subsequent brainstorming 
sessions, participants were given the opportunity to write responses 
individually and this modification ‘catalysed’ the generation of statements. 
In the current study, participants were given a pen and some paper to use 
during brainstorming sessions so that they could contribute any statements 
that they didn’t wish to disclose to the group or if they thought of something 
while someone else was speaking and did not want to forget it. This helped 
to ensure that only one person spoke at a time, which helped to ensure no 
statements were missed or not picked up on the audio recording. 
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Participants were encouraged to generate as many statements as they could 
think of during brainstorming and criticism of other people’s statements was 
discouraged. Participants were advised that, if they disagreed with a 
statement, then they could raise a counter statement.  
 
Data were collected by e-mail or post from participants who did not take 
part in group sessions.  
 
3.5.3 Step 3: Structuring the statements 
(prioritising and clustering) 
 
Statement reduction 
The steering group met to review the full set of statements generated by all 
participants. The aim of this meeting was to ensure the final set of 
statements was 98 or fewer The Ariadne® software package for concept 
mapping (NcGv/Talcott, 1995) can only accept a maximum of 98 
statements). This was achieved by synthesising statements that were the 
same or similar and by excluding statements that were irrelevant or too 
vague.  
 
Different coloured paper was used to print the statements from each group. 
This helped to clarify any ambiguous statements and allowed us to ensure 
that the statements included in the final set included a fair representation of 
the statements generated by all three groups. A random number generator 
was used to allocate a random number to each statement in the final set. The 
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final set of statements was printed on small cards (8cm x 3cm) and two full 
sets of 91 cards were presented to each participant for the prioritising and 
clustering tasks. The two sets of cards were printed on different coloured 
card in order to prevent the cards from becoming mixed. Each set of cards 
was shuffled to ensure that the participants would view the statements in a 
different order to one another as it was felt that this would reduce any 
chance of bias from the order in which statements were viewed. 
 
Preparation for prioritising and clustering  
In preparation for the prioritisation and clustering tasks, each of the 91 
statements was allocated a random number from 1 to 91 using a random 
number generator. Statements were printed on individual coloured cards 
with the random number displayed in the top left corner as shown in Figure 
4.1 below. Appendix 34 shows the final set of 91 statements in numerical 
order using the number allocated by the random number allocator. Each full 
set of 91 statement cards was shuffled so that participants would view the 
statements in a random order that was different to other participants. 
Participants were provided with two full sets of the 91 statements, one for 
the prioritising task and the other for clustering. The sets of cards were 
printed on different coloured card to reduce the chances of the two sets of 
cards getting mixed up during the prioritising or clustering tasks. 
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2.   …if there was more availability of savoury 
gluten-free snacks and not just sugary cakes and 
biscuits. 
 
 
Figure 4.1: Example of a statement card for use in the prioritising and 
clustering task 
 
Structuring: Prioritisation and clustering 
Prioritising and clustering were performed individually by each participant 
without the input from other participants or from the researchers.  
 
Prioritising 
Participants were asked to rate the importance of the 91 statements for 
importance on a 5-point Likert-type scale with 1 being the least important 
and 5 the most important. Participants were asked to place the statements 
into five fairly equal piles representing the priority rank assigned to them 
(Appendix 35). It is unlikely that any of the statements generated during 
brainstorming would be considered to be completely unimportant, and it 
was stressed that the level of importance of a statement should be judged in 
relation to that of the other statements and ranked accordingly. 
 
Clustering 
Participants were asked to group the statements into themes in a way that 
made sense to them. Participants were instructed that they should not put all 
the statements into 1 group or to have each individual statement as its own 
group. Also, participants were advised that they should not have a 
‘miscellaneous’ or ‘other’ group where a group of unrelated statements were 
 145 
 
grouped together. Any statements that were unique and could not be 
grouped with other statements should be put in a ‘pile’ on their own as a 
single statement. After sorting the statements into themes, participants were 
asked to assign a name to each of their piles and to complete a data sheet 
(Appendix 36 ) listing the random number of the clusters under each of their 
cluster names. 
 
3.5.4 Step 4: Analysing the data 
 
Data entry 
Data were entered into the Ariadne® software package for concept mapping 
(NcGv/Talcott, 1995; Severens, 1987).  To ensure anonymity, random 3-
digit reference numbers were used to identify participants, rather than 
imputing participants' names. A coding system was used to identify which 
of the three stakeholder groups each participant belonged to. The full list of 
statements was entered into Ariadne along with the random reference 
number for each statement. The priority rating and clustering data for each 
participant was entered using the statement reference numbers. For the 
prioritisation data imputing, statement reference numbers were entered into 
five columns which represented the different levels of priority (1 = least 
important; 5 = most important). In the same way, the statement reference 
numbers were entered in columns to represent how each participant had 
grouped the statements during the clustering task. 
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Double data inputting was carried out using two separate computers to 
reduce the risk of data imputing errors. Ariadne allows for duplicated entries 
and missing entries to be identified and this further reduced the risk of 
imputing errors.  
 
Data analysis 
The aim of data analysis was to identify the main themes, or concepts, 
relating to adherence to a GFD and to establish the relative importance of 
each concept in relation to the others. Data analysis was also used to 
identify similarities and differences between the perceptions of the three 
stakeholder groups. Data were analysed using multivariate statistical 
techniques (multidimensional scaling (MDS) and cluster analysis) to 
produce interpretable visual concept maps.  
 
Cluster analysis 
The programme calculated how frequently statements were sorted into the 
same group, or theme, by participants during the clustering task.  The output 
of this was a point map which showed each individual statement as a data 
point on a two-dimensional plot (point map).  
 
The number of clusters to include on a map can be increased or decreased 
until an appropriate number which accurately reflects the concepts of the 
topic are represented. The steering group decided on the most appropriate 
number of clusters to include on the concept map. The steering group were 
asked to decide on names for each cluster. The aim was to decide on names 
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that represented the core or common ideas within the group of statements in 
the cluster. The cluster name was agreed on by all members of the steering 
group. In this plot (point map), the similarity between each statement is 
represented as a geographical distance. Statements that were judged to be 
similar by participants appear closer together on the two-axis matrix. 
 
Prioritisation analysis 
The mean priority rating for each statement was calculated by adding 
together the mean priority ratings (from 1 to 5) and dividing the result by 
the number of participants who completed the prioritisation task. The mean 
rating for each cluster was calculated from the mean score of all the 
statements contained within the clusters. This allowed me to identify which 
clusters were more or less important. 
 
Identifying differences and similarities between stakeholder groups. 
I wanted to find out whether or not there was a difference in medians 
between stakeholder groups in relation to the level of importance attributed 
to each of the statements identified from brainstorming. The Kruskal-Wallis 
test is appropriate for use with ranked data and this test was used to identify 
significant differences between the three stakeholder groups. Where 
significant differences were found using the Kruskal-Wallis test, pairwise 
comparisons among the three groups were made using the Mann-Whitney U 
test.  
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3.5.5 Step 5: Interpreting the maps 
 
Each cluster on the concept map was given a label that best described the 
content of the statements clustered within it. Members of the steering group 
were presented with the cluster map as an image on a projector screen and 
on a sheet of paper on the desk. They were instructed to interpret and 
discuss the meaning and importance of the map in relation to the focus 
question and to select appropriate labels for each cluster. Members were 
also given a list of the statements contained in each cluster 
 
3.5.6  Step 6: Utilisation 
 
Step 6 involved the translation of the concept maps. The visual concept 
maps can be used to inform subsequent work and concept mapping is a 
useful method for health researchers when planning and evaluating projects, 
generating hypotheses and developing theories. In this study the concept 
map, together with the results of the systematic review, were used to 
develop a model of adherence to a GFD. Discussion about the model of 
adherence to a GFD and further utilisation of the results from this study are 
presented in Chapter 5. 
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3.6 Summary 
 
This study endeavours to address the gaps in the existing literature by 
utilizing a mixed methods approach known as concept mapping to produce a 
conceptual model of the factors affecting adherence to a GFD in adults with 
CD. This method provides meaningful results that can be easily interpreted 
while still maintaining the richness of data associated with qualitative 
research. Concept mapping facilitates the involvement of multiple 
stakeholder groups. Alternative methods were considered, however, concept 
mapping was judged to be the most appropriate method for achieving the 
aims of this study. This study was designed to generate a conceptual 
framework, or model, of adherence to a GFD using concept mapping. 
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Chapter 4: Results 
 
4.1 Introduction 
 
The aim of this study was to use concept mapping to gain a better 
understanding of the factors affecting adherence to a gluten-free diet (GFD) 
in adults with coeliac disease (CD). A further aim was to compare the 
perspectives of three stakeholder groups: Adults with CD; adults who live 
with them (household members; and healthcare professionals. To achieve 
this aim, I collected statements from participants during brainstorming in 
response to the focus prompt 'It would be easier for adults with coeliac to 
stick to a gluten-free diet…'. Participants then sorted the brainstormed 
statements in order of priority from 1 (least important) to 5 (most important) 
and grouped the statements for similarity (clustering). The previous chapters 
explained and justified the use of concept mapping for achieving the aim of 
this study.  
 
In this chapter I present the results of this mixed methods study in four 
sections. The results of the seven methods of recruitment employed in this 
study are presented in Section 4.2. In Section 4.3 the characteristics of 
participants from three stakeholder groups are presented (adults with CD, 
adults who live with them (household members) and healthcare 
professionals). The results of data collection from brainstorming, 
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prioritisation and clustering activities are presented in Section 4.4 along 
with results of the data reduction activities carried out by the research team. 
The results of data analysis, using Ariadne concept mapping software 
(NcGv/Talcott, 1995) and SPSS™ v.19 software (SPSS Inc. Chicago 
Illinois), are presented in Section 4.5. This section also includes an 
explanation of how the most appropriate number of clusters was decided 
upon to represent the emerging themes. Comparisons are made between the 
results obtained from each of the three stakeholder groups. 
  
4.2 Recruitment 
 
I sought to recruit a diverse sample of participants from three stakeholder 
groups: adults with CD; adult household members; and healthcare 
professionals who work with adult coeliac patients. Seventy-three 
participants were recruited using seven recruitment methods (Table 4.1). 
Not all seven recruitment methods were employed for all three stakeholder 
groups.
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Table 4.1 Number of participants recruited from three stakeholder groups using seven recruitment methods 
Recruitment method Adults with coeliac disease with varying levels of adherence to 
a gluten-free diet 
 
Household 
members 
Healthcare 
professionals 
All 
participants 
 Adherent Partially-
adherent 
Non-
adherent 
Total    
100 invitation letters posted by Coeliac 
UK 
12 (80%) 4 (22%) 0 16 (47%) 10 (48%) 
 
N/A¹ 26 (36%) 
13 invitation packs distributed by Norfolk 
and Norwich University Hospital (NNUH) 
1 (7%) 1 (6%) 0 2 (6%) 0 3 (17%) 5 (7%) 
Press release in local newspapers² 0 8 (44%) 1 (100%) 9 (26%) 8 (38%) N/A¹ 17 (23%) 
Advertisements on Coeliac UK website² 0 3 (17%) 0 3 (9%) 2 (10%) 1 (6%) 6 (8%) 
Advertisement on University of East 
Anglia (UEA) website² 
2 (13%) 2 (11%) 0 4 (12%) 1 (5%) N/A¹ 5 (7%) 
E-mail to the British Dietetic Association 
(BDA) gastroenterology specialist group 
N/A¹ N/A¹ N/A¹ N/A¹ N/A¹ 12 (67%) 12 (16%) 
112 invitation packs posted to GP 
practices 
N/A¹ N/A¹ N/A¹ N/A¹ N/A¹ 2 (11%) 2 (3%) 
Total
4 
15 (100%) 18 (100%) 1 (100%) 34 (100%) 21 (100%)
3 
18 (100%)
3 
73 (100%) 
Notes: 
1. N/A indicates that recruitment did not take place for a particular stakeholder group using the method indicated (e.g. Healthcare professionals were not sent invitation letters 
posted by Coeliac UK). 
2. Once I had recruited sufficient adherent participants through the Coeliac UK invitation letter and Norfolk and Norwich University Hospital (NNUH), I stopped inviting 
adherent adults with CD to participate and only invited partially-adherent and non-adherent adults with CD. 
3. Percentages have been rounded up and, therefore, do not always appear to add up to 100% 
4.  Total shows the sum of participants and the percentage values in each column 
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4.2.1 Recruitment of adults with coeliac disease 
and adult household members  
 
Five methods were employed for recruiting adults with CD and adult 
household members. 
 
Over one third of the participants who were recruited for this study 
responded to invitation letters distributed by Coeliac UK. Thirty-two 
Coeliac UK Members returned completed reply slips and information packs 
were posted to them along with a household member’s pack. Twenty-five 
adults with CD and 11 adult household members returned a reply slip. 
 
To avoid over-recruitment of adults with CD who adhere to the GFD, 
rejection letters (Appendix 33) were posted to nine adults with CD. It was 
not necessary for me to send rejection letters to household members, 
partially-adherent adults with CD or non-adherent adults with CD as I did 
not receive an excessive number of volunteers from these groups. 
 
I contacted all eligible volunteers to arrange face-to-face meetings to gain 
informed consent and to invite the recruited participants to complete a short 
questionnaire (Appendices 15, 16, 18 and 19). During the face-to-face 
meetings, some participants with CD advised me that they did not live with 
another adult and others told me that their household member/s had chosen 
not to be involved in the study. One female participant with CD requested 
that her daughter, who also has CD, was recruited for the study. An 
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invitation pack was sent to the participant’s daughter and she was also 
recruited. A female Coeliac UK Member and her spouse were excluded 
because she was diagnosed with the related condition, dermatitis 
herpetiformis, and not CD, which did not fit with the inclusion criteria 
(Chapter 4).  
 
Information packs were distributed to adults with CD and adult household 
members by Norfolk and Norwich University Hospital (NNUH). 
 
Two NNUH patients with CD (one adherent and one partially-adherent) 
volunteered and were recruited following the distribution of 13 information 
packs during consultations with healthcare professionals. No adult 
household members responded to the invitation packs handed out at NNUH.  
 
Advertisements were placed in two local newspapers, on the University of 
East Anglia website and on Coeliac UK website. 
 
Once a sufficient number of adherent participants with CD had been 
recruited, I invited partially-adherent and non-adherent adults with CD and 
adult household members to participate in the study. Following 
advertisements in two local newspapers (Appendix 26), on the UEA website 
(Appendix 28) and Coeliac UK’s website (Appendix 27), I received 
telephone calls and e-mails from people expressing an interest in taking 
part. Fifteen people were excluded at this stage: 13 adults with CD who 
were adherent to the GF diet; and two people who had not received a 
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positive CD diagnosis. Information packs were posted to 26 adults with CD 
and 12 adult household members who matched our inclusion criteria 
(Chapter 3). Ten adults with CD and one adult household member did not 
respond to the information pack. Despite having already recruited a 
sufficient number of participants who adhere to the GFD, I recruited a 
further two adherent participants who replied to the advertisement on the 
UEA website. These participants had very recently been diagnosed with CD 
and this increased diversity in the group of adherent participants, many of 
whom had been diagnosed for many years. 
 
4.2.2 Recruitment of healthcare professionals 
 
Four methods were used to recruit healthcare professionals.  
 
Information packs distributed to healthcare professionals by NNUH 
Following the distribution of 22 information packs to healthcare 
professionals at NNUH, I received three responses from healthcare 
professionals who were all recruited for this study.  
 
Invitation packs posted to GPs and Practice Nurses in Norwich 
The method that resulted in the least number of participants recruited (n=2) 
was the distribution of 112 invitation packs to GP practices. One GP and 
one Nurse Practitioner volunteered to take part and were recruited for the 
study. 
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Advertisement on Coeliac UK’s website  
One healthcare professional responded to the advertisement on Coeliac 
UK’s website (Appendix 27) and was recruited for the study. 
 
E-mail sent to the British Dietetic Association’s gastroenterology specialist 
group 
Fourteen healthcare professionals responded to the e-mail sent to the British 
Dietetic Association’s (BDA) gastroenterology specialist group. Rejection 
e-mails were sent to two healthcare professionals because they lived and 
worked in Scotland, which did not fit the inclusion criteria for this study. 
Twelve healthcare professionals were successfully recruited following the 
BDA e-mail. 
 
4.3 Participant characteristics 
 
The participant characteristics are summarised in Table 4.2. Over two-thirds 
of the 73 participants recruited for this study were female. The sample of 
adults with CD and adult household members was almost exclusively white 
British. All three stakeholder groups had a higher percentage of females 
compared to males with the healthcare professionals’ group showing the 
highest percentage of females (94%). Adults with CD were 6.6 years 
younger than adult household members. All except one participant (who 
was recruited from Wales) were based in England and over two-thirds of 
participants were recruited from Norfolk. Half of the adults with CD and 
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household members were educated to university degree (or equivalent) or 
postgraduate level.  
 
Healthcare professionals were recruited from four occupational professions: 
 14 (78%) dietitians (including senior, specialist and research 
dietitians); 
 2 (11%) Practice Nurses / Nurse Specialists 
 1 (6%) Gastroenterologist 
 1 (6%) General Practitioner 
 
Healthcare professionals had a history of working with CD patients for a 
mean of 10.2 years (range 1-30 years). It was not possible to calculate the 
mean number of CD patients that healthcare professionals work with 
because one participant quoted ‘more than 100 patients’, another ‘more than 
40 patients’ and others provided either a weekly, monthly or annual figure.  
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Table 4.2 Participant characteristics 
 
 Adults 
with 
coeliac 
disease 
(n=34) 
Adult 
household 
members 
(n=21) 
Healthcare 
professionals 
(n=18) 
All 
participants 
(n=73) 
Age (years)
1 
Mean 
SD 
95% CI 
 
53 
17 
47-58 
 
59
1
 
11
1 
54-64 
 
Data not 
collected 
 
55
1 
15
1 
50-59 
Gender 
Male 
Female 
 
13 (38%) 
21 
 
8 (38%) 
13 
 
1 (6%) 
17 
 
22 (30%) 
51 
Ethnicity 
White British 
Other 
 
33 (97%) 
1 
 
21 (100%) 
0 
 
Data not 
collected 
 
54 (98%) 
1 
Geographical location 
Norfolk 
Outside Norfolk 
 
30 (88%) 
4 
 
17 (81%) 
4  
 
5 (28%) 
13 
 
52 (71%) 
21 
Education 
No formal qualification 
GCSE/A’ Level 
University level 
 
3
 
(9%)
2
 
15 (45%)
2
 
15 (45%)
2
 
 
3 (14%) 
6 (29%) 
12 (57%) 
 
Data not 
collected 
 
6 (11%  
21 (39%) 
27 (50%) 
Notes: 
1. One adult household member did not provide information about his age. The mean 
age and age range for adult household members shown here is the average age of 
the 20 participants who provided their year of birth. 
2. One adult with coeliac disease did not state their level of education.  
 
 
Table 4.3 shows information on level of adherence to a GFD for the adults 
with CD group in relation to demographic and clinical characteristics. The 
number of adherent (n=15) and partially adherent (n=18) participants was 
fairly equal. The single non-adherent participant who was recruited had 
been following a gluten-inclusive diet since his wife died in the 1970s. This 
non-adherent participant reported that he had not experienced any CD 
symptoms since re-introducing gluten into his diet despite having symptoms 
prior to diagnosis.  
 
The mean age of participants with CD who adhere to a GFD was 2.9 years 
higher than the mean age of the partially-adherent participants (50.4 years). 
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The non-adherent participant was more than 25 years older than the mean 
age of the adherent and partially-adherent participants. Sixty-nine per cent 
(n=9) of males with CD were either partially- or non-adherent to the GFD 
compared to 48% (n=10) of females. Eighteen per cent more adherent 
participants were educated to university degree or postgraduate level (n=8 
(53%) compared to the partially-adherent participants (n=6 (35%). 
 
Of the 11 participants who reported severe or very severe symptoms when 
they consume gluten, nine (82%) were adherent to the GFD and two were 
partially-adherent. Participants who experienced no symptoms were either 
partially- or non-adherent to the GFD. 
 
Partially-adherent participants had been diagnosed 7 years longer than the 
adherent participants. The non-adherent 79-year-old participant had been 
diagnosed for 50 years, which was the highest of all participants with CD.  
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Table 4.3 A comparison of the characteristics of adults with coeliac disease 
who are adherent, partially-adherent and non-adherent to a gluten-free diet. 
 
 Adherent 
adults with 
CD 
(n=15) 
Partially 
adherent 
adults with 
CD 
(n=18) 
Non-
adherent 
adults with 
CD (n=1) 
All adults 
with CD 
(n=34) 
Age (years) 
Mean 
SD 
95% CI 
 
53.3 
17 
46-65 
 
50.4 
15 
41-56 
 
79 
-- 
-- 
 
52.6 
17 
46-58 
Gender 
Male 
Female 
 
4 (27%) 
11 
 
8 (44%) 
10 
 
1  
0 
 
13 (38%) 
21 
Ethnicity 
White British 
Other 
 
15 
0 
 
17 
1 
 
1 
0 
 
33 
1 
Severity of symptoms 
No symptoms 
Mild/very mild 
Moderate 
Severe/very severe 
 
0 
2 (13%) 
4 (27%) 
9 (60%) 
 
3 (17%) 
7 (39%) 
6 (33%) 
2 (11%) 
 
1 (100%) 
0 
0 
0 
 
4 (12%) 
9 (26%) 
10 (29%) 
11 (32%) 
Number of years since 
diagnosis 
Mean 
SD 
95% CI 
 
 
3.8 
4 
1-6 
 
 
11.2 
14 
4-19 
 
 
50.0 
-- 
-- 
 
 
9.1 
13 
4-12 
Education
1 
No formal qualification 
GCSE/A’ Level 
University 
degree/postgraduate 
 
1 (7%) 
6 (40%) 
 
8 (53%) 
 
2 (12%)
 
9 (53%)
 
 
6 (35%)
 
 
0 
0 
 
1 (100%) 
 
3 (9%) 
15 (45%) 
 
15 (45%) 
Note: 
1. One adult with coeliac disease did not state their level of education.  
 
 
Four of the 34 subjects with CD reported following another special diet in 
addition to the GFD. One adherent participant reported following a special 
diet for diabetes and another followed a low fibre diet. The two participants 
who followed 'other' special diets (one potassium-regulated diet and the 
other a nut-free diet) both reported partial-adherence to a GF diet. 
 
In this section I showed that participants were recruited with a range of 
characteristics in terms of age, gender, level of education, experience of CD 
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symptoms and length of time since diagnosis. Only one non-adherent adult 
with CD and one non-White British participant with CD were recruited. 
Healthcare professionals from a range of professions and with different 
levels of experience of working with coeliac patients were recruited. 
 
4.4 Brainstorming 
 
Table 4.4 shows that the characteristics of participants who completed 
brainstorming were similar to the total sample population with regards to 
age, gender, ethnicity, geographical location and education. Sixty-nine of 
the 73 recruited participants took part in brainstorming. One partially-
adherent male adult with CD, one partially-adherent female with CD and 
two healthcare professionals (Practice nurse and a dietitian) did not take part 
in brainstorming. These four participants had requested to complete 
brainstorming remotely by post or e-mail, but they did not return any 
brainstormed data. All household members who were recruited for the study 
participated in brainstorming.  
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Table 4.4 A comparison of the characteristics of the participants who 
completed brainstorming with those who did not complete brainstorming 
 Participants who 
completed 
brainstorming 
(n=69) 
Participants 
who did not 
complete 
brainstormi
ng (n=4) 
All participants 
(n=73) 
Age (years)
1 
Mean 
SD 
95% CI 
 
55 
15 
51-59 
 
58 
14 
39-77 
 
55 
15 
51-59 
Gender 
Male 
Female 
 
21 (30%) 
48 
 
1 (25%) 
3 
 
22 (30%) 
51 
Ethnicity
1 
White British 
Other 
 
68 (99%) 
1 
 
2 (100%) 
0 
 
54 (98%) 
1 
Geographical location 
Norfolk 
Outside Norfolk 
 
50 (72%) 
19 
 
2 (50%) 
2 
 
52 (71%) 
21 
Education
1, 2 
No formal qualification 
GCSE/A’ level 
University level 
 
6 (12%) 
19 (37%) 
27 (52%) 
 
0 
2 (100%) 
0 
 
6 (11%  
21 (39%) 
27 (50%) 
Notes: 
1. Data were not collected on age, ethnicity and education for healthcare professionals. 
2. One adult with CD did not provide information on their level of education.  
 
 
Fifty-three percent (n=18) of the adults with CD attended group 
brainstorming sessions, 41% (n=14) completed brainstorming remotely, 
returning their statements by post or e-mail. Forty-three per cent (n=9) of 
household members completed brainstorming in group sessions and 57% 
(n=12) brainstormed remotely. All healthcare professionals were invited to 
brainstorm remotely by post or e-mail. Table 4.5 shows the number of 
adults with CD and household members who attended each group 
brainstorming sessions. Five group brainstorming sessions were held for 
adults with CD and three group brainstorming sessions were held for 
household members. The group sizes were small, ranging from one to seven 
participants. 
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Table 4.5 The number of participants attending the group brainstorming 
session 
 
 Adults with coeliac 
disease (n=18) 
Household members 
(n=9) 
Session 1 7 (39%) 4 (44%) 
Session 2 5 (28%) N/A
1 
Session 3 3 (17%) 3 (33%) 
Session 4 2 (11%) N/A
1
 
Session 5 1 (6%) 2 (22%) 
Total 18 (100%) 9 (100%) 
Note: 
1. N/A indicates that a brainstorming session was not held for adult household members at 
the same time as the adults with CD brainstorming sessions. 
 
 
All 15 adherent participants completed brainstorming (13 attended group 
sessions and two brainstormed remotely). Eleven partially-adherent adults 
with CD brainstormed remotely and five attended group sessions. The one 
non-adherent participant recruited for this study completed brainstorming 
remotely. 
 
Table 4.6 is a comparison of the characteristics of adults with CD and 
household members who attended group brainstorming and those who 
brainstormed remotely. All participants who attended the group 
brainstorming sessions lived in Norfolk. Adults with CD and household 
members who brainstormed remotely were on average 6 years younger than 
those who attended group brainstorming. The percentage of male 
participants was higher in the group of adults with CD and household 
members who attended group brainstorming sessions (44%) compared to 
those who brainstormed remotely (35%). 
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Table 4.6 Characteristics of participants with coeliac disease and household 
members who attended group brainstorming sessions and those who 
brainstormed remotely. 
 
 Adults with 
coeliac disease 
and household 
members who 
attended group 
brainstorming 
sessions (n=27) 
Adults with 
coeliac disease 
and household 
members who 
brainstormed 
remotely (n=26) 
All adults with 
coeliac disease and 
household 
members who 
brainstormed 
(n=53) 
Age (years)
1 
Mean 
SD 
95% CI 
 
58 
15 
52-64 
 
52 
15 
45-58 
 
55 
15 
51-59 
Gender 
Male 
Female 
 
12 (44%) 
15 
 
9 (35%) 
17 
 
21 (40%) 
32 
Ethnicity
2 
White British 
Other 
 
26 (96%) 
1 
 
26 (100%) 
0 
 
52 (98%) 
1 
Geographical  location 
Norfolk 
Outside Norfolk 
 
27 (100%) 
0 
 
19 (73%) 
7 
 
46 (87%) 
7 
Education
2 
No formal qualification 
GCSE/A’ Level 
University level 
 
3 (11%) 
9 (33%) 
15 (56%) 
 
3 (12%) 
10 (40%) 
12 (48%) 
 
6 (12%) 
19 (37%) 
27 (52%) 
Notes:  
1. One male household member who completed group brainstorming did not provide 
information about his age. 
2. One adult with coeliac disease did not provide information on their level of education.  
 
 
Group brainstorming sessions were facilitated by one of four members of 
the research team (HF, KD, SS, AM) with an assistant present when 
available to write notes. None of the sessions ran over the scheduled two 
hours, however, some of the sessions ended up to 30 minutes early when 
participants felt they had exhausted all their ideas and the facilitator had 
used all the prompts (Appendix 31) as necessary.  
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Table 4.7 shows that group and remote brainstorming yielded 903 
statements. Adults with CD generated approximately half of all the 
statements (n=454). 
 
Table 4.7 The number of statements generated during group and remote 
brainstorming sessions by each stakeholder group. 
 
 No. of statements 
generated during 
group brainstorming 
No. of statements 
generated during 
remote brainstorming 
All 
Adults with CD 313 (64%) 141 (34%) 454 (50%) 
Household 
Members 
176 (36%) 102 (25%) 278 (31%) 
Healthcare 
Professionals 
N/A¹ 171 (41%) 171 (19%) 
All 489 (100%) 414 (100%) 903 (100%) 
Note: 
1. N/A indicates that healthcare professionals did not attend group brainstorming sessions.  
 
 
4.5 Statement reduction and preparation for 
prioritisation and clustering. 
 
The maximum number of statements that can be analysed using Ariadne 
concept mapping software is 98. The aim of statement reduction was for the 
research team to reduce the full set of 903 statements to a final set of 98 or 
fewer statements which represented the full range of statements contained in 
the original set. Through discussions held over two sessions, the research 
team reduced the 903 statements to a final set of 91. This was achieved by 
synthesising identical and similar statements and eliminating obscure or 
irrelevant statements. The final set of 91 statements is listed in Appendix 34. 
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Statement reduction session 1 
The research team were presented with the full set of 903 statements printed 
on individual pieces of coloured paper. Three colours of paper were used to 
represent each stakeholder group. Similar statements were placed into piles 
and duplicates, or statements that were very similar, were synthesised. 
Statements that were perceived to be obscure or irrelevant were eliminated. 
The original words of participants were preserved whenever possible, rather 
than translating all statements into our own words. The occasional 
disagreements between research team members were resolved through 
discussions until a consensus was reached. By the end of the first of the two 
statement reduction sessions, the research team had reduced the full set of 
903 statements down to a set of 161 statements.  
 
Statement reduction session 2 
The 161 statements from the first statement reduction session were printed 
on individual pieces of paper with the original synthesised statements 
attached. The process of statement synthesis and elimination was repeated 
by the research team and discussions took place in order for consensus to be 
reached on the final set of 91 statements (Appendix 34). All members of the 
research team agreed that further statement reduction could result in loss of 
meaning and loss of representation of some of the issues raised during 
brainstorming.  
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4.6 Prioritising and clustering the 
statements 
 
Eleven adults with CD and five adult household members attended a group 
session at UEA where they completed both the prioritising and clustering 
tasks. All other participants who completed the prioritising and clustering 
tasks did so remotely.  
 
Group prioritising and clustering sessions were facilitated by the Chief 
Investigator (HF). No assistant was required, however, one session was 
observed by another member of the research team (KD). The combined 
prioritising and clustering group sessions lasted no more than two hours 
with a 15 minute refreshment break half way through. As prioritising and 
clustering are individual tasks, participants were free to leave as soon as 
they had finished. Most participants took almost the full two hours to 
complete the two tasks and none ran over. Participants spent roughly an 
equal amount of time on each of the two tasks, completing the prioritisation 
task before the refreshments break.  
 
Fifty-four participants completed the prioritising task and 52 completed the 
clustering task. Six male and three female participants with CD (four 
adherent, four partially-adherent; and one non-adherent) did not participate 
in prioritising the statements. Seven male and four female adults with CD 
(four adherent, six partially-adherent and one non-adherent) did not take 
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part in clustering the statements. Two male and four female household 
members and four female healthcare professionals did not participate in 
prioritising or clustering the statements. Four healthcare professionals did 
not complete prioritising or clustering (One practice nurse, a community 
dietitian, an advanced gastroenterology dietitian and a specialist dietitian).  
 
Four female and one male household members did not complete the 
prioritising or clustering task. With the exception of two partially-adherent 
adults with CD (one male; one female), all participants who prioritised the 
statements went on to complete the clustering task. Tables 4.8 and 4.9 show 
comparisons of the characteristics of participants who prioritised and 
clustered the statements with those who did not complete these two tasks. 
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Table 4.8 A comparison of the characteristics of participants who 
completed the prioritisation task and those who did not. 
 
 
 Participants who 
completed 
prioritising(n=54) 
Participants who 
did not complete 
prioritising (n=19) 
All 
participants 
(n=73) 
Age (years)
1,2 
Mean 
SD 
95% CI 
 
52 
14 
47-56 
 
63 
14 
55-71 
 
55 
15 
51-59 
Gender 
Male 
Female 
 
14 (26%) 
40 
 
8 (42%) 
11 
 
22 (30%) 
51 
Ethnicity
1 
White British 
Other 
 
53 (98%) 
1 
 
19 (100%) 
0 
 
54 (98%) 
1 
Geographical location 
Norfolk 
Outside Norfolk 
 
40 (74%) 
14 
 
12 (63%) 
7 
 
52 (71%) 
21 
Education
 2,3 
No formal qualification 
GCSE/A’ Level 
University level 
 
1 (2.5%) 
15 (37.5%) 
24 (60%) 
 
5 (36%) 
6 (43%) 
3 (21%) 
 
6 (11%  
21 (39%) 
27 (50%) 
Notes: 
1. One adult household member who completed the prioritising task did not state his year 
of birth.  
2. Healthcare professionals were not asked their year of birth or level of education. 
3. One male adult with coeliac disease who did not complete prioritising did not state hi 
level of education.  
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Table 4.9 Characteristics of participants who completed the clustering task 
and those who did not. 
 
 Participants who 
completed 
clustering(n=52) 
Participants who 
did not complete 
clustering (n=21) 
All  
(n=73) 
Age (years)
1,2 
Mean 
SD 
95%CI 
 
52 
14 
47-56 
 
63 
14 
55-70 
 
55 
15 
51-59 
Gender 
Male 
Female 
 
13 (25%) 
39 
 
9 (43%) 
12 
 
22 (30%) 
51 
Ethnicity
1 
White British 
Other 
 
51 (98%) 
1 
 
21 (100%) 
0 
 
54 (98%) 
1 
Geographical location 
Norfolk 
Outside Norfolk 
 
39 (75%) 
13 
 
13 (62%) 
8 
 
52 (71%) 
21 
Education
2, 3 
No formal qualification 
GCSE/A’ Level 
University level 
 
1 (3%) 
13 (34%) 
24 (63%) 
 
5 (31%) 
8 (50%) 
3 (19%) 
 
6 (11%  
21 (39%) 
27 (50%) 
Notes: 
1. One adult household member who completed the clustering task did not state his year of 
birth.  
2. Healthcare professionals were not asked their year of birth or level of education. 
3. One male adult with coeliac disease who did not complete clustering did not state his 
level of education. 
 
 
The Ariadne manual (Talcott, 1995) advises that the maximum number of 
clusters that should be generated by a participant is 25. None of the 
participants in this study generated more than 25 clusters. The mean number 
of clusters generated by all participants was 10 (range 5 to 18 clusters). 
Table 4.10 shows the mean number of clusters generated by participants in 
each stakeholder group. 
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Table 4.10 The mean number of clusters generated by each stakeholder 
group. 
 
 Adults 
with CD 
(n=23) 
Household 
members 
(n=15) 
Healthcare 
professionals 
(n=14) 
All 
participants 
(n=52) 
Number of statements 
generated 
Mean 
Range 
 
 
10 
5-16 
 
 
8 
6-17 
 
 
12 
6-18 
 
 
10 
5-18 
 
 
4.7 Data analysis 
 
4.7.1 Data entry 
 
Data were entered into the Ariadne software for analysis. Data inputting was 
carried out on two separate computers by the same data inputter and no data 
entry errors were identified. 
 
The Ariadne manual states: 
‘Participants are not limited in the number of piles (clusters) 
they form, nor in the number of statements in each pile. 
However, Ariadne sets an upper limit of 25 clusters per 
participant, each of 40 statements per cluster’. 
                                                         (Talcott, 1995) 
 
Based on the amount of overlap between the 91 statements, the research 
team felt it to be unlikely that the participants would generate as many as 25 
clusters. The highest number of clusters generated was 18. It later became 
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evident that the guidance in the Ariadne manual (Talcott, 1995) was 
incorrect and the maximum number of statements that can be entered into 
the Ariadne software is 12, not 25. Ten participants generated more than 12 
clusters and all of these data could not be entered into Ariadne. I sought 
advice from the software designer who advised me to eliminate the clusters 
containing the least number of statements (Appendix 35). 
 
There were several instances where participants made errors when 
completing data recording sheets (Appendices 36 and 37) for the prioritising 
and clustering tasks. These errors, and the actions taken to resolve them, are 
summarised (Appendix 38). As concept mapping is used to group 
statements for similarity, it was necessary for me to exclude groups of 
unrelated statements that participants had grouped as a 'miscellaneous' 
cluster. Appendix 38 includes details of the removed 'miscellaneous' clusters 
and also the details of when more than 12 clusters were generated. 
  
A total of 32 clusters were removed for those participants who generated 
more than the permitted number of 12 clusters. These 32 clusters were small 
and contained a total of 74 statements. The statement that appeared in the 
deleted clusters the most frequently was '…if they are female' and this 
statement was deleted for five participants who generated more than 12 
clusters. The statement '…if there were more resources for people from 
ethnic minorities' was deleted for four participants who generated more than 
12 clusters. There were six statements that appeared three times in the 
deleted clusters: 
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'…if they have supportive work colleagues' 
'…if there was a wider range of Asian gluten-free products available' 
'…if speciality gluten-free foods tasted nicer' 
'…if speciality gluten-free food was not so high in calories and sugar' 
'…if labels stated "Produced in a factory where gluten is used" rather than 
"May contain gluten" so you can assess the level of risk' 
'…if gluten-free biscuits were made available when gluten-inclusive biscuits 
are served with tea and coffee at work' 
 
The remainder of the removed statements appeared only one or two times 
each in the deleted clusters. According to the software owner, the impact of 
removing these small clusters should have little or no effect on the overall 
results. 
 
4.7.2 Concept maps 
 
A sequence of analyses involving multidimensional scaling and cluster 
analysis were used to produce the concept maps. Two types of concept maps 
were produced: point map and a cluster rating map. The maps represent the 
overall conceptual framework for the study (Kane & Trochim, 2007). 
 
Figure 5.1 shows a point map depicting the relationships between the 91 
statements sorted by participants. Each data point represents a single 
statement and the distance between data points on the map represents how 
often the statements were grouped together by participants in the clustering 
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task. Statements that were grouped together frequently appear close 
together, whereas statements that were grouped together less frequently are 
spatially further apart. The data points on this map are numbered and the 
statements that each of the numbers relates to are listed in Appendix 34.  
 
The steering group met to decide on names for the axes on the point and 
cluster maps. The axes were assigned names based on the content of the 
statements positioned close to them. Examination of the statements in 
relation to the X axis indicated that statements to the right related to 
society's responsibility and on the left, individual responsibility. This axis 
could be viewed as a locus of control continuum from personal 
responsibility to societal responsibility. The Y axis represents psychological 
to practical issues relating to adherence to the gluten-free diet. The X and Y 
axes divide the concept map into four quadrants. 
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Figure 4.1 - Point map for all participants
Psychological 
Issues 
Practical 
Issues 
Society's 
Responsibility 
Individual 
Responsibility 
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Cluster analysis groups together the individual data points into clusters of 
statements that represent similar concepts. In deciding on the most 
appropriate number of clusters to have on the concept map, the research 
team tried reducing and increasing the number of clusters from the default 
number of eight. I mapped how the statements moved as the number of 
clusters was reduced or increased. Appendix 39 shows that when the cluster 
number was increased or decreased the amount of movement of the 
statements was small, often with just one statement moving to form a new 
single statement cluster as the number of clusters was increased. After 
discussion, the panel reached a consensus of a 13-cluster solution and a title 
for each cluster was agreed on. When looking at a 12-cluster solution, it was 
decided that this number of statements was not appropriate as clusters 5 and 
6 from the 13-cluster solution were grouped together to form one single 
cluster and it was felt that the statements in the two clusters did not really 
belong together.  
 
The 13-cluster concept map is shown in Figure 4.2. This cluster rating map 
provides an overview of the main themes of this study and the 13 clusters 
are ranked in order of importance from 1 (most important) to 13 (least 
important). The importance ranking of each cluster is based on the mean 
prioritisation scores of all statements contained within the cluster. 
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1 
2 
 
4 
6 
7 
8 
10 
11 
12 
3
1
1
1 
13 
 
Cluster 
number  
Cluster name Mean 
priority 
score 
1 The Cost of GFF 4.28 
2 The availability of GFF 3.59 
3 Knowledge and 
information about  
   CD and the GFD 
3.19 
4 Access to good quality 
GFF 
3.14 
5 Prescribed GFF 3.08 
6 If they can eat the same as 
other  
   people 
2.99 
7 Eating away from home 2.96 
8 If they are prepared to go 
hungry when there is no 
GFF available 
2.85 
9 Motivation and support 2.81 
10 Social stigma 2.80 
11 Convenience of obtaining  
    Prescribed GFF 
2.56 
12 Diet planning and 
preparation 
2.40 
13 Provision of GFF at work 2.19 
 
9 
Practical 
Issues 
Individual 
Responsibility 
Psychological 
Issues 
Society's 
Responsibility 
3 
9 
12 
5 
5 
4 
7 
10 
Figure 4.2 Cluster map 
Note: 
The clusters are numbered from 1 to 13 in order of priority (Cluster 1 = most important; Cluster 13= least 
important) 
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4.7.3 Analysis of the clusters 
 
Tables 4.11 to 4.23 show the set of statements included in each cluster in 
order of mean preference score. Preference scores are between 1 (least 
important) to 5 (most important).  
 
Cluster 1 – The cost of gluten-free food 
The cost of gluten-free food (GFF) emerged as the most important theme 
relating to adherence to a GFD with a mean prioritisation score of 4.28 
(Table 4.11). This 'cluster' contains just one single statement. The issue of 
the high cost of GFF was mentioned during every group brainstorming 
session and all except for three adults with CD, two household members and 
two healthcare professionals who brainstormed remotely generated a 
statement about the high cost of GFF. This cluster falls within the 
practical/society's responsibility quadrant on the concept map. 
 
Table 4.11 Cluster 1 – The cost of gluten-free food. 
 
Cluster 1: The cost of gluten-free food (mean preference score: 4.28) 
 
Statement/s: 
Mean 
preference 
score 
…if gluten-free food was not so expensive. 4.28 
 
 
Cluster 2 – The availability of GF sandwiches 
The availability of GF sandwiches was the second most important theme to 
emerge from this study in relation to adherence to a GFD. As with cluster 1, 
cluster 2 contains one single statement (Table 4.12).  
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Table 4.12 Cluster 2 – The availability of gluten-free sandwiches 
 
Cluster 2: The availability of gluten-free sandwiches (mean preference score: 
3.59) 
 
Statement/s: 
Mean 
preference 
score 
…if there was more availability of gluten-free sandwiches. 3.59 
 
 
 
The statement in cluster 2 was synthesised from four of the original 
statements relating to GF sandwiches: 
 'More GF sandwiches everywhere!' – adult with CD 
 'If sandwich companies provided at least one choice made with GF 
bread' – adult with CD 
 'If there could be more variety of gluten-free foods in the fast food 
sections at supermarkets…snacks, sandwiches etc. In fact, there are 
very few outlets which provide sandwiches' – adult with CD 
 'Easy access to retail GF sandwiches and snacks' – Healthcare 
professional 
 
Cluster 3 – Knowledge and information about CD and the GFD 
The third highest rated theme to emerge was knowledge and information 
about CD and the GFD. This cluster contains 24 statements as shown in 
Table 4.13.  The statements in the cluster relate not only to the knowledge 
of adults with CD but also to that of healthcare professionals.  
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Table 4.13 Cluster 3 - Knowledge and information about coeliac disease 
and the gluten-free diet 
 
Cluster 3: Knowledge and information about coeliac disease and the gluten-free 
diet 
(mean preference score: 3.19) 
 
Statements: 
Mean 
preference 
score 
...if they understand the health consequences of not sticking to a 
gluten-free diet. 
4.39 
 
...if they received more advice about coeliac disease and the gluten-
free diet around the time of diagnosis. 
3.94 
...if they have a better knowledge of the gluten-free diet. 3.83 
...if they have appropriate follow-up care with quick and easy 
access to dietitians. 
3.81 
...if they experience symptoms when they consume gluten. 3.80 
...if they have immediate access to a dietitian at the time of 
diagnosis.  
3.74 
...if they have a supportive GP. 3.67 
...if healthcare professionals knew more about coeliac disease and 
the gluten-free diet. 
3.65 
...if they have access to information about coeliac disease. 3.60 
...if they believe the diagnosis. 3.31 
...if GPs were better informed about what patients are allowed on 
prescription. 
3.24 
...if they don’t have additional special dietary requirements as well 
as a gluten-free diet (e.g. lactose-free, vegetarian or diabetic). 
3.23 
...if there was an expert point of contact for patients and healthcare 
professionals. 
3.20 
...if they join a coeliac support group (e.g. Coeliac UK). 3.11 
...if they have already been following a gluten-free diet for a long 
time. 
3.07 
...if they can cook gluten-free meals from scratch.  3.00 
...if they have access to another person with coeliac disease who has 
more experience. 
2.98 
...if they are given a blood test to confirm adherence. 2.93 
...if separate cooking utensils are used in the preparation of gluten-
free food at home. 
2.56 
...if they use the internet to get information about coeliac disease 
and the gluten-free diet. 
2.39 
...if TV cookery programmes included gluten-free cooking. 2.38 
...if they are well educated. 2.33 
...if there was more psychological support available. 2.31 
...if there was a mobile phone app to advise them on where to find 
gluten-free food. 
2.20 
 
 
Cluster 4 – Access to good quality gluten-free food 
The fourth most important theme related to access to good quality GFF. The 
statements within this cluster cover a range of issues including food 
labelling, palatability of GFF and availability of GFF. Table 4.14 lists the 
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statements in this cluster. I included the term 'access' in the cluster label 
with the intention that this would cover GF labelling issues, the availability 
of GFF and access to free samples of GFF. The 'good quality' part of this 
cluster heading covers the taste and texture of GFF, nutrient composition 
and the shelf-life of GFF.  
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Table 4.14 Cluster 4 - Access to good quality gluten-free food 
 
Cluster 4: Access to good quality gluten-free food (mean preference score: 3.14) 
 
Statements: 
Mean 
preference 
score 
...if gluten-free bread was of the same quality in taste and texture as 
gluten-inclusive bread. 
4.02 
...if there was a universal gluten-free logo on food packaging used 
internationally on all suitable foods (such as the crossed grain logo). 
3.94 
...if there was a wider variety of gluten-free products in shops and 
supermarkets. 
3.85 
...if there was more gluten-free food available in all food shops and 
supermarkets. 
3.78 
...if gluten ingredients were not added to foods where you wouldn’t expect 
to find gluten (such as ice cream or grated cheese). 
3.72 
...if speciality gluten-free foods tasted nicer. 3.67 
...if there was more availability of savoury gluten-free snacks and not just 
sugary cakes and biscuits. 
3.42 
...if a wider range of non-traditional gluten-free breads were available (e.g. 
tortillas, chapatis, pita bread). 
3.15 
...if supermarket discount offers included gluten-free products. 3.13 
...if gluten-free food was easier to find on the shelves when shopping in 
supermarkets. 
3.13 
...if a wider range of gluten-free ready meals were available. 3.02 
...if there was more consistency between similar products regardless of 
brand or pack size (e.g. some brands of cornflakes are GF but others are 
not). 
2.94 
...if speciality gluten-free food was not so high in calories and sugar. 2.87 
...if food manufacturers didn’t change their ingredients so often. 2.79 
...if they are able to try free samples of gluten-free products before buying 
(e.g. at roadshows). 
2.78 
...if labels stated “produced in a factory where gluten is used” rather than 
“may contain gluten” so you can assess the level of risk. 
2.70 
...if speciality gluten-free food had a longer shelf-life. 2.46 
...if gluten-free products were kept next to similar gluten-inclusive items in 
supermarkets (e.g. gluten-free bread in the bread section, rather than the 
‘free from’ section. 
2.20 
...if there was a wider range of Asian gluten-free products available. 2.06 
 
 
Cluster 5 – Prescribed gluten-free food 
Cluster 5 (Table 4.15) covers a range of issues mostly relating to prescribed 
GFF. During the group brainstorming sessions, there were several 
discussions about the recent cut-backs in prescribed GFF and 
inconsistencies between what GPs are willing to prescribe. 
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Table 4.15 Cluster 5 - Prescribed gluten-free food 
Cluster 5: Prescribed gluten-free food (mean preference score: 3.08) 
 
Statements: 
Mean 
preference 
score 
...if they receive gluten-free food on prescription. 3.78 
...if they get a sufficient amount of gluten-free food on prescription. 3.65 
...if a wider range of gluten-free products were available on 
prescription (e.g. not just bread and flour). 
3.54 
...if gluten-free food was exempt from the prescription charge. 3.30 
...if people on a low income had additional help with the cost of 
gluten-free food. 
3.02 
...if Coeliac UK’s Food and Drink Directory included a wider range 
of products and brands. 
2.81 
...if they were given a personal amount of money to support the 
buying of gluten-free food, rather than getting it on prescription. 
2.43             
...if there were more resources for people from ethnic minorities. 2.11 
 
Two additional statements also related to prescribed GFF, but these 
statements were grouped into different clusters:  
 
"...if GPs were better informed about what patients are allowed on 
prescription" – Cluster 3: Knowledge, information and education. 
 
"…if they didn’t have to go to a pharmacy to collect prescribed gluten-free 
food when it should be obtainable from shops or supermarkets" – Cluster 
11: Convenience of obtaining prescribed GFF. 
 
Cluster 6 – If they can eat the same as other people 
Cluster 6 (Table 4.16) contains two statements that represent eating in a 
social setting. The two statements in cluster 6 appear somewhat dissimilar, 
although they were grouped together frequently by participants. The 
Ariadne manual (Talcott, 1995) advises that, when choosing a name for a 
cluster, it is important to focus on the statements with the highest priority 
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rating within that cluster. Therefore, we agreed to label this cluster 
according to the most highly rated of the two statements 'if they can eat the 
same (gluten-free) food as other people'. Both statements represent issues 
relating to eating in social situations. 
 
Table 4.16 Cluster 6 - If they can eat the same as other people 
Cluster 6: If they can eat the same as other people (mean preference score: 2.99)
1 
 
Statements: 
Mean 
preference 
score 
...if you can eat the same (gluten-free) food as everyone else when 
eating socially. 
3.17 
 
...if hospitals were better at providing gluten-free food. 2.85 
Note: 
The cluster preference score of 2.99 is less than the average of the two 
statement preference scores. The reason for this is that the number of 
participants who prioritised each statement differed and this was taken into 
account when calculating the cluster preference score. The statement ‘…if 
hospitals were better at providing gluten-free food’ was ranked by more 
participants that the other statement in this cluster. As the statement that was 
ranked by more participants had a lower mean preference score, the overall 
cluster prioritisation score is lower than the average of the two statements.  
 
The original statements that were synthesised to produce the statement '…if 
you can eat the same (gluten-free) food as everyone else when eating 
socially' were: 
'…if you can eat identical (gluten-free) food to everyone else' 
'…if people with CD are given the same types of food as non-coeliacs when 
eating socially' 
'…if meals eaten in social situations could include gluten-free substitutes 
which are similar to the foods eaten by other people rather than having to 
eat a different type of meal' 
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The original statements that were synthesised to produce the statement 'if 
hospitals were better at providing GFF' were: 
'…if hospital restaurants could offer gluten-free meals' 
'…if hospitals provided GFFF without having to inform them in advance' 
'…if hospitals were better at providing GFF' 
'…if hospitals were better at providing GFF for patients with CD' 
 
Cluster 7 – Eating away from the home 
The main themes arising from cluster 7 'Eating away from the home' (Table 
4.17) relate to eating in restaurants and availability of GFF when travelling. 
This was the seventh most important theme to emerge from this study. 
During group brainstorming sessions, stories were told by participants about 
difficulties and inconsistencies experienced when travelling by air. We were 
told that some airlines gave passengers the option to select a GF meal, 
however, the airline couldn't guarantee that the passenger would get it. One 
participant who had ordered an on-flight GF meal was told during the flight 
that there were no GF options available, however, other passengers were 
given GF items such as fresh fruit.   
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Table 4.17 Cluster 7 - Eating away from the home 
 
Cluster 7: Eating away from the home (mean preference score: 2.96) 
 
Statements: 
Mean 
preference 
score 
...if restaurants were better at labelling gluten-free options on 
their menus. 
4.15 
...if there were more gluten-free options when eating out. 4.00 
...if staff working in restaurants/cafes were more knowledgeable 
about coeliac disease and the gluten-free diet. 
3.81 
...if food outlets were more careful to avoid gluten 
contamination. 
3.48 
...if they take their own gluten-free food with them when eating 
away from home. 
3.43 
...if there was legislation to ensure all food outlets provide 
gluten-free options. 
3.33 
...if they can get hold of gluten-free food when travelling 
abroad. 
3.07 
...if they are allowed to take gluten-free food with them when 
travelling abroad. 
2.87 
...if restaurants and carveries provided gluten-free gravy. 2.83 
...if motorway services provided gluten-free food. 2.34 
...if airlines were better at providing gluten-free food during 
flight. 
2.30 
...if there was more availability of gluten-free fish and chips. 2.26 
...if pubs stocked gluten-free beers and lagers. 2.20 
...if airports were better at providing gluten-free food. 2.17 
...if gluten-free food was more available when travelling by 
train. 
2.09 
 
Cluster 8 - If they are prepared to go hungry when there is no gluten-
free food available 
Table 4.18 shows a single-cluster statement relating to going hungry when 
gluten-free food is not available.  
 
Table 4.18 Cluster 8 - If they are prepared to go hungry when there is no 
gluten-free food available 
 
Cluster 8: If they are prepared to go hungry when there is no gluten-free food 
available (mean preference score: 2.85) 
 
Statement/s: 
Mean 
preference 
score 
...if they are prepared to go without/go hungry rather than eat 
gluten when there are no gluten-free foods available. 
 
2.85 
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Cluster 9 – Motivation and support 
Cluster 9 (Table 4.19) relates to self-determination, social support and 
motivation. This cluster falls in the psychological and individual 
responsibility quadrant. Determination and having a positive outlook were 
believed to help patients stick to a GFD. In addition, the support and 
motivation from others was also important in relation to adherence. The 
statement "if they are female" was ranked lowest out of the 91 statements by 
all three participant groups. This statement was generated by a mother and 
daughter during a group brainstorming session. The statement arose when 
the mother and daughter were discussing how difficult they thought it would 
be for the father of their household to follow a GFD if he had CD and they 
believed this would be true for other males. During the follow-up group 
sessions with different sets of participants, it became clear that most people 
did not agree with this statement and several participants couldn't 
understand how it could be easier for females to follow a GFD compared to 
males.  
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Table 4.19 Cluster 9 - Motivation and support 
Cluster 9: Motivation and support (mean preference score: 2.81) 
 
Statements: 
Mean 
preference 
score 
...if they are determined to stick to the gluten-free diet and resist 
temptations. 
3.91 
...if they have a positive outlook and focus on what they can eat, 
rather than what they can’t. 
3.81 
...if they have supportive family and friends. 3.57 
...if friends and family are supported/educated so they can 
reliably cater for them. 
3.51 
...if the public had a better understanding of coeliac disease and 
the gluten-free diet. 
3.20 
...if other household members eat gluten-free. 2.68 
...if other people encouraged them to stick to the gluten-free 
diet. 
2.67 
...if they have supportive work colleagues. 2.38 
...if they have someone to speak up for them on their behalf. 2.11 
...if someone cooks for them. 1.74 
...if they are female. 1.37 
 
Cluster 10 – Social stigma 
Cluster 10 is a three-statement cluster relating to issues about not being 
made to feel embarrassed or different when eating in public (Table 4.20). 
Although the cluster ranking is lower than the previous clusters, this was a 
theme that came up many times during group brainstorming sessions where 
people told stories about their experiences of embarrassment and being 
made to feel like they were making an unnecessary fuss by asking for GFF. 
The third statement in this cluster relates to the pressure felt to accept 
gluten-inclusive food and drink when it is offered, rather than making a fuss 
or feeling rude by rejecting the kindness of the person offering it. This issue 
arose a few times during the group sessions and participants had mixed 
opinions about whether they should worry about what other people think 
when they ask for GFF. Some participants were assertive and said they had 
no problem with 'making a fuss' whereas one person said she had hidden 
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away during a wedding because the GFF she had requested wasn't available 
and she didn't want the bride's mother to notice that she wasn't eating 
anything. 
 
Table 4.20 Cluster 10 – Social stigma 
Cluster 10: Social stigma (mean preference score: 2.8) 
 
Statements: 
Mean 
preference 
score 
...if they are confident and not embarrassed by having to ask for gluten-
free food when eating out. 
3.17 
...if they are not made to feel different when eating socially. 3.06 
...if there was less social pressure to accept any gluten-inclusive food 
or drink you are offered. 
2.15 
Note: 
The cluster preference score of 2.8 is less than the average of the three 
statement preference scores. The reason for this is that the number of 
participants who prioritised each statement differed and this was taken into 
account when calculating the cluster preference score. The statement with 
the highest mean preference score was ranked by more participants than the 
other two statements. As the statement that was ranked by more participants 
had a higher mean preference score, the overall cluster prioritisation score is 
higher than the average of the three statements.  
 
Cluster 11 – Convenience of obtaining prescribed gluten-free food 
Cluster 11 is another single-statement cluster (Table 4.21). As discussed 
previously, this statement may have fit better within cluster 5 – 'Prescribed 
GFF'.  During group brainstorming sessions, suggestions were made for a 
voucher scheme whereby patients could be provided with vouchers to buy 
GFF in shops and supermarkets, rather than going to a pharmacy to pick up 
prescribed GF food. Some participants felt the prescription system was out-
of-date now that GFF is more widely available in the shops. 
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Table 4.21 Cluster 11 Convenience of obtaining prescribed gluten-free food 
Cluster 11: Convenience of obtaining prescribed gluten-free food (mean 
preference score: 2.56) 
 
Statement/s: 
Mean 
preference 
score 
...if they didn’t have to go to a pharmacy to collect prescribed 
gluten-free food when it should be obtainable from shops or 
supermarkets. 
2.56 
 
Cluster 12 – Diet planning and preparation 
We took some time to decide on the name of cluster 12. On first glance the 
statements listed in Table 4.22 did not appear to be clearly related, however, 
the four statements in this cluster are related to planning and preparing a 
GFD. Coeliac UK's Food and Drink Directory was discussed during 
brainstorming sessions and participants often use it when shopping for GFF. 
Members receive a copy of the Food and Drink Directory when they join 
Coeliac UK and they are sent a revised edition annually. Some participants 
told us that they did not have a copy of the Directory because they had not 
joined Coeliac UK. One participant cancelled her membership to Coeliac 
UK when the annual membership fee (currently £20) was introduced and, 
therefore, she no longer received the Food and Drink directory. 
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Table 4.22 Cluster 12 - Diet planning and preparation 
 
Cluster 12: Diet planning and preparation (mean preference score: 2.40) 
 
Statements: 
Mean 
preference 
score 
...if they use Coeliac UK’s Food and Drink Directory. 2.98 
...if more gluten-free recipes were available. 2.53 
...if it was free to join Coeliac UK. 2.22 
...if they have plenty of freezer space. 1.87 
 
Cluster 13 – Provision of GFF at work 
The cluster perceived to be the least important related to the provision of GF 
food at work (Table 4.23). Cluster 13 is a single-statement cluster. Table 
4.23 Cluster 13 - Provision of gluten-free food at work 
Cluster 13: Provision of gluten-free food at work 
(mean preference score: 2.19) 
 
Statements: 
Mean 
preference 
score 
...if gluten-free biscuits were made available when gluten-inclusive 
biscuits are served with tea and coffee at work. 
 
2.19 
 
4.7.4 Comparison between the three 
stakeholder groups 
 
Differences between the cluster preference ratings for each stakeholder 
group were tested for statistical significance using the Kruskal-Wallis test. 
No statistically significant difference was found in 12 out of the 13 clusters. 
Cluster 2 (the availability of GF sandwiches) shows a significant difference 
between the mean preference ratings for stakeholder groups (Table 4.24). A 
follow-up test was used to make pairwise comparisons between stakeholder 
groups for cluster 2 to establish which of the three groups had statistically 
using the Mann-Whitney U test and the results of this are shown in Table 
4.25. Significant differences in mean priority scores for cluster 2 were found 
 192 
 
between adults with CD and healthcare professionals (P=0.02) and also 
between household members and healthcare professionals (P=0.04). In both 
instances, the mean preference rating for healthcare professionals was 
significantly lower than the other two stakeholder groups. No other 
statistically significant differences were found between the stakeholder 
group cluster preferences.  
 
Cluster 8 (…if they are prepared to go hungry when there is no gluten-free 
food available) showed a lower mean priority rating for healthcare 
professionals compared to the other two stakeholder groups, however, the 
difference was not statistically significant (P=0.06) (Table 4.24). 
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Table 4.24 Kruskal-Wallis analysis comparing the mean preference scores for the 13 clusters for three stakeholder groups. 
 
Cluster All 
participants 
 
Adults with 
coeliac 
disease  
 
Household 
members 
Healthcare 
professionals 
Kruskal-Wallis 
test 
(P-value) 
1. The cost of gluten-free food 
Rank: 
Mean: 
SD: 
95% CI 
 
1 
4.28 
0.97 
4.01-4.55 
 
1 
4.20 
0.91 
3.82-4.58 
 
1 
4.47 
0.74 
4.06-4.88 
 
1 
4.21 
1.31 
3.46-4.97 
 
0.66 
2. The availability of gluten-free sandwiches 
Rank: 
Mean: 
SD: 
95% CI 
 
2 
3.60 
1.25 
3.25-3.93 
 
2 
3.84 
1.21 
3.34-4.34 
 
2 
3.87 
1.06 
3.28-4.45 
 
7 
2.86 
1.29 
2.11-3.60 
 
0.05 
3. Knowledge, information and education  
Rank: 
Mean: 
SD: 
95% CI 
 
3 
3.20 
0.37 
3.10-3.30 
 
5 
3.11 
0.32 
2.98-3.24 
 
3 
3.20 
0.35 
3.01-3.40 
 
2 
3.35 
0.45 
3.09-3.61 
 
0.21 
4. Access to good quality gluten-free food 
Rank: 
Mean: 
SD: 
95% CI 
 
4 
3.14 
0.44 
3.02-3.26 
 
4 
3.18 
0.40 
3.01-3.34 
 
6 
3.07 
0.58 
2.75-3.39 
 
4 
3.16 
0.35 
2.95-3.36 
 
0.78 
 
5. Prescribed gluten-free food 
Rank: 
Mean: 
SD: 
95% CI 
 
5 
3.08 
0.64 
2.91-3.26 
 
8 
3.00 
0.65 
2.74-3.27 
 
7 
3.05 
0.66 
2.69-3.42 
 
3 
3.26 
0.60 
2.91-3.61 
 
 
 
0.42 
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Cluster All 
participants 
 
Adults with 
coeliac 
disease  
Household 
members 
Healthcare 
professionals 
Kruskal-Wallis 
test 
(P-value) 
6.  If they can eat the same as other people 
Rank: 
Mean: 
SD: 
95% CI 
 
6 
2.98 
0.91 
2.73-3.23 
 
6 
3.10 
0.98 
2.70-3.50 
 
4 
3.20 
0.73 
2.80-3.60 
 
11 
2.54 
0.87 
2.04-3.04 
 
0.10 
7. Eating away from the home 
Rank: 
Mean: 
SD: 
95% CI 
 
7 
2.96 
0.50 
2.82-3.09 
 
7 
3.08 
0.57 
2.84-3.31 
 
8 
2.97 
0.35 
2.78-3.16 
 
8 
2.73 
0.43 
2.48-2.98 
 
0.09 
8. If they are prepared to go hungry when there is 
no gluten-free food available 
Rank: 
Mean: 
SD: 
95% CI 
 
 
8 
2.85 
1.56 
2.43-3.28 
 
 
3 
3.20 
1.53 
2.57-3.83 
 
 
5 
3.07 
1.67 
2.14-3.99 
 
 
12 
2.00 
1.24 
1.28-2.72 
 
0.06 
9. Motivation, support and determination/will 
power 
Rank: 
Mean: 
SD: 
95% CI 
 
9 
2.81 
0.49 
2.69-2.95 
 
9 
2.81 
0.53 
2.60-3.03 
 
9 
2.91 
0.47 
2.66-3.17 
 
9 
2.70 
0.43 
2.45-2.95 
 
0.48 
10.  If they are not made to feel different when 
asking for gluten-free food 
Rank: 
Mean: 
SD: 
95% CI 
 
 
10 
2.80 
0.88 
2.56-3.04 
 
 
10 
2.72 
0.85 
2.37-3.07 
 
 
10 
2.73 
1.08 
2.14-3.33 
 
 
6 
3.02 
0.72 
2.61-3.44 
 
 
 
0.56 
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Cluster All 
participants 
 
Adults with 
coeliac 
disease  
Household 
members 
Healthcare 
professionals 
Kruskal-Wallis 
test 
(P-value) 
11. Convenience of obtaining prescribed gluten-
free food 
Rank: 
Mean: 
SD: 
95% CI 
 
11 
2.56 
1.39 
2.17-2.94 
 
13 
2.24 
1.30 
1.70-2.78 
 
11 
2.60 
1.50 
1.77-3.43 
 
5 
3.07 
1.38 
2.27-3.87 
0.19 
12. Diet planning and preparation / Coeliac UK 
Rank: 
Mean: 
SD: 
95% CI 
 
12 
2.40 
0.56 
2.25-2.56 
 
12 
2.34 
0.58 
2.10-2.58 
 
12 
2.35 
0.52 
2.06-2.64 
 
10 
2.57 
0.57 
2.44-2.90 
 
0.46 
13. Provision of gluten-free foods at work 
Rank: 
Mean: 
SD: 
95% CI 
 
13 
2.19 
1.27 
1.84-2.53 
 
11 
2.56 
1.29 
2.03-3.09 
 
13 
1.93 
1.16 
1.29-2.58 
 
13 
1.79 
1.25 
1.06-2.51 
 
0.08 
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Table 4.25 Results of the Mann-Whitney U test for the cluster which showed a significant difference using the Kruskal-Wallis test. 
 
Cluster All 
participants 
 
Adults with 
coeliac 
disease 
 
Adult 
household 
members  
 
Healthcare 
professionals 
 
Kruskal-
Wallis test 
(P-value) 
Mann-Whitney U test (P-values) Pairwise 
comparisons 
Adults with 
coeliac 
disease and 
adult 
household 
members 
Adults with 
coeliac disease 
and healthcare 
professionals 
Adult 
household 
members and 
healthcare 
professionals 
Cluster 2 - The Availability 
of Gluten-free Sandwiches 
Rank: 
Mean: 
SD: 
95% CI 
 
 
2 
3.60 
1.25 
3.25-3.93 
 
 
2 
3.84 
1.21 
3.34-4.34 
 
 
2 
3.87 
1.06 
3.28-4.45 
 
 
7 
2.86 
1.29 
2.11-3.60 
 
0.046 
 
0.930 
 
0.024 
 
0.036 
 
 
 197 
 
4.7.5 Synthesis of concept mapping results with 
systematic review results 
 
In this section I will synthesise the results of my update to the systematic 
review by Hall et al. (2009) (presented in Chapter 2) with the results of this 
concept mapping study. Tables 4.26 to 4.31 show the results of this 
synthesis. I have used the same six themes that Hall et al. (2009) identified 
in their systematic review to organise the data. 
 
Sociodemographic factors 
The systematic review found very little evidence of an association between 
sociodemographic factors and adherence to a GFD. None of the concept 
mapping clusters fit into this category, which provides further evidence that 
sociodemographic factors are not strongly associated with adherence to a 
GFD. In the concept mapping study, one statement was generated regarding 
adherence to a GFD and gender. The statement suggested that it was easier 
to stick to a GFD if you are female. This statement received the lowest 
priority rating and several participants expressed their disagreement with 
this statement. Overall, sociodemographic factors have not been found to be 
associated with adherence to a GFD. 
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Table 4.26 Sociodemographic factors. 
 
Data 
Source 
Factor Factors 
Associated with 
Adherence 
Factors not 
associated with 
adherence 
Priority
3 
Review Education 3/9
1
 (n=1544)
2 
6/9
1
 (n=853)
2 
N/A 
Review Age 6/17
1
 (n=1797)
2 
11/17
1
 (n =4569)
2 
N/A 
Review Gender 1/12
1
 (n=128)
2 
11/12
1
 (n=6551)
2 
N/A 
 Review Social Class/ 
socioeconomic 
status 
1/3
1
 (n=573)
2 
2/3
1
 (n=282)
2 
N/A 
Review Urban residence 1/1
1
 (n=234)
2 
 N/A 
Review Employment status 
/ Occupation 
 2/2
1
 (n=544)
2 
N/A 
Review Marital status 1/2
1
 n=154
2 
1/2
1
 n=255
2 
N/A 
Review Ethnicity 
(Caucasians more 
adherent than 
Asian) 
1/2
1
 (n=87)
2 
1/2
1
 (n=679)
2 
N/A 
Review Smoking 1/1
1
 N=204
2 
 N/A 
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or not 
associated with adherence (e.g. three out of nine (3/9) studies showed that education was a 
factor associated with adherence and six out of nine (6/9) studies showed no association 
between adherence and education).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. However, none of 
the concept mapping clusters appear in this table. 
 
 
 
Knowledge attitudes and beliefs 
The statements that were grouped into the ‘knowledge, information and 
education’ cluster on the concept map reflect several of the factors included 
in Hall et al.’s (2009) ‘knowledge, attitudes and beliefs’ theme. However 
the concept mapping cluster included the knowledge of both healthcare 
professionals and patients, not just patients’ knowledge, which was not 
highlighted in the systematic review. The closest factor identified from the 
systematic review in relation to the knowledge of healthcare professionals 
was ‘Satisfaction with information from health care provider’. 
 
Some of the individual statements from the ‘knowledge, information and 
education’ concept mapping cluster can be mapped to some of the factors 
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included in Hall et al.’s (2009) ‘Healthcare treatment factors’, ‘Socio-
cultural/environmental factors’ and ‘Quality of life and psychological 
wellbeing’ factors. 
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Table 4.27 Knowledge, attitudes and beliefs. 
Data 
Source 
Factor Factors 
Associated 
with 
Adherence 
Factors not 
associated with 
adherence 
Priority 
Review Knowledge and 
understanding of GFD/ 
GF ingredients 
3/3
1
 (N=719)
2 
 N/A 
Concept 
map 
Knowledge and 
Information about CD 
and the GFD 
N=73  3 
Review Understanding and use 
of food labels 
2/3
1
 (N=365)
2
 1/3
1
 
(N=234)
2
 
N/A 
Review Beliefs about 
harm/consequences 
from exposure to gluten 
/ belief in cyclical nature 
of coeliac disease 
4/5
1
 (N=729)
2 
1/5
1
 (n=278)
2 
N/A 
Review Personality traits (higher 
conscientiousness/higher 
values trait/higher order 
trait/ higher self-
discipline/deliberation) 
associated with better 
adherence 
1/1
1 
( N=154)
2 
 N/A 
Review Intention to adhere 1/1
1
 (N=390)
2 
 N/A 
Review Task or emotion 
oriented coping 
associated with better 
adherence 
1/1
1
 (N=390)
2  
 
Review Self-efficacy 2/2
1
 (n=575)
2
  N/A 
Concept  
map 
Motivation and support n=73  9 
Review Being prepared and 
organised 
1/1
1
 (n=278)
2
  N/A 
Concept 
Map 
Diet planning and 
preparation 
1/1 (n=73)  12 
Review Confidence to ask 
questions about 
contamination was 
associated with better 
adherence 
1/1
1
 (N=278)
2
  N/A 
Review Having trust in others to 
prepare GFF 
1/1
1
 (N=278)
2
  N/A 
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or 
not associated with adherence (e.g. four out of five (4/5) studies showed that beliefs 
about harm/consequences from exposure to gluten / belief in cyclical nature of coeliac 
disease were factors associated with adherence and one out of five (1/5) studies 
showed no association between adherence and beliefs about harm/consequences from 
exposure to gluten / belief in cyclical nature of coeliac disease).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. Cluster numbers 3 
and 12 from the concept map appear in this table. 
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Illness and symptom factors 
None of the concept mapping clusters appeared to fit within this theme and 
the systematic review identified that most factors were not supported or only 
had small studies to support them. The association between body weight and 
adherence to a GFD was not identified in the concept mapping study. Some 
of the factors are covered by individual statements contained within the 
concept mapping clusters.  
 
Table 4.28 Illness and symptom factors. 
Authors Factors Factors 
Associated with 
Adherence 
Factors not 
associated with 
adherence 
Priority
3 
Review Time since 
diagnosis 
1/5
1
 (N=76)
2
 4/5
1
 (N=1090)
2
 N/A 
Review Age at diagnosis 3/9
1
 (N=369)
2
 6/9
1
 (N=1568)
2
 N/A 
Review Presence of 
symptoms at 
diagnosis 
2/6
1
 (N=454)
2
 4/6
1
 (N=1982)
2
 N/A 
Review Diagnostic delay 1/1
1
 (N=300)
2
  N/A 
Review Coeliac disease 
symptoms 
experienced 
4/9
1
 (n=1134)
2 
5/9
1
 (n=920)
2 
N/A 
Review Presence of 
additional food 
intolerances 
2/2
1
 (n=308)
2  
N/A 
Review Body weight 1/1
1
 (N=1018)
2  
N/A 
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or 
not associated with adherence (e.g. four out of nine (4/9) studies showed that coeliac 
disease symptoms was a factor associated with adherence and five out of nine (5/9) 
studies showed no association between adherence and coeliac disease symptoms 
experienced).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. However, none of 
the clusters appear in this table. 
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Healthcare treatment factors 
The two concept mapping clusters that related to prescribed GFF fit closely 
within this theme. The concept map separated the content of what was 
prescribed and how prescribed GFF is delivered. Overall, the importance of 
prescribed GFF does appear to be associated with adherence to a GFD.  
 
Several of the factors included in this theme, appeared elsewhere as 
statements in the concept mapping clusters. For example, the concept 
mapping cluster ‘motivation, support, determination/will power’ included a 
statement about membership of a coeliac support group, which the review 
identified as associated with adherence. This cluster also included support 
from healthcare professionals and family and friends, which is not present in 
this group of factors according to Hall et al. (2009). 
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Table 4.29 Healthcare treatment factors. 
Data 
Source 
Factors Factors 
Associated with 
Adherence 
Factors not 
associated with 
adherence 
Priority 
Review Duration of 
gluten-free diet 
 
1/5
1
 (N=200)
2 
4/5
1
 (N=385)
2 
 
Review Difficulty of 
gluten-free diet 
2/3
1
 (N=3200)
2
 
 
1/3
1
 (N=73)
2 
 
Review Receiving 
gluten-free food 
on prescription 
1/1
1
 (N=287)
2
   
Concept 
Map 
Prescribed 
gluten-free food 
N=73
  
5 
Concept 
Map 
Convenience of 
obtaining 
prescribed 
gluten-free food 
N=73
  
11 
Review Satisfaction 
with 
information 
from health 
care provider 
2/3
1
 (N=321)
2
 1/3
1
 (N=154)
2
 Review 
Review Attendance at 
coeliac clinic 
1/2
1
 (N=99)
2 
1/2
1
 (N=413)
2 
 
Review Regularity of 
follow-up 
3/4
1
 (N=764)
2 
1/4
1
 (N=207)
2 
 
Review Coeliac support 
group 
membership 
3/3
1
 (N=528)
2 
  
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or 
not associated with adherence (e.g. one out of five (1/5) studies showed that duration of 
gluten-free diet was a factor associated with adherence and four out of five (4/5) 
studies showed no association between adherence and duration of gluten-free diet).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. However, none of 
the clusters appear in this table. 
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Socio-cultural/environmental factors 
This group of factors are the ones that map most closely to the concept 
mapping clusters. Hall et al. (2009) concluded that the cost of GFF was not 
important from the data they had at the time. However, new data has shown 
that cost is a significant factor affecting adherence to a GFD in adult CD. 
This finding is supported by the results of this concept mapping study, 
which found the cost of GFF to be the most important factor affecting 
adherence to a GFD.  
 
Statements relating to the availability of GFF were split into three clusters 
by the participants in this study. These clusters highlight not just the 
availability of GFF (e.g. in shops and restaurants) but the specific provision 
of GFF in the workplace and the decisions a person with CD may have to 
make if GFF is not available (i.e. go hungry). In the concept map, factors 
relating to eating away from home were split into two clusters: eating away 
from home, which includes travel and restaurants; and eating the same as 
other people when eating in social situations (including in the hospital). 
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Table 4.30 Socio-cultural/environmental factors 
Data Source Factors Factors 
Associated 
with 
Adherence 
Factors not 
associated 
with 
adherence 
Priority
3 
Review Eating convenience 
foods 
1/1
1
 (N=146)
2
   
Review  Eating away from 
home 
6/7
1
 
(N=3680)
2 
1/7
1
 (N=234)
2 
 
Concept map Eating away from 
home 
73  7 
Review Having supportive 
family and friends 
 1/1
1
 (N=278)
2
  
Concept map If they can eat the 
same as other people 
73  6 
Review Availability of GFF 3/5
1
 (N=499)
2 
2/3
1
 (N=395)
2 
 
Concept Map The availability of 
GF sandwiches 
73  2 
Review Improved choice of 
GFF 
2/2
1
 
(N=3209)
2 
  
Concept Map If they are prepared 
to go hungry when 
there is no GFF 
available 
73  8 
Concept Map Provision of GFF at 
work 
73  13 
Review Quality of GFF 4/5
1
 
(N=3519)
2 
1/5
1
 (N=234)
2 
 
Concept Map Access to good 
quality GFF 
73  4 
Review  Cost of GFF  4/6
1
 
(N=3599)
2 
2/6
1
 (N=308)
2 
 
Concept Map The cost of GFF 73  1 
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or 
not associated with adherence (e.g. six out of seven (6/7) studies showed that eating 
away from home was a factor associated with adherence and one out of seven (1/7) 
studies showed no association between adherence and eating away from home).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. However, none of 
the clusters appear in this table. 
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Only one cluster from the concept map fit within this group of factors 
(social stigma). Social stigma was most closely related with anxiety 
especially the social impact of eating different food to other people. 
Depression was not mentioned in any of the statements generated during 
brainstorming in the concept mapping study. The association between 
adherence to a GFD and depression is unclear from the evidence provided in 
the systematic review. 
 
Table 4.31 Quality of life and psychological well-being 
Data 
Source 
Factors Factors 
Associated with 
Adherence 
Factors not 
associated with 
adherence 
Priority 
Review Depression 5/7
1
 (N=888)
2 
2/7
1
 (N=2805)
2 
 
Review Presence of 
psychological 
disturbance 
 1/1
1
 (N=154)
2 
 
Review Eating disorders 1/1
1
 (N=390)
2 
  
Review Anxiety 3/8
1
 (N=3354)
2 
5/8
1
 (N=1696)
2 
 
Concept 
Map 
Social Stigma 73  10 
Review Anger  1/1
1
 (N=139)
2 
 
Review Mood or stress  1/1
1
 (N=154)
2 
 
Review Quality of life 8/12
1
 (N=4882)
2 
4/12
1
 (N=1368)
2 
 
Review Wellbeing  1/1
1 
(N=28)
2 
 
Notes:  
1. This indicates the number of studies that found a particular factor to be associated or 
not associated with adherence (e.g. five out of seven (5/7) studies showed that 
depression was a factor associated with adherence and two out of seven (2/7) studies 
showed no association between adherence and depression).  
2. n= total number of participants (including controls where relevant) 
3. Priority relates to the priority rating of the concept mapping clusters. However, none of 
the clusters appear in this table. 
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4.7.6 The construct of knowledge 
 
All of the factors and clusters that I identified from my concept mapping 
study and systematic review could be mapped to the six themes in the 
systematic review by Hall et al (2009). However, my categorisation differed 
slightly from that used by Hall et al. (2009). From the results of this study, I 
identified the concept of knowledge as being of a broader base and more 
complex in nature than that identified by Hall et al. (2009). The results show 
that the construct of the concept of knowledge needed to adhere to a GFD 
was made up of seven components: 
 
1. The person with CD needs significant knowledge of what foods 
contain gluten, how to identify gluten ingredients in manufactured 
foods and how to prepare GFF from scratch. They also need 
knowledge of the social skills required to be confident enough to ask 
for a restricted diet in a wide variety of social setting. 
 
2. The family and friends of a person with CD could influence their 
adherence substantially by providing them with GFF at social 
events. This requires the family member or friend of the person with 
CD to understand and apply GF knowledge in their food purchasing 
and preparation. 
 
3. The healthcare professionals working with CD patients need to have 
sufficient knowledge of the GFD. However they also needed to 
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promote prior organisation (e.g. taking food with you) and 
pragmatism (e.g. going hungry). 
 
4. Support from other people with CD is also essential, often in the 
context of membership of Coeliac UK. Other people with CD have 
the practical knowledge of living with a restricted diet in the context 
of a gluten-dependent environment. They have many practical tips 
and advice that can be shared and applied.  
 
5. The knowledge of restaurateurs and chefs in relation to the GFD and 
CD is essential if they are to providing people with CD with safe 
food when eating out.  
 
6. The knowledge of people working in the food industry in relation to 
the GFD and CD is also essential. GFF needs to be appropriately 
labelled and gluten-free ingredients should be chosen over gluten—
inclusive ones where possible (e.g. corn flour as a thickening agent 
in sauces rather than wheat four).  
 
7. The final group is shops and food outlets that provide food to people 
when on the go. The staff need to have a knowledge of the GFD and 
CD so that they can provide a greater choice of GFF that is 
acceptable to all customers (not just those with CD).  
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4.8 Summary 
 
I recruited a reasonably diverse group of 73 participants from three 
stakeholder groups using seven recruitment routes. Participants 
brainstormed 903 statements relating to adherence to a GFD and data 
saturation was achieved. Thirteen concepts were found to be associated with 
adherence to a GFD. A high degree of similarity in the perceptions of the 
three stakeholder groups was found. The cost of GFF was the most 
important factor affecting adherence to the GFD. This finding, along with 
more recently published research, contradicts the evidence that was 
available at the time of a previous systematic review (Hall et al., 2009) 
which reported no association between the cost of GFF and adherence to a 
GFD.  The three stakeholder groups appeared to hold similar views about 
what would help adults with CD stick to a GFD. However, healthcare 
professionals perceived the second most important cluster (the availability 
of GF sandwiches) to be significantly less important than the other two 
stakeholder groups. The availability of GFF away from the home and access 
to GFF on prescription were issues that affect adherence to a GFD. 
 
The results of this CM study were synthesised with my initial systematic 
review. All the clusters mapped to the factors identified in the review, 
however, the concept mapping process helped to clarify the importance of 
these factors to adherence behaviours and also the construction of the 
concepts. The concept of knowledge is broader than the construct that is 
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presented in Hall et al.’s (2009) systematic review as ‘Knowledge attitudes 
and beliefs’.  Some risk factors in the literature did not map to factors 
identified in this concept mapping study, in particular sociodemographic 
factors.  
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Chapter 5: Discussion 
 
5.1 Introduction 
 
The aim of this study was to gain a better understanding of the factors 
affecting adherence to a gluten-free diet (GFD) in adults with CD. A further 
aim was to compare the perspectives of patients, household members and 
healthcare professionals in relation to what helps adults with coeliac disease 
(CD) stick to a GFD. From the concept mapping study and the systematic 
review presented in this thesis, I have identified a number of factors 
associated with adherence to a GFD in adults with CD. In this discussion, I 
interpret the results of my concept mapping study and discuss my findings 
in the context of the existing evidence.  
 
I begin this chapter by discussing the results of recruitment, data collection 
and analysis. I then discuss each of the thirteen concepts identified in this 
concept mapping study in order of priority rating, starting with the cost of 
GFF, which was perceived to be the most important factor affecting 
adherence to a GFD. I discuss the utility and relevance of the theoretical 
models of behaviour change in light of the results of this study. The model 
of adherence to a GFD that I have developed from the results of this study is 
presented in this chapter and I acknowledge the limitations of this study. 
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Recommendations for future research are presented at the end of this 
chapter.  
 
5.2 Recruitment, data collection and data 
analysis 
 
5.2.1 Recruitment 
 
To limit the effects of selection bias, I recruited participants through seven 
channels. Several previous studies have recruited only through coeliac 
support groups, however, people who are members of coeliac support 
groups tend to be better at adhering to a GFD and, therefore, may not be 
representative of the wider population. All seven routes of recruitment have 
their advantages and limitations as outlined in Table 5.1. 
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Table 5.1 The advantages and limitations of the seven channels of 
recruitment used in this study. 
 Advantages Limitations 
Invitation letters 
posted by 
Coeliac UK 
Reaches a group of people 
who have expressed an 
interest in getting involved 
in research. 
People with coeliac disease who are 
members of Coeliac UK may not be 
representative of all people with coeliac 
disease. Members of Coeliac UK are 
more likely to adhere to a GF diet, so 
recruiting partially-adherent or non-
adherent participants is difficult. 
Advertisement in 
local newspapers 
Reaches those who are not 
currently being treated for 
CD and those who are not 
members of Coeliac UK.  
Only those people who read the local 
paper would see the advertisement. May 
be inundated with responses when only 
a small sample is required. 
E-mail to 
healthcare 
professional 
members of the 
British Dietetic 
Association 
Reaches a range of 
healthcare professionals. 
Members may not work with Coeliac 
patients. E-mails are easily ignored. 
Advertisements 
on Coeliac UK 
website 
Reaches a wide audience 
of people with CD, 
healthcare professionals 
and household members 
who use the website. 
Members may have dermatitis 
herpetiformis, not coeliac disease. May 
be inundated with responses when only 
a small sample is required. 
Invitation packs 
distributed by 
hand by Norfolk 
and Norwich 
University 
Hospital 
(NNUH) 
Reach partially-adherent 
and non-adherent as well 
as healthcare professionals 
who work with adult 
coeliac patients. 
Only a small number of healthcare 
professionals work with adult coeliac 
patients at NNUH. There is no patient 
database, so it was not possible to 
distribute patient invitation packs by 
mail. Invitation packs could only be 
handed to patients during outpatient 
appointment, which was a slow process.  
Advertisement 
on the University 
of East Anglia 
(UEA) website 
Reaches a wide audience 
of UEA staff and students. 
The advertisement may not be viewed 
widely. May be inundated with 
responses when only a small sample is 
required. 
Invitation letters 
posted to 
General 
Practitioners and 
Practice Nurses 
Reaches a group of people 
who may have experience 
of the diagnosis of coeliac 
disease and prescribing 
gluten-free food. 
Low response rate is common in this 
population. General Practitioners and 
Practice Nurses may have little contact 
with coeliac patients and, therefore, may 
not feel motivated to participate. 
 
 
When designing this study, I considered the factors that could deter people 
from volunteering to take part. Providing participants with the option of 
completing the brainstorming and statement sorting tasks remotely may 
have encouraged participation in individuals who would find it difficult to 
attend the group sessions. Initially the recruitment of healthcare 
professionals and non-adherent participants was slow. To speed up the 
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recruitment process, I adapted my recruitment strategy to address this and 
was successful in recruiting a satisfactory number of participants (n=73).  
 
The sample of participants with CD and household members represented a 
wide range of age groups and both males and females were represented in 
all three stakeholder groups. However, with the exception of one male 
Gastroenterologist, all other healthcare professionals were female. Dietetics 
and nursing are predominantly female professions and, therefore, the sample 
of participants could be considered to be representative of these professions 
(Sturrock & Lennie, 2009; Nursing and Midwifery Council, 2009).  
The group of participants with CD and household members was not 
ethnically diverse. From these two stakeholder groups I recruited just one 
male participant with CD who was non-white British. I recruited the 
majority of participants from the Norfolk region, which has a relatively 
small proportion of ethnic minorities at just 7.6% of the population  in 2011 
compared to 19.5% in England and Wales as a whole  (Norfolk Insight, 
2011; Office for National Statistics, 2012). 
 
I aimed to recruit a mix of adherent, partially-adherent and non-adherent 
participants for this study. Adherence was measured through self-reporting, 
which is a notoriously inaccurate measure. However, my aim was not to 
measure adherence, but to recruit a diverse group of participants in order to 
collect a varied range of perspectives. The cost of measuring adherence 
using a more accurate test would be expensive and I did not have the budget 
to cover this. 
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Only one non-adherent participant volunteered to take part in this study. 
This participant had switched back to eating a normal gluten-inclusive diet 
when his wife died approximately 30 years ago and he had experienced no 
CD symptoms since then. Including more non-adherent participants may not 
have added value to this study because the focus was on the barriers faced 
by people when attempting to follow a GFD. The non-adherent participant 
included in this study was not attempting to follow a GFD. Fifteen adherent 
and eighteen partially-adherent participants were recruited and, with the 
inclusion of the one non-adherent participant, this sample allowed for the 
collection of data from people with CD who do and those who do not stick 
to a GFD. 
 
GPs have contact with patients at the time of CD diagnosis and when 
prescribing GFF. Therefore, GPs could be a valuable source of information 
in relation to the factors affecting adherence to a GFD. Overall, the 
recruitment of GPs was difficult and I only managed to recruit one GP for 
this study. An alternative recruitment strategy may have been more 
successful. Williamson et al. (2007) report that GPs are less likely to 
participate in research if they believe it will impinge too greatly on their 
time. On top of the time required to read and complete the participant 
documents (Appendices 6-22), concept mapping requires approximately 
three hours of participants’ time. This requirement may have deterred GPs 
(and others) from taking part in this study. By making it clearer to 
participants that they could complete just one or two of the three concept 
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mapping activities (brainstorming, prioritising and clustering), it is possible 
that more people would have volunteered to take part. However, such an 
approach could have resulted in higher attrition rates. 
 
Having an interest in the topic being studied is also linked with higher GP 
participation in research (Williamson et al., 2007). In this concept mapping 
study, a lack of knowledge and support in relation to CD and the GFD 
amongst healthcare professionals was indicated by participants (Appendix 
34, statements 20, 32 and 72). This could reflect a general lack of interest in 
CD and the GFD in this stakeholder group. However, by targeting 
healthcare professionals who are members of Coeliac UK and the BDA, I 
believe that my recruitment strategy was appropriate in targeting healthcare 
professionals who are likely to have an interest in CD. Although, this 
strategy was helpful for recruitment, this sample of healthcare professionals 
is unlikely to be representative of the ‘average’ healthcare professional who 
works with CD patients. Participants from these two groups are likely to be 
more interested and better informed about CD and the GFD.   
 
In summary, my recruitment strategy was successful in that I recruited a mix 
of participants from the three stakeholder groups using seven recruitment 
methods. However, the sample of participants included in this study may not 
be representative of the wider population. In particular, the sample of 
patients and household members was not ethnically diverse, patients were 
mostly members of Coeliac UK and only one fully non-adherent patient was 
recruited. However, I believe that by recruiting participants from three 
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stakeholder groups and using seven different recruitment strategies, I was 
able to recruit a sample of participants that represented a broad range of 
opinions in relation to the factors associated with adherence to a GFD. 
 
5.2.2 Data collection 
 
Brainstorming 
Data generation through brainstorming gave participants the opportunity to 
freely generate statements in relation to the focus prompt ‘It would be easier 
for adults with coeliac disease to stick to a gluten-free diet if…’. Nine 
hundred and three statements were generated through brainstorming and the 
high level of duplication towards the end of brainstorming indicated that 
data saturation had been reached. By anticipating the type of responses that 
could be generated, the steering group believed that the wording of the 
prompt would serve to elicit a wide range of ideas relating to adherence to 
the GFD. However, the wording of the focus prompt could have been 
presented in a number of ways and it is possible that different wording may 
have generated different responses (Kane & Trochim, 2007). 
 
Group brainstorming facilitates the generation of a higher number of ideas 
compared to remote, individual brainstorming (Kane & Trochim, 2007). 
Whether participants brainstormed their ideas remotely or in group 
brainstorming sessions may have affected the type and number of 
statements generated. During group brainstorming, participants generated 
ideas through lively discussions. Participants who brainstormed remotely 
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would not have experienced the same level of interactivity and exchange of 
ideas (Kane and Trochim, 2007). However, healthcare professionals who 
completed brainstorming remotely in the work environment may have had 
their ideas triggered by patients, colleagues and other resources that would 
not have been available to them during a group brainstorming sessions at the 
UEA. Similarly, patients and household members who completed 
brainstorming remotely may also have had their ideas triggered by factors in 
their environment that they may not have considered in a group setting. 
 
Participants who brainstormed remotely may have felt more willing to 
disclose sensitive information that they would have felt uncomfortable to 
disclose in a group setting. In addition, remote brainstorming avoids the 
problems associated with having outspoken participants in the group, who 
dominate the discussion and prevent others from voicing their ideas (Kane 
& Trochim, 2007). To minimise the chance of these issues occurring during 
group brainstorming sessions, the facilitators encouraged participants to 
generate ideas anonymously on pieces of paper and we ensured all 
participants were given equal opportunities to speak, preventing individuals 
from dominating the discussion. By including both remote and group 
brainstorming sessions in this concept mapping study, the limitations 
associated with each method were to some degree mitigated.  
 
Statement reduction  
Including large numbers of statements in a concept mapping study can 
impose practical constraints for participants when completing the 
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subsequent statement sorting activities. We reduced the number of 
statements generated during brainstorming to a final set of 91. As there was 
a high degree of duplication in the statements generated during 
brainstorming, the statement reduction task was less difficult than it might 
otherwise have been. Although subjective, the decisions made by the 
steering group when reducing the statements were reached through 
discussion and detailed analysis of the original data. We were careful to 
ensure that all ideas were represented in the final set of statements and we 
kept editing to a minimum in order to retain the original meaning of the 
statements where possible. It is possible that in changing the wording of 
some statements to make them clearer, or in merging two or more 
statements together, the original meaning may have been altered or lost 
(Kane & Trochim, 2007). However, by involving representatives from the 
three stakeholder groups in the statement reduction process and in agreeing 
on appropriate wording of the statements, I hoped to reduce the likelihood 
of this occurring. 
 
Prioritising and clustering 
Prioritising and clustering are individual activities and, therefore it should 
make little difference whether these tasks are completed in a group setting 
or remotely. Although it was possible to monitor the participants who 
attended the group sessions to ensure their responses were not influenced by 
the people around them, I cannot be certain that the participants who 
completed the tasks remotely were not influenced by the opinions of others 
when sorting the statements. 
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The order in which the two tasks are completed could influence the results. 
Participants may be likely to perceive the statements that they view at the 
start of the task differently to the ones they view when reaching the end. 
Further, participants will be familiar with the statements by the time they 
complete the second task and this familiarity may influence their decisions 
in some way (Kane & Trochim, 2007). To limit the impact of this potential 
source of bias, I shuffled the piles of cards so that all participants would 
view them in a different order.  
 
Participants in concept mapping studies are often reluctant to rank 
statements with a low priority score (Kane and Trochim, 2007). The reason 
for this is believed to be the fact that all statements that were brainstormed 
are likely to have some importance (Kane & Trochim, 2007). Having fairly 
equal piles of statements in the prioritising task allows us to get a better idea 
of the relative values of the statements. Despite this, many concept mapping 
projects have allowed participants to prioritise as many statements as they 
like into each of the five piles on the Likert scale (1=least important, 5=most 
important) (Kane and Trochim, 2007). To avoid the likelihood of 
participants placing fewer statements in the pile with the lowest priority 
score, I asked them to place a fairly equal number of statements in each pile. 
However, this is likely to have made the task more challenging for those 
participants who felt inclined to give all statements higher priority ratings. 
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Sorting the statements into piles for similarity (clustering) helps us to 
identify stakeholders’ views of the relationship between ideas. It is possible 
that some statements in this study may have been deemed to ‘belong’ in 
more than one pile. Participants were instructed not to place individual 
statements in more than one pile because that would make it difficult to 
identify the interrelationships between ideas. Although none of the 
participants reported this restriction to cause them problems, it is possible 
that it would make the deliberation process more complicated. Participants 
may perceive more than one way of sorting the cards and the criteria used 
for sorting the statements are likely to differ between participants. In this 
study, participants were instructed to sort the statements in a way that made 
sense to them. What makes sense to one person does not necessarily make 
sense to somebody else and it is possible that participants differed in the 
criteria they used to sort the statements. However, a synthesis of the results 
for all participants should provide a general overview of how the group as a 
whole perceives the relatedness of the ideas. 
 
Not all of the participants completed brainstorming, prioritising and 
clustering and it is possible that the result may have differed if all 
participants had completed all three tasks. However, Tables 4.4, 4.8 and 4.9 
in Chapter 4 showed that there were not large differences between the 
characteristics of the participants who completed the tasks compared to 
those who did not. 
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5.2.3 Data analysis 
 
Data were input onto separate computers to reduce the chance of data 
inputting errors occurring. Some of the data could not be entered for 
participants who had grouped the statements into more than 12 clusters. To 
reduce the impact that this may have had on the results, I removed the 
clusters with the least number of statements in them in line with the advice 
provided by the software developer (Appendix 35). Some of these ‘clusters’ 
contained just one statement and, therefore, would not have been useful in 
providing information about how the statements relate to each other 
anyway. Therefore, it is unlikely that the results would have been 
substantially different whether or not these small clusters were included in 
the analysis. The owner of the software reassured me that the impact of 
removing these clusters should have little effect on the results (Appendix 
35). 
 
Some errors were identified in the data provided by participants for the 
prioritising and clustering tasks. Where the error could not be corrected, 
these data were not input into Ariadne for analysis. Although it is unlikely 
that this would have had much of an impact on the results, there is a chance 
that it could have altered the findings slightly.   
 
Having participants enter their data directly into a computer programme, 
rather than manually writing their responses on paper, may have reduced the 
likelihood of error. However, Ariadne does not provide such a facility and 
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the resources available for this study were not sufficient to cover the costs of 
using an alternative programme, such as the Concept Systems concept 
mapping software (Concept Systems Incorporated 2013) which is available 
in the United States. 
 
One of the key stages in the concept mapping study is deciding on the 
number of clusters to include in the concept map (Kane & Trochim, 2007). 
The steering group decided on the number of clusters that we felt was most 
appropriate to represent the emerging themes from the data. Decisions about 
how many clusters to include in a concept map are rather subjective. 
However, Appendix 39 shows that there were generally very few changes to 
the statements contained within the clusters when the number of clusters 
was increased or decreased.  
 
5.3 The thirteen factors affecting adherence 
to a gluten-free diet 
 
5.3.1  Cluster 1 - The cost of gluten-free food 
 
A systematic review conducted in 2007 by Hall et al. (2009) found no clear 
association between the cost of GFF and adherence to the GFD at that time. 
However, a study by the same author in 2013 reported a relationship 
between the cost of GFF and adherence to a GFD (Hall et al., 2013). My 
update to the systematic review by Hall et al. (2009) and the results of my 
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concept mapping study support the finding that cost plays an important role 
in relation to adherence to a GFD. Two studies with a total of 308 
participants showed no association between the cost of GFF and adherence 
to a GFD, whereas five studies (including my concept mapping study) with 
3672 participants reported an association between the cost of GFF and 
adherence to a GFD. In addition, a study by Barratt et al. (2011) reported 
that better adherence was linked with having an affluent background and 
being a wealthy achiever. Both these factors could be associated with the 
affordability of GFF. No statistically significant difference was observed 
between the perceptions of the three stakeholder groups in relation to the 
impact of the cost of GFF on adherence to a GFD. All three groups 
perceived the cost of GFF to be the most important factor affecting 
adherence to a GFD.  
 
Studies in the USA and the UK have reported that, on average, all speciality 
GF products were more expensive than their gluten-inclusive counterparts 
(Lee et al., 2007; Coeliac UK, 2009; Singh and Whelan, 2011). Helping 
patients to manage the cost of GFF has been argued to be equally as 
important as helping them to understand the GFD (Cureton, 2007).   
 
To gain a better understanding of the cost burden of the GFD in the UK, 
Coeliac UK conducted the Cost Project in 2009. The Cost Project involved 
over 100 volunteers who visited their local supermarkets to compare the 
cost of GF products with the cost of similar gluten-inclusive products 
(Coeliac UK, 2009). The results showed that all GF items included in the 
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analysis were more expensive than gluten containing equivalent products, 
with GF bread costing over five times the amount of similar gluten-inclusive 
bread. No significant difference was found in the cost of GFF from 
supermarkets in different regions of the UK.  
 
The results showed that supermarket own-brand GFF tended to be more 
expensive than branded GFF across six supermarkets (Asda, Co-op, 
Morrisons, Sainsbury’s, Tesco and Waitrose). Coeliac UK questioned the 
reason for this price difference and they also questioned the reasons why 
three similar products (pitta bread, bread and pizza bases) should have such 
wide variation in price, with pitta bread costing 6.2 times the price of its 
gluten-containing equivalent, bread 5.1 times and pizza bases 2.4 times the 
price of their gluten-containing counterparts. As far as I can find, there has 
been no justification made for the discrepancy in the pricing of these 
products.  
 
According to dietitians, the high cost of GFF is problematic for coeliac 
patients on low incomes (O’Donnell & Edelstein, 2009). In the UK patients 
are assisted with the increased cost of the GFD by the provision of a limited, 
basic range of prescribed GFFs. For many people this provision is not 
exempt from the prescription charge. Despite the availability of GFF on 
prescription for people living with CD in the UK, this concept mapping 
study found the cost of GFF to be the most important factor affecting 
adherence.  
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Recent cut-backs in the amount and type of GFF available on prescription 
may have exacerbated the problem of cost for many patients. ‘Luxury’ items 
such as cakes and biscuits are no longer available on prescription. If people 
with CD choose to eat these ‘luxury’ products they are likely to have to pay 
more for ones that are labelled as GF. Coeliac UK has campaigned against 
the reduction in prescribed GFF and they highlight the importance of this 
provision in helping patients stick to their GFD (Coeliac UK, 2013d). It 
could be argued that people with a wheat allergy face the same difficulties 
as coeliac patients when purchasing expensive speciality food. Despite this, 
prescribed food is not made available by the NHS for people with a wheat 
allergy.  The reason for this could be that the long-term health problems 
associated with CD are not seen in wheat allergy. By assisting patients with 
CD to stick to a GFD, the NHS can reduce the amount of money required 
for treating the health problems associated with non-adherence to a GFD.  
 
Rather than obtaining expensive speciality GF products, patients can be 
educated to avoid specialist GFF and to cook naturally GFF where possible. 
For example, rice is cheap and could be used as an alternative to expensive 
GF products, such as bread and pasta. However, one of the problems 
identified from my systematic review is that the GFD is viewed as 
restrictive and this is a factor that reduces adherence. Therefore, having the 
choice to eat specialist GFF can reduce the perception of restriction and 
enhance adherence.  
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This study has identified the cost of GFF as the most important factor 
affecting adherence. People with CD are being asked to pay more for food 
of lesser quality. However, the higher cost of GFF could act as 'salt on the 
wound', rather than being a factor that affects adherence. The cost of GFF is 
likely to be an issue for people on a limited budget but whether the issue of 
cost actually stops most people with CD from adhering to a GFD is unclear. 
 
5.3.2 Cluster 2 - The availability of gluten-free 
sandwiches 
 
The availability of GF sandwiches was found to be the second most 
important factor affecting adherence to a GFD. This finding, which had not 
been identified in my systematic review, was somewhat surprising to me. 
This ‘cluster’ contained just one single statement that represented a 
synthesis of four statements from the original brainstorming statements (see 
Section 4.7.3). 
 
In Britain sandwiches are eaten commonly at lunchtime, however, this 
finding may not be applicable outside of British diets. The pervasiveness of 
the sandwich as the usual choice for lunch means that GF alternatives can be 
hard to find and restricted in choice. Although some shops now do provide 
GF sandwiches they are still not widely available and they tend to be more 
expensive than regular sandwiches (Coeliac UK, 2013b). Some participants 
stated that they had to rely on bringing packed lunches when away from 
home, otherwise they would go hungry. I have not been able to find any 
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literature relating to the role of the GF sandwich in patients with CD and 
this topic requires further exploration. 
 
Healthcare professionals prioritised the availability of GF sandwiches lower 
than adults with CD and household members. It may well be that they do 
not perceive the day-to-day impact of this limited choice of lunchtime food. 
Healthcare professionals need to be more aware of this problem and help 
patients to overcome this, possibly by encouraging them to prepare 
sandwiches at home to take with them. 
 
5.3.3 Cluster 3 - Knowledge and information 
about coeliac disease and the gluten-free diet 
 
Cluster 3 contains 24 statements relating to knowledge and information 
about CD and the GFD (Table 4.13, Chapter 4). This cluster related to the 
knowledge held by patients, healthcare professionals and others, such as 
friends, family members and those working in the food industry. In Section 
4.7.6 I introduced the ‘concept of knowledge’ that was developed from the 
findings of this study and this included many of the issues highlighted in 
this cluster. The concept of knowledge will be discussed later in this 
chapter. 
 
In the UK, Coeliac UK is the major charity providing information about CD 
and supporting people to follow a GFD. It is recognised that patients have a 
lot to learn at the time of diagnosis, and having multiple sources of valid 
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information may be helpful. Coeliac UK also provides information about 
CD and the GFD for healthcare professionals and people working in the 
food industry and this charity is working hard to educate people and raise 
awareness about CD and the GFD (Coeliac UK, 2013e).  
As well as getting information from Coeliac UK, patients also gather 
information about CD and the GFD from several sources. Online forums 
provide the opportunity for patients to chat and exchange knowledge and 
ideas as well as providing a source of support and encouragement (Veen et 
al. 2010). Patients also look to health professionals to provide them with 
information about CD and the GFD (British Society of Gastroenterology, 
2009). This may include being made aware of the possible health 
consequences relating to non-adherence of a GFD as well as developing 
their knowledge about how to follow a strict GFD. 
 
In the systematic review by Hall et al. (2009) knowledge is grouped 
together with attitudes and beliefs. These factors are all related to the patient 
and not healthcare professionals. Health promotion has for many years been 
dominated by a health education model which emphasises lifestyle and 
behaviour change of patients through education. This model places 
responsibility for health behaviour solely with the patient. An example of 
this approach is emphasised in the statement: 
 
‘The empowered and knowledgeable patient is fundamental to 
the successful management of coeliac disease’  
(British Specialist Nutrition Association Ltd., 2011).  
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The health education model approach has been led by healthcare 
professionals and it is recognised that educating patients as the only method 
of improving adherence is not a strategy that is likely to succeed (Willey et 
al., 2000).  A broader approach that takes into account the knowledge of 
healthcare professionals and other sources of support for people with CD 
may be more useful. 
 
The statements contained within cluster 3 (shown in Table 4.13) reveal a lot 
of dissatisfaction in relation to healthcare professionals’ knowledge about 
CD and GFD.  A statement from the patient’s perspective shown on the 
British Society of Gastroenterology website emphasises this point: 
 
“Patients are frustrated…by a lack of expertise and continuity 
in both primary and secondary care” 
    (British Society of Gastroenterology, 2009) 
 
Several of the statements contained within this cluster suggest that 
healthcare professionals need to increase their level of knowledge about CD 
and the GFD. A study by Nelson et al. (2007) found one-quarter of 
dietitians working with coeliac patients had received no CD training in the 
previous two years. Coeliac UK provides a useful resource for increasing 
the knowledge of patients and healthcare professionals (Coeliac UK, 
2013e). Nelson et al. (2007) reported that almost all dietetic departments 
included in their study referred patients to Coeliac UK. Although the British 
Society of Gastroenterology (2009) advises healthcare professionals to refer 
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patients to Coeliac UK, it is possible that healthcare professionals are 
relying too heavily on the supportive role of Coeliac UK rather than keeping 
their knowledge of CD and the GFD up-to-date. 
 
In contrast, the healthcare professionals included in this concept mapping 
study were found to have similar views to patients and household members 
in relation to the factors that would help patients stick to a GFD. This 
similarity suggests that healthcare professionals have a good insight into 
what it is like to live with CD. However, the sample of healthcare 
professionals involved in this study were self-selected and, therefore, are 
unlikely to be representative of the majority of healthcare professionals who 
work with CD patients. 
 
The people who prepare food for people with CD, such as family, friends 
and chefs in the food industry also need to have a good knowledge of CD 
and the GFD. A study by Karajeh et al. (2005) reported that chef’s 
knowledge of CD was poorer than that of the general public. Restaurant 
chefs were more knowledgeable than take-away chefs but overall there was 
a clear deficit in knowledge about CD and the GFD. This study was 
conducted almost ten years ago and knowledge about CD and the GFD has 
improved since then. Despite this general increase in awareness, the 
statements generated from this concept mapping study and the results from 
the systematic review suggest that the knowledge of people working in the 
food industry is still less than adequate. This issue is discussed further under 
Cluster 7 later in this chapter. 
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5.3.4 Cluster 4 - Access to good quality gluten-
free food 
 
As mentioned in Cluster 1, the quality and accessibility of GFF is relatively 
poor compared to gluten-containing foods. Although the availability and 
quality of GFF in the UK has improved in recent years, poor access to good 
quality and affordable GFF still represents a significant barrier to adherence 
(Singh & Whelan, 2011). Specific problems associated with access to GFF 
are highlighted in the statements included in Cluster 4 (Table 4.14) and in 
the systematic review in chapter 2. In addition, the statements contained in 
Cluster 7 (Eating away from the home) shown in Table 4.17 also highlight 
problems relating to poor accessibility. Cluster 7 is discussed later in this 
chapter.  
 
With regards to the quality of GFF, the statements contained in Cluster 4 
suggest that efforts made to improve the quality of GFF have not been 
entirely successful and patients are still dissatisfied with the taste and 
texture of GFF. This is particularly evident in relation to the quality of GF 
bread (Table 4.14). In addition, poor access to non-traditional types of GF 
bread, such as pita bread, chapatis and tortillas has also been highlighted. 
Despite this, Coeliac UK’s Food and Drink Directory (Coeliac UK, 2013b) 
lists several non-traditional GF breads that are available from several 
supermarkets. Whether these items are regularly stocked in these 
supermarkets is not clear and in their Cost Project, Coeliac UK (2009) found 
that only one UK supermarket chain had pita bread available in store. 
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It can be difficult for people with CD to easily identify GFF when shopping 
because there has not been universal adoption of the cross-grain logo in 
manufactured products. In the UK, new GFF labelling legislation has made 
it more difficult for manufacturers to label their foods as ‘gluten-free’ (Food 
Standards Agency, 2012). Patients are often required to have a good 
understanding of gluten-containing ingredients if they are to avoid them 
(Coeliac UK 2013a). Many food products have gluten added as a thickener, 
binding or bulking agent and identifying these ‘hidden’ sources of gluten 
can be difficult (Singh & Whelan, 2011). Manufacturers can change the 
ingredients used in their products without highlighting it on the packaging. 
Food which had previously been ‘safe’ can change to contain gluten with 
little or no notification to consumers and this can result in accidental gluten 
consumption. 
 
Overall, the association between access to GFF and adherence to a GFD is 
not clear and the evidence in the systematic review shown in Table 2.9 is 
contradictory. The link between the quality of GFF and adherence to a GFD 
is clearer. The results of my systematic review and concept mapping study 
show that having access to GFF that tastes good and has a good texture is 
associated with better adherence to a GFD. 
 
5.3.5 Cluster 5 - Prescribed gluten-free food 
 
Clusters 5 and 11 both relate to prescribed GFF. The main theme of this 
cluster relates to obtaining an adequate amount and range of GF products on 
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prescription. Cluster 11 focuses on the practicalities of obtaining GFF on 
prescription. The evidence base for this issue is small because it only applies 
to the UK. 
 
My systematic review identified just one study relating to the role of 
prescribed GFF on adherence to a GFD. This study reported that the 86.1% 
of participants who were receiving GFF on prescription had better 
adherence to a GFD compared to participants who were not receiving 
prescribed GFF (Hall et al., 2013).  
 
Participants in this concept mapping study reported discrepancies in the 
amount and type of GFF made available on prescription by GPs (Table 
4.13). There is a need for more consistency in what GPs prescribe and 
Coeliac UK has campaigned against the cut-backs in the variety and 
quantity of GFF offered on prescription and the “post-code lottery” in its 
provision (Coeliac UK, 2013b). Recent reductions in NHS spending on 
prescribed GFF may prove futile if adherence to the GFD worsens as a 
result. 
 
5.3.6 Cluster 6 - Eating the same as other people 
 
There were two statements in this cluster which largely appear to be 
unrelated (Table 4.16).  The first statement (…if you can eat the same 
gluten-free food as everyone else when eating socially) highlighted the 
social role of food, where not sharing in communal meals (e.g. at weddings) 
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can be perceived as being ungrateful or disrespectful. Sverker et al. (2005) 
report on the emotional aspect of not being able to eat the same as other 
people. People with CD report feeling isolated and ashamed when they 
cannot eat the same food as other people (Sverker et al., 2005). 
 
The second statement in this cluster relates to the provision of GFF in 
hospital. A study by Zarkadas et al. (2006) also identified the hospital as 
being a difficult setting in relation to following a GFD. The relationship 
between these two statements could be that they both focus on difficulties 
when eating in a public setting. Not only did the participants not wish to 
‘cause problems’ for the hospital staff when asking for a specialist diet, but 
they were often disappointed by the lack of knowledge and GFF provision. 
This indicates that patients were not being supported in their adherence to a 
GFD in hospital. Patients in hospital are vulnerable and the consequences of 
non-adherence to a GFD at this time may lead to further deterioration in 
their health. Some patients may choose to go hungry, rather than consume 
gluten-containing food in hospital and this is also likely to have a negative 
impact on their recovery. The hospital setting is one which should be set up 
to promote good health and this dissonance could be regarded as 
unacceptable.   
 
Similar problems can occur when eating socially and issues around not 
wanting to draw attention to oneself or ‘make a fuss’ when asking for GFF 
when eating socially have been evidenced in this study and in previous 
research (Sverker et al., 2005; Zarkadas, 2006). 
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5.3.7 Cluster 7 - Eating away from home  
 
At home, people with CD have more control over what GFF is available and 
in ensuring safety from contamination. The results of the concept mapping 
study and systematic review show a strong correlation between eating away 
from home and poorer adherence to a GFD. When eating away from the 
home, it can be difficult to find GFF (Zarkadas, 2006). In particular this can 
be problematic when travelling (Zarkadas, 2006).  The statements in Cluster 
7 (Table 4.17) highlight a number of problems experienced by people with 
CD when eating away from the home. 
 
The results of this study suggest that patients may find it easier to stick with 
their GFD if they take their own GFF with them when eating out, or if they 
provide GF ingredients to the restaurant (e.g. GF gravy granules) Airlines 
need to improve their provision of GFF, particularly during long flights 
when passengers with CD may have to endure several hours with nothing to 
eat. The statements in this cluster show a great desire for restaurants and 
their staff to be better informed about CD and GFF so that patients’ needs 
can be more discretely and easily accommodated. This is another 
component of the complex construct of knowledge that is needed to support 
people with CD to adhere to their diet. 
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5.3.8 Cluster 8 - If they are prepared to go 
hungry when there is no gluten-free food 
available 
 
It was interesting that people with CD and those that lived with them were 
more pragmatic about the fact that in order to remain adherent they may at 
times have to go hungry. This finding had not been reported in any of the 
studies included in my systematic review. It was implied in the statements 
that this would generally mean missing just one meal or snack. It was also 
highlighted (in the previous cluster) that this could be mitigated by the 
person with CD being organised enough to take GFF with them when in 
locations where GFF could be hard to find.  
 
Healthcare professionals did not rate this issue as highly as the other two 
stakeholder groups. This could be because they would be uncomfortable 
giving such advice to patients or they may believe that with the correct 
preparation, patients should not need to go hungry. However participants in 
my study highlighted that being prepared to go hungry is sometimes 
necessary. This reinforces the findings of my systematic review  that people 
who have an overall tendency to plan and be organised were more likely to 
be adherent to a GFD (Edwards-George et al., 2009). 
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5.3.9 Cluster 9 - Motivation and support 
 
This cluster represents self-motivation and the social support provided by 
family, friends and work colleagues. People who interact with people with 
CD can be very influential and practically supportive in their adherence 
behaviours, including speaking up for them (e.g. in restaurants) and cooking 
GFF for them. Online conversations between people with CD can help to 
motivate them to stick to a GFD (Veen et al., 2010). 
 
Self-efficacy, conscientiousness and self-discipline, being prepared and 
organised were factors related to adherence that were reported in the 
systematic review (Table 2.6). Self-motivation is a similar trait that was also 
associated with adherence to a GFD in this concept mapping study. As well 
as educating patients about the GFD, it is also important that they are 
motivated to change their behaviour. Some of the models of behaviour 
change discussed in Chapter 1 may provide a useful tool for changing 
patient behaviour and this is discussed in more detail later in this chapter. 
 
The sole statement relating to sociodemographic factors was located in this 
cluster. “If they are female” was a statement generated by a mother and 
daughter, both with CD, in relation to the father of their household who they 
believed would experience greater difficulty following a GFD due to his 
lack of kitchen skills. However, this statement was rated the lowest of all 
statements generated in this study. The link between gender and food 
preparation is highly variable within the UK and my systematic review 
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identified no sociodemographic factors that were consistently associated 
with adherence. Therefore, I do not consider this to be an important finding.  
Hall et al. (2009) also reported no consistent relationship between gender 
and adherence to a GFD. 
 
5.3.10 Cluster 10 - Social stigma 
 
It has to be recognised that food is not just nutritive, it plays an important 
social function. Many celebrations, ceremonies and gatherings are marked 
with the provision of food; often specialist to that event (e.g. Christmas 
pudding and birthday cake) (Gibney et al., 2006). Additionally, food is a 
way of expressing love and care for other people. Therefore, it is 
unsurprising that people on a restricted diet can face negative social 
consequences when they refuse the food that is offered to them.  
 
Sverker et al. (2005) report on some of the dilemmas faced by people living 
with CD including one man who was ridiculed by his work colleagues for 
eating GF crisp bread. People with CD need to have considerable 
communication skills and tact in order for them to communicate their 
dietary needs. However, it is also helpful if other people have the 
knowledge that this request is genuine and not ‘faddy’. Again this highlights 
the complexity of the knowledge construct needed for GFD adherence. 
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5.3.11 Cluster 11 - Convenience of obtaining 
prescribed gluten-free food 
 
Hippocrates famously said "Let food be thy medicine and let thy medicine be 
food". Thinking of food as medicine is quite common in ordinary life e.g. 
superfoods, nutrient supplements. Despite this, the statements in cluster 11 
suggest that participants did not feel that it is appropriate to collect their 
food from a pharmacy when it is available in shops. Most people with CD 
who are adherent will have no symptoms and may not perceive themselves 
as being ill. It may feel odd to them to collect food from a venue where they 
would normally only collect medication.  
 
To make the process of obtaining GFF on prescription less burdensome for 
GPs and patients, some areas of the UK have introduced a pharmacy-led 
supply scheme (Coeliac UK 2014b). The scheme removes the need for 
patients to get a prescription from a GP for their GFF (Coeliac UK, 2014b). 
Although this is a step in the right direction, this study has found that 
participants do not want to collect their prescribed GFF from a pharmacy. 
 
The current system of prescribing GFF is politically defensible but not 
pragmatic. GFFs are now more widely available in the shops and having to 
collect prescribed GFF from a pharmacy may no longer be necessary for 
most people. Patients may be inconvenienced when collecting prescribed 
GFF in bulk from a pharmacy. This system may be inconvenient for patients 
who have little freezer or storage space and for those who do not own a car. 
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During one brainstorming session, participants discussed the benefit of 
having a voucher system to spend in shops and supermarkets rather than 
collecting large quantities of GFF from a pharmacy.  
 
Additionally the NHS is set up to distribute medications, not foods and 
inevitably this leads to large mark-ups on the cost of provision of GFF 
compared to the cost of these foods in the supermarket. Recent media 
attention has highlighted the unnecessary over-spending by the NHS on 
prescribed GFF and a more pragmatic and cost-effective system is overdue 
(Coeliac UK, 2012). Perhaps it is time to review the system in which 
prescribed GFF is made available to patients and introduce a system that is 
more convenient and appropriate for patients.  
 
5.3.12 Cluster 12 - Diet planning and 
preparation 
 
The utility of membership of Coeliac UK for practical advice on GFF and 
recipes was recognised by participants in this study. This reinforces the 
finding of the systematic review which reported that membership of a 
support group is linked with adherent behaviours. One source of 
dissatisfaction that was noted from one of the statements generated in this 
study related to the cost of membership of Coeliac UK, which previously 
was free of charge. 
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Having the skills to identify GF products when out shopping and the skills 
to cook GF meals are also important in relation to following a GFD. 
Additionally the practicalities of storing GFF in bulk required that people 
considered having a large freezer. This may be particularly useful when 
collecting prescribed GFF in bulk, such as bread, which may not have a long 
shelf-life.  
 
5.3.13 Cluster 13 - Provision of gluten-free food 
at work 
 
This was a single statement cluster that focuses on the issue of biscuits 
being provided with coffee in a work context. Again this highlights the day-
to-day impact of lack of availability of GFF, which is similar to the issue of 
poor availability of lunchtime sandwiches (Cluster 2). This cluster also links 
with issues of being prepared (taking your own GFF with you), being 
prepared to go hungry, feeling stigmatised by your dietary choices, and 
being unsupported by your work colleagues in your health. 
 
Although this was the least important cluster in this study, its importance to 
the CD population in general may be higher than is indicated here. The 
reason for this is that many of the participants with CD in this study were of 
retirement age, therefore, work-related issues were likely to be of lesser 
importance to them.  
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5.4  The concept of knowledge 
In Chapter 4 the results of this concept mapping study were synthesised 
with the results of the systematic review by Hall et al. (2009) and my 
updated systematic review. From this I identified the ‘concept of 
knowledge’ in relation to the GFD.  
 
The concept of knowledge acknowledges that it is simplistic and 
unachievable to expect a person with CD to be the sole repository for 
knowledge of how to adhere to a GFD. It is interesting that my systematic 
review identified trusting other people to prepare their food as being 
associated with poorer adherence. It is impractical in modern life to expect 
people with CD to never eat food unless they themselves have prepared it. 
Therefore the knowledge base of the importance of a GFD and the health 
consequences that non-adherence causes, must be more generally known. 
The individual with CD is required to develop a good understanding of CD 
and GFF if they are to stick to a GFD. They are also required to develop 
coping strategies for living in a gluten-dependent environment where other 
people may not understand their dietary requirements. Developing the social 
skills and resilience necessary to be able to request GFF in any situation and 
to always avoid gluten-containing products is not easy for the person with 
CD. Improved education about CD and the GFD for friends, family, people 
in the catering and food manufacturing industry, healthcare professionals, 
colleagues at work etc. is required in order to reduce some of the challenges 
 244 
 
faced by people with CD. However, improving knowledge about the GFD is 
not an easy task. 
 
In the following section, I discuss some of the models of behaviour 
change in relation to changing the adherence behaviour of adults 
with CD. These models were previously introduced in Chapter 1. I 
follow that by presenting a model of adherence to the GFD that I 
have developed from the results of this study.  
 
5.5 Changing behaviour in adults with 
coeliac disease 
 
In the previous section I acknowledged that it is not just the person with CD 
who needs to change in order for adherence to a GFD to be made easier. 
There are many societal and environmental factors that make behaviour 
change difficult to achieve (Ni Mhurchu et al., 1997). On an individual 
level, knowledge, attitudes, beliefs, and intentions also play a role in 
determining behaviour (Ni Mhurchu et al., 1997). Theoretical models of 
behaviour have been designed to operate at an individual, rather than a 
societal level (Gibney et al., 2007). I will discuss how individuals with CD 
can be helped to adhere to a GFD in an environment where gluten is 
difficult to avoid.  
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As acknowledged in chapter 1, patients are required to make substantial 
changes to their behaviour when they are diagnosed with CD. Theoretical 
models can be used to develop interventions to target behaviour change and 
it is useful to know which is the most suitable model or models to use 
(Gibney et al., 2006). In Chapter 1 I introduced six theoretical models of 
behaviour change that could be used to target adherence to a GFD. These 
include: The health belief model (HBM); the theory of reasoned action 
(TRA) and planned behaviour; behavioural learning theory; social cognitive 
theory (SCT); information motivation behaviour (IMB) skills theory; and 
the transtheoretical (stages of change) model. Each model has its strengths 
and limitations and these were discussed in Chapter 1. 
 
The results of this concept mapping study and systematic review provide us 
with a better understanding of the factors that influence adherent behaviour 
in adults with CD. The results of this study have also provided a clearer 
understanding of how these factors operate at both an individual and a 
societal level. In addition, this study has identified how these factors interact 
to make it more or less difficult for a person with CD to stick to a GFD. 
This study has shown that adherence to a GFD is affected by a wide range 
of individual and societal factors, including both the psychological and 
practical issues associated with following a restricted diet. Therefore, a 
holistic approach to behaviour change would be most appropriate for 
addressing these issues. Rather than focusing on one single theoretical 
model, I will take a blended approach, drawing together several themes 
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from a number of models that could be useful in improving adherence to a 
GFD.  
 
The transtheoretical (stages of change) model acknowledges that people 
have different levels of readiness to change and individuals are motivated in 
different ways (Gibney et al., 2006). Although this model does not take 
account of social influences, it could be useful in addressing intentional 
non-adherence in people with CD. This model includes Bandura’s self-
efficacy theory, which could be used in targeting individual’s beliefs about 
their ability to stick to the GFD. According to this model, helping people to 
believe they are able to stick to a GFD may improve adherence. 
  
The HBM could be used to address attitudes and beliefs relating to the 
seriousness of non-adherence to a GFD in coeliac patients. By educating 
patients about the possible consequences of not following a GFD, they may 
begin to understand the risks associated with their non-adherent behaviour 
and this could trigger behaviour change. Similarly, the TRA could also be 
used to address attitudes and beliefs about the consequences of non-
adherence to the GFD. According to this model, patients who believe that 
following a GFD is beneficial to their health are more likely to adhere to a 
GFD. However, whether an individual takes action to change their 
behaviour may depend on their level of self-efficacy, motivation and locus 
of control. Ford et al. (2012) found that patients with CD who have a strong 
sense of personal control and a better understanding of CD had higher self-
efficacy. The patients with higher self-efficacy were found to be better at 
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adhering to a GFD (Ford et al., 2012). As discussed in Chapter 1, people 
who feel that they are in control of their own actions are more likely to 
engage in behaviour change. 
 
Feeling motivated is an important factor in behaviour change (Gibney et al., 
2007). In Chapter 1 I introduced the idea of financial incentives for 
improving adherence to a GFD. The cost of GFF was found to be the most 
important factor affecting adherence in this study and, therefore, it is 
possible that financial incentives could be a powerful motivator for 
adherence. As recognised in the transtheoretical (stages of change) model, 
individuals are motivated in different ways. Although financial incentives 
may work in motivating some people to change their behaviour, this will not 
work for everyone. 
 
Feeling motivated and believing that you can stick to a GFD may not be 
sufficient to change dietary behaviour in CD. Following a GFD is 
complicated and this study has shown that patients also require the 
knowledge, skills and resources necessary for adherence.  Issues such as the 
high cost and poor availability of GFF and a lack of the skills required to 
read food labels and cook GF meals cannot be resolved by changing an 
individual’s attitudes and beliefs alone. In addition, Herman & Mack (1975) 
recognised the impact of imposing restraint on eating in dieters and they 
found that paradoxically trying to eat less resulted in overeating. Trying to 
cut gluten out of the diet could have the same cognitive effect, with gluten-
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containing foods becoming more desirable because the person with CD is 
told they cannot have them. 
 
Social cognition models, such as the TPB highlight the role of behavioural 
intention, attitudes and motivation (Azjen, 1991). Research has shown that 
behavioural intention is linked with behaviour change in a number of health 
behaviours, including condom use, intention to exercise and intention to 
attend cervical screening appointments (Ogden et al., 2007). Whether or not 
a patient with CD intends to stick to their GFD could be a good indicator of 
behaviour. In a study by Hall et al. (2013) 40.1% of patients reported 
intentionally consuming gluten in the previous six months. Assisting 
patients in changing their intentions towards sticking to a GFD could be 
helpful in an intervention to improve adherence to a GFD. Sainsbury et al. 
(2013a) reported an intention-behaviour gap in relation to adherence to a 
GFD in patients with CD. This was believed to be due to psychological 
symptoms in patients with CD, including depression (Sainsbury et al., 
2013a). Psychological disorders are more commonly seen in patients with 
CD and this may make behaviour change more problematic. However, 
Hauser et al. (2010) found no connection between adherence to a GFD and 
anxiety/depression. 
 
As previously stated, I believe that an intervention to improve adherence to 
a GFD needs to take account of the societal as well as individual influences 
on behaviour. Such an intervention would also need to address both the 
psychological and practical aspects of following a GFD. In the following 
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section I introduce my model of adherence to a GFD which takes account of 
both the individual and societal influences on adherence as well as the 
practical and psychological influences.  
 
5.6 A model of adherence to the gluten-free 
diet 
 
To understand the complexity of adherence to a GFD in CD, I developed a 
model of adherence to a GFD based on the findings from this study. The 
model provides a framework for developing an intervention to improve 
adherence in CD. This model was developed from the concept maps and it 
represents the domain of ideas collected from three stakeholder groups. The 
concept map was divided into four quadrants which represent four 
overriding themes that influence an individual's ability to follow a GFD 
(psychological, practical, individual and societal influences). The model of 
adherence is based around these four interrelated themes (Figure 5.1) and it 
highlights the resilience that is required by patients in light of the pressures 
from society (e.g. high cost of GFF, poor availability of GFF). The factors 
associated with adherence to a GFD identified in the systematic review by 
Hall et al. (2009) and my updated review overlapped with the findings from 
my concept mapping study and all factors can be represented within this 
model. I will discuss the content of these four quadrants in more detail in the 
following four sections. 
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As with the concept map in Figure 4.2, the model of adherence is divided 
into four quadrants. The thirteen clusters from the concept mapping study 
are represented in the same quadrant on the model as they appeared on the 
concept map (Figure 4.2), Four of the six themes identified in the systematic 
review will be discussed in relation to the quadrants on the model. The other 
two themes (sociodemographic and sociocultural/environmental factors) 
span across all four quadrants and will not be discussed separately for each 
quadrant. For example, a person’s age may have both a practical and 
psychological influence on adherence to a GFD and the influence of a 
person’s age can operate at either an individual or societal level. 
Sociodemographic factors were not found to be associated strongly with 
adherence to a GFD in either the systematic review or the concept mapping 
study (Table 4.26). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 A model of adherence to a GFD in adults with CD 
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5.6.1 Society’s responsibility/Psychological 
issues quadrant (top right) 
 
Four of the 13 concepts (clusters) from the concept map are represented in 
this quadrant: 
 Cluster 2 - The availability of GF sandwiches 
 Cluster 6 - If they can eat the same as other people 
 Cluster 7 - Eating away from home 
 Cluster 13 - Provision of GFF at work 
 
The theme of this quadrant relates to the availability of GFF and the 
difficulties associated with following a GFD in a society where gluten is 
regularly consumed. By being located on the right-hand side of the model, 
this demonstrates that the concepts in this quadrant are mostly the 
responsibility of society, rather than the individual. Poor availability of GFF 
has a psychological impact on patients, often leaving them feeling deprived 
and embarrassed for ‘making a fuss’ (Sverker et al., 2005; Zarkadas, 2006).  
 
With the exception of the sociodemographic and sociocultural/ 
environmental factors, which spanned all four quadrants, none of the other 
themes from the systematic review (Hall et al. 2009) were closely linked 
with this quadrant. 
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5.6.2 Society’s responsibility/practical issues  
quadrant (bottom right) 
 
Four of the 13 concepts (clusters) from the concept map and one of the 
themes from the systematic review are represented in this quadrant: 
 Cluster 1 - The cost of GFF 
 Cluster 4 - Access to good quality GFF 
 Cluster 5 - Prescribed GFF) also in next quadrant 
 Cluster 11 - Convenience of obtaining prescribed GFF 
 Systematic review theme - Healthcare treatment factors 
 
This quadrant represents the interplay of factors that cause practical 
difficulties for patients when trying to stick to a GFD and the issues are 
mostly influenced by societal factors. Issues relating to the availability of 
GFF are covered in this quadrant as well as the previous one, however, in 
this quadrant the impact of poor availability is related to the practical effect 
this has on patients. Access to prescribed GFF is also included in this cluster 
along with the difficulties associated with obtaining GFF from a pharmacy. 
The cost of GFF is also a practical issue related to following a GFD and this 
was shown to be the most important factor affecting adherence to a GFD 
from the perspectives of all three stakeholder groups.  
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5.6.3 Individual responsibility/Practical issues 
quadrant (bottom left) 
 
Four of the 13 concepts (clusters) from the concept map and two of the 
themes from the systematic review are represented in this quadrant: 
 Cluster 3 - Knowledge and information about CD and the GFD 
 Cluster 5 - Prescribed GFF) also in previous quadrant 
 Cluster 9 - Motivation and support 
 Cluster 12 - Diet planning and preparation 
 Systematic review theme - Knowledge, attitudes and beliefs 
 Systematic review theme - Illness and symptom factors (also under 
individual / practical issues) 
 
The themes in this quadrant relate to the knowledge, skills and motivation 
patients require if they are to stick to a GFD. These themes also relate to the 
knowledge and skills that healthcare professionals, friends, family, work 
colleagues etc. are required to possess in order to support the person with 
CD. The quadrant includes the importance of motivation for patients and 
this could include being motivated by other people as well as self-
motivation.  
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5.6.4 Individual responsibility / Psychological 
issues quadrant (top left) 
 
Two of the 13 concepts (clusters) from the concept map and two of the 
themes from the systematic review are represented in this quadrant: 
 Cluster 8 - If they are prepared to go hungry when there is no GFF 
available 
 Cluster 10 - Social stigma 
 Systematic review theme - Illness and symptom factors (also under 
individual / practical issues) 
 Systematic review theme - Quality of life and psychological well-
being 
 
The themes in this final quadrant relate to the psychological issues 
associated with adherence to a GFD. Issues such as will power, 
determination and intention as well as the psychological effects of having 
CD are presented in this quadrant. Issues in this quadrant could be tackled to 
help patients stick to a GFD with the use of the models of behaviour as 
discussed in Section 5.5. 
 
Overall, the model of adherence represents the wide range of factors 
associated with adherence to a GFD. This model demonstrates that 
adherence is not the sole responsibility of the patient. CD impacts patients at 
both a psychological and practical level and an intervention to improve 
adherence would address these wide-ranging factors. 
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In the following section I discuss how this model could be utilised in 
practice along with recommendations for future work and I end this chapter 
by discussing the limitations of this study. 
 
5.7 Future work 
 
To improve non-adherence it is important to understand why patients with 
CD do not stick to a GFD. This study has identified a wide-range of factors 
affecting adherence to a GFD. More research is needed to understand how 
these factors influence adherence and how they can be addressed. 
Conflicting evidence exists with regards to the relationship between 
demographic factors and adherence to a GFD. This was highlighted by the 
fact that the one statement relating to gender was given the lowest priority 
rating of all 91 statements. In addition, the systematic review found 
conflicting evidence in relation to gender and adherence to a GFD. More 
research is needed into the non-sociodemographic influences on adherence.  
  
An intervention to improve adherence to a GFD would need to take into 
account the societal and individual influences on adherence as well as the 
practical and psychological aspects of following a GFD. The model of 
adherence developed from the results of this study would provide a useful 
framework for developing an intervention. 
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An online intervention could be the next logical step to help improve 
adherence in patients with CD. An online intervention should be relatively 
cheap to deliver, however not all homes in the UK have online access, so 
other delivery methods would also be required (e.g. face-to-face or 
telephone delivery). Sainsbury et al. (2013b) conducted a randomised 
controlled (RCT) trial in Australia which was an online intervention of six 
training modules that addressed many of the issues identified in this study. 
This RCT showed improvements in adherence to a GFD, however, only 
50% of participants completed the modules. A similar intervention could be 
developed for a UK audience that is designed around the model of 
adherence presented in this chapter. 
 
In order to help and support patients with CD, healthcare professionals are 
required to have sufficient knowledge and understanding of the difficulties 
faced when following a GFD. Therefore, a similar training package would 
be a useful and cost-effective method of training for healthcare 
professionals. This would have the potential of improving healthcare for 
patients. 
 
5.8 Limitations of this study 
 
This study possibly suffers from selection bias. Participants were self-
selected and the 100 Coeliac UK members who were invited came from a 
population that is predominantly female, white and of a higher educational 
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level (Ford et al., 2012). Participants were mostly recruited within 
approximately a 10 mile radius of Norwich which may not be representative 
of the wider UK population. For example, this area is not as ethnically 
diverse as many other parts of the UK. All but one of the 73 participants 
were white British. Previous studies suggest that participants from Asian 
ethnic groups are less adherent to a GFD and the factors affecting adherence 
for them may differ from my findings (Butterworth et al.,2004).  
 
I only included one hospital in the recruitment of participants and this 
university hospital may not be representative of an average hospital in the 
UK. Due to this the results may not be generalisable to the wider population. 
By recruiting through several channels, many of the limitations identified 
for each individual recruitment method was reduced. For example, one 
limitation of recruiting through Coeliac UK is that the sample of members 
may not be representative of the wider population of adults with CD. By 
also recruiting through the local press and NNUH, the sample population 
could be said to be more representative.  
 
As I had limited funds available for this study, it was not possible to obtain 
a clinical assessment of adherence to a GFD and I relied on self-reporting by 
patients. However, accurate measurement of adherence was unnecessary as 
the aim of this study was to recruit a group of participants with a range of 
levels of adherence, not to measure adherence per se. Only one fully non-
adherent participant with CD volunteered to take part in the study and this 
participant took part in brainstorming, but not prioritising or clustering. 
 258 
 
Although this study has identified several factors associated with adherence 
to a GFD, further studies with larger sample sizes are needed.  
 
Some of the data from the prioritising and clustering tasks was either 
missing or could not be used. This may have affected the results of the 
study. However, the software designer advised me that the impact of 
removing the clusters containing a small number of statements should have 
little impact on the results. 
 
Overall, the participants included in this study provided a broad range of 
opinions in relation to the factors affecting adherence to a GFD. However, 
the sample included only one non-adherent patient with CD, one patient 
from a non-white British ethnic group, one male healthcare professional, 
one GP and one gastroenterologist. The majority of participants were 
recruited from Norfolk and the results of this study may not be generalisable 
to the wider population. 
 
5.9 Summary 
 
This is the first study to explore the factors affecting adherence to a GFD in 
adults with CD using concept mapping. CD is a common and debilitating 
condition affecting approximately 1% of the population. There is no cure for 
CD, however, it is effectively treated with a strict GFD. Although it is clear 
that lifelong adherence to a GFD is difficult, we don’t fully understand the 
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reasons for non-adherence. Up to 58% of people with CD do not adhere to 
this treatment and this increases their risk of developing serious health 
problems. The aim of this study was to gain a better understanding of the 
factors that affect adherence to a GFD from the perspectives of adults with 
CD, household members and healthcare professionals using concept 
mapping. Concept mapping was a useful method for studying the range of 
interconnected factors associated with adherence to a GFD and achieving 
the aims of this study.  
 
Overall, I identified 13 concepts relating to adherence to a GFD from the 
perspectives of patients, household members and healthcare professionals. 
Concept mapping allowed me to identify the complex interplay of factors 
associated with adherence to a GFD and their relative importance. The high 
cost of gluten-free food was identified as the most important factor. The 
results of this study suggest that reducing the cost of GFF may be a primary 
target for an adherence intervention. However, it is possible that the high 
cost of GFF is a ‘salt on the wound’ issue that people are dissatisfied with, 
but it may not actually prevent adherence. The high cost of gluten-free food 
can be mitigated by providing gluten-free food on prescription. However, 
the effectiveness and practicality of the current method of prescribing GFF 
to reduce patient costs needs to be reviewed.  
 
Knowledge about coeliac disease and the gluten-free diet has been shown to 
be a complex construct that does not solely reside in the person with coeliac 
disease. The knowledge of healthcare professionals, family, friends and staff 
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in restaurants is important in supporting people with coeliac disease in 
sticking to a gluten-free diet.  
 
There was little difference between perceptions of the three stakeholder 
groups around the factors affecting adherence to a GFD. Healthcare 
professionals need to understand the pervasive provision of lunchtime 
sandwiches can be very impactful day to day, and that patients with coeliac 
disease may have to decide to go hungry rather than become non-adherent if 
they cannot find any gluten free foods when away from home. Following a 
GFD for life requires a good deal of planning and preparation.  
 
Together, the results of my concept mapping study and systematic review 
were used to develop a comprehensive model of adherence to a GFD which 
can be used in designing an intervention to improve adherence to a GFD. It 
is anticipated that improvements in adherence to a GFD will improve the 
lives of people with CD and reduce NHS costs. This model of adherence to 
a GFD takes into account the wide range of factors that impact on 
adherence.  
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Appendices 
 
  
Appendix 1 - Systematic review search strings 
 
Seven database searches were carried out on 16 August 2013. The full 
search string used for each database is shown below along with the number 
of articles found (hits). The search included articles published between 2007 
and August 2013. Where the database allowed, I restricted the search to full 
articles, English language and human studies only. 
 
 
1. AMED (Ovid) (1806-2013) - systematic review search string 
Number or hits: 1 
Search string: 
Celiac OR Coeliac OR Gluten sensitiv$ OR Gluten-sensitiv$ enteropath$ 
AND 
Adher$ OR Comply OR Complian$ OR Concordan$ OR Manag$ OR Non-
adher$ OR Non-complian$ 
AND 
Gluten OR Gluten-free OR Diet$ OR Treat$ OR Therap$ 
 
 
2. CINAHL Plus (EbscoH) - systematic review search string 
Number or hits: 221 
Search string: 
Celiac OR Coeliac OR Gluten sensitive* OR Gluten-sensitiv* enteropath* 
AND 
Adher* OR Comply OR Complian* OR Concordan* OR Manag* OR Non-
adher* OR Non-complian* 
AND 
Gluten OR Gluten-free OR Diet* OR Treat* OR Therap* 
 
 
3. Cochrane Library - systematic review search string 
Number of hits: 45 
Search string: 
Celiac disease/ (MESH term) OR Coeliac OR Gluten sensitiv* OR Gluten-
sensitive enteropath* 
AND 
Adher* OR Comply OR Complian* OR Concordan* OR Manag* OR Non-
adher* OR Non-complian* 
AND 
Diet, Gluten-free (MESH term) OR Gluten OR Gluten-free OR Diet* OR 
Treat* OR Therap* 
  
 
4 EMBASE (Ovid) - systematic review search string 
Number of hits: 1011 
Search string: 
Celiac disease/ (MESH term) OR Coeliac OR Gluten sensitiv$ OR Gluten-
sensitiv$ enteropath$ 
AND 
Adher$ OR Comply OR Complian$ OR Concordan$ OR Manag$ OR Non-
adher$ OR Non-complian$ 
AND 
Diet, Gluten-free/(MESH term) OR Gluten OR Glutens/ (MESH term) OR 
Gluten-free OR Diet/ (MESH term) OR Treat$ OR Therap$ 
 
 
5. Medline Ovid (1948-2012) - systematic review search string 
Number of hits: 488 
Search string: 
Celiac disease/ (MESH term) OR Coeliac OR Gluten sensitiv$ OR Gluten-
sensitive enteropath$ 
AND 
Adher$ OR Comply OR Complian$ OR Concordan$ OR Manag$ OR Non-
adher$ OR Non-complian$ 
AND 
Diet, gluten-free/(MESH term) OR Glutens/ (MESH term) OR Gluten OR 
Gluten-free OR Treat$ OR Therap$ 
 
 
6. PsychINFO (1806-2013) - systematic review search string 
Number of hits: 7 
Search string: 
Celiac OR Coeliac OR Gluten sensitiv$ OR Gluten-sensitive enteropath$ 
AND 
Adher$ OR Comply OR Complian$ OR Concordan$ OR Manag$ OR Non-
adher$ OR Non-complian$ 
AND 
Gluten OR Gluten-free OR Diet$ OR Treat$ OR Therap$ 
 
 
 
 
 
 
 
 
  
 
7. PubMed Central - systematic review search string 
Number of hits: 39 
Search string: 
Celiac Disease/ (MESH term) OR Coeliac OR Gluten sensitive* OR 
Gluten-sensitive enteropath$ 
AND 
Adher* OR Comply OR Complian* OR  Concordan* OR Manag* OR 
Non-adher* OR Non-complian* 
AND 
Gluten OR Gluten-free OR Diet* OR Nutrition* OR Treat* OR Therap* 
 
 
 
  
Appendix 2 - Systematic review excluded papers  
 
The table below shows a list of the 71 studies that were excluded from the 
systematic review after reading the full paper. 
Authors Title Year  Reason for exclusion 
Angeli et al. An epidemiologic survey 
of celiac disease in the 
Terni area (Umbria Italy) 
in 2002-2010 
2012 Not factors affecting adherence 
Araujo et al. 
 
Coeliac disease. 
Following the diet and 
eating habits of 
participating individuals 
in the Federal District, 
Brazil. 
 
2011 Age range of participants is not 
specified – the results may include 
patients aged <18 years 
Arigo Psychiatric comorbidities 
in women with celiac 
disease 
2011 This paper makes the association 
between adherence and various 
symptoms, but not the factors 
affecting adherence. 
Autodore Celiac Disease and its 
treatment 
2012 Not factors affecting adherence 
Aziz et al. Are patients with coeliac 
disease seeking alternative 
therapies to a gluten-free 
diet? 
2011 Not factors affecting adherence 
Bakshi et al.  Emerging therapeutic 
options for celiac disease: 
Potential alternatives to a 
gluten-free diet. 
2012 Not factors affecting adherence 
Barada et al. Celiac disease in the 
developing world. 
2012 Not primary research. 
Bellini et al. Compliance with the 
gluten-free diet: The role 
of locus of control in 
celiac disease 
2011 Includes children and adolescents. 
Biagi et al. A gluten-free diet score to 
evaluate dietary 
compliance in patients 
with coeliac disease. 
2009 Measuring compliance – not 
factors affecting 
adherence/compliance. 
Biagi et al. A score that verifies 
adherence to a gluten-free 
diet: A cross-sectional, 
multicentre validation in 
real clinical life. 
2012 Measuring compliance – not 
factors affecting 
adherence/compliance. 
Blazina et al.  Bone mineral density and 
importance of strict 
gluten-free diet in children 
and adolescents with 
celiac disease. 
2010 No separate data for 18 year olds 
Bold & 
Rostami 
Gluten tolerance; potential 
challenges in treatment 
strategies 
 
2011 Not factors affecting adherence 
  
 
Cammarota et 
al.  
A highly accurate method 
for monitoring 
histological recovery in 
patients with celiac 
disease on a gluten-free 
diet using an endoscopic 
approach that avoids the 
need for biopsy: a double-
center study. 
2007 Not factors affecting adherence. 
Cassellas et al. Factors that impact health-
related quality of life in 
adults with celiac disease: 
A multicenter study 
2008 Includes 15 to 17 year olds. 
Chawla Diagnosis and 
management of celiac 
disease 
2010 Paper unavailable (interlending too 
expensive) 
Comino et al.  Monitoring of gluten-free 
diet compliance in celiac 
patients by assessment of 
gliadin 33-mer equivalent 
epitopes in feces. 
2012 Not factors affecting adherence. 
Cosnes et al. Incidence of autoimmune 
disease in celiac disease: 
protective effect of gluten-
free diet 
2008 Not factors affecting adherence 
Cureton The gluten-free diet: Can 
your patient afford it? 
2007 Not primary research 
Da Silva Kotze A Brazilian experience of 
the self transglutaminase-
based test for celiac 
disease case finding and 
diet monitoring. 
2009 Not factors affecting adherence 
Dipper et al.  Anti-tissue 
transglutaminase 
antibodies in the follow-
up of adult coeliac 
disease. 
2009 Not factors affecting adherence 
Gabrovska Monitoring of daily 
gliadin intake in patients 
on gluten-free diets. 
2011 Not factors affecting adherence 
Garcia-
Manzanares et 
al. 
Nutritional and dietary 
aspects of celiac disease 
2011 Not primary research 
Hauser et al. Anxiety and depression in 
adult patients with celiac 
disease on a gluten-free 
diet. 
2010 Measures anxiety and depression, 
but not in relation to adherence 
Hauser et al. Predictors of irritable 
bowel-type symptoms and 
healthcare-seeking 
behaviour among adults 
with celiac disease. 
2007 Only included adherent 
participants. Not factors affecting 
adherence 
Hauser et al.  Predictors of reduced 
health-related quality of 
life in adults with coeliac 
disease. 
2007 Not factors affecting adherence 
Herman et al Patients with celiac 
disease are not followed 
up adequately. 
2012 Not factors affecting adherence 
  
 
Holmes & 
Moor 
Coeliac disease in Asians 
in a single centre in 
southern Derbyshire. 
2012  
Hopman et al. Gluten tolerance in adult 
patients with celiac 
disease 20 years after 
diagnosis? 
2008 Not factors affecting adherence 
Hwang et al. Duodenal histology vs. 
celiac disease-specific 
serology: which is the best 
tool for assessing 
compliance with the 
gluten-free diet at one 
year after diagnosis? 
2013 Not factors affecting adherence 
Jacobsson et al. Impact of an active patient 
education program on 
gastrointestinal symptoms 
in women with celiac 
disease following a 
gluten-free diet: a 
randomized controlled 
trial. 
2012 Only included women who were 
adherent to GFD. Not factors 
affecting adherence 
Kaukinen et al.  Coeliac disease – A 
diagnostic and therapeutic 
challenge. 
2010 Not factors affecting adherence 
Kemppainen et 
al. 
Unkilned and large 
amounts of oats in the 
coeliac disease diet: A 
randomized, controlled 
study. 
2008 Not factors affecting adherence 
Kinsey et al. A dietary survey to 
determine if patients with 
coeliac disease are 
meeting current healthy 
eating guidelines and how 
their diet compares to that 
of the British general 
population 
2008 Not factors affecting adherence 
Kurpa et al.  Factors associated with 
dietary adherence to 
gluten-free diet. 
2012 Includes adults and children 
Lanzini et al. Complete recovery of 
intestinal mucosa occurs 
very rarely in adult 
coeliac patients despite 
adherence to gluten-free 
diet. 
2009 Not factors affecting adherence 
Lee et al. Economic burden of a 
gluten-free diet. 
2007 Assessment of the cost and 
availability of gluten-free 
products, but not in relation to 
adherence 
 
 
 
Leffler et al. A simple validated gluten-
free diet adherence survey 
for adults with celiac 
disease. 
 
2009 Measuring adherence, not factors 
affecting adherence. 
  
 
Lerner New therapeutic strategies 
for celiac disease. 
2010 Not primary research 
Lovik et al. Oats in a strictly gluten-
free diet is associated with 
decreased gluten intake 
and increased serum 
bilirubin. 
2010 This study evaluated the effects of 
oat consumption on adherent 
adults with CD, not related to 
adherence or factors affecting 
adherence to GFD 
Mancini et al. Celiac disease and the 
athlete. 
2011 Not primary research 
Mounajjed et 
al. 
The liver in celiac disease: 
Clinical manifestations, 
histologic features, and 
response to gluten-free 
diet in 30 patients. 
2011 Not factors affecting adherence 
Nachman et al. Quality of life in celiac 
disease patients. 
Prospective analysis on 
the importance of clinical 
severity at diagnosis and 
the impact of treatment. 
2009 Not factors affecting adherence 
O'Donnell Dietitians' perceptions of 
adherence to a gluten-free 
diet among low-income 
individuals with celiac 
disease 
2009 The patient age range is not 
specified, but the results mention 
missing days off school, which 
suggests children were included in 
the Dietitians' reports. 
Olen et al. Coeliac disease 
characteristics, 
compliance to a gluten 
free diet and risk of 
lymphoma by subtype.  
2011 Not factors affecting adherence 
Olsson et al. The everyday life of 
adolescent coeliacs: issues 
of importance for 
compliance with the 
gluten-free diet. 
2008 <18 years of age 
Olsson et al. Food that makes you 
different: the stigma 
experienced by 
adolescents with celiac 
disease. 
2009 Includes participants aged 18 years 
but the data is combined with 
children aged <18 years 
Paarlahti et al. Predictors of persistent 
symptoms and reduced 
quality of life in treated 
coeliac disease patients: A 
large cross-sectional 
study. 
2013 Factors associated with symptoms, 
not adherence 
Purnak et al. Mean platelet volume 
could be a promising 
biomarker to monitor 
dietary compliance in 
celiac disease. 
2011 Not factors affecting adherence 
Roos et al. Gastrointestinal symptoms 
and well-being of adults 
living on a gluten-free 
diet: a case for nursing in 
celiac disease. 
 
 
 
2009 Gluten-free diet and wellbeing, not 
factors affecting adherence 
  
 
Rubio-Tapia et 
al. 
Mucosal recovery and 
mortality in adults with 
celiac disease after 
treatment with a gluten-
free diet. 
2010 Not factors affecting adherence 
Ryan & 
Grossman 
Celiac disease: 
implications for patient 
management. 
2011 Not factors affecting adherence 
Sainsbury et al. Reduced quality of life in 
coeliac disease is more 
strongly associated with 
depression than 
gastrointestinal 
symptoms. 
2013 This is the same as an included 
study (Sainsbury et al. 2013) 
Sainsbury et al. A randomized controlled 
trial of an online 
intervention to improve 
gluten-free diet adherence 
in celiac disease 
2013 The inclusion criteria was age >16 
years. Data were not presented for  
participants aged >18 years 
Shamir Population screening for 
celiac disease: Follow up 
of patients identified by 
positive serology. 
2007 Age of participants not reported. 
Researcher based at a children's 
hospital. 
Shepherd & 
Gibson 
Nutritional inadequacies 
of the gluten-free diet in 
both recently-diagnosed 
and long-term patients 
with coeliac disease. 
2013 Nutritional intake, not factors 
affecting adherence 
Silano et al. Effect of a gluten-free diet 
on the risk of enteropathy-
associated T-cell 
lymphoma in celiac 
disease 
2008 Consequence of non-adherence, 
not factors affecting adherence. 
Sverker et al. Sharing life with a gluten-
intolerant person—the 
perspective of close 
relatives 
2007 How coeliac disease affects close 
relatives, not factors affecting 
adherence. 
Terasaki & 
Ajam 
Case report: Revisiting 
celiac disease. 
2009 Not factors affecting adherence 
Tursi et al. Complications in celiac 
disease under gluten-free 
diet. 
2009 Adherence is measured, but not 
factors affecting adherence. 
Ukkola Patients' experiences and 
perceptions of living with 
coeliac disease - 
implications for 
optimizing care 
2012 Includes 16 to 17 year olds, but not 
separate data for this age group. 
 
 
 
 
 
 
Usai et al. Effect of gluten-free diet 
and co-morbidity of 
irritable bowel syndrome-
type symptoms on health-
related quality of life in 
adult coeliac patients. 
 
 
 
2007 Quality of life, not factors 
affecting adherence 
 
 
 
  
 
Veen Quitting is not an option: 
An analysis of online diet 
talk between celiac 
disease patients. 
2010 Age of participants not known 
Vilppula et al. Clinical benefit of gluten-
free diet in screen-
detected older celiac 
disease patients. 
2011 Not factors affecting adherence 
Violato et al. Resource use and cost 
associated with coeliac 
disease before and after 
diagnosis in 3,646 cases: 
Results of a UK primary 
care database analysis. 
2012 Not factors affecting adherence 
Volta et al. Usefulness of antibodies 
to deamidated gliadin 
peptides in celiac disease 
diagnosis and follow-up. 
2008 Measure of adherence, but not 
factors affecting adherence 
Wagner et al. Quality of life in 
adolescents with treated 
coeliac disease: influence 
of compliance and age at 
diagnosis 
2008 Children and adolescents - No 
separate data for 18 year olds 
Whitaker Patient perceptions of the 
burden of coeliac disease 
and its treatment in the 
UK 
2009 Assessing the burden of coeliac 
disease, not factors affecting 
adherence 
Whitehead  Obesity and coeliac 
disease: possible effects of 
the gluten-free diet. 
2013 Not primary research. 
Wild et al. Evidence of high sugar 
intake, and low fibre and 
mineral intake, in the 
gluten-free diet. 
2010 Not factors affecting adherence 
Zanchi et al. Rapid anti-
transglutaminase assay 
and patient interview for 
monitoring dietary 
compliance in celiac 
disease 
2013 Not factors affecting adherence 
Zanini Five year time course of 
celiac disease serology 
during gluten-free diet: 
Results of a community 
based "CD-watch" 
program. 
2010 Measure of adherence, not factors 
affecting adherence. 
 
 
  
 
Appendix 3 Characteristics of the studies included in systematic review 
Article Country Study Design Study Aims Source of 
Participants 
Participant Characteristics Adherence 
Assessment 
% non-
adherence 
Factors 
Affecting 
Adherence 
Intervention 
/study group 
Control or 
comparison 
group/s 
Total 
Barratt et 
al., 2011 
UK Cross-sectional To assess which 
factors impact 
on quality of 
life in CD 
Recruited 
during 
outpatient 
appointments 
n=225 
 
26% male 
 
Mean duration 
on GFD = 8 
years 
n=348 n=573 Reported as 'fully-
adherent' = every 
day for past 28 
days; partially 
adherent = at least 
half of these days; 
non-adherent = 
none of these 
days. 
65% adherent; 
31% partially-
adherent; 4% 
non-adherent. 
Quality of life; 
Age, Marriage, 
Affluence; 
Education; 
Gender; Disease 
duration; 
Screening 
detection. 
Black et 
al., 2011 
UK Cross-sectional To investigate 
the effect of CD 
and GFD on 
dietary habits 
and QoL 
Postal 
invitation to 
Coeliac UK 
Members 
N=146 
 
18% male 
 
Biopsy-
confirmed 
n/a n=146 Food frequency 
questionnaire 
96% adherent Availability of 
breakfast 
cereals; eating 
out/socialising; 
eating 
convenience 
foods. 
Casella et 
al., 2012 
 
Italy Retrospective 
cohort 
To compare CD 
in older and 
younger adults 
and to assess the 
effects of a 
GFD 
Identified 
from records 
on a database 
N = 59  
 
Older patients 
> 65 years 
n=1166 
 
Younger 
patients 18-64 
years 
n=1225 Serology and 
histological 
characteristics 
tested before and 
during GFD. 
Assessment 
during interview 
by physician. 
90% adherent. Age 
  
 
Edwards-
George 
2009 
USA Cross-sectional To determine 
the relationship 
between 
personality 
traits, 
psychological 
symptoms and 
GFD adherence 
Outpatients at 
clinic 
n=157 
 
Following 
GFD for >3 
months 
 
Mean age 
50.3 years 
n/a n=157 Assessment by 
expert Dietitian 
44.2% Excellent 
adherence 
 
34.4% Good 
adherence 
 
21% Non-
adherent 
Mood 
(depression); 
Anxiety; Low 
values trait; low 
conscientiousne
ss; low order 
trait; low 
deliberation 
trait; low self-
discipline trait; 
other food 
intolerance; 
presence of 
symptoms when 
gluten is 
consumed; 
Availability of 
gluten-free 
food; Cost of 
gluten-free 
food. 
Errichello 
et al., 
2010 
Italy Cross-sectional To identify risk 
and protective 
factors in 
relation to GFD 
adherence in a 
group of young 
people 
 
 
 
 
 
 
 
Outpatient 
clinic 
n=204 
 
38% male 
 
Aged 13-30 
years. 
n/a n=204 Interview 73.5% no 
dietary 
transgressions; 
26.5% 
occasional or 
frequent 
transgressions. 
 
 
 
 
 
Non-smoker 
  
 
Ford et 
al., 2012 
UK Cross-sectional To explore the 
illness 
perceptions and 
self-efficacy 
beliefs of adults 
with CD and to 
report their 
subjective levels 
of HRQoL 
Coeliac UK n=228 
 
20% male 
 
95% White 
British 
 
Mean age of 
males = 61 
years 
Mean age for 
females = 52 
years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
n/a n=228 Self-reported on a 
5-point Likert 
scale 
87% adherent 
 
13% partially-
adherent 
Belief in 
cyclical nature/ 
chronicity of 
coeliac disease; 
Consequences 
of non-
adherence are 
serious; Self-
efficacy; Age; 
Psychological 
wellbeing; 
Quality of life. 
  
 
Hall et al., 
2013 
 
UK Cross-sectional To determine 
the rates of 
intentional and 
inadvertent non-
adherence and 
to examine the 
factors 
associated with 
both 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients 
registered 
with family 
practices 
n=287 n/a n=287 Self-reported 40.1% reported 
intentional 
gluten 
consumption in 
the last 6 
months. 
Membership of 
coeliac support 
group; Better 
quality of 
gluten-free 
food; Cost of 
gluten-free 
food; Receiving 
gluten-free food 
on prescription; 
Regular follow-
up; Better 
choice of 
gluten-free 
products; 
Clearer 
information 
when eating out; 
Availability of 
gluten-free 
food; Perceived 
tolerance to 
gluten; Clearer 
and universal 
labelling; Age at 
diagnosis; self-
efficacy; gender 
 
 
 
 
 
 
 
 
  
 
Hopman 
et al., 
2009 
UK Cross-sectional To investigate 
whether dietary 
(non-) 
compliance is 
associated with 
health-related 
quality of life 
(HRQoL) of 
celiac patients 
Hospital 
patients 
n=33 
following a 
GFD 
n=8 gluten-
transgressions 
(partially 
adherent) 
 
n= 12 normal 
gluten-
containing 
diet (non-
adherent) 
n=53 Self-reported 
adherence. Food 
frequency 
questionnaire 
38% partially- 
or non-adherent 
Duration of 
gluten-free diet; 
Osteoporosis; 
Osteopenia; 
Symptoms if 
gluten is 
consumed; Age; 
Age at diagnosis 
Hutchinso
n et al., 
2010 
UK Retrospective 
cohort 
To examine the 
time to 
histopathologica
l recovery and 
to assess 
correlations 
between 
histopathologica
l 
disease score, 
gender, age and 
compliance with 
a 
gluten-free diet 
Hospital 
patients 
n=284 n/a n=284 Self-reported. 
Biopsy 
12% poor 
adherence (88% 
good adherence) 
Age at 
diagnosis; 
Gender 
Kabbani 
et al., 
2012 
USA Retrospective 
cohort 
To assess 
changes in BMI 
after diagnosis 
in a large 
coeliac 
population 
Coeliac clinic 
(electronic 
records) 
1018 
 
24% male 
 
Biopsy proved 
CD 
 
 
 
 
 
n/a n=1018 Assessment by 
expert Dietitian. 
Gastroenterologist
s' notes and 
serology results.  
 
 
 
 
 Age; Gender; 
BMI; Ethnicity 
(White) 
  
 
Kurpa et 
al., 2012 
 
Finland Cross-sectional To establish 
whether the 
shift of 
diagnostics and 
follow-up of 
coeliac disease 
from tertiary 
centres to 
secondary has 
affected the 
success of 
treatment, and 
to identify 
predictors for 
dietary non-
adherence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hospital 
patients 
n=843 
 
n=94 <18 
years 
n=749 >18 
years 
n/a n=843 
(of 
which 
749 
were 
adults) 
Structured dietary 
interview 
10% partially 
adherent (no 
non-adherent). 
Age 
  
 
Lee et al., 
2012 
USA Cross-sectional To investigate 
the impact of 
both coeliac 
disease and the 
gluten-free diet 
on quality of 
life 
 
Coeliac 
support 
groups 
n=1743 
 
23% male 
 
26% age 18-
45 
44% age 46-
65 
30% over 65 
n-1179 
 
61% male 
 
30% age 18-
45 
43% age 45-
65 
28% over 65 
n=2922 Self-reported Males and 
females 
reported 98% 
compliance 
However, a 
surprising 
number 
admitted to 
dietary 
indiscretion 
Eating away 
from home 
(with friends 
and in 
restaurants); 
The poor taste 
of gluten-free 
food; Cost of 
gluten-free 
food; 
Restrictiveness 
of the diet; A 
gluten-free diet 
is difficult to 
follow; Anxiety 
(the gluten-free 
diet is difficult 
in social 
settings); 
Quality of life; 
Gender. 
Mahadev 
et al., 
2013 
USA Cross-sectional To determine if 
Dietitian use 
was associated 
with quality of 
life, symptom 
severity or 
gluten-free diet 
adherence 
 
 
 
 
 
 
Celiac 
Disease 
Center of 
Colombia 
University 
n=413 
 
23% male 
 
24% aged >60 
years 
n/a n=413 CD adherence test 
(CDAT) 
Not stated Dietitian use 
  
 
Nachman 
et al., 
2010 
Argentina Prospective 
cohort 
To assess 
quality of life in 
coeliac disease 
and to 
determine the 
influence of 
gluten-free diet 
adherence on 
quality of life 
Patients at a 
small bowel 
disease clinic 
n=53 
Newly 
diagnosed, 
biopsy-
confirmed 
 
Mean age 38 
years 
 
9% male 
n=70 n=123 Assessment by 
lead physician, 
interview with 
Dietitians and 
self-report. 
Alimentary 
assessments did 
not identify any 
patients as non- 
compliant at all, 
possibly 
because those 
on unrestricted 
diet voluntarily 
missed the 
scheduled visits. 
At the 4-year 
visit, strictly 
compliant 
(n=27) and 
partially 
compliant 
patients (n=26) 
Quality of life 
Paavola et 
al., 2012 
Finland Cross-sectional To investigate 
the effect of 
long-term 
gluten-free 
dietary 
treatment on 
gastrointestinal 
symptoms and 
psychological 
well-being 
 
 
 
 
 
 
 
Newspaper 
advertisement
s and coeliac 
support group 
newsletter 
n= 96 screen 
detected 
 
n= 370 non-
screen 
detected 
 
n= 110 
 
Non-coeliacs 
n=576 Structured 
interview 
88% adherent Screen 
detection/non-
screen detection 
(presence of 
symptoms at 
diagnosis. 
  
 
Sainsbury 
et al., 
2011 
Australia Cross-sectional To predict the 
level of gluten-
free diet 
adherence in 
adults with 
coeliac disease 
Coeliac 
support group 
Phase 1 
 (elicitation 
interviews 
n=13 (7 male) 
 
Phase 2 
(online 
survey) n=265 
16.6% male 
n/a n=278 Self-reported 
(CDAT) 
47.5% excellent 
or very good 
adherence. 35.8 
moderate 
adherence 7.9% 
fair to poor 
adherence. 8.8% 
missing data. 
Anxiety (social 
stigma/not 
wanting to 
cause offence or 
inconvenience 
others); 
Depression; 
Quality of life; 
Belief in long-
term 
consequences of 
non-adherence; 
Knowledge of 
gluten-free 
ingredients; 
Trusting others 
to prepare 
gluten-free 
food. 
Sainsbury 
et al., 
2013 
 
Australia Cross-sectional To examine the 
potential role of 
psychological 
symptoms in 
limiting the 
translation of 
positive 
intention into 
strict gluten free 
diet adherence 
 
 
 
 
Coeliac 
support group 
n=390 
 
17.2% male 
 
Mean age 
44.2 years 
n/a n=390 Self-reported 
(CDAT) 
56.7% 
excellent/very 
good; 37.2% 
moderate; 6.2% 
fair/poor. 
 
Limited options; 
Severity of 
symptoms; 
Depression; 
Task-oriented 
coping; 
Emotion-
oriented coping; 
Intention to 
adhere; Risk of 
eating disorders. 
 
 
 
 
 
  
 
Sey et al., 
2011 
 
Canada Prospective 
cohort 
To test the 
safety of oats 
 
Patients at 
London 
Health 
Sciences 
Centre 
n=15 adults 
with biopsy 
confirmed CD 
for >1 year 
 
Asymptomatic 
on GFD for 1 
year and 
normal tTG 
level. 
 
 
 
 
 
 
 
 
n/a n=15 Random food 
diaries (self-
report) 
All participants 
were adherent at 
the start of the 
study (this was 
an inclusion 
criterion) 
Travelling 
(Eating away 
from home). 
Smith and 
Goodfello
w 2011 
USA Cross-sectional To examine 
factors and 
perceived 
causes that 
interfere with 
adherence to a 
gluten-free diet, 
identify coping 
strategies and 
examine the 
relationship 
between coping 
strategies and 
quality of life 
 
 
 
Gluten 
intolerance 
group (GIG) 
website. 
n=156 
 
Mean age 
51.5 years 
n/a n=156 Inclusion criterion 
was that 
participants were 
on a GFD for 6 
months 
(adherence was 
not measured in 
any other way) 
n/a Eating with 
family or 
friends; 
Following a 
gluten-free diet 
in social settings 
is 
uncomfortable; 
Eating at a 
restaurant; 
Travelling; 
Dislike the taste 
of gluten-free 
food; Cost of 
gluten-free 
products 
  
 
Sverker et 
al., 2009 
 
Sweden Cross-sectional To explore con- 
sequences of 
dilemmas in 
everyday lives 
for women and 
men, as 
personally 
affected by 
coeliac disease 
or as close 
relatives to 
someone 
affected and to 
put these 
experiences into 
context 
regarding 
household 
activities 
Hospital 
patients 
(identified 
from 
Dietitians' 
patient 
registers) 
n=43 adults 
with CD (32 
female; 11 
male) 
 
n= 23 close 
relatives (17 
male; 6 
female) 
 
28 male  
38 female 
n/a n=66 None n/a Hunger leads to 
gluten 
consumption if 
nothing gluten-
free is available 
Van Hees 
et al., 
2013 
The 
Netherlands 
Cross-sectional  To investigate 
whether long-
term adherence 
to a gluten-free 
diet is related to 
depressive 
symptoms in 
coeliac disease 
patients 
Coeliac 
support group 
n=2265 
 
Average age 
52 years 
(range 18-93 
years) 
n/a n=2265 Self-reported 50.2%=strict 
adherence 
46.3% sufficient 
3.6% 
insufficient. 
Mood 
(depression) 
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Research study: What helps adults with coeliac disease stick to a gluten-free 
diet? 
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the Newcastle North Tyneside 2 Research Ethics Committee on 21 April 2011. 
This is a PhD student research project which is being funded entirely by the 
University of East Anglia.  
 
The attached paperwork includes separate documents for the three stakeholder 
groups who will participate in this study. I have inserted a reference in the top right 
corner of each document to identify which stakeholder group the document relates 
to: 
 
AWCD = Adults with coeliac disease 
HM = Household members 
HP = Healthcare professionals 
 
I look forward to hearing from you in due course. 
 
Yours faithfully 
 
 
 
 
Helen Flaherty 
Chief Investigator 
 
 
Room 1.33 
Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Tel: 01603 593665 
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Appendix 5 Research protocol 
 
Research Protocol 
 
General Information 
 
Protocol version and date: Version 1. 20 March 2011 
 
Project Title: Gluten-free diet adherence in coeliac disease: 
Exploring multiple perspectives. 
 
Researchers: 
Helen Flaherty - Chief Investigator and PhD Student 
Dr Katherine Deane - Primary Academic Supervisor 
Prof Richard Gray - Secondary Academic Supervisor 
 
Edith Cavell Building 
Faculty of Health 
University of East Anglia 
Norwich 
NR4 7TJ                                                    
 
Funding: 
This study is a PhD research project which is funded by the 
University of East Anglia. 
 
Other Organisations Involved in this Study: 
Coeliac UK 
3rd Floor, Apollo Centre, Desborough Road, High 
Wycombe, Buckinghamshire, HP11 2QW. 
 
Norfolk and Norwich University Hospital (NNUH) 
Colney Lane, Norwich, Norfolk, NR4 7UY. 
 
Norfolk PCT  
Lakeside 400, Old Chapel Way, Broadland Business Park, 
Thorpe St Andrew, Norwich, NR7 0WG.  
 
 
Project Summary 
 
Coeliac disease (CD) is an autoimmune disease characterised by a 
permanent, inappropriate immune response to ingested gluten. This 
condition is believed to affect around 1% of the UK population 
(Coeliac UK, 2010). Life-long adherence to a strict gluten-free diet 
(GFD) is currently the only effective treatment for CD and non-
  
 
adherence is associated with a variety of health problems and 
increased healthcare costs. Studies have shown that non-adherence 
may be as high as 58% for people with CD (Coeliac UK, 2010b; 
Leffler et al., 2008). The aim of this study is to develop a theoretical 
model to understand adherence to the GFD using concept mapping.  
 
Concept mapping is a mixed methodology designed to increase 
understanding of complex topics and to identify which aspects are of 
greater or lesser importance (Kane and Trochim, 2007). Seventy-five 
participants will be purposefully selected to represent the views of 
three stakeholder groups: 25 adults with CD; 25 adult household 
members; and 25 healthcare professionals. Participants will 
formulate statements relating to adherence to a GFD during 
brainstorming sessions. Next, the statements will be rated for 
importance and clustered into themes by the stakeholders. The 
results will be aggregated using ‘Ariadne’ concept mapping software 
to produce visual ‘concept maps’.  
 
The topology of thoughts and ideas generated from this study will be 
used to construct a model of adherence based on the common views 
of stakeholders. This model can be used to design an intervention, or 
‘adherence package’ to guide healthcare professionals in providing 
appropriate care for people with CD. We anticipate that 
improvements in adherence to a GFD will reduce NHS costs as well 
as improve the health and quality of life of people with CD. 
 
Abbreviations 
 
CD  Coeliac disease 
GF  Gluten-free 
GFD   Gluten-free diet  
GFF  Gluten-free food 
IBS  Irritable bowel syndrome 
NNUH  Norfolk and Norwich University Hospital 
NHS  National Health Service 
VA  Villous Atrophy 
UK  United Kingdom 
 
1. BACKGROUND INFORMATION AND 
RATIONALE 
 
1.1 What is Coeliac Disease? 
CD is an autoimmune disease found in genetically susceptible 
people and it is characterised by a permanent intolerance to dietary 
gluten. Gluten is a prolamin found in wheat, rye and barley and is 
present in many commonly consumed products, such as bread, 
breakfast cereals, pasta, beer, cakes and biscuits. The only effective 
  
 
treatment for CD is the lifelong elimination of gluten from the diet 
(Leffler et al., 2008). Poor adherence to a GFD is associated with 
higher rates of morbidity and mortality, often due to an increased risk 
of the development of enteropathy-associated T-cell lymphoma 
(Silano et al., 2007). CD has a broad clinical spectrum ranging from 
asymptomatic (silent coeliac disease) to more severe symptoms 
including chronic diarrhoea, severe lethargy, gastric distension and 
pain (Dewar and Ciclitira, 2005). Inflamed and flattened small 
intestinal mucosa (villous atrophy (VA)) is common in CD and can 
result in impaired absorptive function which commonly leads to 
nutrient deficiency diseases, such as iron-deficiency anaemia and 
osteoporosis (Patient UK, 2010). 
 
1.2 The Epidemiology of Coeliac Disease 
 
1.2.1 Prevalence 
The accuracy of estimates of the prevalence of CD has improved in 
recent years through the development of more reliable serological 
tests (Rostom et al., 2005). Serological screening studies have 
shown that CD prevalence in the UK population is around 1%, 
however, as few as 1 in 10 cases are accurately diagnosed (Dewar & 
Ciclitira, 2005). This may be due to misdiagnosis (often CD 
symptoms are indistinguishable from irritable bowel syndrome (IBS) 
symptoms) or because the person is asymptomatic (silent CD). 
Improvements in the detection of CD and the possibility of mass 
screening may lead to a higher prevalence of CD in future years 
(Dewar & Ciclitira, 2005; Whittaker et al., 2009). In a study by Rubio-
Tapia et al. (2009), 9,133 frozen serum samples from healthy adults 
collected between the years of 1948 and 1954 were tested for CD. 
The results were compared with serological tests on 7,210 healthy 
young men and 5,558 older men. This study indicated that the 
prevalence of CD is increasing, regardless of whether cases are 
diagnosed. A Finnish study demonstrated similar results, showing 
that CD prevalence had doubled in the last two decades (Lohi et al., 
2007). Improving adherence to the GFD for an increasing number of 
people will present a significant challenge for healthcare 
professionals and a better understanding of the factors affecting 
adherence is required. 
 
Genetic studies have shown that the prevalence of CD for first-
degree relatives is between 10-15% (Martucci et al., 2003). Ethnic-
specific data for adults with CD in the UK are scarce, however, 
studies show that CD is common across many ethnic groups (Green, 
2005). CD diagnosis tends to be more common in females than 
males, although the reasons for this remain unclear (Green, 2005). In 
the past, CD was most commonly diagnosed in childhood, however, 
the pattern of CD diagnosis is changing and the average age of 
diagnosis in the UK is now between 40-60 years (Dewar and Ciclitira, 
2005; Coeliac UK, 2010d). Adherence to a GFD may be particularly 
  
 
difficult for people diagnosed with CD in older age when their gluten-
inclusive dietary habits have become long-established. 
 
1.2.2 Disease Progression 
 
CD is associated with a doubling of mortality rates compared to the 
normal population (Rubio-Tapia et al., 2009). This condition is also 
linked with substantial morbidity and the clinical manifestations of CD 
can be devastating for patients (Rubio-Tapia et al., 2009). The 
modes of presentation of CD vary from person to person and can be 
either the classic diarrhoea-predominant form, the asymptomatic 
‘silent’ form or patients can present with atypical symptoms (Green, 
2005; Griffiths, 2008). The classic clinical manifestations of CD 
include weight-loss, diarrhoea, steatorrhoea (fatty stools) and 
malabsorption of nutrients (Griffiths, 2008). The most common 
feature is iron-deficiency anaemia and this is found in two-thirds of 
adults with CD (Griffiths, 2008). Osteoporosis is also high among 
people with CD and this is linked with impaired calcium and vitamin D 
absorption. However, CD is a systemic disease, not just an ailment of 
the alimentary tract and a host of atypical disorders have now been 
attributed to the presence of CD (Griffiths, 2008; Rewers 2005). 
These include lethargy, infertility and neurological disorders (Griffiths, 
2005). Malignancies related to CD include T-cell lymphoma, gastric, 
oesophageal, bladder, breast and brain cancer (Hourigan, 2006). 
The risk of malignancy in unmanaged CD is thought to be two-fold 
that of the wider population; for small intestinal lymphoma the risk 
may be as high as 50-fold (Leeds et al., 2008). Holmes et al., (1989) 
found that the risk of malignancy was similar to the wider population 
after 5 years on a GFD whereas the risk was elevated in patients 
who did not adhere to the GFD.   
 
Adherence to a strict, lifelong GFD results in symptomatic, serologic 
and histologic remission and the normalisation of mortality rates 
(Pietzak, 2005; Leffler at al. 2008). In addition, the complete removal 
of gluten from the diet is associated with improved psychological 
wellbeing and quality of life for people with CD (Leffler et al., 2008). 
Non-adherence to a GFD is often the reason for the persistence of 
symptoms after diagnosis and is associated with higher rates of 
morbidity and mortality (Leffler et al., 2008; Hall et al., 2009). 
 
1.3 Treatment: The gluten-free Diet 
 
The GFD was established over 50 years ago as a treatment for CD 
and, so far, the efficacy of this treatment has not been disproven 
(Ciccocioppo and Corazza, 2005). Central to this treatment is the 
evidence that mortality is normalised and symptoms are eliminated 
with the introduction of a lifelong GFD (Leffler et al., 2008). The 
removal of gluten from the diet leads to mucosal recovery and 
  
 
reduces the risks associated with gluten exposure, such as small 
bowel cancer (Griffiths, 2008).   
 
Gluten is naturally present in wheat, rye and barley and some people 
with CD may also react to oats, although the evidence for this is 
inconclusive (Garsed and Scott, 2007). Gluten-containing crops are 
widely consumed in the UK and adopting a GFD can involve drastic 
changes to normal dietary habits (Zarkadas et al., 2006). Some 
gluten-free food (GFF) is available on prescription through the NHS, 
although this is not exempt from prescription charges (Coeliac UK, 
2010d). The provision of GFF on prescription is thought to make it 
easier for people with CD to follow a GFD (Coeliac UK, 2010d). 
 
A GFD can include foods which are naturally gluten-free (GF), such 
as fruit and vegetables, meat and dairy products as well as gluten-
free substitutes, such as GF bread, GF biscuits and GF pasta. 
Although the term ‘gluten-free’ implies that no gluten is present, this 
is not necessarily true (Thompson, 2001). Most people with CD can 
tolerate small amounts of gluten, however, the amount of gluten 
people with CD can consume without experiencing any deleterious 
effects varies between individuals (Akobeng and Thomas, 2008).  
 
New GFF labelling legislation is currently being introduced in the UK 
and this will limit the permitted amount of gluten present in foods 
labelled as ‘gluten-free’ to 20 parts per million (ppm) (Food 
Standards Agency, 2010). Foods containing up to 100 ppm can be 
labelled as ‘low in gluten’ under this new legislation. If several of 
these products are eaten together, some people may exceed their 
tolerable threshold and experience CD symptoms (Akobeng & 
Thomas, 2008). Some foods that are currently labelled as GF will no 
longer be permitted under the new legislation (Food Standards 
Agency, 2010). This may reduce the number of GF products 
available to consumers, possibly making adherence to a GFD more 
difficult. 
 
1.4 Adherence to a Gluten-free Diet  
 
1.4.1 Definition of Adherence 
 
The term ‘adherence’ is defined as the extent to which a patient’s 
behaviour coincides with the advice of healthcare professionals 
(Haynes et al., 2008). ‘Adherence’ suggests that the patient has 
control over their choice to follow the advice of healthcare 
professionals, whereas the term ‘compliance’ has authoritarian 
connotations linked with obedience (Vermeire, 2003). In the context 
of this study, adherence refers to a lifelong exclusion of wheat rye 
and barley from the diet (Leffler at al., 2008). Foods labelled as 
‘gluten-free’ or ‘low in gluten’ may contain small amounts of gluten, 
however, consumption of these products will not be regarded as non-
  
 
adherent. The reason for this is that the amount of gluten present in 
these products should not be sufficient to trigger a response (Food 
Standards Agency, 2010) and the use of these products in the CD 
diet is recommended by healthcare professionals. 
 
 
1.4.2 Measuring Adherence to the Gluten-free Diet 
 
A systematic review by Hall et al. (2009) found that adherence to a 
GFD in adults with CD ranged from 42% to 91%. Adherence to a 
GFD can be measured in several ways. In a study by Ciacci et al. 
(2002) serological test results were found to be a valid test of 
adherence when measured against intestinal biopsy results. Leffler et 
al. (2007) and Butterworth (2004) used self-reported measures of 
adherence to the GFD using Likert scales. Leffler et al. (2007) also 
applied three additional methods to confirm the validity of self-
reported adherence using the same subjects. This included: analysis 
by a nutritionist; a 3-day food diary or 24-hour recall; and serological 
testing. This study found self-reported levels of adherence to be 
congruent with the other measures with a slight tendency for over-
estimation. This inconsistency could have been due to accidental 
gluten contamination. To establish the level of adherence to a GFD in 
potential participants with coeliac disease, we will ask individuals to 
rate their level of adherence from the following three options: 
1). I always stick to a strict gluten-free diet  
2). I occasionally consume food/drinks containing gluten 
3). I do not follow a gluten-free diet 
 
1.4.3 Factors Affecting Adherence to a GFD in Adults with 
CD. 
   
Although CD is easily and effectively treated with a GFD, the 
participants in a study by Whitaker et al. (2009) reported that 
following a strict GFD was a substantial burden. A systematic review 
investigating the factors affecting adherence to a GFD in adults with 
CD by Hall et al. (2009) found that adherence was most strongly 
associated with cognitive, emotional and socio-cultural factors, 
membership of a CD advocacy group and regular dietetic follow-up. 
Hall et al. (2009) reported that the evidence presented in the 38 
studies included in this systematic review was of variable quality and 
further research is needed. The study by Leffler et al. (2008), which 
examined a sample of 154 adults with CD in the United States, found 
that adherence to a strict GFD was significantly associated with 13 
factors including: membership to a CD advocacy group; 
understanding of the GFD; ability to follow a GFD when away from 
the home; and ability to follow a GFD despite changes in mood or 
stress levels. Low sensory acceptance and the cost of GFF have 
also been associated with poor adherence (Olsson et al., 2008; 
Mendoza, 2005). Travelling and eating out can be problematic for 
  
 
people with CD and a study by Karajeh et al. (2004) reported that 
less than one-fifth of UK chefs had heard of CD. Kong et al. (2003) 
found that poor availability of GFF in the workplace was a barrier to 
adherence.  
 
 
1.5 Study Rationale 
 
It is estimated that 1% of the UK population has CD. Following a 
strict GFD for life is currently the only successful treatment for this 
disease. The GFD is simple in theory, however, as many as 58% of 
people with CD do not adhere to a strict GFD (Leffler et al., 2007). 
Poor adherence is associated with increased morbidity and mortality 
as well as increased healthcare costs. While the factors affecting 
adherence to a GFD for people with CD have been explored in 
previous studies, this body of research has suffered from a lack of 
strong theoretical and conceptual guidance. This study will develop a 
conceptual model of adherence to a GFD which can be used to 
design an adherence intervention. In a systematic review of 
adherence to a GFD in adult patients with CD, Hall et al. (2009) 
found little evidence of the use of interventions to improve 
adherence. 
 
Concept mapping focuses on user involvement and it is a useful tool 
for understanding complex behaviour, such as adherence to a 
gluten-free diet. This methodology also allows for the generation of 
multiple points of view and it uncovers similarities and differences in 
the perspectives of different stakeholder groups. 
 
Much of the research into adherence to a GFD for people with CD 
has been conducted outside the UK. The factors affecting adherence 
to a GFD in the UK may differ to those found in other countries for 
several reasons, including: differences in the cost and availability of 
GFF; the provision of GFF on prescription in the UK; and differences 
in the type and amount of help and support available for people with 
CD. The method of investigation used in this study (Concept 
mapping) will allow for the identification of factors affecting 
adherence to a GFD for adults living in the UK, rather than focusing 
on pre-determined adherence factors identified in previous studies 
which may not be relevant in the UK. Concept mapping is ideally 
suited for investigating topics which do not have an objective, 
absolute truth. Three stakeholder groups will be involved in this 
study. Differences and similarities in opinion can be identified and a 
‘common denominator’ can be established.  
 
 
 
 
  
 
2. STUDY AIMS AND OBJECTIVES 
 
Aim:   
The aim of this project is to develop a theoretical model, or 
conceptual framework, of adherence to a GFD using concept 
mapping. This model can be used to guide the development of a 
novel adherence intervention for people with CD. To achieve this 
aim, we will work with adults who have been medically diagnosed 
with coeliac disease, spouses or other adults who live in the same 
household as a person with CD (household member) and healthcare 
professionals who work with people with CD to gain an 
understanding of adherence modifying factors and their relative 
importance. 
 
Objectives:   
Primary objective: To use concept mapping to develop a common 
framework that can be used to design an adherence intervention.  
Secondary objectives: To produce visual maps depicting how the 
adherence statements generated during the brainstorming sessions 
relate to one another and how important the statements are 
perceived to be by the three stakeholder groups.   
 
3. STUDY DESIGN AND METHOD OF 
INVESTIGATION 
 
3.1 Steering Group and Research Team 
 
3.1.1 Steering Group  
A steering group has been set up and all members will be involved in 
making decisions relating to each stage of the research process. The 
steering group includes: The Chief Investigator (Helen Flaherty); 
three adults with coeliac disease; a Gastroenterology Consultant 
from Norfolk and Norwich University Hospital (NNUH) (Dr Ian 
Fellows); Coeliac UK's Head of Diet and Health (Norma McGough); 
and the academic supervisory team (Dr Katherine Deane and 
Professor Richard Gray).  
 
3.1.2 Research Team  
The research team will consist of Helen Flaherty, Katherine Deane 
and Richard Gray (as above). It will also have Ada Mackovova who 
will act as a research assistant to the study. Ada Mackovova is also a 
PhD student at the University of East Anglia and will be trained by 
Helen Flaherty and Katherine Deane in appropriate consent 
procedures and how to assist in the concept mapping process. All of 
the research team have been trained in Good Clinical Practice 
(GCP). 
 
  
 
3.2 Concept Mapping 
 
3.2.1 The Concept Mapping Process 
 
This study is designed to generate a conceptual framework, or 
model, of adherence to a GFD using concept mapping methods. 
Concept mapping is a qualitative and quantitative methodology which 
will be used to explore the factors affecting adherence to a GFD from 
the perspectives of a diverse group of stakeholders. Participants’ 
thoughts and ideas are articulated during group brainstorming 
sessions and recorded as statements. Statements are clustered and 
rated by participants and this data will be analysed and represented 
in an objective form as visual maps using the Ariadne software 
package. These ‘maps’ will allow us to see which adherence factors 
are of greater or lesser importance according to the group of 
participants. A conceptual model of adherence will be generated from 
the results of the data analysis. This model can then be used to 
inform the development of a subsequent adherence intervention 
aimed at assisting healthcare professionals to provide effective 
support and resources to help improve adherence to a GFD.   
 
Concept mapping is a phased methodology which will be conducted 
as follows:  
 
Step 1: Preparation 
 Development of focus for the conceptualization: The 
focus is the question that will be put to the participants 
in the brainstorming session in order to generate as 
many responses as possible. The focus question for 
the brainstorming sessions in this study will be ‘what 
helps adults with coeliac disease stick to a gluten-free 
diet?’.   
 Selection of participants: Three groups of stakeholders 
will be selected for inclusion in this study: 25 adults with 
CD; 25 adult household members; and 25 healthcare 
professionals. 
 Setting a schedule: The location, dates and times will 
be set for the group brainstorming sessions and the 
clustering and rating sessions. These will be held 
separately for each stakeholder group. 
 
Step 2:  Generation of statements 
 Brainstorming - Separate brainstorming sessions will be 
held for each of the three stakeholder groups. 
Participants will be asked to use the focus question as 
a starting point for free association and to generate as 
many statements as possible in response to the focus 
question “what helps adults with coeliac disease stick to 
  
 
a gluten-free diet?”. An example of a possible 
statement is ‘If gluten-free foods were cheaper”. 
 Statement reduction – In this step, members of the 
steering group will eliminate duplicated statements, 
statements that are not understandable and statements 
which are regarded to be too specific. The aim of this 
activity is to create a rationalised set of up to 
approximately 80 statements. 
 
 
Step 3: Structuring of statements – clustering and 
prioritising 
Both the clustering and the prioritising tasks are 
performed individually by each participant. Participants 
will be given a full set of up to 80 cards and each card 
will have a single statement printed on it. 
 Clustering – for this activity, participants will be asked 
to sort the statements into groups or piles in a way that 
makes sense to them. Participants will be required to 
give a name to each of their piles. 
 Prioritisation (ranking) – participants will be asked to 
assign a value from 1 to 5 for each statement with 1 
representing the lowest and 5 representing the highest 
priority. All statements will be divided into five equal 
piles representing the priority assigned to them. 
 
Step 4: Concept mapping analysis 
 The data will be analysed using specialised concept 
mapping software (Ariadne). A series of maps will be 
produced to represent the data generated from the 
structuring tasks.   
 
Step 5: Interpreting the maps  
 At this stage, the relationships between ideas and 
clusters of ideas can be seen. 
 Different stakeholder groups’ perspectives and the 
thoughts and ideas of the group as a whole can be 
compared. 
 
Step 6: Utilization of maps 
 At this stage, decisions are made about how the results 
will be used in practice.  
 
3.2.2 The Concept Mapping Sessions 
 
Participants will be invited to attend two group sessions in a local 
community centre in Norwich or at the University of East Anglia. The 
Chief Investigator will ensure that there is comfortable seating, 
adequate lighting and facilities for any participants with disabilities. 
  
 
Session 1: Brainstorming 
The first session will be a brainstorming session, lasting 
approximately two hours. This will include an introduction and a short 
break where gluten-free refreshments will be provided. The Chief 
Investigator and Research Assistant will facilitate the brainstorming 
sessions. Separate brainstorming sessions will be held for each of 
the three stakeholder groups and around eight participants will be 
assembled for each session. 
 
The quality of the brainstorming session is dependent on the 
involvement of participants. Detailed instructions will be provided in 
the participant information sheet and in the introduction at the start of 
the brainstorming session. The date and time of the session will be 
set well enough in advance to fit it into participants’ schedules. In 
addition a telephone call, e-mail or postal reminder will be provided 
approximately one week prior to the session.  
The brainstorming sessions will involve working as a group to 
generate statements around the focus question ‘what helps adults 
with coeliac disease stick to a gluten-free diet?’. The focus statement 
will be posted and clearly visible for the duration of the session. The 
essence of the brainstorming session is that participants freely 
associate ideas and all participants have an equal influence on the 
outcome. The end result of the brainstorming session will be a set of 
statements that describe the conceptual domains of interest. 
 
During the session, statements will be recorded on a flipchart and 
displayed clearly for the participants to see. An audio recording of the 
session will also be made using a Dictaphone. The Chief Investigator 
will be responsible for the quality of statements and for ensuring that 
they meet certain criteria in order to be useable in the following 
sessions. 
    
Remote generation of ideas: If any of the participants are unable to 
attend the group brainstorming sessions, it will be possible for them 
to generate statements remotely by the use of electronic mail, by 
telephone or by post. This situation is not ideal as there is less 
interactivity and exchange of ideas among the stakeholders. The 
main benefit of offering the facility of remote statement generation is 
that it will help to keep participant drop-out rates low.  
 
After the brainstorming sessions, the research team will refine and 
reduce the statements to eliminate duplicates and any statements 
that are too specific. The aim of this is activity is to have a final set of 
approximately 80 statements (the software can analyse a maximum 
of 98 statements). 
 
Session 2: Structuring the Statements 
The second session will also last around two hours with an 
introduction and a short break with gluten-free refreshments. This 
  
 
stage requires the participants to complete two separate tasks; these 
tasks are carried out individually by each participant. Participants will 
be given a full set of numbered statements printed on individual 
cards. Both tasks will be performed in relation to the focus question 
which will be displayed for participants to see throughout the session. 
 
Although these are individual tasks, we feel it is appropriate to run 
this as a group session because some participants may require 
assistance from the Chief Investigator or the assistant. For 
healthcare professionals and participants who cannot attend a group 
meeting, this will be offered as a remote activity, either electronically 
(e-mail) or by post. 
 
 
Task 1 – Prioritisation: Participants will be asked to sort their cards 
into five equal piles according to how important they perceive each 
statement to be using the following ratings: 
 1 = Relatively Unimportant 
 2 = Somewhat Important 
 3 = Moderately Important 
 4 = Very Important 
 5 = Extremely Important 
 
Task 2 – Clustering: Participants will be asked to group the 
statements into piles in a way that makes sense to them according to 
content and they will be asked to label each cluster. Participants may 
not group all the statements into one single pile or have every 
statement as its own pile (however, some piles may contain just one 
statement). Each statement can only be used once and, therefore, 
cannot be sorted into more than one pile.   
 
 
3.2.3 Data analysis 
 
The results of the structuring stage are entered into the Ariadne 
software programme for analysis. 
 
In stage 4 of the concept mapping process, the data generated from 
stage 2 is entered into the computer programme, Ariadne. Ariadne 
will combine the ideas of the three stakeholder groups and present 
them as a group product. Analysis begins by counting how often 
participants have clustered statements into a single category. The 
more often statements are clustered together, the closer they will 
appear on the ‘map’. This closeness represents a strong link 
between the statements. Statements that appear close together on 
the map are combined to form clusters of related statements and a 
box is drawn around them. Next, Ariadne calculates the average 
rating for each individual statement and for each cluster from the 
prioritisation task. The relative importance of the different aspects is 
  
 
reflected by the height of the points on the concept map. Analysis 
can be carried out to compare the results from different stakeholder 
groups or individual participants.     
 
In stage 5, the clusters on the concept map will be given a label 
which best describes the content or theme of the cluster. This task 
will be performed as a group discussion involving the steering group.   
 
Stage 6 involves the translation of the concept map and agreement 
on how the results can be used in practice as agreed by the steering 
group. The concept map sheds light on the views and priorities of the 
group as a whole and this information can be used as the basis for 
decision making.     
 
3.3 Study Population  
 
3.3.1 Recruitment of participants and selection criteria 
 
In order to explore a diverse range of perspectives about the factors 
affecting adherence to a GFD, seventy-five participants will be 
recruited for this study from three stakeholder groups: 
 25 adults diagnosed with CD 
 25 adults living in the same household as an adult diagnosed 
with CD (household members) 
 25 healthcare professionals 
 
Participants will be selected based on the inclusion criteria listed 
below. Only adults will be recruited for this study as we want qualified 
healthcare professionals and people (either with CD or those living 
with adults with CD) who are able to be fully in charge of their dietary 
choices and food buying decisions. 
 
INCLUSION CRITERIA:   
ADULTS WITH COELIAC DISEASE 
Adults aged 18+ 
Has been medically diagnosed with coeliac disease 
Living within approximately a 10 mile radius of Norwich 
Subjects will be a member of Coeliac UK and/or registered as a 
patient with coeliac disease at Norfolk and Norwich University 
Hospital 
Must be capable of giving informed consent 
Because the method involves agreeing the wording of statements, 
only English speaking participants will be enrolled  
 
Adults with celiac disease will be recruited by letter of invitation which 
will be sent on our behalf by Coeliac UK and Norfolk and Norwich 
University Hospital. Coeliac UK will include a reply slip and pre-paid 
return envelope with the letter. Coeliac UK members who return a 
  
 
reply slip will then be sent an invitation letter, a participant 
information sheet, a reply slip to indicate their wish to participate in 
the study, a pre-paid return envelope and a household member’s 
pack. Patients with CD attending NNUH will be sent the invitation 
letter along with a participant information sheet, a reply slip, a pre-
paid return envelope and a household member’s pack in one single 
mailing. Although all potential participants will receive the same 
documents, Coeliac UK requested that their members are sent an 
invitation letter and reply slip separate to the other documents, 
whereas NNUH would like all the documents to be sent out together. 
 
As we are interested in hearing about factors that both help and 
prevent people with CD sticking to a gluten-free diet, we will 
endeavour to recruit participants with a range of GFD adherence 
behaviours. In order to do this, we will ask the person with CD to 
indicate their level of adherence to a GFD, along with their contact 
details on the reply slip. We will select a reasonably equal proportion 
of the three levels of adherence: 
 
1. I always stick to a gluten-free diet 
2. I partially stick to a gluten-free diet 
3. I do not follow a gluten-free diet 
 
Return of this information to the research team indicates consent for 
us to have information on their level of adherence to a GFD. 
 
INCLUSION CRITERIA:   
SPOUSES OR OTHER ADULTS LIVING WITH AN ADULT WHO 
HAS COELIAC DISEASE (HOUSEHOLD MEMBERS) 
Adults aged 18+ years 
Has been living in the same household as a person who has been 
medically diagnosed with coeliac disease for at least one year 
Living within approximately a 10 mile radius of Norwich 
Must be capable of giving informed consent 
Because the method involves agreeing the wording of statements, 
only English speaking participants will be enrolled 
 
Adults with CD will also be sent a pack marked ‘Adult household 
member’s pack’ enclosed with their invitation documents. We will ask 
adults with CD to identify their spouse or other adult who lives with 
them (household member) and to pass on the adult household 
member’s pack to that person should they wish to do so. This pack 
will contain an invitation letter, a participant information sheet, a reply 
slip and a pre-paid return envelope. We intend to recruit household 
members for this study even if the person with CD who they live with 
does not also volunteer. A sample of 25 participants will be selected 
from the responses.  
 
  
 
The Chief Investigator will visit adults with CD and household 
members at their home or other appropriate venue to take consent. 
During this meeting, the Chief Investigator will collect baseline 
characteristics through a short questionnaire.  
 
INCLUSION CRITERIA: 
HEALTHCARE PROFESSIONALS 
Currently working with at least one adult patient with coeliac disease 
Has at least one year’s experience of working with adult patients with 
coeliac disease 
Working or living within approximately a 10 mile radius of Norwich 
Must be capable of giving informed consent 
Because the method involves agreeing the wording of statements, 
only English speaking participants will be enrolled 
 
Healthcare professionals will be recruited on the basis that they have 
treated people with CD for at least one year and are currently treating 
at least one adult patient with CD. An invitation letter, participant 
information sheet, a short questionnaire, a consent form and pre-paid 
return envelope will be sent to all healthcare professionals who work 
with adults with CD at NNUH. We will also recruit by sending the 
invitation documents to GP practices in Norwich. Efforts will be made 
to recruit a diverse range of healthcare professionals including 
General Practitioners, Nurses, Gastroenterologists and Dietitians. 
We do not intend to meet healthcare professionals face-to-face to 
gain informed consent, they will complete the consent form and 
return it to us by post.  
 
All individuals who return a reply slip indicating that they wish to take 
part in the study will be contacted and informed whether or not they 
have been selected for the study. We will notify participants of when 
and where the group meetings will be held and we will send 
reminders by post, e-mail or telephone approximately seven days 
prior to the meetings. 
 
If we do not receive sufficient responses through this process, we will 
recruit additional participants by sending reminder letters to 
individuals we have previously contacted, invitation letters to 
individuals not previously contacted, by delivering presentations 
and/or publications via Coeliac UK or NNUH.  
 
Should any suitable participants arrive at either of the two meetings 
having not been consented, then consent will be taken face-to-face 
before the session commences. 
 
Collection of baseline characteristics 
All participants will be asked to complete a short questionnaire which 
will collect baseline characteristics. For adults with CD and 
household members, questionnaires will be completed during face-
  
 
to-face meetings with the Chief Investigator at the time when 
informed consent is obtained. For healthcare professionals, the 
questionnaire will be sent out with the invitation letter and this should 
be completed and returned with the consent form. The following data 
will be collected in the questionnaires: 
 
For people with CD: 
 Name 
 Address 
 Telephone number/s 
 E-mail address 
 Gender 
 Length of time since CD diagnosis 
 Any other special diets followed 
 Severity of symptoms when gluten is consumed 
 Ethnicity 
 Age 
 Level of education 
 
For adult household members: 
 Name 
 Address 
 Telephone number/s 
 E-mail address 
 Relationship to the person with CD 
 Gender 
 Gender of the person with CD 
 Ethnicity 
 Age 
 Level of Education 
 
For healthcare professionals working with patients with CD: 
 Name 
 Address 
 Telephone number/s 
 E-mail address 
 Job title 
 Professional qualifications 
 Length of time working with coeliac patients 
 Number of people with CD on current patient list 
 
We will ask all interested participants to indicate the best time of the 
week for them to attend the group sessions by putting ticks in the 
appropriate boxes on a table of possible days/times (see below). This 
information will be used when we plan the group sessions: 
 
 
 
  
 
 MON TUES WED THURS FRI SAT SUN 
Morning 
(9am-
12pm) 
       
Afternoon 
(12pm-
4pm) 
       
Evening 
(6pm-9pm) 
       
 
3.4 Duration of the Project 
This study is being carried out as a three year PhD research project, 
ending in April 2013. It is anticipated that the group brainstorming 
sessions and the statement sorting sessions will be conducted within 
approximately an eight month period.  
 
 
4. DISSEMINATION AND OUTCOME 
 
The research findings will be disseminated through academic 
journals and the results will be presented at conferences. We will 
work closely with Coeliac UK and relevant NHS and health 
organisations in disseminating the research findings. A report of the 
results will be sent to participants at the end of this study. 
  
The findings of this study will be used to guide the development and 
subsequent testing of a novel adherence intervention to enable 
healthcare professionals to assist patients to be better at sticking to a 
GFD. 
 
 
5. PROBLEMS ANTICIPATED 
Hall et al. (2009) highlight the fact that people who adhere to the 
GFD may be more likely to respond to research documentation, such 
as questionnaires, compared to people who do not adhere to the 
GFD. It would be unethical for us to force anybody to participate in 
this study, so this problem is unavoidable. However, we will seek to 
specifically recruit participants with a variety of levels of adherence to 
a GFD. We will also recruit healthcare professionals who are likely to 
work with patients with varying degrees of adherence and adults who 
live in the same household as someone with CD who may have 
varying levels of adherence to a GFD.   
 
Some potential participants will spend time reading the participant 
information sheet and completing and returning the reply 
slip/questionnaire, yet they may not be selected to participate in the 
study. We will send out letters to those people who are not selected 
to thank them for their interest in the study and to explain why they 
  
 
have not been selected. The findings of our research will be 
published in a lay report for Coeliac UK which should allow most of 
these potential participants to read the findings of the study even 
though they were unable to participate. 
As this study is based in Norwich, the results may not reflect the 
wider population of adults with CD. In particular, we do not expect to 
be able to recruit an ethnically diverse population of people with CD 
from Norwich, as Norwich does not have substantial numbers of 
people from ethnic minorities in its population. In addition, the study 
will not include people who are not members of Coeliac UK or do not 
receive NHS healthcare for CD. 
 
There is the potential for researcher bias in this study. In order to limit 
researcher bias, the Chief Investigator and Research Assistant will 
not provide prompts to generate responses during the brainstorming 
sessions. The focus question will be stated at the start of the session 
and participants will be allowed to express their ideas freely without 
discussion or criticism from other participants or members of the 
research team. 
 
For health professionals participating, there is a risk that the Chief 
Investigator could be made aware through discussion of 
unprofessional practice. Any practice that is potentially detrimental to 
a vulnerable person may have to be reported to an appropriate 
authority. Health professionals will be advised of this risk in the 
information sheet provided to them. 
 
 
6. STUDY ADMINISTRATION AND ETHICAL 
ISSUES 
 
6.1 Informed Consent 
Invitation letters and participant information sheets will be sent to 
potential participants belonging to the three stakeholder groups. 
These documents will explain the purpose and nature of the study 
along with details of what will be required of individuals if they decide 
to take part.  
 
One of the inclusion criteria is that participants are capable of giving 
informed consent. To ensure this, visits will be made to the selected 
participants who have CD and household members prior to the study 
to gain informed consent face-to-face. This will allow the research 
team to identify and eliminate participants who are not capable of 
giving informed consent. It is expected that this meeting will take 
place in the participant’s home. An alternative meeting place will be 
arranged if the participant requests this (e.g. a room at the 
university). For health professionals, professional competency is 
assumed and, therefore, the Chief Investigator will not request a 
  
 
meeting to obtain informed consent. For this group of participants, 
the signed consent form can be returned by post. Should any 
suitable participants arrive at either of the two meetings having not 
consented, then consent will be taken face-to-face before the session 
commences. 
 
Participation in this research will involve attending two group 
sessions. At the beginning of each session, the Chief Investigator will 
remind all group members that participation in the research is 
optional and individuals are free to withdraw from the study at any 
time without giving a reason. Participants who complete the concept 
mapping tasks remotely will also be reminded that participation is 
optional and that they are free to withdraw at any time. 
 
We will conduct process consent throughout the research study. 
Should anyone indicate that they are unwilling to continue they will 
be able to withdraw without being required to provide a reason. This 
will have no influence on the clinical care provided to them. 
 
6.2 Safety considerations 
Possible risks: 
 Visiting participants in their own home in order to gain 
informed consent carries an element of risk for members of 
the research team. The researchers will follow the University's 
Lone Worker Policy. In practice this will mean that prior to 
every meeting, the visiting researcher will e-mail the address 
and time of the meeting to the academic supervisor. In 
addition, the visiting researcher will carry a fully charged 
mobile phone in case of an emergency and will telephone the 
academic supervisor immediately before and after every 
meeting. Should the researcher feel unsafe during a meeting 
with a participant, she will leave the property immediately and 
telephone the academic supervisor (and the appropriate 
emergency services if necessary). 
 Health and Safety precautions and insurance cover for the 
meeting room will be covered by the venue owners. 
 Although the risk of harm is considered to be low, a potential 
issue that may arise is that some participants may become 
upset when discussing issues related to CD and the GFD. The 
Chief Investigator and Research Assistant will monitor for 
signs of distress and will withdraw a participant from the group 
if they show signs of becoming distressed. Participants will be 
reminded at the start of the group sessions that they can 
withdraw from the study at any time without giving a reason. 
 Although it seems unlikely, some of the issues raised during 
group meetings may cause anger in some participants. The 
Chief Investigator will be accompanied by a Research 
Assistant for all group meetings. The risk of harm to the Chief 
  
 
Investigator, Research Assistant and participants is believed 
to be low. 
 The two group sessions will include a break with 
refreshments. To avoid causing harm through gluten-
consumption, all the food and drinks provided will be gluten-
free. The food packaging will be made available so that people 
with any other food intolerance or allergy can check whether 
the items are suitable for them. This action will be taken with 
all three groups. 
 
6.3 Confidentiality 
 
Care will be taken to avoid disclosing participants’ identities. 
Anonymity in all publications relating to this research will be 
guaranteed. Invitation letters will be distributed to adults with CD on 
behalf of the research team by NNUH and Coeliac UK. This 
eliminates the need for us to gain access to personal information 
when recruiting subjects for this study. NNUH will distribute invitation 
letters and participant information sheets to healthcare professionals 
who work with adult patients with coeliac disease. We will recruit 
healthcare professionals from General Practices by sending invitation 
letters and participant information sheets directly to them. 
 
Completed questionnaires and consent forms will be locked in a 
secure filing cabinet within a locked room at the University of East 
Anglia. In order to protect participants’ identities, each participant will 
be allocated a reference number which will be printed on all their 
related documentation. Documents received from individuals who are 
not selected for participation in this study will be shredded within six 
months. Data will also be stored as a password protected document 
on a university computer with password security. Paper documents 
relating to participants will be shredded six months after the study 
ends. Electronic files will be deleted two years after the study ends.   
 
The data collection method employed in concept mapping is a 
collective activity and this makes it difficult to identify which 
participant provided which data. In addition, the research team will 
screen all statements generated for personally identifying statements 
(e.g. I trust the advice I receive from Dr Smith) and anonymise them 
(e.g. I trust the advice I receive from my GP). At the start of the two 
group sessions, individuals will be advised that they are free to 
withdraw from the study at any time, however, the data gathered up 
until that point will still be used in the study. All information gathered 
during this study will be anonymised and cannot be traced back to 
the dissenting individual. An audio recording device will be used 
during the two group meetings. All audio recordings of the 
brainstorming sessions will be deleted after transcription. 
 
  
 
6.4 Resource Requirements 
 A Research Assistant to join the Chief Investigator for the group 
meetings 
 Concept mapping software (Ariadne) for analysing the data 
 A suitable meeting room for brainstorming sessions 
 Pens, paper, flip chart, statements printed on cards and a 
Dictaphone 
 Gluten-free (GF) Refreshments for all group meetings 
 Transport costs for the participants, the Chief Investigator and 
Research Assistant 
 
 
  
6.5 Study Plan 
 
6.5.1 Flow chart  
 
Approximately May – June 2011 - Recruitment of subjects 
Distribute invitation letters and participant information sheets 
Notify those who have and have not been selected for the study 
 Gain informed consent 
Collect baseline characteristics using questionnaires 
Send confirmation of the dates for the group meetings 
↓ 
Approximately June – July 2011 
Send a reminder one week prior to the group session  
Group session 1: Brainstorming 
↓ 
Approximately July – September 2011 
Statement reduction task 
↓ 
Approximately October - December 2011 
Send a reminder one week prior to the group session  
Group session 2: Clustering and prioritising the statements 
↓ 
Approximately January – March 2012 
Input the data using Ariadne software 
↓ 
Approximately April 2012 – June 2012 
Develop a Model of Adherence using the concept maps 
↓ 
Approximately July –September 2012  
Make recommendations for how the concept map could be used in 
planning and assessing health care for people with CD 
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Appendix 6 - Invitation letter to adults with coeliac 
disease from Coeliac UK  
 
Coeliac UK logo to be added by Coeliac UK 
 
Dear 
 
Re: Invitation to participate in a research study: What helps adults 
with coeliac disease stick to a gluten-free diet? 
 
Coeliac UK is working with the University of East Anglia (UEA) on a study 
to explore what helps adults with coeliac disease stick to a gluten-free diet. 
This study has gained ethical approval and it meets all of the necessary 
research standards. 
 
As you have already expressed an interest in taking part in research, we 
would like to know if you would be willing to take part in this study. If you 
are interested and you would like to receive more information, please 
complete the enclosed reply slip and return it in the envelope provided by 
(insert date (allow approx 2 weeks)).  
 
If you choose not to take part, then you do not need to do anything further. 
Please be assured that we have not passed any of your details to the UEA. 
They will only have your information if you return the consent form to them. 
All information collected about you during the study will be strictly 
confidential. 
 
The study will involve attending two group meetings in Norwich which will 
last approximately two hours each. During these meetings you will be 
asked to share your ideas about what helps adults with coeliac disease 
stick to a gluten-free diet.  
 
You can participate in this study regardless of whether or not you stick to a 
gluten-free diet. You will need to have been medically diagnosed with 
coeliac disease and aged eighteen years or over. 
  
The UEA are recruiting for this study via a number of routes, such as GP 
surgeries or dietetics clinics. It is possible that you may receive more than 
one invitation to this study but you only need to respond to one.  
 
Coeliac UK is dedicated to supporting research to help improve the lives of 
people with coeliac disease and dermatitis herpetiformis. As research also 
remains a high priority for our Members we do hope that you will be able to 
take part. 
 
Yours sincerely 
 
 
 
Coeliac UK 
  
 
 
Appendix 7 – Letter sent to people who responded to 
Coeliac UK’s invitation letter 
University of East Anglia 
1.33 Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Phone: 01603 593665 
E-mail:  h.flaherty@uea.ac.uk 
 
Dear 
 
Re: Invitation to participate in a research study: What helps adults 
with coeliac disease stick to a gluten-free diet? 
 
Coeliac UK recently wrote and invited you to participate in the above 
study. Thank you for contacting us to request more information about 
this study. 
 
It is up to you to decide whether or not to take part. Before you 
decide, please read the attached information sheet and discuss it with 
others if you wish. If you would like to take part, please complete the 
reply slip and return it to us in the envelope provided as soon as 
possible. 
 
We are also looking to recruit spouses or other adults who live with a 
person who has coeliac disease for this study. If there is someone 
living with you who you think might be interested in joining this study, 
please give them the enclosed envelope addressed to ‘Adult household 
member’.  
 
Participation in this study is optional for both you and your spouse or other 
adult household member. 
 
Because recruitment for this study is via a number of routes it is possible 
that you will receive more than one invite to this study. Please ignore the 
second invitation. 
 
Yours Sincerely 
 
 
Helen Flaherty 
Chief Investigator 
 
 
  
Appendix 8 - Letter sent to patients with coeliac 
disease by Norfolk and Norwich University Hospital 
 
Norfolk and Norwich University Hospital 
Colney Lane 
Norwich 
NR4 7UY 
 
Phone: 01603 288356 
E-mail:  ian.fellows@nnuh.nhs.uk 
 
 
 
 
Dear Sir/Madam, 
 
Re: Invitation to participate in a research study: What helps adults 
with coeliac disease stick to a gluten-free diet? 
 
You are being invited to take part in a research study as a person with 
coeliac disease who is attending, or has attended, a clinic at Norfolk 
and Norwich University Hospital. It is up to you to decide whether or 
not to take part. Before you decide, please read the attached 
information sheet and discuss it with others if you wish.  
 
If you decide that you would like to take part, please complete the 
enclosed reply slip and return it in the envelope provided as soon as 
possible. 
 
We are also looking to recruit spouses or other adults who live with a 
person who has coeliac disease for this study. If there is someone 
living with you who you think might be interested in joining this study, 
please give them the enclosed envelope addressed to ‘Adult household 
member’.  
 
Participation in this study is optional for both you and your spouse or other 
adult household member. 
 
Because recruitment for this study is via a number of routes it is possible 
that you will receive more than one invitation to this study. Please ignore 
the second invitation. 
 
Yours faithfully 
 
 
Dr Ian Fellows 
Consultant, Gastroenterology and General Medicine 
  
Appendix 9 Invitation letter sent to household 
members 
 
1.33 Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
Tel: 01603 593665 
E-mail: h.flaherty@uea.ac.uk 
 
Dear Sir/Madam, 
 
Re: Invitation to participate in a research study: What helps adults 
with coeliac disease stick to a gluten-free diet? 
 
You are being invited to take part in a research study because a person 
who you live with has coeliac disease.  
 
It is up to you to decide whether or not to take part. Before you decide, 
please read the attached information sheet and discuss it with others if you 
wish. Participation in this study is optional for both you and the person with 
coeliac disease. 
 
If you decide that you would like to take part, please complete the enclosed 
reply slip and return it in the envelope provided as soon as possible. 
 
Yours faithfully 
 
 
Helen Flaherty 
Chief Investigator 
 
  
Appendix 10 Invitation letter sent to healthcare 
professionals by Norfolk and Norwich University 
Hospital 
 
Norfolk and Norwich University Hospital 
Colney Lane 
Norwich 
NR4 7UY 
 
Phone: 01603 288356 
E-mail:  ian.fellows@nnuh.nhs.uk 
 
Dear Sir/Madam, 
 
Re: Invitation to participate in a research study: What helps adults 
with coeliac disease stick to a gluten-free diet? 
 
You are being invited to take part in a research study because you are 
a healthcare professional who works at Norfolk and Norwich 
University Hospital. We are looking to recruit healthcare professionals 
who currently work with at least one adult patient who has coeliac 
disease.  
 
It is up to you to decide whether or not to take part. Before you 
decide, please read the attached information sheet and discuss it with 
others if you wish.   
 
If you decide that you would like to take part, please complete the 
enclosed consent form and short questionnaire and return them in the 
envelope provided as soon as possible. 
 
Yours faithfully 
 
 
 
 
 
Dr Ian Fellows 
Consultant, Gastroenterology and General Medicine 
 
  
Appendix 11 Invitation letter sent to General 
Practices 
 
University of East Anglia 
1.33 Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
Phone: 01603 593665 
E-mail: h.flaherty@uea.ac.uk 
Dear Sir or Madam, 
 
Re: Invitation to participate in a research study: What helps adults with 
coeliac disease stick to a gluten-free diet? 
 
You are being invited to take part in a research study because you are a 
healthcare professional working at a General Practice in Norwich. We are 
looking to recruit healthcare professionals who currently work with at least 
one adult patient who has coeliac disease.  
 
It is up to you to decide whether or not to take part. Before you decide, 
please read the attached information sheet and discuss it with others if you 
wish.   
 
If you decide that you would like to take part, please complete the enclosed 
consent form and short questionnaire and return them in the envelope 
provided as soon as possible. 
 
Yours faithfully 
 
 
Helen Flaherty 
Chief Investigator 
 
 
 
 
  
 
Appendix 12 Participant information sheet for adults 
with coeliac disease 
1.33 Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
Tel: 01603 593665 
E-mail: h.flaherty@uea.ac.uk 
 
Information sheet for people with coeliac disease 
Research study: What helps adults with coeliac disease stick to a gluten-free 
diet? 
 
Dear Sir/Madam 
 
We would like to invite you, as a person with coeliac disease, to take part in a 
research study which aims to explore how people with coeliac disease manage 
sticking with a gluten-free diet. 
 
The study is being conducted by PhD student, Helen Flaherty, who is the Chief 
Investigator in this study. Helen is working under the supervision of two academic 
supervisors, Dr Katherine Deane and Prof Richard Gray at the University of East 
Anglia. Before you give your full consent, please take time to read the following 
information carefully and discuss it with others if you wish. Please ask us if there is 
anything that is not clear or if you would like more information. 
 
Participation in this study is optional for both you and your spouse or adult 
household member and you are free to withdraw at any time without giving a 
reason. 
 
Part 1 tells you the purpose of this study and what will happen if you participate. 
Part 2 gives you more detailed information about the conduct of the study.  
 
If you would like to take part in this study, please complete the enclosed reply slip 
and return it to us in the envelope provided as soon as possible. Helen Flaherty will 
contact you within three weeks of receiving your reply slip to arrange to visit you 
in your home (or elsewhere if you prefer). During this meeting Helen will discuss 
the study with you, answer your questions and ask you to sign a consent form. You 
will also be asked to fill in a short questionnaire which should take no longer than 
five minutes to complete. 
 
Thank you for taking your time to read this.   
 
Yours Sincerely 
 
 
Miss Helen Flaherty 
Chief Investigator 
  
 
Part 1 
 
What is the purpose of the study? 
The only effective treatment for coeliac disease is a diet that is free from gluten. 
Gluten is found in wheat, rye and barley. Some people may also have an adverse 
reaction to oats. Removing food and drinks from the diet which contain gluten, 
such as bread, breakfast cereals, pasta, beer and cakes, can be difficult. It is known 
that many people with coeliac disease do not stick to a strict gluten-free diet. 
 
In this study we will explore the factors influencing whether or not adults with 
coeliac disease stick to a gluten-free diet. To do this, we will collect information 
from 25 adults with coeliac disease, 25 spouses or other adults who live with a 
person with coeliac disease and 25 healthcare professionals. The study will 
determine whether these three groups of people have the same or different ideas 
about why people with coeliac disease do or do not stick to a gluten-free diet. The 
results of this study can be used to design an intervention aimed at improving 
healthcare for people with coeliac disease. 
 
This study is being undertaken for educational purposes, as part of my PhD. 
 
Why have I been invited? 
You have been invited to participate in this study because you have coeliac disease 
and you are attending, or have attended, a clinic at Norfolk and Norwich University 
Hospital. 
 
Are there any inclusion or exclusion criteria? 
We are seeking to recruit 25 adults who have been medically diagnosed with 
coeliac disease to take part in this study. These people should be aged 18 years or 
over and live within approximately a 10 mile radius of Norwich. Participants will 
be registered with Coeliac UK and/or Norfolk and Norwich University Hospital. 
As we are interested to hear about the things that both increase and decrease a 
person’s ability to stick to a strict gluten-free diet, we are looking to recruit people 
who fit in to any of the following categories: 
 
 I follow a strict gluten-free diet at all times 
 I partially follow a gluten-free diet 
 I do not follow a gluten-free diet at all 
 
Do I have to take part? 
Participation in this study is voluntary and it is up to you to decide. If you agree to 
take part, we will ask you to sign a consent form. You are free to withdraw at any 
time without giving a reason. This would not affect the standard of care you 
receive. 
 
What will happen to me if I take part? 
Before we can include you in this research study, the Chief Investigator, Helen 
Flaherty, will meet with you to discuss the study and to ask you to sign a consent 
form. This meeting should last no longer than 30 minutes. Helen can meet with you 
in your own home or, if you prefer, the meeting can take place elsewhere. You will 
also be required to complete a short questionnaire, which should take you no longer 
than five minutes. 
 
You will then be invited to participate in two group meetings with other people 
who have coeliac disease. These meetings will take place between November 2011 
  
 
and March 2012 at the University of East Anglia. The meetings are really informal 
discussions and each is expected to last approximately two hours. There will be a 
break during both meetings and refreshments will be provided (gluten-free of 
course!). The group meetings will be run by the Chief Investigator, Helen Flaherty, 
and there will be at least one research assistant present at both meetings. 
 
In the first meeting, you and the other members of your group will be asked to 
produce statements that answer the question “What helps a person with coeliac 
disease stick to a gluten-free diet?”. The discussion will be tape-recorded and 
statements will be written on flip charts. You will also have a note pad on which 
you can individually write your statements if you wish. There is no pressure on any 
individual to make statements and any information you provide during the meeting 
will be kept anonymous. 
 
The second meeting involves looking through the statements that were generated 
by all three participant groups during the first meetings. There will be around 80 
statements. You will be asked to sort the statements into five equal piles indicating 
their relative importance and then you will be asked to group the statements into 
themes. 
 
Expenses and payments: 
Although we do not have funding to compensate you for your time, we will refund 
your travel expenses. 
 
What are the possible disadvantages and risks of taking part? 
The risk of you being harmed as a result of this study is very low. If you feel 
distressed at any time during this study, you are free to withdraw without having to 
provide a reason. If the Chief Investigator and/or research assistant become 
concerned about your health at any stage, we will suggest that you withdraw from 
the study and we may advise you to speak to a healthcare professional. 
 
A possible disadvantage for participants is that you will be asked to give up four 
hours of your time to attend two two-hour group meetings. Although you will not 
be compensated for your time, we will reimburse your travel expenses and we will 
provide gluten-free refreshments during both meetings. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help you but it is our intention to use the 
information we get from this study to inform a lay report of this research for 
Coeliac UK and a professional report for a peer reviewed journal which will, 
hopefully, help improve the treatment of people with coeliac disease. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. 
 
This completes part 1. If the information in part 1 interests you and you would 
like to participate in this study, please read the additional information in part 
2 before making any decision. 
  
 
Part 2 
 
Once I take part, can I change my mind? 
Yes! After you have read this information and asked us any questions, we will ask 
you to complete an Informed Consent Form. However, if at any time, before, 
during or after the study you wish to withdraw, please just contact the Chief 
Investigator, Helen Flaherty. You can withdraw at any time and you do not have to 
explain the reason why you have decided to withdraw. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. The Chief Investigator, 
Helen Flaherty, can be contacted by telephone: 01603593665 (office) / 
07920406094 (mobile) or email: h.flaherty@uea.ac.uk. If you remain unhappy and 
wish to complain formally, you can do this by contacting Helen’s academic 
supervisor, Dr Katherine Deane, by telephone: 01603 597047 or e-mail: 
K.Deane@uea.ac.uk. Alternatively, you can write to us at:  
 
Dr Katherine Deane / Helen Flaherty 
Edith Cavell Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone‘s negligence then you may have grounds for a legal 
action for compensation against the University of East Anglia but you may have to 
pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
Yes. All information collected about you during the course of this study will be 
kept strictly confidential. Your personal details, such as your name and address, 
will be recorded and stored anonymously according to the Data Protection Act 
(1998). Your name will be substituted by a coded reference number so that your 
information cannot be traced back to you. Paper documents which contain your 
data will be stored in a locked cabinet in a locked room at the University of East 
Anglia. Paper documents will be shredded six months after the end of this study. 
Electronic data will be stored securely on a password protected computer at the 
University of East Anglia for two years. After this, all data will be deleted. Data 
will only be viewed by the Chief Investigator and members of the research team.   
 
If the data collected in this study is used in a written report, such as a thesis or 
published paper, we will not use your name or personal details. Any information 
you provide will be kept anonymous, however, you are not obliged to disclose any 
information that you would prefer to keep private. 
 
What will happen to the results of the study? 
The results of this study can be used to develop an intervention to help improve 
adherence to a gluten-free diet for people with coeliac disease. This may improve 
the quality of life of many people with coeliac disease as well as reducing the cost 
of healthcare.   
 
  
 
We aim to publish the results of this study in a lay report for Coeliac UK, in 
scientific journals and the study will be used as part of a written PhD thesis. You 
will not be personally identifiable in any report or publication relating to this study. 
 
The results of this study will be made available to you upon your request. Please 
use the contact details shown at the top of this information sheet when requesting 
the results. 
 
Who is organising and funding the research? 
This study is part of a three year student PhD research project funded by the 
University of East Anglia. The Chief Investigator is PhD student, Helen Flaherty. 
Helen will work under the supervision of Dr Katherine Deane and Professor 
Richard Gray.   
 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
by the Newcastle North Tyneside 2 Research Ethics Proportionate Review Sub-
Committee. In addition, the research study has been reviewed by staff at Coeliac 
UK and Norfolk and Norwich University Hospital. 
 
Further information and contact details: 
Please do not hesitate to contact us if you require further information about any of 
the following issues: 
 
Specific information about this research project.   
 Helen Flaherty 
 Edith Cavell Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 597130 / 07920406094 
 E-mail: h.flaherty@uea.ac.uk  
 
Advice as to whether you should participate.  
Please do not hesitate to contact your General Practitioner or other 
healthcare professional if you are unsure of whether to take part. 
You can also discuss your participation in this study with your 
friends and family. 
 
Who you should approach if you are unhappy with the study.  
 
Dr Katherine Deane 
 Edith Cavell Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 597047 
  E-mail: K.Deane@uea.ac.uk 
 
 
Thank you for taking your time to read this information sheet. Please 
complete and return the enclosed reply slip in the envelope provided if you 
would like to participate in this study. 
  
Appendix 13 Participant information sheet for 
household members 
 
Edith Cavell Building 
University of East Anglia 
Norwich 
NR4 7TJ 
Tel: 01603 593665 
E-mail: h.flaherty@uea.ac.uk 
 
Information sheet for spouses (or other adults) who live with a person with 
coeliac disease  
Research study: What helps adults with coeliac disease stick to a gluten-free 
diet? 
 
Dear Sir/Madam, 
 
We would like to invite you to take part in a research study which aims to explore 
how people with coeliac disease manage sticking with a gluten-free diet.   
 
The study is being conducted by PhD student, Helen Flaherty, who is the Chief 
Investigator in this study. Helen is working under the supervision of two academic 
supervisors, Dr Katherine Deane and Prof Richard Gray at the University of East 
Anglia. Before you give your full consent, please take time to read the following 
information carefully and discuss it with others if you wish. Please ask us if there is 
anything that is not clear or if you would like more information. 
 
Participation in this study is optional and you are free to withdraw at any time 
without giving a reason. 
 
Part 1 tells you the purpose of this study and what will happen if you participate. 
Part 2 gives you more detailed information about the conduct of the study.  
 
If you would like to take part in this study, please complete the enclosed reply slip 
and return it to us in the envelope provided as soon as possible. Helen Flaherty will 
contact you within three weeks of receiving your reply slip to arrange to visit you 
in your home (or elsewhere if you prefer). During this meeting Helen will discuss 
the study with you, answer your questions and ask you to sign a consent form. You 
will also be asked to fill in a short questionnaire which should take no longer than 
five minutes to complete. 
 
Thank you for taking your time to read this.   
 
Yours faithfully 
 
 
 
Miss Helen Flaherty  
Chief Investigator 
  
 
Part 1 
 
What is the purpose of the study? 
The only effective treatment for coeliac disease is a diet that is free from  gluten. 
Gluten is found in wheat, rye and barley. Some people may also have an adverse 
reaction to oats. Removing food and drinks from the diet which contain gluten, 
such as bread, breakfast cereals, pasta, beer and cakes, can be difficult. It is known 
that many people with coeliac disease do not stick to a strict gluten-free diet. 
 
In this study we will explore the factors influencing whether or not adults with 
coeliac disease stick to a gluten-free diet. To do this, we will collect information 
from 25 adults with coeliac disease, 25 spouses or other adults who live with 
someone with coeliac disease and 25 healthcare professionals. The study will 
determine whether these three groups of people have the same or different ideas 
about why people with coeliac disease do or do not stick to a gluten-free diet. The 
results of this study can be used to design an intervention aimed at improving 
healthcare for people with coeliac disease. 
 
This study is being undertaken for educational purposes, as part of my PhD. 
 
Why have I been Invited? 
You have been invited to participate in this study because you are a spouse or other 
adult who lives with a person who has coeliac disease. 
 
Are there any inclusion or exclusion criteria? 
We are seeking to recruit 25 participants who are either a spouse or other adult who 
lives with an adult who has been diagnosed with coeliac disease. These people 
should be aged 18 years or over and live within approximately a 10 mile radius of 
Norwich. 
 
Do I have to take part? 
Participation in this study is voluntary and it is up to you to decide. If you agree to 
take part, we will ask you to sign a consent form. You are free to withdraw at any 
time without giving a reason. This would not affect the standard of care you 
receive. 
 
What will happen to me if I take part? 
Before we can include you in this research study, the Chief Investigator, Helen 
Flaherty, will meet with you to discuss the study and to ask you to sign a consent 
form. This meeting should last no longer than 30 minutes. Helen can meet with you 
in your own home or, if you prefer, the meeting can take place elsewhere. You will 
also be required to complete a short questionnaire, which should take you no longer 
than five minutes. 
 
You will then be invited to participate in two group meetings with other spouses or 
adults who live with a person with coeliac disease. These meetings will take place 
between November 2011 and March 2012 at the University of East Anglia. The 
meetings are really informal discussions and each is expected to last approximately 
two hours. There will be a break during both meetings and refreshments will be 
provided. The group meetings will be run by the Chief Investigator, Helen Flaherty 
and there will be at least one research assistant present at both meetings. 
 
In the first meeting, you and the other members of your group will be asked to 
produce statements that answer the question “What helps a person with coeliac 
  
 
disease stick to a gluten-free diet?”. The discussion will be tape-recorded and 
statements will be written on flip charts. You will also have a note pad on which 
you can individually write your statements if you wish. There is no pressure on any 
individual to make statements and any information you provide during the meeting 
will be kept anonymous. 
 
The second meeting involves looking through the statements that were generated 
by all three participant groups during the first meetings. There will be around 80 
statements. You will be asked to sort the statements into five equal piles indicating 
their relative importance and then you will be asked to group the statements into 
themes. 
 
Expenses and payments 
Although we do not have funding to compensate you for your time, we will refund 
your travel expenses.  
 
What are the possible disadvantages and risks of taking part? 
The risk of you being harmed as a result of this study is very low. If you feel 
distressed at any time during this study, you are free to withdraw without having to 
provide a reason. If the Chief Investigator and/or research assistant become 
concerned about your health at any stage, we will suggest that you withdraw from 
the study and we may advise you to speak to a healthcare professional. 
 
A possible disadvantage for participants is that you will be asked to give up four 
hours of your time to attend two two-hour group meetings. Although you will not 
be compensated for your time, we will reimburse your travel expenses and we will 
provide refreshments during both meetings. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help your spouse or the person you live with 
but it is our intention to use the information we get from this study to inform a lay 
report of this research for Coeliac UK and a professional report for a peer reviewed 
journal which will, hopefully, help improve the treatment of people with coeliac 
disease. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. 
 
This completes part 1. If the information in part 1 interests you and you would 
like to participate in this study, please read the additional information in part 
2 before making any decision. 
 
 
 
 
 
 
  
 
Part 2 
 
Once I take part, can I change my mind? 
Yes! After you have read this information and asked us any questions, we will ask 
you to complete an Informed Consent Form. However, if at any time, before, 
during or after the study you wish to withdraw, please just contact the Chief 
Investigator, Helen Flaherty. You can withdraw at any time and you do not have to 
explain the reason why you have decided to withdraw. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. The Chief Investigator, 
Helen Flaherty, can be contacted by telephone: 01603593665 (office) / 
07920406094 (mobile) or email: h.flaherty@uea.ac.uk. If you remain unhappy and 
wish to complain formally, you can do this by contacting Helen’s academic 
supervisor, Dr Katherine Deane, by telephone: 01603 597047 or e-mail: 
K.Deane@uea.ac.uk. Alternatively, you can write to us at: 
 
Dr Katherine Deane / Helen Flaherty 
Edith Cavell Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone‘s negligence then you may have grounds for a legal 
action for compensation against the University of East Anglia but you may have to 
pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
Yes. All information collected about you during the course of this study will be 
kept strictly confidential. Your personal details, such as your name and address, 
will be recorded and stored anonymously according to the Data Protection Act 
(1998). Your name will be substituted by a coded reference number so that your 
information cannot be traced back to you. Paper documents which contain your 
data will be stored in a locked cabinet in a locked room at the University of East 
Anglia. Paper documents will be shredded six months after the end of this study. 
Electronic data will be stored securely on a password protected computer at the 
University of East Anglia for two years. After this, all data will be deleted. Data 
will only be viewed by the Chief Investigator and members of the research team.   
 
If the data collected in this study is used in a written report, such as a thesis or 
published paper, we will not use your name or personal details. Any information 
you provide will be kept anonymous, however, you are not obliged to disclose any 
information that you would prefer to keep private. 
 
What will happen to the results of the study? 
The results of this study can be used to develop an intervention to help improve 
adherence to a gluten-free diet for people with coeliac disease. This may improve 
the quality of life of many people with coeliac disease as well as reducing the cost 
of healthcare.   
We aim to publish the results of this study in a lay report for Coeliac UK, in 
scientific journals and the study will be used as part of a written PhD thesis. You 
will not be personally identifiable in any report or publication relating to this study. 
  
 
The results of this study will be made available to you upon your request. Please 
use the contact details shown at the top of this information sheet when requesting 
the results. 
 
Who is organising and funding the research? 
This study is part of a three year student PhD research project funded by the 
University of East Anglia. The Chief Investigator is PhD student, Helen Flaherty. 
Helen will work under the supervision of Dr Katherine Deane and Professor 
Richard Gray.   
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
by the Newcastle North Tyneside 2 Research Ethics Proportionate Review Sub-
Committee. In addition, the research study has been reviewed by staff at Coeliac 
UK and Norfolk and Norwich University Hospital. 
 
Further information and contact details: 
Please do not hesitate to contact us if you require further information about any of 
the following issues: 
 
Specific information about this research project.   
 Helen Flaherty 
 Edith Cavell Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 597130 / 07920406094 
 E-mail: h.flaherty@uea.ac.uk  
 
Advice as to whether you should participate.  
Please do not hesitate to contact your General Practitioner or other 
healthcare professional if you are unsure of whether to take part. 
You can also discuss your participation in this study with your 
friends and family. 
 
Who you should approach if you are unhappy with the study.  
Dr Katherine Deane 
 Edith Cavell Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 597047 
E-mail: K.Deane@uea.ac.uk 
 
Thank you for taking your time to read this information sheet. Please 
complete and return the enclosed reply slip in the envelope provided if you 
would like to participate in this study.  
 
  
Appendix 14 Participant information sheet for 
healthcare professionals 
 
1.33 Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Tel: 01603 593665 
E-mail: h.flaherty@uea.ac.uk 
 
 
Information sheet for healthcare professionals  
 
Research study: What helps adults with coeliac disease stick to a gluten-free 
diet? 
 
Dear Sir or Madam, 
 
We would like to invite you to take part in a research study which aims to explore 
how people with coeliac disease manage sticking with a gluten-free diet. 
 
The study is being conducted by PhD student, Helen Flaherty, who is the Chief 
Investigator in this study. Helen is working under the supervision of two academic 
supervisors, Dr Katherine Deane and Prof Richard Gray at the University of East 
Anglia. Before you give your full consent, please take time to read the following 
information carefully and discuss it with others if you wish. Please ask us if there is 
anything that is not clear or if you would like more information. 
 
Participation in this study is optional and you are free to withdraw at any time 
without giving a reason. 
 
Part 1 tells you the purpose of this study and what will happen if you participate. 
Part 2 gives you more detailed information about the conduct of the study.  
 
If you would like to take part in this study, please complete the enclosed consent 
form and short questionnaire and return them in the envelope provided as soon as 
possible. It should take you no longer than five minutes to complete these forms. 
After receiving your completed consent form and questionnaire, Helen Flaherty 
will contact you with further information about the study. 
 
Thank you for taking your time to read this.   
 
Yours faithfully 
 
 
 
Miss Helen Flaherty 
Chief Investigator 
 
 
  
 
Part 1 
What is the purpose of the study? 
The only effective treatment for coeliac disease is a diet that is free from gluten. 
Gluten is found in wheat, rye and barley. Some people may also have an adverse 
reaction to oats. Removing food and drinks from the diet which contain gluten, 
such as bread, breakfast cereals, pasta, beer and cakes, can be difficult. It is known 
that many people with coeliac disease do not stick to a strict gluten-free diet. 
 
In this study we will explore the factors influencing whether or not adults with 
coeliac disease stick to a gluten-free diet. To do this, we will collect information 
from 25 adults with coeliac disease, 25 spouses or other adults who live with 
someone with coeliac disease and 25 healthcare professionals. The study will 
determine whether these three groups of people have the same or different ideas 
about why people with coeliac disease do or do not stick to a gluten-free diet. The 
results of this study can be used to design an intervention aimed at improving 
healthcare for people with coeliac disease.  
 
This study is being undertaken for educational purposes, as part of my PhD. 
 
Why have I been Invited? 
You have been invited to participate in this study because you are a healthcare 
professional working in Norwich who treats people with coeliac disease. 
  
Are there any inclusion or exclusion criteria? 
We are seeking to recruit 25 healthcare professionals who have a current caseload 
of at least one adult coeliac patient. Participants should have at least one year’s 
experience of working with coeliac patients and should live or work within 
approximately a 10 mile radius of Norwich. 
 
Do I have to take part? 
Participation in this study is voluntary and it is up to you to decide. You are free to 
withdraw at any time, without giving a reason. If you wish to take part in this 
study, please return your completed consent form and questionnaire in the envelope 
provided. 
 
What will happen to me if I take part? 
Before we can include you in this study, you will need to complete the enclosed 
consent form and questionnaire and return them to us in the envelope provided. 
You will then be invited to participate in a group meeting with other healthcare 
professionals who work with adult coeliac patients. This meeting will take place 
between November 2011 and March 2012 in the Edith Cavell Building, opposite 
Norfolk and Norwich University Hospital. The meeting is really an informal 
discussion and is expected to last no more than two hours. There will be a break 
during the meeting and refreshments will be provided. The group meeting will be 
run by the Chief Investigator, Helen Flaherty and there will be at least one research 
assistant present. 
 
In the meeting, you and the other members of your group will be asked to produce 
statements that answer the question “What helps a person with coeliac disease stick 
to a gluten-free diet?”. The discussion will be tape-recorded and statements will be 
written on flip charts. You will also have a note pad on which you can individually 
write your statements if you wish. There is no pressure on any individual to make 
statements and any information you provide during the meeting will be kept 
  
 
anonymous. If you are unable to attend the group meeting we will be able to record 
your statements by e-mail or post.  
 
There will be a second activity which we will ask you to complete either 
electronically (e-mail) or by post. This will take place between 1 to 4 months after 
the group meeting. This activity involves looking through the statements that were 
generated by all three participant groups during the first meetings. There will be 
around 80 statements. You will be asked to sort the statements into five categories 
indicating their relative importance and then you will be asked to group the 
statements into themes. 
 
Expenses and payments: 
Although we do not have funding to compensate you for your time, we will refund 
your travel expenses. 
 
What are the possible disadvantages and risks of taking part? 
The risk of you being harmed as a result of this study is very low. If you feel 
distressed at any time during this study, you are free to withdraw without having to 
provide a reason.  
 
For health professionals participating in this study, there is a risk that the chief 
investigator could be made aware of unprofessional practice during discussions and 
this would have to be reported to an appropriate authority.  
 
A possible disadvantage for participants is that you will be asked to give up two 
hours of your time to attend the two-hour brainstorming group meeting. Although 
you will not be compensated for your time, we will reimburse your travel expenses 
and we will provide refreshments during the meeting. 
 
What are the possible benefits of taking part? 
We cannot promise that the study will help you or your patients directly but it is 
our intention to use the information we get from this study to inform a lay report of 
this research for Coeliac UK and a professional report for a peer reviewed journal 
which will, hopefully, help improve the treatment of people with coeliac disease. 
 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this 
is given in Part 2. 
 
Will my taking part in this study be kept confidential? 
Yes. We will follow ethical and legal practice and all information about you will be 
handled in confidence. The details are included in Part 2. 
 
This completes part 1. If the information in part 1 interests you and you would 
like to participate in this study, please read the additional information in part 
2 before making any decision. 
 
 
 
 
 
 
  
 
Part 2 
Once I take part, can I change my mind? 
Yes! After you have read this information and asked us any questions, you can 
complete the enclosed Informed Consent Form. However, if at any time, before, 
during or after the study you wish to withdraw, please just contact the Chief 
Investigator, Helen Flaherty. You can withdraw at any time and you do not have to 
explain the reason why you have decided to withdraw. 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions. The Chief Investigator, 
Helen Flaherty, can be contacted by telephone: 01603593665 (office) / 
07920406094 (mobile) or email: h.flaherty@uea.ac.uk. If you remain unhappy and 
wish to complain formally, you can do this by contacting Helen’s academic 
supervisor, Dr Katherine Deane, by telephone: 01603 597047 or e-mail: 
K.Deane@uea.ac.uk. Alternatively, you can write to us at:   
 
Dr Katherine Deane / Helen Flaherty 
Edith Cavell Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
In the event that something does go wrong and you are harmed during the research 
and this is due to someone‘s negligence then you may have grounds for a legal 
action for compensation against the University of East Anglia but you may have to 
pay your legal costs. 
 
Will my taking part in this study be kept confidential? 
Yes. All information collected about you during the course of this study will be 
kept strictly confidential. Your personal details, such as your name and address, 
will be recorded and stored anonymously according to the Data Protection Act 
(1998). Your name will be substituted by a coded reference number so that your 
information cannot be traced back to you. Paper documents which contain your 
data will be stored in a locked cabinet in a locked room at the University of East 
Anglia. Paper documents will be shredded six months after the end of this study. 
Electronic data will be stored securely on a password protected computer at the 
University of East Anglia for two years. After this, all data will be deleted.  Data 
will only be viewed by the Chief Investigator and members of the research team.   
 
If the data collected in this study is used in a written report, such as a thesis or 
published paper, we will not use your name or personal details. Any information 
you provide will be kept anonymous, however, you are not obliged to disclose any 
information that you would prefer to keep private. 
 
What will happen to the results of the study? 
The results of this study can be used to develop an intervention to help improve 
adherence to a gluten-free diet for people with coeliac disease. This may improve 
the quality of life of many people with coeliac disease as well as reducing the cost 
of healthcare.   
We aim to publish the results of this study in a lay report for Coeliac UK, in 
scientific journals and the study will be used as part of a written PhD thesis. You 
will not be personally identifiable in any report or publication relating to this study. 
 
  
 
The results of this study will be made available to you upon your request. Please 
use the contact details shown at the top of this information sheet when requesting 
the results. 
 
Who is organising and funding the research? 
This study is part of a three year student PhD research project funded by the 
University of East Anglia. The Chief Investigator is PhD student, Helen Flaherty. 
Helen will work under the supervision of Dr Katherine Deane and Professor 
Richard Gray.   
 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
by the Newcastle North Tyneside 2 Research Ethics Proportionate Review Sub-
Committee. In addition, the research study has been reviewed by staff at Coeliac 
UK and Norfolk and Norwich University Hospital. 
 
Further information and contact details: 
Please do not hesitate to contact us if you require further information about any of 
the following issues: 
 
Specific information about this research project.   
 Helen Flaherty 
 1.33 Elizabeth Fry Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 593665 / 07920406094 
 E-mail: h.flaherty@uea.ac.uk  
 
Advice as to whether you should participate.  
If you are unsure of whether to take part, you can discuss your 
participation in this study with your friends and family or another 
healthcare professional. 
 
Who you should approach if you are unhappy with the study.  
Dr Katherine Deane 
 Edith Cavell Building 
 University of East Anglia 
 Norwich 
 NR4 7TJ 
 Tel: 01603 597047 
  E-mail: K.Deane@uea.ac.uk 
 
 
Thank you for taking your time to read this information sheet. Please 
complete and return the enclosed consent form and questionnaire in the 
envelope provided if you would like to participate in this study.
  
Appendix 15 Questionnaire for adults with coeliac disease 
Quesionnaire 
 
Research Study: What helps adults with coeliac disease stick to a gluten-
free diet? 
Please complete this questionnaire if you have been medically diagnosed with 
coeliac disease and you are aged 18 years or over. 
_________________________________________________________________ 
1)  Your gender:  (Please tick)        □Male      □Female 
 
2)  How many years ago were you diagnosed with coeliac disease?   
 
............................... 
 
3).  Do you follow any other special diet/s: (Please select all that apply) 
□Vegetarian/vegan □Nut-free □Lactose-free   □Other (Please 
state)...................... 
 
4)  How severe are your symptoms when you eat gluten? (Please tick) 
 
Very severe          Severe          Moderate          Mild          Very mild          No 
symptoms      
   □                □           □            □           □              □          
    
6)  Your ethnic group: (Please tick)    
White:  □British    □Irish                 □Other white background 
Mixed:    □White and Asian      □White and Black African       
□White and Black Caribbean     □Other mixed background     
       Asian or Asian British:    □Bangladeshi   □Chinese         □Indian                
                                                  □Pakistani        □Other Asian background 
Black or Black British:     □Caribbean      □African           □Other black 
background 
 
Other ethnic background (Please state) ................................................................... 
 
7)  In what year were you born?   _  _  _  _ 
 
 
 
 
 
  
 
 
 
8)  What is your highest educational qualification? (Please tick) 
□  No formal qualification   
□  GCSE/O Level or equivalent  
□  A’ Level or equivalent 
□  University Degree or equivalent  
□  Postgraduate Degree/Diploma or equivalent 
 
 
Thank you for taking the time to complete this questionnaire.   
Please return it to us in the envelope provided. 
 
 
  
Appendix 16  Questionnaire for household 
members 
Questionnaire 
 
Research Study: What helps adults with coeliac disease stick to 
a gluten-free diet? 
Please complete this questionnaire if you are aged 18 years or over 
and you have lived in the same household as an adult who has 
coeliac disease for at least one year.   
_______________________________________________________ 
 
1)  What is your relationship to the person with coeliac disease?  
(e.g. husband / girlfriend / friend etc.)  ........................................ 
 
2)  Your gender:  (Please tick)        □Male      □Female 
 
3)  The gender of the person with coeliac disease:  (Please tick)       
□Male     □Female 
 
4)  Your ethnic group: (Please tick)    
White:  □British    □Irish                 □Other white 
background 
Mixed:    □White and Asian      □White and Black 
African       
□White and Black Caribbean □Other mixed 
background     
       Asian or Asian British:   □Bangladeshi   □Chinese         
□Indian                                         □Pakistani   □Other Asian 
background 
Black or Black British:     □Caribbean      □African            
                                               □Other black background 
 
Other ethnic background (Please state)…….................................... 
 
 
5)  In what year were you born?   _  _  _  _ 
 
 
 
 
  
 
 
6)  What is your highest educational qualification? (Please tick) 
□  No formal qualification   
□  GCSE/O Level or equivalent  
□  A’ Level or equivalent 
□  University Degree or equivalent  
□  Postgraduate Degree/Diploma or equivalent 
 
 
Thank you for taking the time to complete this questionnaire.   
Please hand your completed questionnaire to a member of the 
research team or return it in the envelope provided.    
 
 
  
Appendix 17 Questionnaire for healthcare 
professionals 
Questionnaire 
 
Research Study: What helps adults with coeliac disease stick to 
a gluten-free diet? 
Please complete this questionnaire if you are a healthcare 
professional who has worked with adult patients with coeliac disease 
for at least one year and if you currently work with at least one adult 
coeliac patient. 
_______________________________________________________ 
1)  Please state your job title: 
……..........………………………………………………………… 
 
2)  For how many years have you worked with patients with 
coeliac disease? ......years 
 
3)  How many patients with coeliac disease do you currently 
work with?  ....................... 
 
4)  Please provide details of your professional qualification/s: 
................…………………………………………....................................
.............................................................................................................. 
 
5)  Please tick the appropriate box/es to show when you are 
most likely to be available to attend the group meeting/s:   
 
 MON TUES WED THURS FRI SAT SUN 
Morning (9am-12pm)        
Afternoon (12pm-4pm)        
Evening (6pm-9pm)        
 
Name:  Title:  (please circle)   Dr  /  Mr  /  Mrs  /  Miss  /  Ms  /  
Other:…… 
First name/s:  ..............................  Surname:  ...................................... 
 
Preferred contact address:   
 
House number/name: .........................Street:  ................................  
 
Town/City:  ................................. Postcode:  .................................. 
 
Preferred contact tel number:   
 
...............................................................(Home/work/mobile) 
  
 
Preferred contact e-mail address:  
........................................................................................ 
How would you prefer to be contacted (please tick):            
 
Phone             E-mail              Post 
 
 
 
Thank you for taking the time to complete this questionnaire.   
Please return your completed questionnaire in the envelope provided 
along with your signed consent form. We will be in touch within 3 
weeks of receiving these documents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Appendix 18 Consent form for adults with coeliac 
disease 
 
              Consent form for adults with coeliac disease 
 
Research Project: What helps adults with coeliac disease stick 
to a gluten-free diet? 
 
Chief Investigator: Helen Flaherty  
Participant Identification Number for this study:           Please initial box  
 
1. I confirm that I have read and understand the information 
sheet dated 16/05/2011 (version 3) for the research project 
called “What helps adults with coeliac disease stick to a 
gluten-free diet?”.  
 
 
2. I have had a chance to think about it and ask any 
questions. I confirm that my questions have been answered 
satisfactorily.  
 
 
3. I know that I don’t have to do this, it is my own choice. If I 
start joining in the research, I know that I can stop if I want to 
at any time. I will still be cared for in the same way, whether I 
join in or not and I do not have to give a reason for stopping.  
 
 
4. I agree to have the group meeting audio-recorded. I 
understand that the audio-recordings will be listened to by the 
research team at the University of East Anglia and they will 
be deleted within 3 months. 
 
5. I agree to take part in the above study.  
 
 
Name of Participant (please print): ................................................ 
   
 
Signature:  ........................................................ Date:  ............ 
 
 
Name of Person taking consent (please print):  ............................ 
 
 
Signature:  ........................................................ Date:  ............... 
When completed: 1 copy for participant; 1 copy (original) for researcher site file. 
  
 
Appendix 19  Participant consent form for 
household members 
 
 
Consent form for spouses (or other adults) who live 
with a person with coeliac disease 
 
 
Research Project: What helps adults with coeliac disease stick 
to a gluten-free diet? 
 
Chief Investigator: Helen Flaherty  
 
Participant Identification Number for this study: 
            Please initial box  
 
1. I confirm that I have read and understand the information 
sheet dated 16/05/2011 (version 3) for the research project 
called “What helps adults with coeliac disease stick to a 
gluten-free diet?”.  
 
2. I have had a chance to think about it and ask any 
questions. I confirm that my questions have been answered 
satisfactorily  
 
3. I know that I don’t have to do this, it is my own choice. If I 
start joining in the research, I know that I can stop if I want to 
at any time. I will still be cared for in the same way, whether I 
join in or not and I do not have to give a reason for stopping.   
 
4. I agree to have the group meeting audio-recorded. I 
understand that the audio-recordings will be listened to by the 
research team at the University of East Anglia and they will 
be deleted within 3 months.  
 
5. I agree to take part in the above study.  
 
Name of Participant (please print):  ............................................... 
   
Signature:  ............................................ Date:  ....................... 
 
 
Name of Person taking consent (please print):  ........................... 
 
Signature:  ................................................... Date:  ............................ 
 
 
When completed: 1 copy for participant; 1 copy (original) for researcher site file. 
 
  
Appendix 20  Participant consent form for healthcare 
professionals 
Consent form for healthcare professionals 
 
 
Research Project: What helps adults with coeliac disease stick 
to a gluten-free diet? 
 
Chief Investigator: Helen Flaherty  
 
Participant Identification Number for this study:           Please initial box  
 
1. I confirm that I have read and understand the information 
sheet dated 09/12/2011 (version 4) for the research project 
called “What helps adults with coeliac disease stick to a 
gluten-free diet?”.  
 
2. I have had a chance to think about it and ask any 
questions. I confirm that my questions have been answered 
satisfactorily.  
 
3. I know that I don’t have to do this, it is my own choice. If I 
start joining in the research, I know that I can stop if I want to 
at any time. I do not have to give a reason for stopping.  
 
4. . I agree to take part in the above study. 
 
Name of Participant (please print):................................................ 
 
 
Signature:  ....................................... Date:  .................................. 
 
 
 
Please keep one copy of this consent form and return the other 
copy to us in the envelope provided along with your completed 
questionnaire. 
 
 
 
 
  
 
Appendix 21  Reply slip for adults with coeliac 
disease 
 
REPLY SLIP 
Research study: What helps adults with coeliac disease stick to a 
gluten-free diet? 
If you are an adult who has been diagnosed with coeliac disease and you 
are interested in participating in this study, please complete this reply slip 
and return it to us in the envelope provided. We will not give your details to 
anybody outside of our research team here at the University of East Anglia. 
Any information you provide will be kept strictly confidential.  
Name:    
Title:  (please circle)   Dr  /  Mr  /  Mrs  /  Miss  /  Ms  /  Other: 
.......................... 
First name/s:  ..................................... Surname:  …..................................... 
Address:    
House number/name:...................................................................................   
Street:  .......................................................................................................... 
Town/City:  .................................................Postcode:................................... 
Phone: 
Home:  .........................  Mobile:  ........................  Work:  ............................. 
E-mail:  .............................................................................................. 
 
 
 
 
  
 
 
As we are interested to hear about the things that both increase and 
decrease a person’s ability to stick to a strict gluten-free diet, we are 
looking to recruit people who do and people who do not stick to a gluten-
free diet. Please state your current level of adherence to a gluten-free diet 
by ticking the appropriate box below: 
□  I stick to a gluten-free diet all of the time      
□  I partially stick to a gluten-free diet 
□  I do not follow a gluten-free diet 
If you are returning this reply slip to us, you should be willing to attend two 
two-hour meetings in Norwich. Please tick the appropriate box/es to show 
which times during the week you are most likely to be available to attend 
these meeting/s:   
 
 MON TUES WED THURS FRI SAT SUN 
Morning (9am-12pm)        
Afternoon (12pm-4pm)        
Evening (6pm-9pm)        
 
Signature:  .......................................... Date: ..................................... 
 
Thank you for completing this form. Please return it to us in the 
envelope provided as soon as possible. 
 
 
 
  
Appendix 22 Reply slip for household members 
REPLY 
SLIP 
Research study: What helps adults with coeliac disease stick to 
a gluten-free diet? 
If you live with an adult who has been diagnosed with coeliac disease 
and you are interested in participating in this study, please complete 
this reply slip and return it to us in the envelope provided. We will not 
give your details to anybody outside of our research team here at the 
University of East Anglia. Any information you provide will be kept 
strictly confidential.  
 
Name:   
Title:  (please circle)   Dr  /  Mr  /  Mrs  /  Miss  /  Ms  /  Other: ...................... 
First name/s:  ......................................   Surname:  ...................................... 
 
Address:    
House number/name:...................................................................................   
Street:  .......................................................................................................... 
Town/City:  ...........................................  Postcode:  .................................... 
 
Phone:  
Home:  .......................  Mobile:  ..........................  Work:  ............................. 
 
E-mail:  ....................................................................................... 
 
 
 
 
 
 
  
 
If you are returning this reply slip to us, you should be willing to attend two 
two-hour meetings in Norwich. Please tick the appropriate box/es to show 
which times during the week you are most likely to be available to attend 
these meeting/s:   
 MON TUES WED THURS FRI SAT SUN 
Morning (9am-12pm)        
Afternoon (12pm-4pm)        
Evening (6pm-9pm)        
 
Signature:  ................................................................  Date:  ............... 
 
Thank you for completing this form. Please return it to us in the 
envelope provided as soon as possible. 
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Appendix 24  Research and development 
application and approvals 
 
  
 
 
 
 
  
 
Appendix 25 Ethics substantial amendment approval 
letter 
 
 
 
  
 
 
 
  
 
  
Appendix 26 Press release 
The following press release was placed in two local newspapers (The 
Eastern Daily Press and the Norwich Evening News) to invite partially-
adherent and non-adherent people with coeliac disease and household 
members to participate in this study. This was done after we had recruited a 
sufficient number of adherent participants.   
 
Press Release 
Researchers are looking to recruit people with coeliac disease, who do not 
follow a strict gluten-free diet, for a new study at the University of East 
Anglia. 
 
The researchers want to find out what could help adults with coeliac disease 
to be better at sticking to a gluten-free diet for life. 
 
“Following a gluten-free diet for life can be very challenging for people 
with coeliac disease. We are interested to hear from adults with coeliac 
disease who do not currently follow a strict gluten-free diet” said Dr 
Katherine Deane. 
 
“Their views are very important for us in identifying the things that could 
help people with coeliac disease to be better at sticking to a gluten-free 
diet,” she added. 
 
As well as recruiting people with coeliac disease, the researchers are also 
recruiting spouses or other adults who live in the same household as the 
person with coeliac disease to take part in the study. 
 
Volunteers will be asked to complete two tasks which can be done in their 
own time and returned to the researchers by e-mail or post. The first task 
will take approximately 30 minutes, and the second approximately 60 
minutes.  
 
Alternatively, participants can complete the tasks during group sessions held 
at the University of East Anglia (with approximately six other volunteers in 
each group). These group sessions will take between one to two hours each 
and refreshments with be provided. 
 
The researchers are looking for 15 adults with coeliac disease and 15 
spouses or other adult household members to volunteer for this study. All 
volunteers need to be aged 18 years or over.  
 
To find out more about the research or to volunteer, please contact the 
researcher, Helen Flaherty, by emailing h.flaherty@uea.ac.uk, or call 01603 
593665 or 07920 406094. 
 
  
 
  
  
 
Appendix 27 – Advertisement on Coeliac UK’s 
website for healthcare professionals 
 
 
Invitation to participate in research study 
 
Coeliac UK is working with the University of East Anglia (UEA) on a 
study to explore what helps adults with coeliac disease stick to a 
gluten-free diet. We are seeking the opinions of healthcare 
professionals who have worked with an adult with coeliac disease in 
the last year. We would like to know if you would be willing to take 
part in this study. The study will involve two tasks which can be 
completed in your own time and submitted online or by post. Each 
task should take you no longer than one hour to complete.  
 
If you are interested in taking part, please contact Helen Flaherty at 
the University of East Anglia who will provide you with further 
information about the study before you decide. This study has gained 
ethical approval and it meets all of the necessary research 
standards. 
 
 
E-mail address:      h.flaherty@uea.ac.uk   
 
Tel:                       07920406094  
 
Postal address:      Helen Flaherty 
1.33 Elizabeth Fry Building 
Faculty of Medicine and Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
 
 
 
 
 
  
 
Appendix 28 Advert on the University of East Anglia 
website 
 
The following advertisement was placed on the University of East 
Anglia website: 
 
 
Researchers at the University of East Anglia are looking to recruit 
people with coeliac disease who are aged 18 years or over and who 
do not currently follow a strict gluten-free diet. 
 
The researchers want to find out what could help adults with coeliac 
disease to be better at sticking to a gluten-free diet for life. 
 
“Following a gluten-free diet for life can be very challenging for 
people with coeliac disease. We are interested to hear from adults 
with coeliac disease who do not currently follow a strict gluten-free 
diet” said Dr Katherine Deane. 
 
“Their views are very important for us in identifying the things that 
could help people with coeliac disease to be better at sticking to a 
gluten-free diet” she added. 
 
As well as recruiting people with coeliac disease for this study, the 
researchers are also recruiting spouses or other adults who live in 
the same household as the person with coeliac disease. 
 
Volunteers will be asked to complete two tasks which can be done in 
your own time and returned to the researchers by e-mail or post. The 
first task will take approximately 30 minutes and the second will take 
approximately 60 minutes. Alternatively, participants can complete 
the tasks during group sessions held at the University of East Anglia 
(with approximately 6 other volunteers in each group). These group 
sessions will take between 1 to 2 hours each and refreshments with 
be provided (gluten-free, of course!). 
 
The researchers are looking for 15 adults with coeliac disease and 
15 spouses or other adult household members to volunteer for this 
study. 
 
To find out more about the research or to volunteer, please contact 
the researcher, Helen Flaherty, by emailing h.flaherty@uea.ac.uk or 
call 01603 593665 / 07920406094. 
 
 
  
Appendix 29 Advertisement sent by Coeliac UK to 
the British Dietetic Association (BDA) 
Gastroenterology Specialist Group 
 
Invitation to participate in research study 
 
Coeliac UK is working with the University of East Anglia (UEA) on a 
study to explore what helps adults with coeliac disease stick to a 
gluten-free diet. We are seeking the opinions of healthcare 
professionals who have worked with an adult with coeliac disease in 
the last year. We would like to know if you would be willing to take 
part in this study. The study will involve two tasks which can be 
completed in your own time and submitted online or by post. Each 
task should take you no longer than one hour to complete.  
 
If you are interested in taking part, please contact Helen Flaherty at 
the University of East Anglia who will provide you with further 
information about the study before you decide. This study has gained 
ethical approval and it meets all of the necessary research 
standards. 
 
 
E-mail address:      h.flaherty@uea.ac.uk   
 
Tel:                       07920406094  
 
Postal address:      Helen Flaherty 
1.33 Elizabeth Fry Building 
Faculty of Medicine and Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
  
Appendix 30 Letter of confirmation for group 
meeting 
Room 1.33 
Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Phone: 01603 593665 
Mobile: 07920 406094 
E-mail:  h.flaherty@uea.ac.uk 
 
Dear 
 
Research study: What helps adults with coeliac disease stick to a gluten-
free diet?  
Brainstorming session - Friday 16th September 2011 7:00pm–9:00pm  
 
Thank you for agreeing to take part in the above brainstorming session on 
Friday 16th September at 7:00pm. This meeting will last up to two hours and 
there will be a break with refreshments. 
 
The meeting will be held in the Edith Cavell Building, which is opposite the 
Norfolk and Norwich University Hospital on Colney Lane (see enclosed 
maps). As the main entrance to the Edith Cavell Building will be locked on 
Friday evening, my colleagues and I will meet you at the main entrance 
when you arrive.  
 
The Edith Cavell Building has its own car park which is accessed from 
Colney Lane. Parking is free and you can use the disabled parking spaces 
if you wish. There are regular buses direct to the Hospital from Norwich 
centre (bus numbers 12, 21, 22 and 24). 
 
We would like to reimburse any travel expenses you may incur. Please 
complete the enclosed expenses claim form, attaching your travel 
tickets/receipts or stating the number of miles travelled by car. You can 
hand the form to me on Friday or at the second meeting which you will be 
invited to attend later this year. Alternatively, you can post the form to me at 
the above address. 
 
If you have any questions or need further information, please feel free to 
contact me using the details shown at the top of this letter. I will be 
available on my mobile phone on the evening of the meeting. 
 
Yours Sincerely 
 
 
 
Helen Flaherty 
PhD student, University of East Anglia 
 
 
  
 
Appendix 31 Brainstorming script and prompts to 
be used during brainstorming 
 
Brainstorming Session Script and prompts 
 
 
Script 
 
At the start: 
  
Thank you all for coming along tonight, it is nice to see you all again 
and we really appreciate you giving up your time to participate in this 
study.  
 
I’d like to introduce you to my supervisor, Dr Katherine Deane and 
two of my fellow PhD students who have kindly volunteered to help 
out, Steve Smith and Ada Mackovova (we should wear name 
badges). (do you want to say something about yourselves or should I 
say more about you?). To make it easier for us to remember all your 
names, we would be grateful if you would wear name badges (have 
stickers and marker pens to hand). 
 
Tonight’s brainstorming session will last up to two hours and we’ll 
take a break at 8pm for refreshments.  
 
Following any restricted diet can be very difficult and studies have 
shown that up to 58% of adults with CD do not stick to a gluten-free 
diet. There are many reasons why this may be and through this 
research, we hope to identify what would help adults with coeliac 
disease to be better at sticking to a gluten-free diet. 
 
One definition of brainstorming is: “A means of getting a large 
number of ideas from a group of people in a short time”. The aim of 
tonight’s brainstorming session is to generate as many of your ideas 
as possible in response to the focus question “what helps adults with 
coeliac disease stick to a gluten-free diet”. To do this, we will ask you 
to complete the following sentence: “It would be easier for adults with 
coeliac disease to stick to a gluten-free diet if...”. For example you 
could say, “It would be easier for adults with coeliac disease to stick 
to a gluten-free diet if gluten-free food was cheaper”.  
 
You or your household member may be very good at sticking to the 
GFD and you may have strategies in place to help you manage the 
diet which we would really like to hear about. For example, if your 
local shops don’t stock much GFF, you may shop online as a 
strategy to help you stick to the diet. Two statements could be 
generated in relation to this:  
  
 
 
1. “It would be easier for adults with coeliac disease to stick to a 
gluten-free diet if more gluten-free food was available in local 
shops”.  
 
2. “It would be easier for adults with coeliac disease to stick to a 
gluten-free diet if they shop for gluten-free food online”. 
 
You will not be required to analyse or discuss the statements. We 
simply want to collect as many statements as possible. There is a 
need to suspend judgement and to accept ideas that you might think 
are wild or silly. If you have an idea that you would rather not share 
with the group, you can write it down and hand it to one of us at the 
end. 
 
Tonight’s session will be tape recorded so that we can ensure we 
don’t miss anything. The recording will be listened to again by the 
research team and then it will be deleted. To help with the clarity of 
the recording, we would be grateful if just one person speaks at a 
time. If you have an idea while someone else is talking and you don’t 
want to forget it, then please write it down. Everyone should have an 
equal opportunity to contribute their ideas. 
 
I also ask that you respect each other’s views even if you do not 
agree with them. If you disagree with someone’s statement, you can 
generate a conflicting statement. 
 
I would also like to remind you that you are free to withdraw at any 
time without having to explain your reason.  
 
Does anybody have any questions before we begin? 
 
 
Fire evacuation procedures - THE EARLHAM, COLNEY AND 
BLUEBELL ROOMS (FIRST FLOOR) 
In the event of discovering a fire, please raise the alarm. 
 Leave via the entrance/exit door  
 Turn left and exit via the solid “push bar” fire exit door 
 Take the internal staircase down and exit through the glass “push 
bar” door at the bottom. 
 Carefully cross the road and wait on the pavement opposite the 
Sportspark. 
Do not re-enter the building unless authorised to do so by a member of 
Sportspark Staff 
 
 
At the break: 
Please help yourself to drinks and the GF snacks which have been 
donated by gluten-free food companies. In return for their generosity, 
  
 
I agreed to distribute their leaflets, so please take these if you wish. I 
have some additional gluten-free food donations for the people with 
CD to take away and try at home (put together a bag for each person 
with leaflets in). For household members/spouses, we will give the 
person who you live with a pack when they attend their brainstorming 
session.  
 
At the end:  
Thank you all for coming along and giving up your time. I hope you 
have enjoyed taking part. You have provided us with some valuable 
data and we really appreciate your contributions. If you do have any 
more ideas that you think of later or if there is anything that you didn’t 
wish to raise during the meeting, you can contact me later with the 
details.  
 
I will be in touch with you again later in the year to invite you to the 
second and final group meeting where you will be asked to prioritise 
the statements generated during the brainstorming sessions and to 
group them into themes. 
 
I hope you have a safe journey home. For those of you who have 
parked in the Sportspark car park, please don’t forget to get your 
ticket validated as you leave. Anyone travelling by public transport or 
taxi, don’t forget to keep your ticket or to get a receipt so that we can 
reimburse your costs. Does anyone want to hand in a travel 
expenses claim form tonight? 
 
 
Prompts to be used by the group facilitator if necessary 
If the session dries up, the facilitator may want to prompt on the 
following points... 
 
And what about... 
 The cost of gluten-free food? 
 The availability of gluten-free food: 
o When Travelling 
o When eating out 
o In the workplace 
o When shopping 
o On prescription 
 Social eating/drinking 
 Social support from friends and family 
 The role of  
o Coeliac support groups 
o Healthcare professionals 
 Gluten-free food labelling 
 The taste and texture of gluten-free food 
 Your knowledge about the gluten-free diet 
 Information available about the gluten-free diet  
  
 
 Symptoms experienced if you do eat gluten (duration, severity, 
type of symptoms) 
 Length of time on the gluten-free diet  
 Additional special dietary requirements 
 Age at diagnosis / age now 
 Cooking skills and domestic arrangements 
 Household structure 
 
 
  
Appendix 32 Letter sent to gluten-free food 
companies 
Room 1.33 
Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Phone: 01603 593665 
E-mail:  h.flaherty@uea.ac.uk 
 
 
29 February 2012 
 
 
 
Dear Sir/Madam, 
I am a PhD student at the University of East Anglia and I am 
conducting a study into adherence to a gluten-free diet in adults with 
coeliac disease. I will collect data from seventy-five participants 
during two group meetings.  
I would like to provide my participants with gluten-free snacks and 
samples and, as the budget for my research is very small, I would be 
extremely grateful if Nature’s Path Organic would be willing to donate 
some samples of your gluten-free products for this purpose. In return 
for your generosity, I will make the participants aware of your 
donation and I would be very happy to display any promotional 
leaflets you may wish to send.  
Thank you for considering my request. If you have any questions or 
need further information, please feel free to contact me.  
 
Yours faithfully 
 
 
Helen Flaherty 
PhD student, University of East Anglia 
 
 
 
 
  
Appendix 33 Rejection letters 
 
 
 
 
Room 1.33 
Elizabeth Fry Building 
University of East Anglia 
Norwich 
NR4 7TJ 
 
Phone: 01603 593665 
E-mail:  h.flaherty@uea.ac.uk 
 
 
07 July 2011 
 
 
 
Dear xxxx, 
 
Re: Research study: What helps adults with coeliac disease stick to a 
gluten-free diet? 
 
Thank you for responding to the invitation to participate in the above 
research project. Although we appreciate you taking the time to 
respond to the invitation letter, we have now received sufficient 
numbers of replies and, regrettably, we are unable to include you in 
this study.   
 
Thank you for taking the time to reply to our invitation and for your 
interest in our research.  
 
Yours Sincerely 
 
 
Helen Flaherty 
PhD student, University of East Anglia 
 
 
 
 
 
 
  
 
Appendix 34 Final set of 91 statements  
 
This table shows a list of the final set of 91 brainstormed statements 
arranged in a random order and numbered from 1 to 91. 
No. Statement (in response to the focus statement: It would be easier for adults with 
coeliac disease to stick to a gluten-free diet… 
 
1 ...if there was more availability of gluten-free fish and chips. 
2 ...if there was more availability of savoury gluten-free snacks and not just sugary 
cakes and biscuits. 
3 ...if restaurants were better at labelling gluten-free options on their menus. 
4 ...if gluten ingredients were not added to foods where you wouldn’t expect to find 
gluten (such as ice cream or grated cheese). 
5 ...if motorway services provided gluten-free food. 
6 ...if they use Coeliac UK’s Food and Drink Directory. 
7 ...if people on a low income had additional help with the cost of gluten-free food. 
8 ...if separate cooking utensils are used in the preparation of gluten-free food at 
home. 
9 ...if staff working in restaurants/cafes were more knowledgeable about coeliac 
disease and the gluten-free diet. 
10 ...if other household members eat gluten-free. 
11 ...if they received more advice about coeliac disease and the gluten-free diet around 
the time of diagnosis. 
12 ...if they can cook gluten-free meals from scratch.  
13 ...if they are given a blood test to confirm adherence. 
14 ...if there was a universal gluten-free logo on food packaging used internationally 
on all suitable foods (such as the crossed grain logo). 
15 ...if airlines were better at providing gluten-free food during flight. 
16 ...if airports were better at providing gluten-free food. 
17 ...if other people encouraged them to stick to the gluten-free diet. 
18 ...if restaurants and carveries provided gluten-free gravy. 
19 ...if a wider range of gluten-free ready meals were available. 
20 ...if healthcare professionals knew more about coeliac disease and the gluten-free 
diet. 
21 ...if there was an expert point of contact for patients and healthcare professionals. 
22 ...if someone cooks for them. 
23 ...if they believe the diagnosis. 
24 ...if they have supportive work colleagues. 
25 ...if pubs stocked gluten-free beers and lagers. 
26 ...if gluten-free food was exempt from the prescription charge. 
27 ...if they use the internet to get information about coeliac disease and the gluten-
free diet. 
28 ...if they have already been following a gluten-free diet for a long time. 
29 ...if they are prepared to go without/go hungry rather than eat gluten when there are 
no gluten-free foods available. 
30 ...if the public had a better understanding of coeliac disease and the gluten-free diet. 
31 ...if they are not made to feel different when eating socially. 
32 ...if they have a supportive GP. 
33 ...if there was a mobile phone app to advise them on where to find gluten-free food. 
34 ...if friends and family are supported/educated so they can reliably cater for them. 
35 ...if gluten-free food was more available when travelling by train. 
  
 
36 ...if more gluten-free recipes were available. 
37 ...if you can eat the same (gluten-free) food as everyone else when eating socially. 
38 ...if supermarket discount offers included gluten-free products. 
39 ...if they get a sufficient amount of gluten-free food on prescription. 
40 ...if they take their own gluten-free food with them when eating away from home. 
41 ...if there was legislation to ensure all food outlets provide gluten-free options. 
42 ...if there was a wider range of Asian gluten-free products available. 
43 ...if TV cookery programmes included gluten-free cooking. 
44 ...if they are allowed to take gluten-free food with them when travelling abroad. 
45 ...if they have a positive outlook and focus on what they can eat, rather than what 
they can’t. 
46 ...if speciality gluten-free food had a longer shelf-life. 
47 ...if hospitals were better at providing gluten-free food. 
48 ...if they have someone to speak up for them on their behalf. 
49 ...if they are confident and not embarrassed by having to ask for gluten-free food 
when eating out. 
50 ...if they had a better knowledge of the gluten-free diet. 
51 ...if there was more availability of gluten-free sandwiches. 
52 ...if it was free to join Coeliac UK. 
53 ...if they have immediate access to a Dietitian at the time of diagnosis.   
54 ...if food outlets were more careful to avoid gluten contamination. 
55 ...if they receive gluten-free food on prescription. 
56 ...if Coeliac UK’s Food and Drink Directory included a wider range of products and 
brands. 
57 ...if a wider range of gluten-free products were available on prescription (e.g. not 
just bread and flour). 
58 ...if there was a wider variety of gluten-free products in shops and supermarkets. 
59 ...if they understand the health consequences of not sticking to a gluten-free diet. 
60 ...if they join a coeliac support group (e.g. Coeliac UK). 
61 ...if there was less social pressure to accept any gluten-inclusive food or drink you 
are offered. 
62 ...if there was more psychological support available. 
63 ...if gluten-free products were kept next to similar gluten-inclusive items in 
supermarkets (e.g. gluten-free bread in the bread section, rather than the ‘free from’ 
section. 
64 ...if speciality gluten-free foods tasted nicer. 
65 ...if gluten-free food was easier to find on the shelves when shopping in 
supermarkets. 
66 ...if they have access to information about coeliac disease. 
67 ...if a wider range of non-traditional gluten-free breads were available (e.g. tortillas, 
chapatis pita bread). 
68 ...if speciality gluten-free food was not so high in calories and sugar. 
69 ...if they are well educated. 
70 ...if there was more consistency between similar products regardless of brand or 
pack size (e.g. some brands of cornflakes are GF but others are not). 
71 ...if they have access to another person with coeliac disease who has more 
experience. 
72 ...if GPs were better informed about what patients are allowed on prescription. 
73 ...if labels stated “produced in a factory where gluten is used” rather than “may 
contain gluten” so you can assess the level of risk. 
74 ...if they have supportive family and friends. 
75 ...if they didn’t have to go to a pharmacy to collect prescribed gluten-free food 
when it should be obtainable from shops or supermarkets. 
76 ...if they were given a personal amount of money to support the buying of gluten-
free food, rather than getting it on prescription. 
77 ...if there were more gluten-free options when eating out. 
78 ...if they don’t have additional special dietary requirements as well as a gluten-free 
  
 
diet (e.g. lactose-free, vegetarian or diabetic). 
79 ...if gluten-free biscuits were made available when gluten-inclusive biscuits are 
served with tea and coffee at work. 
80 ...if they have plenty of freezer space. 
81 ...if they are female. 
82 ...if they experience symptoms when they consume gluten. 
83 ...if gluten-free bread was of the same quality in taste and texture as gluten-
inclusive bread. 
84 ...if they are able to try free samples of gluten-free products before buying (e.g. at 
roadshows). 
85 ...if gluten-free food was not so expensive. 
86 ...if there was more gluten-free food available in all food shops and supermarkets. 
87 ...if there were more resources for people from ethnic minorities. 
88 ...if food manufacturers didn’t change their ingredients so often. 
89 ...if they can get hold of gluten-free food when travelling abroad. 
90 ...if they have appropriate follow-up care with quick and easy access to dietitians. 
91 ...if they are determined to stick to the gluten-free diet and resist temptations. 
 
  
Appendix 35 E-mail communication with the owner of the 
Ariadne concept mapping software. 
 
From: Talcott [peter.severens@talcott.nl] 
Sent: 18 June 2012 10:15 
To: Helen Flaherty (NSC) 
Subject: RE: Ariadne question 
Helen, 
  
Sorry I missed the email. My Talcott account is from my holding company. I do not look very regular 
at it. 
I cannot check from here what is in the manual but 12 clusters is indeed what the software handles. 
What I normally did is leave out the very small clusters. It is no problem for the statistical 
procedure (clusters with only 1 already had no effect, clusters with 2 items have a very small 
effect). Another (but not very scientific option because is not following a non-ambient rule) is to 
put together clusters that resemble each other (this at least works in my business but we use 
Ariadne only to generate good ideas for marketing). The first option is to prefer from your 
perspective. 
I cannot help you further with that. At least I will check the manual and change it. 
  
Peter 
  
From: Helen Flaherty (NSC) [mailto:H.Flaherty@uea.ac.uk]  
Sent: Monday, June 18, 2012 10:42 AM 
To: 'peter.severens@talcott.nl'; P.W.M.Severens@inter.NL.net; peter.severens@acxiom.com 
Cc: 'directie@sbodevonder.nl' 
Subject: RE: Ariadne question 
Importance: High 
  
Hi Peter, 
  
I e-mailed you on 28th May with a question about Ariadne. I have just found some other e-mail 
addresses for you and I wondered whether the one I sent my previous e-mail to may no longer be 
the one you use. Please see below my question about the Ariadne software.  I hope you are able to 
help. 
  
Many thanks, 
Helen 
  
Helen Flaherty 
  
PhD student 
1.33 Elizabeth Fry Building 
Faculty of Medicine and Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
Tel: 01603 593665 
Mobile: 07920406094 
  
  
From: Helen Flaherty (NSC)  
Sent: Monday, May 28, 2012 12:08 PM 
To: peter.severens@talcott.nl 
Subject: FW: Ariadne question 
  
Dear Peter, 
  
I am a PhD student at the University of East Anglia, England and I am using the Ariadne software 
that you kindly provided last year. I met Barbara when she came over to deliver some training for 
us about a year ago and this was really helpful. 
  
I hope you don’t mind me contacting you but I have a question about the software and I would be 
very grateful if you or Barbara could help. I sent the e-mail below to Barbara, but I’m not 
completely sure if I have the correct e-mail address for her. 
  
When sorting the data, a few of the participants in my study have generated more than 12 clusters. 
Page 14 of the Ariadne handbook says that participants can generate up to a maximum of 25 
clusters, however, the software only seems to allow me to input data for a maximum of 12 clusters 
per participant. Do you know whether it is possible to input data for more than 12 clusters and, if 
so, could you please advise me on how to do this. 
  
Many thanks, 
Helen 
  
  
  
Helen Flaherty 
  
PhD student 
1.33 Elizabeth Fry Building 
Faculty of Medicine and Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
Tel: 01603 593665 
Mobile: 07920406094 
  
From: Helen Flaherty (NSC)  
Sent: Friday, May 18, 2012 9:24 AM 
To: 'directie@sbodevonder.nl' 
Subject: Ariadne question 
  
Hi Barbara, 
  
I hope you are well. You may remember me from the Ariadne training session that you ran for us 
last June in Norwich. I have a quick question about Ariadne and I wondered whether you may be 
able to help. 
  
I have reached the stage of asking my participants to rate and cluster the statements and I have 
started inputting the data into Ariadne. As per the guidance in the Ariadne handbook, I have told 
participants that they can produce as many clusters/groups as they like (max of 25). However, I 
  
cannot fathom out how to increase the number of groups from 12 in Ariadne. I would be very 
grateful if you are able to advise. 
  
Many thanks, 
Helen 
  
Helen Flaherty 
  
PhD student 
1.33 Elizabeth Fry Building 
Faculty of Medicine and Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
NR4 7TJ 
 
Tel: 01603 593665 
Mobile: 07920406094 
   
  
Appendix 36 Prioritisation data collection sheets 
Task 1 
Ranking the statements in order of importance from 1 
to 5 
 
You have a set of 91 statements. Each statement completes the sentence “It 
would be easier for adults with coeliac disease to stick to a gluten-free 
diet if...”.  
 
There are two steps involved in task 1. Please read the instructions below 
before starting this task. 
 
 
Step 1  
Please divide the statements into five groups in order of how important you 
think each one is in relation to the focus statement: “It would be easier for adults 
with coeliac disease to stick to a gluten-free diet if...”. You can use the boxes 
numbered 1 to 5 on the attached sheet (page 2) to put your statements in order. 
 
Score 1 refers to statements which you think are least important. 
Score 5 should be the statements you consider to be most important. 
 
It is important that you divide the statements into five groups of roughly the 
same size. Each group should contain no less than 16 statements and no more 
than 20 statements. 
 
Every statement must be put in a group and none of the statements should be 
left out. 
 
 
Step 2 
Once you have completed step 1, please fill in the grid on page 3. Each 
statement has a random number printed on it. Please write the numbers shown 
on the statements in each of your five piles in the appropriate boxes on the grid.  
 
Once you have completed the grid on page 3, please return it to us in the 
envelope provided (along with your completed grid for Task 2 (page 3 of Task 
2). 
 
 
 
 
 
 
 
  
Task 1  - Ranking the statements from 1 to 5 
 
Step 1 - Please rank the statements in order of importance from 1 to 5 in 
relation to the focus statement: “It would be easier for adults with coeliac 
disease to stick to a gluten-free diet if...” 
 
When you have finished, please compete the grid on page 3 and return it to us in 
the envelope provided. 
Least  
Important 
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Important 
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Place your statements here 
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Place your statements here 
 
3 
 
 
Place your statements here 
 
4 
 
 
Place your statements here 
 
5 
 
 
Place your statements here 
 
  
  
Appendix 37 Clustering data collection sheets 
Task 2 
Grouping the statements into themes 
You have a set of 91 statements. Each statement completes the sentence “It 
would be easier for adults with coeliac disease to stick to a gluten-free diet 
if...”.  
 
There are two steps involved in task 2. Please read the instructions below before 
starting this task. 
 
Step 1 
Please group together the statements which you consider to be related, or which 
have something in common. The importance of the statements is not relevant here.  
 
You can use the attached sheets (all numbered as ‘page 2’) to help put your 
statements into groups.  
 
You may form as many groups as you like.  
 
Please make sure that: 
 Not all statements are placed into one single group. 
 Statements are not all put into their own individual group. 
 Each statement is only used once. 
 You do not have a group of ‘miscellaneous’ statements or a group containing 
statements that you think are not related to one another. 
 Every statement must be put in a group and none of the statements should 
be left out. 
 
Step 2 
Once you have completed step 1, please choose a name for each of your groups 
and write the names in the grid on the attached sheet (page 3). You can use the 
additional sheet (also labelled as page 3) if necessary.  
 
Each statement has a random number printed on it. Please write the numbers 
shown on the statements in each of your groups in the boxes next to the relevant 
group name on the grid (page/s 3).  
 
Once you have completed the grid, please return it to us in the envelope provided 
(along with your completed grid for Task 1 (page 3 of Task 1). 
 
         
 
Task 2 - Grouping the statements into themes 
Step 2 
Please write the name of each of your groups in the left-hand column in the grid below. The order in which you list the 
groups is not important. Each statement has a random number printed on it. Please write the numbers shown on the 
statements next to the appropriate group name on the grid. The order in which you write the statement numbers is not 
important.  
 
You can write your list of statement numbers over more than one line if there is not sufficient space in a single line. 
Please use the additional sheet if necessary.  
 
Name of group                     
                     
                     
                     
                     
                     
                     
                     
                     
                     
Please return this sheet to us in the envelope provided along with your results for Task 1 (Page 3 of Task 1)
  
Please return this sheet to us in the envelope provided along with your results for Task 1 (Page 3 of Task 1) 
Name of group                     
                     
                     
                     
                     
                     
                     
                     
                     
                     
 
 
  
Appendix 38 Data inputting errors and actions taken to resolve them 
Errors with the data generated from the prioritising and clustering exercises: 
Participa
nt ref no. 
TASK 1 - Prioritisation TASK 2 – Clustering 
258 No errors I removed a 15-statement cluster labelled ‘trivial’ because the statements 
contained within it are not necessarily related to each other. The prioritisation of 
statements shows whether or not statements are perceived to be trivial or not. 
680 No errors More than 12 clusters generated (2 clusters removed: Food Labelling; and taste) 
482 1 Statement missing No errors 
615 No errors 3 statements missing and more than 12 clusters generated (3 clusters removed: 
Recipes; ethnic; and IT Help). 
455 No errors 1 statement missing. 
879 No errors 1 statement missing and 1 statement was duplicated. Both entries of the 
duplicated statement were removed. 
126 1 statement missing and 1 statement was duplicated. Both 
entries of the duplicated statement were removed. 
No errors. 
366 No errors More than 12 clusters generated (2 clusters removed: Gender; and different 
ethnic backgrounds). 
970 No errors 1 statement missing and more than 12 clusters generated (5 clusters removed: 
Product information; habit; other dietary issues; self-determination; and 
packaging information). 
954 1 statement was duplicated. Both entries of the duplicated 
statement were removed. 18 statements were missing (task not 
completed). 
Task not completed (no data). 
512 No errors More than 12 clusters generated (4 clusters removed: Ethic origin; financial; 
diet; and no coeliac relevance – this last cluster would have been removed 
anyway as the statements are not necessarily related). 
598 No errors 1 statement missing and more than 12 clusters generated (6 clusters removed: 
         
 
Media support; work environment; public understanding; gender; ethnic food 
choices; and healthy eating). 
116 1 statement missing and 1 statement was duplicated. Both 
entries of the duplicated statement were removed. 
1 statement was duplicated. Both entries of the duplicated statement were 
removed. 
904 No errors 2 statements missing. I have removed five clusters as they were not 
themes/concepts and the statements contained within them were not necessarily 
related. The clusters were named: Nice touch; things I consider adequate; not 
necessary; not likely; does this make a difference? 
162 No errors More than 12 clusters generated (1 cluster removed: Eating out). 
600 No errors Task not completed (no data). 
540 No errors 1 statement missing. 
710 2 statements missing 1 statement was duplicated. Both entries of the duplicated statement were 
removed. 4 statements were missing 
647 No errors 1 statement missing and more than 12 clusters generated (3 clusters removed: 
Storage; labelling; and work). 
178 No errors 1 statement missing and more than 12 clusters generated (3 clusters removed: 
Dietetic services; ethnic minorities; and financial). 
909 No errors More than 12 clusters generated (5 clusters removed: Psychological support; 
ingenuity; financial help; being normal; and taste and texture). 
679 1 statement was duplicated in the same group (removed one 
entry) 
1 statement missing 
1 statement missing. 
475 No errors More than 12 clusters generated (3 clusters removed: Gender; at work; and 
believing the diagnosis). 
685 1 statement missing and 1 statement was duplicated. Both 
entries of the duplicated statement were removed. 
Had a ‘miscellaneous group’ – removed. 
269 No errors Had an “Irrelevant”group – removed. 
637 No errors 1 statement missing. 
715 No errors Had a “Miscellaneous” group – removed. 
  
Appendix 39 Movement of statements between 
clusters as the number of clusters was increased or 
decreased 
 
Statements within the clusters are shown in order of mean preference 
score. 
 Comparison of 4 and 5 clusters for all participants: 
 4 Clusters 5 clusters 
Cluster 1 Statements: 3, 77, 9, 54, 40, 41, 37, 
49, 89, 31, 44, 47, 18, 5, 15, 1, 25, 
79, 16, 61, 35. 
NO CHANGE 
Cluster 2 Statements: 85, 83, 14, 58, 86, 4, 
64, 2, 67, 38, 65, 19, 70, 68, 88, 84, 
73, 75, 46, 63, 42. 
NO CHANGE 
Cluster 3 Statements 59, 11, 91, 50, 45, 90, 
82, 55, 53, 32, 20, 39, 66, 74, 57, 
34, 23, 26, 72, 78, 21, 30, 60, 28, 7, 
12, 6, 71, 13, 29, 56, 10, 17, 8, 36, 
76, 27, 24, 43, 69, 62, 52, 33, 48, 
87, 80, 22, 81. 
Statements: 55, 39, 57, 26, 7, 6, 56, 
36, 76, 52, 87, 80  
Cluster 4 Statement: 51  59, 11, 91, 50, 45, 90, 82, 53, 32, 
20, 66, 74, 34, 23, 72, 78, 21, 30, 
60, 28, 12, 71, 13, 29, 10, 17, 8, 27, 
24, 43, 69, 62, 33, 48, 22, 81. 
Cluster 5  NO CHANGE 
Cluster 3 in the 4-cluster table splits to create clusters 3 and 4 in the 5-
cluster table.  
 
Comparison of 5 and 6 clusters for all participants: 
 5 Clusters 6 clusters 
Cluster 1 SPLIT 3,77, 9, 54, 40, 41, 89, 44, 18, 5, 15, 
1, 25, 79, 16, 35 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE 37, 49, 31, 47, 61 
Cluster 6  NO CHANGE 
Cluster 1 in the 5-cluster table has split to form 2 clusters (clusters 1 and 5) 
in the 6-cluster table.  
 
 
 
 
         
 
Comparison of 6 and 7 clusters for all participants: 
 6 Clusters 7 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 SPLIT 59, 11, 91, 50, 45, 90, 82, 53, 32, 
20, 66, 74, 34, 23, 72, 78, 21, 30, 
60, 28, 12, 71, 13, 10, 17, 8, 27, 24, 
43, 69, 62, 33, 48, 22, 81. 
Cluster 5 NO CHANGE 29 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7  NO CHANGE 
The only difference is that statement 29 moves from cluster 4 in the 6-
cluster table to form its own cluster (cluster 5) in the 7-cluster table. 
 
Comparison of 7 and 8 clusters for all participants: 
 7 Clusters 8 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 SPLIT 6, 36, 52 & 80 
Cluster 4 NO CHANGE 55, 39, 57, 26, 7, 56, 76 & 87  
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8  NO CHANGE 
The only difference between the cluster-7 and the cluster 8-table is that 
cluster 3 from the 7-cluster table is divided into 2 clusters (cluster 3 and 4) 
in the 8-cluster table. 
 
Comparison of 8 and 9 clusters for all participants: 
 8 Clusters 9 clusters 
Cluster 1 SPLIT 3, 77, 9, 54, 40, 41, 89, 44, 18, 5, 
15, 1, 25, 16, 35. 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9  79 
The only difference between these two is that cluster 1 in the 8-cluster table 
has split to form 2 clusters (cluster 1 and cluster 9) in the 9-cluster table. 
         
 
Comparison of 9 and 10 clusters for all participants: 
 9 Clusters 10 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 SPLIT 49, 31, 61 
Cluster 8 NO CHANGE 37, 47 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10  NO CHANGE 
The only difference between the 9-cluster and 10-cluster tables is that 
cluster 7 in the 9-cluster table has split in 2 to form clusters 7 and 8 in the 
10-cluster table. 
 
Comparison of 10 and 11 clusters for all participants: 
 10 Clusters 11 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 SPLIT 83, 14, 58, 86, 4, 64, 2, 67, 38, 65, 
19, 70, 68, 88, 84, 73, 46, 63, 42. 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE 85, 75 
Cluster 11  NO CHANGE 
The extra cluster is formed in the 11-cluster table from 2 statements taken 
from cluster 2 in the 10-cluster table. 
 
 
 
 
 
 
 
         
 
Comparison of 11 and 12 clusters for all participants: 
 11 Clusters 12 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 SPLIT 75 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12  85 
Cluster 10 in the 11- cluster table is split to form cluster 10 and cluster 11 in 
the 12-cluster table.  
Comparison of 12 and 13 clusters for all participants: 
 12 Clusters 13 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 SPLIT 59, 11, 50, 90, 82, 53, 32, 20, 66, 
23, 72, 78, 21, 60, 28, 12, 71, 13, 8, 
27, 43, 69, 62, 33. 
Cluster 6 NO CHANGE 91, 45, 74, 34, 30, 10, 17, 24, 48, 
22, 81. 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 NO CHANGE NO CHANGE 
Cluster 13  NO CHANGE 
The only difference was that cluster 5 split to form a new clusters 5 and 6 in 
the 13-cluster table.  
 
 
 
 
 
         
 
Comparison of 13 and 14 clusters for all participants: 
 13 Clusters 14 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 SPLIT  6, 52 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE  36, 80 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 NO CHANGE NO CHANGE 
Cluster 13 NO CHANGE NO CHANGE 
Cluster 14  NO CHANGE 
The 4 statements in cluster 3 were split into 2 clusters (cluster 3 and cluster 
9) in the 14-cluster table.  
 
Comparison of 14 and 15 clusters for all participants: 
 14 Clusters 15 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 SPLIT 49, 31 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 NO CHANGE 61 
Cluster 13 NO CHANGE NO CHANGE 
Cluster 14 NO CHANGE NO CHANGE 
Cluster 15  NO CHANGE 
Cluster 8 split to form clusters 8 and 12 in the 15-cluster table. 
 
 
 
 
         
 
Comparison of 15 and 16 clusters for all participants: 
 15 Clusters 16 clusters 
Cluster 1 SPLIT 41, 1 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE  3, 77, 9, 54, 40, 89, 44, 18, 5, 15, 
25, 16, 35 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 NO CHANGE NO CHANGE 
Cluster 13 NO CHANGE NO CHANGE 
Cluster 14 NO CHANGE NO CHANGE 
Cluster 15 NO CHANGE NO CHANGE 
Cluster 16  NO CHANGE 
Cluster 1 was split to form cluster 1 and cluster 3 in the 16-cluster table. 
 
Comparison of 16 and 17 clusters for all participants: 
 16 Clusters 17 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 SPLIT 55, 39, 26, 7, 56, 76. 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 NO CHANGE NO CHANGE 
Cluster 8 NO CHANGE NO CHANGE 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 SPLIT NO CHANGE 
Cluster 13 NO CHANGE 57, 87 
Cluster 14 NO CHANGE NO CHANGE 
Cluster 15 NO CHANGE NO CHANGE 
Cluster 16 NO CHANGE NO CHANGE 
Cluster 17  NO CHANGE 
Cluster 5 in the 16-cluster table has split to form clusters 5 and 13 in the 
17-cluster table. 
 
         
 
Comparison of 17 and 18 clusters for all participants: 
 17 Clusters 18 clusters 
Cluster 1 NO CHANGE NO CHANGE 
Cluster 2 NO CHANGE NO CHANGE 
Cluster 3 NO CHANGE NO CHANGE 
Cluster 4 NO CHANGE NO CHANGE 
Cluster 5 NO CHANGE NO CHANGE 
Cluster 6 NO CHANGE NO CHANGE 
Cluster 7 SPLIT 78, 12, 8, 43, 33. 
Cluster 8 NO CHANGE 59, 11, 50, 90, 82, 53, 32, 20, 66, 
23, 72, 21, 60, 28, 71, 13, 27, 69, 
62. 
Cluster 9 NO CHANGE NO CHANGE 
Cluster 10 NO CHANGE NO CHANGE 
Cluster 11 NO CHANGE NO CHANGE 
Cluster 12 NO CHANGE NO CHANGE 
Cluster 13 NO CHANGE NO CHANGE 
Cluster 14 NO CHANGE NO CHANGE 
Cluster 15 NO CHANGE NO CHANGE 
Cluster 16 NO CHANGE NO CHANGE 
Cluster 17 NO CHANGE NO CHANGE 
Cluster 18  NO CHANGE 
Cluster 7 split to create clusters 7 and 8 in the 18 cluster table. 
 
 
 
